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Abstract 
The baculovirus insect cell system has been used widely for biopesticide applications 
and for the production of recombinant proteins, vaccines and vectors for gene delivery. To 
be commercially viable, especially for the low margin applications of biopesticides and 
veterinary vaccines, the yield of this production system needs to be improved. One of the 
important approaches is the infection of insect cell cultures at high cell densities in order to 
maximize volumetric production. However, the cell specific yield gradually reduces with 
increasing infection cell density (ICD). As a result, the volumetric production can not 
improve further regardless of efforts to increase the uninfected cell density in batch or fed-
batch cultures. The phenomenon known as “the cell density effect” appears not only during 
the late stage of protein production, but also during the early stage of virus replication and 
transcription. Discovering the changes in intra and extracellular metabolites between low 
and high ICDs may reveal evidence for improving yields. This PhD thesis focuses on the 
development of an intracellular metabolite extraction protocol for infected insect cell 
cultures and for measuring intra and extracellular metabolites of infected cells of different 
baculovirus infected insect cell systems. 
Prior to analyzing the intracellular metabolites of low and high ICDs, an extraction 
protocol was developed and validated for insect cell cultures, especially infected insect 
cells. The ice-cold saline quenching solution developed for mammalian cells did not work 
well for insect cells, especially for infected cultures. Therefore, a modification of the 
quenching solution was made by an addition of 0.2% Pluronic® F-68 that successfully 
protected the cell membrane during quenching and washing procedures. In addition, one 
wash was found to be enough for removal of medium originated metabolites adhering on 
the surface of cell membranes. The ATP recovery (over the direct extract) of the extraction 
protocol using ice-cold saline quenching solution plus 0.2% Pluronic® F-68 after one wash 
was almost 90% for Spodoptera frugiperda (Sf9) cells infected with a recombinant 
Autographa californica multiple nucleopolyhedrovirus (rAcMNPV) and Helicoverpa zea 
(HzAM1) cells infected with a wild-type Helicoverpa armigera single nucleopolyhedrovirus 
(HearNPV) at 24 hours post infection (hpi). 
The intracellular metabolite patterns and substrate consumption rates of low versus 
high ICDs was first investigated for the Sf9/rAcMNPV system in Sf900™III medium. A 
preliminary study was conducted to identify how late post-infection the cell membrane 
integrity was maintained during the quenching and washing processes. The result showed 
that the extraction protocol is efficient up to 48 hpi for infected Sf9 cells. Levels of 
intracellular nucleotides (tri-phosphates), amino acids (AA), and TCA cycle intermediates 
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(α-ketoglutarate, pyruvate) during an infection at a low ICD (2×106 cells/mL) were shown to 
be higher than those during an infection at a high ICD (6×106 cells/mL) with significant 
differences being found in many cases. Some evidence of AA uptake rates of infected Sf9 
cells at a low ICD being higher than those at a high ICD was also found. Reductions in 
intracellular metabolite concentrations and AA consumption rates with increasing ICD were 
more severe at late infection stages. 
The use of a chemically defined medium (CDM) allows improved intra and 
extracellular metabolite studies. Although some achievements in cell metabolism have 
been obtained from insect cells propagated in hydrolysate containing media, a CDM is 
useful for gaining additional insights into the metabolism of the cells. Results from the 
current study using a prototype CDM from Life Technologies shows that Sf9 cells grew 
well in the CDM and the infected Sf9 cells in this medium can produce recombinant protein 
(β-Gal) at a level (per cell basis) that is slightly higher than that for infected Sf9 cells in the 
control Sf900™III medium. The differences in intracellular metabolite concentrations 
between low and high ICDs for infected Sf9 cells in the CDM followed similar trends to 
those for infected Sf9 cells in Sf900™III. However, the differences in AA consumption 
rates between low and high ICDs for infected Sf9 cells in the CDM were much larger than 
those for the infected Sf9 cells in Sf900™III. The presence/absence of peptides in the 
medium is most likely the main reason for the difference between these two media. An 
underestimation of AA consumption rates post-infection was suggested from a comparison 
of the AA uptake data for cells infected in the CDM medium versus those infected in the 
peptide containing medium (Sf900™III). 
Intracellular metabolite concentrations and substrate consumption patterns of the 
HzAM1cell/HearNPV system in Sf900™III medium was also investigated as a comparison 
to the Sf9 cells/rAcMNPV system. This system is important for the production of a 
biopesticide to target the major heliothis caterpillar pest. A preliminary study showed that 
the metabolite extraction protocol developed was efficient for infected HzAM1 until 48-60 
hpi. As found for infected Sf9 cells, many intracellular metabolite concentrations for 
infected HzAM1 also significantly reduced with increasing ICD. Reduction in intracellular 
nucleotide tri-phosphates with increasing cell density prior to infection may be a key 
limiting factor leading to the decline in viral DNA and mRNA production and consequently, 
the drop in protein yield found  with increasing ICD. In addition, consumption of AAs also 
reduced when the ICD increased especially at late infection stages. Furthermore, a 
reduction in the intracellular concentration of some of the TCA cycle intermediates 
associated with an increasing ICD might also contribute to the cell density effect. 
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This thesis makes an important contribution to the methodology for quantifying 
intracellular metabolites of insect cells in culture and of virus infected cells in general. It 
identifies a number of metabolites, in particular some nucleotides that may be limiting 
baculovirus yields during high cell density infections. 
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Fig. 1.1 Diagram of a baculovirus infection cycle in nature (Moscardi et al., 2011). OBs 
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environment (pH 9.5-11.5) of the midgut (B) degrades OBs and releases ODVs to infect 
midgut epithelial cells (C). Infected cells produce BVs, which bud out (D) and infect other 
cells (E). After secondary infection (F), virus accumulates in occlusion bodies (G). Finally, 
the larval body disintegrates and millions of polyhedra are released to the environment (H). 
Fig. 1.2 The two phenotypes of baculovirus: budded virus (BV) and occlusion derived virus 
(ODV) (Blissard, 1996). 
Fig. 1.3 Baculovirus infection cycle in cell culture (Slack and Arif, 2007). Several phases of 
virusinfection cycle are illustrated beginning with the rounding of newly infected cells and 
finishingand ending with cell lysis and release of OBs. Times indicated are based on the 
infection cycle of AcMNPV. 
Fig. 1.4 Schematics of sample preparation steps for intracellular metabolite analysis 
Fig. 3. 1 Evaluation of three ice-cold (0.5-1oC) quenching solutions (QS) for the recovery 
of intracellular ATP in uninfected Sf9 cells. The QSs were 1.1 %w/v NaCl (NaCl), 1.1 %w/v 
NaCl + 0.2 %w/v Pluronic® F-68 (NaCl+P), and 0.8 %w/v NaCl + 0.2 %w/v Pluronic® F-68 
+ 1.65 g/L Sucrose + 0.5 g/L CaCl2 + 0.918 g/L MgSO4 + 1.2 g/L KCl + 0.35 g/L NaHCO3 + 
1.16 g/L NaH2PO4.H2O (NaCl+P+S). Early-exponential phase Sf9 cell cultures (1x10
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cells/mL) were either direct extracted (DE) with 1:1 cold 100% acetonitrile (-40oC), 
quenched with 1:5 QS (Q0W), quenched and washed once with 1:5 QS (Q1W), quenched 
and washed twice with 1:5 QS (Q2W), or unquenched by adding 1:5 room temperature QS 
(UQ). The quenched/washed and unquenched cell pellets were extracted with cold 50 
%v/v acetonitrile in deionized water (-40oC). Cell extracts were freeze-dried and 
resuspended in deionized water prior to analysis using the ATPlite luminescence assay. 
(A) Intracellular ATP concentration. (B) Cell viability prior to the extraction step. Error bars 
show the standard deviation of biological triplicates. 
Fig. 3.2 Total cell density and volumetric protein production profiles over time for two 
baculovirus-infected insect cell systems used for intracellular metabolite analysis. (A) Sf9 
cells infected with recombinant β-Galactosidase-expressing AcMNPV at a TOI of 1.5×106 
cells/mL and an MOI of 20 PFU/cell. (B) HzAM1 cells infected with occlusion body (OB) 
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producing wild-type HaSNPV at a TOI of 0.75×106cells/mL and an MOI of 17 PFU/cell. 
Error bars show the standard deviation of biological triplicates.  
Fig. 3.3 Intracellular concentrations of ATP, ADP and AMP (adenosine phosphates, AdoP) 
and recoveries of total AdoP and ATP (R-Total AdoP, R-ATP), from uninfected and 
baculovirus-infected insect cells after being direct extracted (DE), quenched but not 
washed (Q0W), quenched and washed one or two times (Q1W, Q2W) and unquenched 
(UQ). Ice-cold NaCl+P (0.5-1oC) was used for both quenching and washing, while room 
temperature NaCl+P was used for the UQ case. 100% acetonitrile (-40oC) was used for 
direct extraction of cell cultures, while 50 %v/v acetonitrile in deionized water (-40oC) was 
used to extract quenched and unquenched cell pellets. (A) Uninfected Sf9 cells, sampled 
at 1×106 cells/mL. (B) Infected Sf9 cells, with rβ-Gal-AcMNPV at a TOI of 1.5×106 cells/mL 
and an MOI of 20 PFU/cell, sampled at24 hpi (C) Uninfected HzAM1 cells, sampled at 
1×106 cells/mL. (D) Infected HzAM1 cells, with wtHearNPV at a TOI of 0.75×106 cells/mL 
and an MOI of 17 PFU/cell, sampled at 24 hpi. Error bars show the standard deviation of 
biological triplicates. 
Fig. 3.4 Intracellular concentrations of amino acids from uninfected and baculovirus-
infected insect cells after being quenched but not washed (Q0W), and quenched with one, 
two or three wash steps (Q1W, Q2W, Q3W), using ice-cold NaCl+P as the quenching 
solution (QS). Non-standard Norvaline (Nva) was spiked into the QS as a means of 
gauging washing efficiency. Ice-cold NaCl+P (0.5-1oC) was used for both quenching and 
washing, and 50%v/v acetonitrile in deionized water (-40oC) was used to extract the cell 
pellets. (A) Uninfected Sf9 cells, sampled at 1×106 cells/mL. (B) Infected Sf9 cells, with 
rAcMNPV at a TOI of 1.5×106 cells/mL and an MOI of 20 PFU/cell, sampled at 24 hpi (C) 
Uninfected HzAM1 cells, sampled at 1×106 cells/mL. (D) Infected HzAM1 cells, with 
wtHearNPV at a TOI of 0.75×106 cells/mL and an MOI of 17 PFU/cell, sampled at 24 hpi. 
Error bars show the standard deviation of biological triplicates.  
Fig. 4.1 The kinetics of cell growth, cell size expansion and viability (a), specific vDNA and 
-Gal production (b), intracellular levels and the recovery at different times post-infection 
(c) and the intracellular amino acids (AAs) (d) of Sf9 cells infected with a recombinant 
baculovirus (rAcMNPV) at an MOI of 10 PFU/cell. Infections were conducted in Sf900™III 
serum free medium at infection cell densities (ICD) of 2.5×106 cells/mL, and a multiplicity 
of infection (MOI) of 10 PFU/cell. The experiment was conducted in shaker-flask 
suspension cultures. Each data point is the average from three biological replicates, and 
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the error bars represent the standard deviation. Abbreviations, TCD: total cell density, Via: 
viability, Dia: cell diameter, INF: infected, UINF: uninfected. 
Fig. 4.2 Total cell density and cell hypertrophy (a), specific vDNA and -Gal production (b), 
and total cell protein vs -Gal (c) of Sf9 cells infected with a rAcMNPV. Infections were 
conducted in Sf900™III serum free medium at low (2×106) and high (6×106 cells/mL) ICDs 
and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-flask suspension 
cultures. Each data point is the average from three biological replicates, and the error bars 
represent the standard deviation. Abbreviations, TCD: total cell density, Via: viability, Dia: 
cell diameter, LICD: low infection cell density, HICD: high infection cell density 
Fig. 4.3 Multivariate analysis of intracellular metabolite concentrations of Sf9 infected cells 
at low (2x106 cells/mL) and high (6x106 cells/mL) ICDs. Orthogonal projection to latent 
structures–discriminant analysis (OPLS-DA) scores (a) and loadings (b) plots of the 5 time 
points post-infection at low and high ICDs, classified by cell density. OPLS-DA model 
metrics: Predictive component R2X = 0.197; R2 = 0.913; Q2 = 0.869; R2Y = 1: Orthogonal 
component R2X = 0.278.  
Fig. 4.4 Intracellular concentrations of organic acids and UDP sugars for infected Sf9 cells 
at low (2×106) and high (6×106 cells/mL) ICDs. Infections were conducted in Sf900™III 
serum free medium at an MOI of 10 PFU/cell in shaker-flask suspension cultures. Each 
data point is the average from three biological replicates, and the error bars represent the 
standard deviation. 
Fig. 4.5 Stacked bar charts of (a) adenosine, (b) uridine, (c) guanosine and (d) cytidine 
nucleotide concentrations of Sf9 infected cells over 5 time points post-infection at low 
(2x106 cells/mL) and high (6x106 cells/mL) ICDs. Infections were conducted in Sf900™III 
serum free medium at an MOI of 10 PFU/cell. The experiment was conducted in shaker-
flask suspension cultures. Each data point is the average from three biological replicates, 
and the error bars represent the standard deviation. 
Fig. 4.6 Intracellular AA concentration of infected Sf9 cells at various times post-infection 
at low (a) and high (b) ICDs, and the comparison between low and high ICD for 
intracellular AA levels at 0 hpi (c) and 36 hpi (d). Infections were conducted in Sf900™III at 
low (2×106) and high (6×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment 
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was conducted in shaker-flask suspension cultures. Each data point is the average from 
three biological replicates, and the error bars represent the standard deviation. 
Fig. 4.7 AA consumption rates between early (0-24 hpi) and late (24-60 hpi) infection 
stages for low (a) and high ICD (b) and between low and high ICDs for early (c) and late 
infection (d) of Sf9 cells infected with a rAcMNPV. Infections were conducted in Sf900™III 
at low (2×106) and high (6×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The 
experiment was conducted in shaker-flask suspension cultures. Each data point is the 
average from three biological replicates, and the error bars represent the standard 
deviation. 
Fig. 4.8 AA consumption rates (mmol/mm3 cell biomass/hour) between early (0-24 hpi) 
and late (24-60 hpi) infection stages for low (a) and high ICD (b) and between low and high 
ICDs for early (c) and late infection (d) of Sf9 cells infected with a rAcMNPV. Infections 
were conducted in Sf900™III at low (2×106) and high (6×106 cells/mL) ICDs and at an MOI 
of 10 PFU/cell. The experiment was conducted in shaker-flask suspension cultures. Each 
data point is the average from three biological replicates, and the error bars represent the 
standard deviation. 
Fig. 4.9 Ratios of AA levels between high versus low ICDs for extra- and intra-cellular AAs 
at 0 hpi (a) and 36 hpi (b) and ratios between intra- versus extra-cellular AA levels for low 
and high ICDs at 0 hpi (c) and 36 hpi (d) of Sf9 cells infected with a recombinant 
baculovirus (rAcMNPV). Infections were conducted in Sf900™III at low (2×106) and high 
(6×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in 
shaker-flask suspension cultures. Each data point is the average from three biological 
replicates, and the error bars represent the standard deviation. 
Fig. 4.10 Extracellular concentrations of sugars and organic acids for infected Sf9 cells at 
low (2×106) and high (6×106 cells/mL) ICDs over various times post-infection. Infections 
were conducted in Sf900™III serum free medium at an MOI of 10 PFU/cell in shaker-flask 
suspension cultures. Each data point is the average from three biological replicates, and 
the error bars represent the standard deviation. 
Fig. 5.1 Free AA concentrations of Sf900™III and CDM media. Sf900™III would be 
expected to contain other AAs in the form of small peptides from the yeast hydrolysate 
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present in the medium. However the AA levels shown for the CDM are expected to 
represent the total AA concentration present in the medium. 
Fig. 5.2 Stock cell maintenance of Sf9 cells propagated either in Sf900™III (blue) or CDM 
(red) over 50 days (a). Cells were passaged every 3-4 days at a seeding cell density of 4-
5×105 cells/mL. The growth curve of Sf9 cells propagated either in Sf900™III (blue) or 
CDM (red) over 168 hours post-inoculation (b). Cell specific β-Gal yield of Sf9 cells 
infected at an MOI of 10 PFU/cell either in Sf900™III or CDM at low (1×106 cells/mL) and 
high (6×106 or 5×106 cells/mL for Sf900™III or CDM, respectively) ICDs, (c). Cell cultures 
were maintained in shaker flasks with three biological replicates and the error bars are the 
standard deviation of the triplicates. 
Fig. 5.3 The kinetics of cell growth and cell viability (a), cell size expansion (b) and specific 
β-Gal yield (c) of infected Sf9 cells propagated in CDM at low (1×106 cells/mL) and high 
(5×106 cells/mL) ICDs. Infections were conducted at a multiplicity of infection (MOI) of 10 
PFU/cell in shaker-flask suspension cultures. Each data point is the average from three 
biological replicates, and the error bars represent the standard deviation. 
Fig. 5.4 Multivariate analysis of intracellular metabolite concentrations of infected Sf9 cells 
propagated in CDM at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs. Orthogonal 
projection to latent structures–discriminant analysis (OPLS-DA) scores (a) and loadings (b) 
plots of the 4 time points post-infection at low and high ICDs, classified by cell density. 
OPLS-DA model metrics: Predictive component R2X = 0.279; R2 = 0.987; Q2 = 0.907; 
R2Y = 1: Orthogonal component R2X = 0.203. Infections were conducted at a multiplicity 
of infection (MOI) of 10 PFU/cell in shaker-flask suspension cultures. 
Fig. 5.5 Stacked bar charts of (a) adenosine, (b) uridine, and (c) cytidine nucleotide 
concentrations for four time points post-infection of infected Sf9 cells propagated in CDM 
at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs. Infections were conducted at an 
MOI of 10 PFU/cell in shaker-flask suspension cultures. Each data point is the average 
from two biological replicates, and the error bars represent the standard deviation. 
Fig. 5.6 Intracellular AA concentrations of infected Sf9 cells at four times post-infection for 
low (a) and high (b) ICDs, and the comparison between low and high ICDs for intracellular 
AA levels at 0 hpi (c) and 36 hpi (d). Infections were conducted in CDM at low (1×106 
cells/mL) and high (5×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment 
xviii 
 
was conducted in shaker-flask suspension cultures. Each data point is the average from 
two biological replicates, and the error bars represent the standard deviation. (*) indicates 
significant differences in the levels observed. 
Fig. 5.7 Comparison of AA consumption rates (mmol/cell/hour) between early (0-24 hpi) 
and late (24-60 hpi) infection stages for low (a) and high ICDs (b) and between low and 
high ICDs for early (c) and late infection stages (d) of Sf9 cells infected with a rAcMNPV. 
Infections were conducted in CDM at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs 
and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-flask suspension 
cultures. Each data point is the average from two biological replicates, and the error bars 
represent the standard deviation. (*) indicates significant differences in the levels 
observed. 
Fig. 5.8 Comparison of AA consumption rates (mmol/mm3 of cell volume/hour) between 
early (0-24 hpi) and late (24-60 hpi) infection stages for low (a) and high ICDs (b) and 
between low and high ICDs for early (c) and late infection stages (d) of Sf9 cells infected 
with a rAcMNPV. Infections were conducted in CDM at low (1×106 cells/mL) and high 
(5×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in 
shaker-flask suspension cultures. Each data point is the average from two biological 
replicates, and the error bars represent the standard deviation. (*) indicates significant 
differences in the levels observed. 
Fig. 5.9 Ratios of AA levels between high versus low ICDs for extra- and intra-cellular AAs 
at 0 hpi (a) and 36 hpi (b), and ratios between intra- versus extra-cellular AA levels for low 
and high ICDs at 0 hpi (c) and 36 hpi (d) of Sf9 cells infected with a recombinant 
baculovirus (rAcMNPV). Infections were conducted in CDM at low (1×106 cells/mL) and 
high (5×106 cells/mL) ICDs, at an MOI of 10 PFU/cell. The experiment was conducted in 
shaker-flask suspension cultures. Each data point is the average from two biological 
replicates, and the error bars represent the standard deviation. (*) indicates significant 
differences in the levels observed. The ratios of alanine are off scale in some cases in the 
above figure and so are listed here: 3.7, 2.6 and 3.2 for extra and intracellular at 0 hpi and 
extracellular at 36 hpi, respectively. 
Fig. 5.10 Ratios of specific β-Gal yield between high and low ICDs for infected Sf9 cells in 
Sf900™III and CDM media. The ratio was calculated from the average values (from 
biological triplicates) for high and low ICDs and the error bar is the standard deviation 
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calculated from standard deviations of the dividend and divisor. Data for infected Sf9 cells 
in Sf900™III medium was from the dataset in Chapter 4. 
Fig. 5.11 Ratios of intracellular ATP (a), total adenosine (b), UTP (c) and CTP (d) between 
high and low ICDs for infected Sf9 cells in Sf900™III and CDM media. The ratio was 
calculated from the average values (from biological duplicates) for high and low ICDs and 
the error bar is the standard deviation calculated from standard deviations of the dividend 
and divisor. Data for infected Sf9 cells in Sf900™III medium was from the dataset in 
Chapter 4. 
Fig. 5.12 Ratios of intracellular KGA (a), FUM (b), UDPG (c) and UDPGA (d) between high 
and low ICDs for infected Sf9 cells in Sf900™III and CDM media. The ratio was calculated 
from the average values (from biological triplicates) for high and low ICDs and the error 
bar is the standard deviation calculated from standard deviations of the dividend and 
divisor. Data for infected Sf9 cells in Sf900™III medium was from the dataset in Chapter 4. 
Fig. 5.13 Ratios between high/low ICDs forintracellular AAs at various time post-infection 
of infected Sf9 cells in Sf900™III (a) and CDM (b), and the comparison of these ratios for 
infected Sf9 cells in Sf900™III and CDM at 0 hpi (c) and 36 hpi (d). The ratio was 
calculated from the average values (from biological triplicates) for high and low ICDs and 
the error bar is the standard deviation calculated from standard deviations of the dividend 
and divisor. Data for infected Sf9 cells in Sf900™III medium was from the dataset in 
Chapter 4. 
Fig. 5.14 Comparison of AA consumption rates of uninfected cultures between Sf9 cells 
propagated in Sf900™III and CDM over the exponential period of 0-72 hours post-
innoculation. The values were the average of biological triplicates and the error bar is the 
standard deviation of the triplicates. Data for infected Sf9 cells in Sf900™III medium was 
from the dataset in Chapter 4. 
Fig. 6.1 The kinetics of cell growth, cell size expansion and viability (a), specific vDNA and 
OB yields (b) and intracellular ATP levels and the recovery over various times post-
infection (c) of HzAM1 cells infected with a wide-type baculovirus (HearNPV) at a 
multiplicity of infection (MOI) of 5 PFU/cell. Infections were conducted in Sf900™III 
medium at infection cell densities (ICD) of 1×106 cells/mL. The experiment was conducted 
xx 
 
in shaker-flask suspension cultures. Each data point is the average from three biological 
replicates, and the error bars represent the standard deviation. 
Fig. 6.2 Total cell density (a), cell hypertrophy (b), specific vDNA (c) and OB production (d) 
of HzAM1 cells infected with a wild-type HearNPV. Infections were conducted in Sf900™III 
serum free medium at various ICDs from 0.5-4×106 cells/mL at an MOI of 5 PFU/cell. The 
experiment was conducted in shaker-flask suspension cultures. Each data point is the 
average from three biological replicates, and the error bars represent the standard 
deviation. For OB yield, measurement was conducted only one at 168 hpi due to the low 
accuracy of OB counts at earlier stages. 
Fig. 6.3 Correlations between the peak yields (volumetric or specific) of vDNA (a, b) or 
OB(c, d) and the peak cell density (PCD) from HzAM1 cell cultures infected with a wild-
type baculovirus (HearNPV) at various ICDs of 0.5 to 4×106 cells/mL, and a MOI of 5 
PFU/cell. The experiment was conducted in shaker-flask suspension cultures. Each data 
point is the average from three biological replicates, and the error bars represent the 
standard deviation. Significance testing was performed separately for each experimental 
set of data points with different letters indicating values that are significantly different 
according to Tukey's HSD (α=0.05). 
Fig. 6.4 Intracellular concentrations of adenosine (a), uridine (b) and cytidine (c) 
nucleotides and amino acids of uninfected HzAM1 cell cultures at various cell densities 
from 0.5 to 8×106 cells/mL. Cultures were propagated in Sf900™III serum free medium. 
The experiment was conducted in shaker-flask suspension cultures. Each data point is the 
average from three biological replicates, and the error bars represent the standard 
deviation. Significance testing was performed separately for each experimental set of data 
points with different letters indicating cases that are significantly different according to 
Tukey's HSD (α=0.05). 
Fig. 6.5 Multivariate analysis of intracellular metabolite concentrations of infected HzAM1 
at low (0.5x106 cells/mL) (green) and moderate high (2x106 cells/mL) (blue) ICDs. 
Orthogonal projection to latent structures–discriminant analysis (OPLS-DA) scores (a) and 
loadings (b) plots of the 6 time points post-infection at low and high ICDs, classified by cell 
density. OPLS-DA model metrics: Predictive component R2X = 0.124; R2 = 0.857; Q2 = 
0.685; R2Y = 1: Orthogonal component R2X = 0.26. Infections were conducted in 
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Sf900™III serum free medium at an MOI of 5 PFU/cell. The experiment was conducted in 
shaker-flask suspension cultures. 
Fig. 6.6 Stacked bar charts of (a) adenosine, (b) uridine, and (c) cytidine nucleotide 
concentrations of 6 time points post-infection of infected HzAM1 cells at low (0.5x106 
cells/mL) and moderate high (2x106 cells/mL) ICDs. Infections were conducted in 
Sf900™III medium at an MOI of 5 PFU/cell (HearNPV). The experiment was conducted in 
shaker-flask suspension cultures. Each data point is the average from three biological 
replicates, and the error bars represent the standard deviation. 
Fig. 6.7 Intracellular AA concentrations at 6 times post-infection at low (a) and high (b) 
ICDs , and the comparison between low and high ICDs for intracellular AA levels at 0 (c) 
and 36 hpi (d) of infected HzAM1 cells. Infections were conducted in Sf900™III at low 
(0.5x106 cells/mL) and high (2x106 cells/mL) ICDs and at an MOI of 5 PFU/cell (HearNPV). 
The experiment was conducted in shaker-flask suspension cultures. Each data point is the 
average from three biological replicates, and the error bars represent the standard 
deviation. Data from the same AA with an (*) was significant difference according to 
Tukey’s HSD test (α=0.05). 
Fig. 6.8 Comparison of AA consumption rates (mmol/cell/hour) between early (0-18 hpi) 
and late (18-72hpi) infection stages for 3 different infection cell densities of 0.5×106 (a) 
2×106 (b), and 4×106 cells/mL (c) of infected HzAM1 cells. Infections were conducted in 
Sf900™III at an MOI of 5 PFU/cell (HearNPV). The experiment was conducted in shaker-
flask suspension cultures. Each data point is the average from three biological replicates, 
and the error bars represent the standard deviation. Data from the same AA with an (*) 
was significant difference according to Tukey’s HSD test (α=0.05). 
Fig. 6.9 Comparison of AA consumption rates (mmol/cell/hour) among 3 infection cell 
densities of 0.5×106, 2×106, and 4×106 cells/mL at either early (0-18 hpi)  (a) or late (18-
72hpi) (b) infection stagesof infected HzAM1. Infections were conducted in Sf900™III at an 
MOI of 5 PFU/cell (HearNPV). The experiment was conducted in shaker-flask suspension 
cultures. Each data point is the average from three biological replicates, and the error bars 
represent the standard deviation. 
Fig. 6.10 Comparison of AA consumption rates (mmol/mm3 of cell biomass/hour) among 3 
infection cell densities of 0.5×106 cells/mL, 2×106 cells/mL, and 4×106 cells/mL at either 
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early (0-18 hpi) (a) or late (18-72 hpi) (b) infection stages of infected HzAM1 cells. 
Infections were conducted in Sf900™III at an MOI of 5 PFU/cell (HearNPV). The 
experiment was conducted in shaker-flask suspension cultures. Each data point is the 
average from three biological replicates, and the error bars represent the standard 
deviation. 
Fig. 6.11 Ratios of AA levels between high versus low ICDs for extra- and intra-cellular 
AAs at 0 hpi (a) and 36 hpi (b) and ratios between intra- versus extra-cellular AA levels for 
low and high ICDs at 0 hpi (c) and 36 hpi (d) ofinfected HzAM1 cells. Infections were 
conducted in Sf900™III at low (0.5×106 cells/mL) and high (2×106 cells/mL) ICDs and at 
an MOI of 5 PFU/cell (HearNPV). The experiment was conducted in shaker-flask 
suspension cultures. Each data point is the average from three biological replicates, and 
the error bars represent the standard deviation. 
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Table 2.1 HPLC gradient for nucleotide quantification 
Table 2.2 Gradient profile for LCMS/MS 
Table 3.1 Intracellular ATP and total adenosine phosphate (AdoP) levels in quenched but 
not washed (Q0W), quenched and washed one or two times (Q1W, Q2W) and 
unquenched (UQ) samples, expressed as a percentage of the levels in the corresponding 
direct extracted (DE) sample, from uninfected Sf9 and HzAM1 cells, and from rAcMNPV-
infected Sf9 and wt-HearNPV-infected HzAM1 cells. Ice-cold NaCl + P (0.5–1oC) was used 
for both quenching and washing, while room temperature NaCl + P was used for the UQ 
case. One hundred percent acetonitrile (-40oC) was used for direct extraction of cell 
cultures, while 50% v/v acetonitrile in deionized water (-40oC) was used to extract 
quenched and unquenched cell pellets. 
Table 3.2 Comparison of intracellular ATP concentrations in insect, mammalian and 
microbial cells, in direct extracted (DE) and quenched-unwashed (Q0W) samples. 
Table 4.1. Total cell protein (TCP) per cell increase post-infection (pi) and the proportion of 
β-Gal protein over TCP increase pi for Sf9 cells infected with a recombinant baculovirus 
(rAcMNPV) at either low (2×106) or high (6×106 cells/mL) ICDs. 
Table 4.2 Selected significant intracellular metabolites (other than amino acids) over 
various times post-infection for Sf9 cells infected with a recombinant baculovirus 
(rAcMNPV) at either low (2×106) or high (6×106 cells/mL) infection cell densities (ICDs). 
Data represented as an average of biological triplicates. 
Table 4.3 Glucose and AA consumption rates (×10-12mmol/cell/hour) of uninfected and 
rAcMNPV infected Sf9 cells at low and high ICDs. Uninfected and infected cultures were 
set up at 0.5×106 cells/mL. For uninfected cultures no infection was made and sampling 
was conducted at every 24 hours until the total cell density reached 6×106 cells/mL. For 
infected cells, cultures were infected with a baculovirus at an MOI of 10 PFU/cell when the 
cell density reached 2×106 cells/mL (48 hours) or 6×106 cells/mL (84 hours) and sampling 
was conducted every 12 hours until 60 hours post-infection. Data is the average of 
biological triplicates. 
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Table 4.4 Comparison of sugar and AA consumption rates (×10-6 mmol/mm3 cell 
biomass/hour) between uninfected and infected cells at low (2×106) and high (6×106 
cells/mL) ICDs. Detailed description is presented in Table 4.3. 
Table 5.1.Intracellular metabolites concentrations (mM) over various times post-infection 
for Sf9 cells infected with a recombinant baculovirus (rAcMNPV) in a chemically defined 
medium at either low (1×106) or high (5×106 cells/mL) infection cell densities (ICDs). Data 
represented as an average of biological duplicates. The metabolites listed were selected 
on the basis of showing significant variations in levels between different ICDs or times post 
infection following the analysis shown in Fig. 5.4. 
Table 5.2 Glucose and amino acid consumption rates (×10-12 mmol/cell/hour) of uninfected 
and infected Sf9 cells infected with a rAcMNPVat low (1×106) and high (5×106 cells/mL) 
ICDs in a chemically defined medium (CDM). Uninfected and infected cultures were set up 
at 0.5×106 cells/mL. For the case of uninfected cultures no infection was made and 
sampling was conducted at every 24 hours during the 24-hour doubling time period. For 
infected cases, cultures were infected with a baculovirus at an MOI of 10 PFU/cell at 1×106  
and 5×106 cells/mL and sampling was conducted every 12 hours until 60 hours post-
infection. Data is the average of biological duplicates. 
Table 5.3 Comparison of AA consumption rates (×10-6 mmol/mm3 cell volume/hour) 
between uninfected and infected Sf9 cells infected with a rAcMNPV at low (1×106 
cells/mL) and high (5×106 cells/mL) ICDs in a chemically defined medium (CDM). Further 
description details are as shown in Table 2. 
Table 6.1 Intracellular metabolite concentrations (mM) for HzAM1cells infected with a wild-
type baculovirus (HearNPV) at either low (0.5×106) or moderately high (2×106 cells/mL) 
infection cell densities (ICDs) over various times post-infection. Data represented as an 
average of biological triplicates. The metabolites listed were selected on the basis of 
showing significant variations in levels between different ICDs or times post infection 
following the analysis shown in Fig. 6.5. 
 
Table 6.2 Glucose and amino acid consumption rates (×10-12 mmol/cell/hour) of uninfected 
and infected HzAM1 cells infected with a wide-type HearNPV at various ICDs. Uninfected 
and infected cultures were set up at 0.5×106 cells/mL. For the case of uninfected cultures 
no infection was made and sampling was conducted every 24 hours during the period that 
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the culture maintained a 24-hour doubling time. For infected cultures, cultures were 
infected with an MOI of 5 PFU/cell at 0.5, 2 and 4×106 cells/mL and sampling was 
conducted every 12 hours until 60 hours post-infection. Data is the average of biological 
triplicates. 
Table 6.3 Comparison of AA consumption rates (x10-6mmol/mm3 cell volume/hour) of 
uninfected and infected HzAM1 cells infected with a wild-type HearNPV at various ICDs. 
Further details are as described in Table 6.2. 
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Chapter 1 
Introduction 
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1.1 Introduction 
This chapter presents an overview of the background related to the research project. 
It includes highlights of the application of baculovirus insect cell systems, the biology of 
baculoviruses, in vitro production of baculoviruses and a description of the cell density 
effect, an overview of insect cell metabolism and metabolomics approaches used to study 
metabolism. The end of this chapter presents a thesis outline which lists the key research 
questions to be investigated in this thesis. 
1.2 The application of baculovirus insect cell expression systems 
The baculovirus insect cell expression systems have become a useful tool for 
efficient production of recombinant eukaryotic proteins (Jarvis, 2009; Kost et al., 2005; 
Mena and Kamen, 2011), and have evolving applications in human biologics such as 
humanized N-glycoproteins, baculovirus display immunogens and gene delivery vectors 
for mammalian cells (Aucoin et al., 2010; Kost et al., 2005). Recently, baculovirus-
expression has gained considerable momentum as a regulatory-approved manufacturing 
platform for human (Cervarix®, Provenge®) and veterinary (Ingelvac®, Porcilis®) vaccines 
(Mena and Kamen, 2011).  
Besides being a valuable commercial tool for recombinant protein production, the 
baculovirus insect cell systems have been extensively studied for the production of 
baculoviruses which can be developed as effective biopesticides to control various types 
of insect pests (Chakraborty et al., 1996; Chakraborty et al., 1999; Pedrini et al., 2006), 
especially as part of an integrated pest management program (Moscardi et al., 2011; 
Szewczyk et al., 2009).  
1.2.1 Baculovirus insect cell systems and recombinant protein production 
As mentioned above, the baculovirus insect cell systems have been used widely for 
recombinant protein production. In fact, baculoviruses have been employed to express a 
wide variety of heterologous proteins in insect cell cultures (Buerger et al., 2007; Caron et 
al., 1990; Chan et al., 1998; Hink et al., 1991; Hitchman et al., 2010; Nishikawa et al., 
2003; Possee et al., 1999; Weiss, 1992). The reasons for using baculovirus insect cell 
systems include high levels of post translational modifications, potentially high expression 
levels by using the baculovirus polyhedrin promoter, stability of vector constructs and a 
large genome capacity (Mena and Kamen, 2011). In fact, insect cells possess pathways 
that facilitate the folding, modification, and assembly of the protein product (Kost et al., 
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2005). It has been proven in many studies that insect cells are able to carry out many of 
the processing events such as glycosylation, phosphorylation, fatty acid acylation, 
amidation, proteolytic processing and cellular targeting required for the formation of 
biologically active, heterologous proteins that are antigenetically, immunogenically and 
functionally similar to their native proteins (Luckow and Summers, 1988; O'Reilly et al., 
1994).  
In addition, there is an interest in using the baculovirus insect cell expression system 
as a research tool for producing human and veterinary vaccines (Mena and Kamen, 2011; 
van Oers, 2006), and as vectors for gene delivery (Hitchman et al., 2010; Hu, 2008). Being 
well-documented as safe for vertebrates and the ability to transduce mammalian cells, 
baculoviruses are being evaluated as efficient vectors to deliver antigens for vaccination 
(Yang et al., 2007). The cervical cancer vaccine (from GlaxoSmithKline) is the first human 
vaccine produced in insect cells with a baculovirus vector that has been marketed. Another 
human product, a prostate cancer vaccine (ProvenceTM) approved by the Federal Drug 
Administration (USA) is also made using the baculovirus expression system. Other human 
vaccines in the late stage of clinical development include the recombinant hemagglutinin 
based influenza vaccine, FluBlok®, developed by Protein Sciences Corporation (Meriden, 
Connecticut, USA), and the therapeutic vaccine for diabetic type 1 treatment, Diamyd®, 
developed by Diamyd Medical AB (Stockholm, Sweden) (Mena and Kamen, 2011). 
Furthermore, baculoviruses show an ability to enter a wide range of mammalian cells 
and thus, may be useful to use as vectors for gene delivery. By the 1990s, numerous cell 
lines had been transduced successfully (Boyce and Bucher, 1996; Hofmann et al., 1995). 
Since then, the use of baculoviruses as vectors for gene therapy has gradually gained in 
popularity for use in this area (Kost and Condreay, 2002; Kost et al., 2005). The inability to 
replicate in mammalian cells and the low cytotoxicity property of baculoviruses make them 
good candidates for gene therapy in vitro (Airenne et al., 2009). Recently, baculovirus 
vectors have been developed as potential vectors for gene therapy (Airenne et al., 2010), 
either as a gene carrier or as a production system for other gene therapy vectors such as 
adeno-associated viruses (Hu, 2006; Shan et al., 2006). It can be used for in vivo targeting 
of genes to several organs such as brain and liver (Hu, 2008) and to stem cells for tissue 
engineering (Lin et al., 2010). 
1.2.2 Baculovirus biopesticides 
Insect pests cause severe damage to crops worldwide and are one of the major 
causes of loss of agricultural yield. Chemical pesticides have been used widely to control 
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pests in agriculture for many years with premium efficiency. However, increasing 
resistance to existing chemical pesticides (Franzmann et al., 2008; Jacobson et al., 2009), 
increasing concern about the environment and food safety issues, and the desire of 
farmers to use safer pesticides are all reasons for the interest in biopesticides. The use of 
biological approaches as alternatives for pest control is the smart choice of modern 
agriculture towards sustainable agriculture and organic farming practices. 
Biological approaches as alternatives for chemical pesticides include the use of 
environmentally friendly biological agents and/or genetic modification of crops to ensure 
pest resistance. Transgenic crops have been developed and are used widely, with the 
most common transgenic crops for insect pest control being Bt cotton and maize. 
However, field evolved insect resistance to transgenic crops even with gene pyramiding 
(Tabashnik et al., 2009), the high cost of development and registration, the resistance of 
the public to gene modification of crops (Moscardi et al., 2011), and limited access of 
farmers to such biotech crops due to intellectual property issues are all limitations for the 
widespread use of this pest control measure. Therefore, biological agents, especially 
baculoviruses remain of interest as alternatives to the use of chemical pesticides.  
Baculoviruses, among other insect viruses, are regarded as safe and selective 
bioinsecticides, restricted to invertebrates (Moscardi, 1999). Baculoviruses are one of the 
most promising biocontrol agents, with a low chance of resistance development and 
proven high safety levels (Szewczyk et al., 2006). More than 50 baculovirus-based 
pesticides have been registered and used worldwide (Moscardi et al., 2011). In fact, 
baculoviruses have been used to control caterpillar pests that affect major crops such as 
soybean, sorghum, maize, tomato, cotton, pigeon pea, and pepper in many countries 
including Brazil, China, India, America, and Australia (Buerger et al., 2007; Szewczyk et 
al., 2009). It is considered as an ideal tool for Integrated Pest Management (IPM) 
programs (Buerger et al., 2007; Moscardi et al., 2011). 
1.3 Baculovirus biology and infection cycle  
Baculoviruses belong to the family of Baculoviridae, which are a diverse group of 
viruses found mostly in insects and they appear as pathogens of several insects. They are 
known to infect arthropods and are not known, so far, to have any non-arthropod hosts 
(O'Reilly et al., 1994). They are characterized by rod-shaped occluded viruses with 
circular, double-strand DNA ranging from 80 to 200 kbp (Pan et al., 2007; Szewczyk et al., 
2009). The family is composed of 4 genera of Alphabaculovirus (Lepidopteran 
nucleopolyhedrovirus), Betabaculovirus (Lepidopteran granulovirus), Gammabaculovirus 
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(Hymenopteran nucleopolyhedrovirus) and Deltabaculovirus (Dioteran 
nucleopolyhedrovirus) (Jehle et al., 2006; Moscardi et al., 2011; Szewczyk et al., 2009). 
The majority of baculoviruses used as biological agents for pest control are in the genus of 
nucleopolyhedrovirus (NPVs) (Pedrini et al., 2006). These viruses are excellent candidates 
for use as biopesticides due to their high virulence to their specific host, narrow host 
range, and the fact that they cause little damage to beneficial insects, and result in minimal 
disruption to other biological control measures (Burges et al., 1980; Moscardi, 1999; 
Teakle, 1995). The NPVs are usually divided into two morphotypes: based on single 
(SNPVs) or multiple (MNPVs) nucleocapsids packaged into each envelope (Granados and 
Hashimoto, 1989; Shuler et al., 1995; Szewczyk et al., 2006; Vlak, 1992). 
 
Fig. 1.1 Diagram of a baculovirus infection cycle in nature (Moscardi et al., 2011). OBs enter a 
caterpillar through ingestion along with plant material (A) and the high alkaline environment (pH 
9.5-11.5) of the midgut (B) degrades OBs and releases ODVs to infect midgut epithelial cells (C). 
Infected cells produce BVs, which bud out (D) and infect other cells (E). After secondary infection 
(F), virus accumulates in occlusion bodies (G). Finally, the larval body disintegrates and millions of 
polyhedra are released to the environment (H). 
Baculoviruses have been isolated from more than 700 invertebrates (Tanada and 
Kaya, 1993), and are widely known as safe and effective microbial insecticides. The 
baculovirus life cycle involves two virus forms, the occlusion-derived virus (ODV) 
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contained within occlusion bodies (OB) and the budded virus (BV). Primary infections are 
initiated when caterpillars ingest OBs, which dissolve in the alkaline midgut to release 
ODVs. Midgut cells then release BVs which transmit secondary infection to other cell-
types. Numerous OBs are then produced, which are released into the environment upon 
caterpillar liquefaction. Fig. 1.1 represents the natural life cycle of baculoviruses. 
These two virus phenotypes (BV and ODV) have different roles and are generated at 
different stages during the baculovirus life cycle (Faulkner and Carstens, 1986; Rohrmann, 
1992). BVs are produced during the late stages of viral infection and spread the infection 
from cell to cell within the insect and are highly infectious to cultured cells. ODVs are 
produced very late in the viral replication cycle, in which virions remain within insect cell 
nuclei, accumulate and are occluded in polyhedra. These occluded virions are released 
upon disintegration of dead insects and contaminated foliage is ingested by other 
susceptible insects (Funk et al., 1997). ODVs only spread infection from insect to insect 
but do not normally spread the infection within insect tissues. 
 
Fig. 1.2 The two phenotypes of baculovirus: budded virus (BV) and occlusion derived virus (ODV) 
(Blissard, 1996). 
Since the infection process of these two forms of NPVs is different, the structure of 
the envelope is clearly different. Every polyhedron is surrounded by a polyhedron 
envelope that is alkali-soluble, which allows them to dissolve under the high pH 
environment of the insect midgut, releasing virions. However, the occluded viral form is 
highly stable in the external environment (Szewczyk et al., 2006), which is a major factor in 
allowing persistence of the virus and subsequent initiation of sporadic infections of insect 
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populations at intervals of one year or more (Funk et al., 1997; Rohrmann, 1999). 
Therefore, OB is the form of the virus for use as a biopesticide (Rohrmann, 1999; Slack 
and Arif, 2007). In contrast, BVs acquire an envelope when they bud through the 
cytoplasmic membrane which has been modified by a viral-encoded glycoprotein called 
gp64, and it is adapted for movement and infection of tissues within the insect (Funk et al., 
1997). The structure of both phenotypes of NPVs is shown in Fig. 1.2. 
 
 
Fig. 1.3 Baculovirus infection cycle in cell culture (Slack and Arif, 2007). Several phases of virus 
replication are illustrated beginning with the rounding of newly infected cells and finishing with the 
lytic release of OBs. Indicated times are relative to the infection cycle of AcMNPV. 
In cell culture, the infection cycle takes place in three basic phases: early, late and 
very late. These three phases correspond biologically to 1) the early phase that entails 
reprogramming of the cell for virus replication; 2) the late phase that involves producing 
OB 
20 h 
Virogenic 
stroma 
6 h 
0 h 
Nucleus 
12 h 
ODV 
Inner 
Nuclear 
Membrane 
BV 
Nuclear 
ring zone 
48 h 
24 h 
 8 
BV’s; and 3) the very late phase involving production of OB’s (O'Reilly et al., 1994; Slack 
and Arif, 2007). The infection cycle in cell culture is illustrated in Fig. 1.3. 
Understanding changes inside the cells corresponding to various phases in the 
infection cycle may reveal the cause of the drop in the cell specific yield during high cell 
density infections and provide options for improving virus yields. For example, during the 
very late phase that involves polyhedra protein/OB production, there is likely to be a high 
demand for energy and amino acids, but at this stage the cell is entering a death phase 
and so the uptake of nutrients at this time may be compromised. 
1.4 In-vitro production and the cell density effect 
1.4.1 In vitro production of baculovirus biopesticides 
Baculoviruses have been produced in vivo for commercial use as biopesticides. To 
date, over 50 baculovirus biopesticide products against different insect pests worldwide 
are produced in vivo either in the field or in the laboratory using caterpillars raised in 
insectaries (Moscardi et al., 2011). The in vivo production of baculoviruses, however, is 
associated with several disadvantages including being labour intensive and costly 
(Agathos, 1991; Black et al., 1997), and it is difficult to have quality control over the purity 
of products especially when requiring large scale production (Powell and Faull, 1989). In 
contrast, in vitro production of baculoviruses using insect cell culture offers several 
advantages including higher purity of product (Shuler et al., 1995) as well as the possibility 
to select desirable cell clones which may provide greater viral yield (Weiss et al., 1994).  
Thus, in vitro production has been indicated as a key element in making biopesticides 
more desirable in the market (Szewczyk et al., 2006). 
In addition, in vitro production of baculoviruses also avoids the complexity of rearing 
insect larvae for virus infection and production in vivo. Moreover, hundreds of cell lines 
have been developed and the specific cell strains can be stored for later use  leading to 
great potential for the production of baculoviruses in vitro (Moscardi et al., 2011). In 
general, it is possible to develop an efficient process to harvest biologically active OB free 
from contaminants that would be cheap compared with virus produced in vivo (Weiss et 
al., 1994). 
While in vivo production is simple and low cost at small scale, it becomes costly as 
scale increases and it is widely believed that in vitro production is essential for 
baculoviruses to be more broadly commercialized. Baculoviruses display genetic instability 
in culture which is a limitation to in vitro production that is caused by the accumulation of 
mutant few polyhedra, FP phenotypes (de Rezende et al., 2009; Pedrini et al., 2004), and 
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the formation of Defective Interfering Particles (DIPs) (Moscardi et al., 2011). These 
limitations can be minimized by a production process developed by Dr Reid’s laboratory 
(Reid and Lua, 2005). The current method of producing baculoviruses starting with 
caterpillar ODVs is capable of producing of 2×1012 OB/L. However, in vitro baculovirus 
yields still need to be increased 4 fold over current yields (to 8×1012 OB/L) to be 
commercially successful. In order to increase the yield, it is necessary to infect the cell at 
high cell densities. Unfortunately, the specific yield drops when increasing the cell density 
at the time of infection. Cells infected at lower cell densities, (0.5×106 to 1×106 cells/mL), 
have been shown to produce 600 OB/cell, but the yield drops in half to about 300 OB/cell 
for infections at  high cell densities (3-4×106 cells/mL). Hence, if the yield of 600 OB/cell 
can be achieved for high density infections, it is feasible to increase the yields to be more 
commercially successful. In other words, it is necessary to overcome the challenge for 
improving yields that is related to the cell density effect. 
1.4.2 The cell density effect 
The cell density effect is the phenomenon of the reduction in cell specific yield with 
increasing infection cell density (ICD), and it is well documented for baculovirus infected 
insect cells. The cell density effect has been reported mainly for Sf9 cells (Carinhas et al., 
2009; Caron et al., 1990; Doverskog et al., 2000; Jesionowski and Ataai, 1997; Radford et 
al., 1997; Reuveny et al., 1993; Taticek and Shuler, 1997; Wong et al., 1996; Yamaji et al., 
1999). There are a few investigations conducted in other cell lines such as Anticarsia 
gemmatalis (saUFL-AG-286) (Micheloud et al., 2009), Trichopulsia ni (Hi5) (Chico and 
Jager, 2000; Ikonomou et al., 2004; Taticek and Shuler, 1997; Yang et al., 1996), and 
Heliothis zea (HzAM1) (Chakraborty et al., 1996), which show that the cell density effect 
applies generally to baculovirus infected insect cell systems. 
There have been many speculations on the cause of the cell density effect including 
nutrient limitation, toxic compound accumulation, cell-to-cell contact inhibition, but the 
reasons for this drawback remain unidentified (Doverskog et al., 1997; Taticek and Shuler, 
1997). It has been suggested that the cause of the drop in productivity at high cell 
densities for baculovirus infection processes is related to nutrient limitations rather than 
accumulation of toxins (Drews et al., 1995; Radford et al., 1997; Wong et al., 1996). This is 
supported by the fact that there is an increase in the cell specific yield with an 
improvement of the nutrient supply through fed-batch strategies (Chan et al., 1998; Elias et 
al., 2000; Jardin et al., 2007) or fresh medium replacement (Chakraborty et al., 1996; 
Doverskog et al., 2000; Ikonomou et al., 2004; Jesionowski and Ataai, 1997; Lindsay and 
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Betenbaugh, 1992; Radford et al., 1997; Reuveny et al., 1993). The nutrient limitation may 
involve micronutrients such as vitamins or trace elements, some of which are cofactors for 
enzymes involved in critical processes such as catabolism (e.g. pyruvate dehydrogenase) 
and DNA replication (e.g. DNA polymerase). These limitations may also result in the 
limiting of nucleotides for viral DNA replication and transcription. However, the process 
limitation for the cell density effect may not be entirely related to nutrient supply, and there 
could be many factors involved in this issue and the mechanism causing the cell density 
effect is not fully understood. There could be complex interactions between the virus 
infection process, cellular physiology and the physio-chemical environment. Recently, the 
reduction in recombinant protein production at high cell densities has been shown to be 
strongly correlated with limitations in the upstream processes of virus replication and 
transcription (Huynh et al., 2013). Other possible factors causing low productivity in high 
density cultures have been suggested including oxygen limitations (Lecina et al., 2006; 
Palomares et al., 2004; Taticek and Shuler, 1997), the cell cycle phase at the time of 
infection (Calles et al., 2006; Doverskog et al., 2000) and the history of the culture 
(Doverskog et al., 2000). 
In order to identify the cause of the cell density effect and to overcome this 
bottleneck, many attempts have been made. These include the measurement of 
extracellular metabolites to identify the limiting nutrients in the medium (Caron et al., 1990; 
Drews et al., 1995; Reuveny et al., 1993); the measurement of consumption rates and 
fluxomics analysis (Bernal et al., 2009); and supplementing culture media with glucose, 
glutamine, complex nutrient mixtures, and key intermediate metabolites (Carinhas et al., 
2010; Reuveny et al., 1993).  However, the limitation of these approaches is that the 
metabolite levels in the media do not necessarily reflect intracellular metabolite levels. For 
many reasons, some metabolites may not get into the cells even if they are available in the 
culture medium at reasonable levels. Therefore, intracellular metabolite measurements 
can provide a better understanding of what happens inside the cells and consequently, 
appropriate actions may be taken to improve yields. 
The metabolite environment inside the cells at low and high cell densities at the time 
of infection may reveal the cause of the cell density effect. In particular, intracellular 
metabolite measurements in combination with consumption rates of key metabolites may 
identify limitations during high cell density infections. It is possible for example that poor 
transport into cells of key metabolites at high cell densities post-infection contribute to the 
cell density effect, rather than a limitation of metabolites in the medium. 
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1.5 Insect cell metabolism  
The metabolism of different insect cell lines has been reported by many research 
groups. In particular, the metabolism of Spodoptera frugiperda (Sf9) and Trichoplusia ni 
(Tn5B1-4 or High Five) cell lines have been studied thoroughly (Bedard et al., 1993; 
Benslimane et al., 2005; Drews et al., 1995; Drews et al., 2000; Ferrance et al., 1993; 
Ohman et al., 1995; Reuveny et al., 1993; Rhiel et al., 1997; Sugiura and Amann, 1996), 
as these two cell lines have been extensively used for recombinant protein production. In 
addition to Sf9 and High Five cells, the metabolism of other cell lines including Helicoverpa 
zea (Lua and Reid, 2003) and Anticarsia gemmatalis (de Rezende et al., 2009; Gioria et 
al., 2006) have also been investigated to a significant degree.  
Generally, there are some common aspects of  insect cell metabolism including the 
utilization of  sugars, peptides, amino acids, organic acids, vitamins, lipids and organic 
salts (Agathos 1991), and the production of alanine, lactate and ammonium ions as by-
products (Rhiel et al., 1997; Sugiura and Amann, 1996). Glucose is usually the preferred 
carbon and energy source of insect cells (Bedard et al., 1993; Rhiel et al., 1997). Several 
studies with Spodoptera frugiperda cell lines demonstrated the importance of glucose for 
cell growth (Bedard et al., 1993; Bhatia et al., 1997; Drews et al., 1995; Mendonca et al., 
1999; Reuveny et al., 1993). The high level of glucose consumption in Sf9 cell cultures is 
indicative of the presence of an active glycolytic pathway (Neermann and Wagner, 1996; 
Raghunand and Dale, 1999). Consumption of maltose usually occurs during the early 
growth phase in media containing both glucose and maltose (Bedard et al., 1993; 
Ferrance et al., 1993), while fructose was only consumed after glucose depletion 
(Ikonomou et al., 2003). Sucrose, on the other hand, is not consumed by either Sf9 
(Bedard et al., 1993; Drews et al., 1995; Reuveny et al., 1993) or Hi5 (Rhiel et al., 1997) 
cells. 
It has been reported in many studies that glutamine is a key nutrient for insect cells 
(Bedard et al., 1993; de Rezende et al., 2009; Ferrance et al., 1993; Reuveny et al., 1993; 
Wang et al., 1993). The main by-product of insect cell metabolism is alanine (Bedard et al., 
1993; Drews et al., 1995; Ohman et al., 1995; Reuveny et al., 1993), but no inhibitory 
effect related to alanine has been reported (Doverskog et al., 1997). Lactate and ammonia 
production levels are minimal even at high substrate concentrations and not inhibitory 
unless other culture conditions become adversely inhibitory (Bedard et al., 1993; 
Benslimane et al., 2005; Drews et al., 2000; Ferrance et al., 1993; Ikonomou et al., 2003; 
Rhiel et al., 1997; Sugiura and Amann, 1996; Wang et al., 1993). These are only some 
 12 
common aspects of  insect cell metabolism,  the specific consumption level and preference 
of substrates as well as by-product formation level are different between cell lines and 
depend on the cultivation conditions. 
It is suggested that different insect cell lines have different nutrient requirements as 
well as different levels of waste product accumulation during cell culture. The consumption 
of glutamine is considered as the most significant compared to the other amino acids for 
Sf9 cells, and this suggests that glutamine may have a possible role in the energy 
metabolism of Sf9 cells. Unlike Sf9 cells, HzAM1cells show a preference for asparagine 
over glutamine (Lua and Reid, 2003), and this is similar for the High Five cells. It has been 
reported for Sf9 cells that the production levels of lactate and ammonia are minimal even 
at high substrate concentrations (Bedard et al., 1993; Benslimane et al., 2005; Drews et 
al., 2000; Ferrance et al., 1993; Ikonomou et al., 2003; Rhiel et al., 1997; Sugiura and 
Amann, 1996; Wang et al., 1993). In contrast, HzAM1 cells showed a significant level of 
ammonia production in Sf900™II medium, which is an asparagine and glutamine rich 
medium (Lua and Reid, 2003). However, given the absence of asparagine and glutamine 
in the medium, there is no accumulation of ammonia (Lua and Reid, 2003).  Insect cells 
may consume ammonium ions as a nitrogen source in glutamine free media (Ohman et 
al., 1995), and when infected with a baculovirus (Wang et al., 1993; Wang et al., 1996). 
These studies indicate that the by-product formation pattern observed is not only 
characterized by the cell line used but also is strongly influenced by the cultivation 
conditions (Drews et al., 2000). Similarly, it has been shown that alanine accumulated at 
very high levels as a metabolic byproduct (Bedard et al., 1993; Drews et al., 2000; Ohman 
et al., 1995; Rhiel et al., 1997). However, no alanine was formed by Sf9 cells during 
glucose limitations (Ohman et al., 1995), indicating that much of the glucose in culture is 
utilized for biosynthesizing precursors (Bhatia et al., 1997).  
The metabolism of insect cells before and after infection with a baculovirus is 
different, and it has been suggested that post infection cell metabolism increases. Several 
groups found a higher consumption of glucose, glutamine and other amino acids, an 
increase in alanine production, and a higher oxygen uptake, up to 80% (Palomares et al., 
2004) during the post infection period. Nevertheless, there is no report on the growth 
inhibition of Sf9 cell lines related to alanine (Doverskog et al., 1997), and the reduced yield 
in insect cell cultures at high cell densities is most likely caused by nutrient depletion rather 
than inhibition by waste products (Drews et al., 1995).  
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1.6 Metabolomics approach  
1.6.1 Definition of metabolomics 
The definition of metabolomics was first introduced by Fiehn (2002), although studies 
on the metabolome had been done earlier (Oliver et al., 1998; Tweeddale et al., 1998). 
According to Fiehn, metabolomics addresses the identification and quantification of all the 
metabolites in a living system. However, the study of the complete metabolome is 
unachievable because of the complexity of the metabolome in chemical and structural 
diversity as well as its broad dynamic range. In other words, there is no analytical 
technique that is able to measure the complete set of metabolites. Therefore, several 
terms are used to distinguish different types of analysis as shown below. Definitions and 
their application in metabolomic studies can be different from group to group. 
Definitions of common terms used in the field of metabolomics are listed below: 
Metabolome: A complete set of metabolites present in a biological system that participate 
or are generated in its metabolism (Dettmer et al., 2007; Oldiges et al., 2007). 
 Metabolic fingerprinting: Global screening approach to classify crude samples with 
minimal sample preparation based on metabolite patterns or “fingerprints” (Dettmer et al., 
2007; Dunn, 2008). Identification and quantification is limited and the strategy is employed 
as a tool for discrimination of samples from different biological origins or status. It is also 
defined as the study of the intracellular metabolome (Dunn, 2008). 
Metabolic footprinting: Analysis of the extracellular metabolites in cell culture medium. 
Unlike intracellular metabolite analysis, there is no requirement for quenching and 
extraction of metabolites (Dunn, 2008; Oldiges et al., 2007). 
Metabolite profile: Analysis of a set of metabolites related to a class of compounds 
(carbohydrates, amino acids) or a specific biochemical pathway (Dettmer et al., 2007; 
Dunn, 2008; Fiehn, 2001; Villas-Boas et al., 2005b). The analysis uses a particular 
analytical technique, together with an estimate of quantity (Castrillo et al., 2003; Roessner 
et al., 2000). 
Metabolite targeted analysis: Quantitative analysis of a small number of identified 
metabolites related to a specific part of the metabolism (Dunn, 2008; Fiehn, 2002; 
Mashego et al., 2007; Villas-Boas et al., 2005b). 
1.6.2 The application of metabolomics and its challenges 
Metabolomic approaches, which offer an analysis of metabolite levels in biological 
samples, have been employed widely recently. Metabolomic studies have been done in 
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yeast and bacteria (Allen et al., 2003; Bhattacharya et al., 1995; Buchholz et al., 2002; 
Castrillo et al., 2003; Chassagnole et al., 2002; de Koning and van Dam, 1992; Gonzalez 
et al., 1997; Markuszewski et al., 2003; Tweeddale et  al., 1998; Villas-Boas et al., 2005a). 
These approaches have also been applied for the investigation of the metabolome in 
plants and animals with a particular focus on metabolomic studies in mammalian systems. 
Several metabolomic studies in mammalian cells have been conducted such as with 
adherent cultured human fibroblasts (Bennett et al., 2008), Madin–Darby canine kidney 
(MDCK) (Ritter et al., 2008) and hepatic cells (Hofmann et al., 2008), human breast cancer 
cell lines (Teng et al., 2009), as well as suspension cultured Chinese hamster ovary (CHO) 
and mouse NS0 myeloma cells (Dietmair et al., 2010; Sellick et al., 2009). 
In comparison to transcriptomics or proteomics, the study of metabolomics offers 
some advantages. Firstly, the metabolome reflects the functional level of the cell more 
appropriately because the metabolome is the downstream product of the genome. 
Changes in the metabolome are expected to be amplified relative to the proteome or the 
transcriptome (Urbanczyk-Wochniak et al., 2003). Secondly, the metabolome is a highly 
discriminatory system for studying changes in biology. It has been shown in certain 
situations that although alterations in the concentrations of proteins or transcripts are 
neither significant nor detectable, the concentration of metabolites can significantly change 
(Dunn and Ellis, 2005). Finally, the metabolome is a high-throughput strategy because 
costs for metabolomics experiments are low compared to proteomic and transcriptomic 
experiments (Dunn, 2008; Fiehn, 2002; Goodacre et al., 2004). In short, metabolomic 
studies are ‘complementary’ to transcriptomic and proteomic studies in order to determine 
gene functions of an organism (Dunn and Ellis, 2005; Fiehn, 2002; Urbanczyk-Wochniak 
et al., 2003). However, metabolomic approaches face particular challenges resulting from 
properties of the metabolites. These properties include rapid turnover, structure diversity, 
wide range of metabolite concentrations, and a huge number of metabolites. 
Rapid turnover 
Many metabolites are extremely labile, such as cytosolic glucose, with a turnover rate 
of approximately 1 mM/s and ATP at the rate of 1.5 mM/s (de Koning and van Dam, 1992; 
Theobald et al., 1997; Weibel et al., 1974). Due to the rapid turnover of metabolites, 
samples must be quenched immediately upon sampling to ensure that the measured 
metabolite concentration reflects the metabolic state of the sample at the sampling time 
point.  
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Diversity of metabolite structure 
Different atomic arrangements form a diverse set of metabolites of low molecular 
weight (less than 1000 Da). The diversity in molecular structure is expressed in the 
number of atoms in the molecule, the carbon skeleton, the number and location of active 
groups, the presence of stable and unstable atomic bonds as well as the geometric 
structure of the molecule. Variability in atomic structure provides wide variations in 
chemical (molecular weight, polarity, solubility) and physical (volatility) properties. This 
structure diversity makes the determination of the complete metabolome simultaneously 
impossible (Villas-Boas et al., 2005b). Therefore, all sample preparation and analytical 
techniques for metabolite determination have been developed to target classes of 
metabolites and to achieve as much information as possible. There is no unique extraction 
procedure for metabolome analysis that will cover all intracellular metabolites. 
Wide range of metabolite concentrations 
It is estimated that the range of metabolite concentrations inside a cell can vary 
approximately 7-9 orders of magnitude (pmol–mmol) (Dunn and Ellis, 2005; Ryan and 
Robards, 2006). The large range of abundance together with the large variation in the 
nature of metabolites provides additional challenges to the analytical technologies 
employed in metabolomic studies. 
Huge number of metabolites 
The total number of metabolites varies depending on the biological system 
investigated. Several hundred metabolites are postulated to be present in microorganisms, 
while much higher numbers, up to thousands of metabolites are expected in more complex 
organisms. The metabolome of yeast (Saccharomyces cerevisiae) is estimated to be 
around 600 metabolites, whereas, more than 200,000 metabolites are expected in plants 
and humans (Dunn and Ellis, 2005; Mungur et al., 2005; Ryan and Robards, 2006). In 
addition, (Schwab, 2003), reported that microorganisms generally have fewer metabolites 
than genes, whereas complex organisms such as plants, have more metabolites than 
genes in a biological system. Multiple mRNAs could be formed from a single gene, 
multiple proteins from one mRNA, and multiple metabolites may be formed from one 
enzyme, because many enzymes may accept more than one substrate, although enzymes 
generally have high selectivity. Therefore, as indicated above, it is impossible to date to 
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isolate and measure all metabolites together as desired for a comprehensive metabolomic 
study. 
1.6.3 Sample preparation for metabolome analysis 
Sample preparation is one of critical steps in metabolome analysis. According to 
Ritter et al. (2008), the most difficult part in a metabolomic study is the identification of an 
appropriate sample preparation method. It is because sample preparation is affected by 
many factors including the organism under investigation, the cultivation mode, the medium 
composition, and the assay used to quantify the metabolites. The differences in cell wall or 
cell membrane structure and cell size may influence the efficiency of quenching and the 
rate of metabolite leakage (Sellick et al., 2009). Undoubtedly quenching and extraction 
methods are sample- and cell-dependent (Sellick et al., 2009; Sellick et al., 2010), and 
they need to be validated for each organism of interest (Faijes et al., 2007); otherwise, 
extractions can lead to enormous errors (Bolten et al., 2007). 
Sample preparation and cell extraction makes the intracellular metabolites accessible 
to the different analytical methods employed, but it is almost impossible to avoid losses, 
mainly due to the diverse chemical and physical properties of the metabolome (Villas-Boas 
et al., 2005a). Fig. 1.4 illustrates the key steps required for a sample preparation 
procedure to measure intracellular metabolites. The two most important steps in this 
scheme are the quenching and extraction. They are the most critical technical features for 
characterization of the intracellular metabolites (Sellick et al., 2009). 
  
 
 
 
 
Fig. 1.4 Schematics of sample preparation steps for intracellular metabolite analysis 
 
In most sample preparation protocols for metabolome analysis, an initial quenching of 
the cells to stop metabolism, followed by extraction of the metabolites are included. Some 
extraction protocols, for suspension culture cells, quench cell activity directly with a cold 
extraction solution before removal of the medium. This approach presumes that the 
majority of the cellular metabolites will not be present in the medium and hence, can be 
presumed to have an intracellular localization (Sellick et al., 2009). However, there are a 
large number of metabolites that are present in both the culture medium and inside the 
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cells, (e.g., amino acids), or that may be secreted to the extracellular medium during 
growth. Consequently, direct extraction approaches are associated with the risk of 
overestimating intracellular pools, because the metabolites present in the extracellular 
medium are not removed (Canelas et al., 2008). This is a particular restriction for animal 
cells, which are grown in complex and “metabolite-rich” media (Sellick et al., 2009). 
Therefore, extraction approaches must remove, or minimize as much as possible, 
contamination of intracellular metabolites by those in the medium when dealing with 
animal cells in culture. 
 “Quenching” or stopping cellular metabolism 
As many metabolites turnover rapidly such as cytosolic glucose and ATP as 
mentioned above, quenching cells upon sampling is necessary to stop cellular metabolism 
and to prevent metabolite turnover. It is ideal if the time between sampling and quenching 
is shorter than the turnover rates of such metabolites to prevent alteration in the 
intracellular metabolite concentrations, and to ensure that measured metabolite levels are 
accurate at the time of sampling. Otherwise, the measured metabolite concentration does 
not reflect a snapshot of the sample at the sampling time point. In order to shorten the 
interval between sampling of the cells and their metabolic inactivation, cells should be 
quenched immediately together with their culture medium upon sampling (Villas-Boas and 
Bruheim, 2007). If separation of cells from medium is conducted upon sampling without 
quenching, it is difficult to get an accurate metabolite level at the sampling time point as 
the cells cannot be filtered or centrifuged fast enough to prevent alteration in the 
intracellular metabolite levels (Villas-Boas and Bruheim, 2007).  
Because of the rapid turnover rate of many primary metabolites, in the range of 
1mM/s to 1.5mM/s, an efficient quenching method should be employed to allow assessing 
a reliable metabolite profile. According to Mashego et al. (2007) and Alvarez-Sanchez 
(2010), quenching should meet the following criteria. Firstly, inactivation of the metabolism 
in samples should be faster than the turnover rates of such metabolites. Secondly, the 
integrity of the cell membrane should be retained during quenching to eliminate the 
leakage of intracellular metabolites from the cells. Thirdly, the chemical and physical 
properties of metabolites and their concentration should not be changed during the 
quenching process. Finally, metabolites extracted from quenched samples should be 
tractable for subsequent analysis. 
Two strategies which have usually been applied for inactivation of metabolism 
include instant changes of temperature or pH of the sample (Alvarez-Sanchez, 2010; 
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Villas-Boas et al., 2005a). Traditionally, rapid quenching of microbial metabolic activity has 
been achieved by a rapid change of sample temperature to either low (<-400C) or high 
(>800C) or by applying instantly a change to extreme pH, either low (by adding acids) or 
high (by adding alkali solutions), (Mashego et al., 2007). In addition, automated quenching 
using special equipment has been reported (Wiendahl et al., 2007). These are based on 
using an on-line coupling of a fast sampling device for a bioreactor, and rapidly cooling 
down the sampled cell suspension. With this automated approach, the sampling device is 
pre-cooled at -500C, which is ideal for ceasing cellular metabolism. However, this 
quenching method requires a special device which is a limitation for general use. 
By changing the temperature, instantaneous inactivation of metabolism is often 
achieved by rapidly decreasing the culture temperature to values far below 0°C (Faijes et 
al., 2007). Other authors, (Wittmann et al., 2004), claimed that quenching is mainly carried 
out by cooling at values usually lower than -20oC, assuming that such a low temperature 
does not severely affect sample integrity by cold shock. The lower temperature leads to 
the slower turnover rate of all the enzymes within the cell and it results in an efficient 
quenching process (Sellick et al., 2009). Another approach of quenching is applying a fast 
increase of temperature, which also interrupts cell metabolism as in the addition of ethanol 
at 94oC (Faijes et al., 2007). However, this method generates potential degradation of 
thermo-labile metabolites and increases cell permeability (Winder et al., 2008). Therefore, 
a quenching solution with a low melting point, (far below 0oC), is often preferred. 
 The most common quenching solution is cold methanol (usually 60% v/v in water, at 
–40oC), which stops metabolism of the cells in a very short time (Bolten and Wittmann, 
2008; Lu et al., 2008; Ritter et al., 2008; Sellick et al., 2009). Methanol possesses several 
advantages of a good quenching solution including miscibility with water, low melting point, 
and low viscosity (Canelas et al., 2008). Cold methanol quenching, (non-buffered or 
buffered with HEPES or AMBIC or NaCl), has been used widely for  yeast and bacteria 
(Bolten and Wittmann, 2008; Canelas et al., 2008; de Koning and van Dam, 1992; Faijes 
et al., 2007; Gonzalez et al., 1997; Hans et al., 2001; Loret et al., 2007). However, it has 
been reported that there is a leakage of intracellular metabolites from yeast and bacteria 
due to cellular membrane disruption during quenching such cells with non-buffered or even 
buffered cold methanol (Bolten et al., 2007; Villas-Boas et al., 2005a; Winder et al., 2008; 
Wittmann et al., 2004). That is why it is not used frequently for animal cells, which lack a 
cell wall, and are more prone to cell membrane damage. 
For mammalian cells, the use of AMBIC, (0.85%), supplemented in cold methanol 
(60%,-40oC), improved significantly intracellular metabolite concentrations over the use of 
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methanol alone (Sellick et al., 2009). However, Dietmair et al., (2010), pointed out the use 
of cold methanol, with or without AMBIC, induces leakage of intracellular metabolites from 
CHO cells. These authors found that, cold sodium chloride, (0.9%), is the most appropriate 
quenching solution for fragile mammalian cells. Animal cells, (mammalian cells and insect 
cells), are highly sensitive to osmolarity changes and the cellular membrane is rapidly 
disrupted by organic solvents. Therefore, higher melting point quenching solutions, 
(around 0oC), that cause minimal cell membrane damage, would be most suitable for 
animal cells. 
Separation of cells from spent medium 
Following quenching, the cells should be separated from the spent medium-
quenching solution mixture. This step aims to minimize the dilution effect of extracting the 
cells in the presence of the medium/quenching solution and allows separate quantification 
of intracellular and extracellular metabolites (Bolten et al., 2007; Villas-Boas et al., 2005a). 
The separation step is usually done by fast filtration or cold centrifugation. Fast filtration 
usually takes several seconds (Bolten et al., 2007), and hence metabolite levels can 
change during the filtration. Thus, fast filtration is only a suitable approach for metabolites 
with low turnover rates (de Koning and van Dam, 1992). Cold centrifugation tends to be 
used frequently because sample handling is conducted at low temperatures and hence the 
turnover of metabolites is eliminated or minimized (Mashego et al., 2007; Villas-Boas et 
al., 2005a). Cold centrifugation tends to be the preferred choice among these two cell 
separation methods (Mashego et al., 2007). 
In the separation step, additional washes may be included to get rid of metabolites 
derived from the culture medium, especially for animal cells which are grown in a complex 
and rich medium. However, the introduction of additional washes increases damage of the 
cells (Dietmair et al., 2010), and results in leakage of intracellular metabolites from the 
cells (Sellick et al., 2009), or results in metabolite turnover and a change in the metabolite 
profile (Plassmeier et al., 2007). Therefore, the application of additional washes should be 
considered carefully and often involves a compromise between the benefits derived from 
the wash and the loss of intracellular metabolites following washing. In the case of 
washing being unavoidable, such as in the measurement of intracellular metabolites for 
insect cells grown in a very rich medium, development of a quenching solution that can 
protect the cells during the quenching and washing process is required. 
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Metabolite extraction 
Following the quenching and separation steps, metabolites are usually extracted from 
cell pellets using extraction solvents. The extraction is performed to lyse the cells and 
release the intracellular metabolites. Ideally, the extraction method should extract all or the 
maximum number of metabolites as possible in the sample with the highest efficiency and 
minimum degradation (Faijes et al., 2007; Maharjan and Ferenci, 2003; Sellick et al., 2009; 
Villas-Boas and Bruheim, 2007). However, it is difficult to develop an extraction procedure 
suitable for all metabolites due to their physical and chemical diversity. There is no unique 
extraction procedure for metabolome analysis, among many different procedures, that is 
optimal for extraction of all metabolites (Faijes et al., 2007; Villas-Boas et al., 2005b). 
A series of extraction methods using different solutions have been employed to 
extract intracellular metabolites of different living organisms from bacteria and yeast to 
plant and animal cells and tissues. To be selected as an extraction agent, the agent should 
neither physically nor chemically modify the metabolites targeted for analysis (Mashego et 
al., 2007). Furthermore, extraction solvents should be compatible with the subsequent 
analytical procedures (Villas-Boas et al., 2005b). A wide range of different extraction 
solutions have been reported including alcohols, water, acids, bases and organic solvents 
at high or low temperature (de Koning and van Dam, 1992; Dietmair et al., 2010; Faijes et 
al., 2007; Grob et al., 2003; Maharjan and Ferenci, 2003; Ritter et al., 2008; Sellick et al., 
2009; Shryock et al., 1986; Villas-Boas et al., 2005a; Villas-Boas et al., 2005b; Winder et 
al., 2008), and each solution is only suitable for specific classes of metabolites and certain 
cell types (Canelas et al., 2009; de Koning and van Dam, 1992; Grob et al., 2003; 
Maharjan and Ferenci, 2003; Rabinowitz and Kimball, 2007; Shryock et al., 1986; Tomiya 
et al., 2001; Villas-Boas et al., 2005b). Therefore, the extraction protocol is selected 
depending on the aim of study and the target biological sample (Alvarez-Sanchez, 2010), 
as well as being based on the nature and level of metabolites extracted (Dunn and Ellis, 
2005). While targeted analysis requires a highly selective extraction that provides clean 
and concentrated extracts, metabolic profiling is possible using a non-selective extraction 
procedure (Alvarez-Sanchez, 2010). The selection of an extraction method in particular 
depends on the cell type to be studied. Cell size and cellular composition can significantly 
affect the extraction procedure required (Sellick et al., 2010). 
A huge number of publications report on optimized quenching and extraction 
procedures for yeast and bacterial cells (Bolten et al., 2007; de Koning and van Dam, 
1992; Faijes et al., 2007; Maharjan and Ferenci, 2003; Villas-Boas et al., 2005a; Winder et 
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al., 2008). Whereas, there are comparatively few papers comparing quenching and 
extraction methods in mammalian cells (Dietmair et al., 2010; Grob et al., 2003; Ritter et 
al., 2008; Sellick et al., 2009; Sellick et al., 2010).  Ritter et al., (2008) did a screening of 
different extraction protocols for Madin–Darby canine kidney, (MDCK), cells and 
recommended that methanol/chloroform (MeOH/CHCl3) and MeOH/Boil are promising 
candidates for the investigation of a large number of intracellular metabolites by anion 
exchange chromatography analysis. Sellick et al., (2010) reported that the extraction of 
metabolites from CHO cells using two 100% methanol extractions followed by a final water 
extraction recovered the greatest range of metabolites. Dietmair et al., (2010), evaluated 
the efficiency of 12 different extraction protocols from the literature and found that cold (-
40oC) acetonitrile at 50% in water is the most efficient extraction solution for CHO cells. 
Previously, Grob et al., (2003), also concluded 20 to 60% acetonitrile in water is the best 
solvent for extracting nucleotides in mouse lymphoma cells.  
Sample concentration 
After extraction, cell extracts need to be concentrated before analysis because they 
are diluted in a large volume of extraction solvents. In addition, extraction solvents should 
be removed from the sample prior to analysis since the solvents may interfere with the 
analytical methods used to quantify the metabolites (Villas-Boas et al., 2005b). Solvent 
removal can be done using solvent evaporation under vacuum. However, this method is 
relatively time consuming and the temperature required for solvent evaporation does not 
favor many metabolites (Ferreira et al., 1995). Freeze drying is most suitable due to the 
avoidance of thermal degradation during the concentration since metabolites are dried 
from a frozen solution. Furthermore, being free of water, many metabolites usually show 
good stability, which allows storage almost indefinitely (Villas-Boas et al., 2005b). 
1.6.4 Analysis of metabolites 
Following sample preparation, metabolites in the samples are quantified using 
different analytical techniques. Due to the natural complexity of metabolites and the 
convoluted nature of metabolism, various analytical approaches have been applied 
recently in an effort to measure multiple metabolites. In principle, almost every analytical 
technique or detection method can be employed for different parts of a metabolomic 
analysis. However, highly selective and sensitive multifunctional methods are obviously 
favoured since they allow the reliable detection of a large spectrum of compounds 
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requiring only small sample volumes (Oldiges et al., 2007). Analytical methods used for 
analyzing metabolites include thin-layer chromatography (Maharjan and Ferenci, 2003; 
Tweeddale et al., 1998), high-performance liquid chromatography (HPLC) (Dietmair et al., 
2010; Groussac et al., 2000; Meyer et al., 1999; Ritter et al., 2006; Wittmann et al., 2004), 
nuclear magnetic resonance spectroscopy (Raamsdonk et al., 2001; Tang et al., 2004) 
and chromatography coupled to mass spectrometry (MS) (Buchholz et al., 2001; Koek et 
al., 2006; Ramautar et al., 2006). 
HPLC is a common analytical technique used to analyze metabolites. For nucleotides 
and nucleotide sugars, HPLC is one of the most simple and rapid methods for measuring a 
range of these metabolites at the same time (Kochanowski et al., 2006). In addition, the 
accuracy of this technique for quantification of a wide range of substances is very reliable. 
However, only compounds with similar characteristics can be analyzed simultaneously, 
and co-eluting peaks often cannot be distinguished. Another disadvantage is that only very 
abundant metabolites can be detected with HPLC as the detection limit requires analyte 
concentrations to be in the micromolar range and in addition unknown metabolites are 
difficult to identify. 
The application of mass spectrometry (MS) for analysis of cellular metabolites has 
grown dramatically over the last two decades, and today it is the single most important 
detector method in biotechnology (Villas-Boas et al., 2005b). Chromatography (gas and 
liquid chromatography), and more recently capillary electrophoresis, coupled to MS stands 
out for its potential for high sensitivity and specificity (Bajad et al., 2006), which provides a 
very powerful analytical system (Oldiges et al., 2007). These combinations offer 
tremendous opportunities for analysis of complex biological samples since they are able to 
determine and identify a large number of metabolites in a single analysis (Villas-Boas et 
al., 2005b). 
It is impossible today to measure all of the intracellular metabolites due to the nature 
and complexity of metabolites inside the cells. The current analytical protocols available 
allow analyzing a selected number of metabolites relating to the provision of energy and 
materials for the generation of cell biomass and production of waste products, including 
nucleotides, amino acids,  sugars, and organic acids.  
1.7 Insect cell culture medium  
Medium for insect cell cultures is very complex (Castro et al., 1992). Originally, insect 
cell culture medium was developed based on the composition of hemolymph, which was 
used to design a chemically-defined basal medium containing inorganic salts, vitamins, 
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amino acids, organic acids and sugars (Wyatt, 1956). However, it is necessary to add 
heat-treated hemolymph or vertebrate serum into the basal medium to supply undefined 
substrates which are thought to be essential to support insect cell growth. Serum is a more 
suitable medium supplement than hemolymph, and it provides an ideal condition for cell 
growth and virus infection (Goodwin, 1991; Hewlett, 1991). However, the presence of 
serum in insect cell culture medium is associated with many limitations due to its high cost, 
lot-to-lot variability, inconsistent supply, the risk of disease transmission, and 
contamination with adventitious agents (Schlaeger, 1996). Moreover, the protein content in 
serum can potentially interfere with downstream processes (Reid et al., 2013). Hence, the 
next breakthrough in insect cell media was the development of serum-free and protein-free 
media (abbreviated as SFM). 
The development of SFM has involved the replacement of growth factors, lipids and 
shear protectants in serum by protein hydrolysates and a manufactured lipid emulsion 
which contains the shear protectant Pluronic F-86 (Inlow et al., 1989; Schlaeger, 1996). By 
this way, the basis of the well-established IPL41 SFM for lepidopteran insect cell lines was 
developed (Inlow et al., 1989), and its improved commercial derivatives including EX-
CELL® 401 (Sigma-Aldrich) and Sf900™II (Life Technologies) SFM (Schlaeger, 1996). 
Further improvement of SFM with the reduction in hydrolysate content has resulted in 
next-generation formulations such as Sf900™III SFM (Life Technologies). 
The use of hydrolysates in insect cell culture medium is considered as a revolution in 
SFM development. However, the reliance on hydrolysates for supplying amino acids and 
growth factors has disadvantages in terms of the lot-to-lot variability of these undefined 
components (Reid et al., 2013). The variations of materials and processes for hydrolysate 
production lead to the variations of the end product and the medium and ultimately the cell 
culture process (Pasupuleti and Braun, 2010). Although ultrafiltration processes may help 
to improve the consistency, the underlining variability in chemical composition is still 
present (Reid et al., 2013). In addition, hydrolysates also provide an amount of undesirable 
components together with desirable ones. Desirable components include amino acids, 
peptides and low molecular weight growth factors while undesirable components include 
high levels of inorganic salts (Pasupuleti and Braun, 2010), and possibly some undefined 
components imparting cellular toxicity (Lu et al., 2007). Other problems associated with 
protein hydrolysates include a wide divergence in aqueous solubility that limits their 
inclusion at high levels, especially in concentrated feeds. The problem associated with 
hydrolysates may be addressed by the development of a chemically defined medium 
(CDM). CDM are also useful for further metabolomics and fluxomics studies. Currently, 
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CDM formulations are well established for mammalian cell culture, but are not yet 
available for insect cell culture (Reid et al., 2013). 
1.8 The thesis outline 
The improvement of the yield of baculovirus-insect cell expression systems is 
essential for commercial viability of the products from these systems. The challenge for 
improving the yield of baculovirus insect cell systems is that protein yield (per cell basis) 
drops when cells are infected at a high cell density, which is known as “the cell density 
effect”.  Many research groups have investigated the extracellular environment through the 
measurement of extracellular metabolites to identify the limiting nutrients in the medium 
(Caron et al., 1990; Drews et al., 1995; Reuveny et al., 1993), the measurement of 
consumption rates and fluxomics analysis (Bernal et al., 2009), the supplement of glucose, 
glutamine, complex nutrient mixtures, and key intermediate metabolites to culture media 
(Carinhas et al., 2010; Reuveny et al., 1993), in order to overcome the cell density effect.  
However, the limitation of these approaches is that the metabolite levels in the media 
might not necessarily reflect intracellular metabolite levels. For many reasons, some 
metabolites may not get into the cells at high cell densities post-infection, although they 
are available in the culture medium at reasonable levels. Therefore, the metabolite 
environment inside the cells at low and high cell densities at the time of infection provides 
a better understanding of what happens inside the cells and may reveal the cause of the 
cell density effect. In particular, intracellular metabolite measurements in combination with 
consumption rates of key metabolites may identify limitations during high cell density 
infections. Especially, at the very late phase of infection which involves a high level of 
protein production, it is likely that a high demand for energy and amino acids is placed 
upon the cell, but the cell is entering a death phase at this time and so the uptake of 
nutrients may be compromised. Thus, a key research question is whether the intracellular 
levels of key metabolites (e.g. amino acids) are low during the late stage of high density 
infections compared to appropriate controls (low ICDs)? 
In order to address the issue regarding possible intracellular limitations during high 
cell density infections, key metabolites involved in the supply of energy and substrates for 
DNA, RNA, and protein synthesis such as intracellular nucleotides and amino acids should 
be measured. However, there is no sample preparation protocol for quantitative 
intracellular metabolite analysis available for insect cells. Thus, a methodology for 
quantitative intracellular metabolite analysis of insect cells was developed and optimized 
(Chapter 3). In this chapter, two particular baculovirus applications were tested, 
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representing recombinant protein production (Autographa californica nucleopolyhedrovirus 
(AcMNPV) in Spodoptera frugiperda (Sf9) cells) and biopesticide production (Helicoverpa 
armigera nucleopolyhedrovirus (HearNPV) in Heliothis zea (HzAM1) cells).   
Following the development of a methodology for quantitative intracellular metabolite 
analysis of insect cells (Chapter 3), the limitations related to the drop in specific yield for a 
high cell density infection of Sf9 cells in Sf900™III medium was investigated using a 
metabolomics approach (Chapter 4). In this chapter, substrate consumption rates as well 
as intracellular metabolite levels of infected cells at low and high cell densities at the time 
of infection were measured and compared between these two infection conditions. 
Reasons for studying the Sf9 system prior to the HzAM1 system include the vast amount 
of information on cell metabolism, and the well documented cell density effect for the Sf9 
system. In addition, recombinant AcMNPV viruses produce high titer stocks and the 
production of certain recombinant proteins is easily quantified. Finally there are strong 
commercial interests for this system for the production of recombinant proteins, vaccines 
and vectors for gene therapy. 
Ideally, the cells should be cultured using a fully chemically defined medium (CDM) 
for the investigation of extra- and intra-cellular environments. However, a CDM for insect 
cells is not commercially available and the development of such a CDM is beyond the 
scope of a research laboratory. Fortunately, a prototype CDM for insect cell culture was 
made available for testing by Life Technologies. This CDM contains no peptides, and the 
free amino acid levels are higher than in Sf900™III. It is interesting to investigate any 
differences in intracellular metabolite levels of the Sf9 cells in the CDM compared to that 
for cells in Sf900™III, especially for high cell density infections. Substrate consumption 
rates and intracellular metabolite levels of infected cells at low and high infection cell 
densities were measured and compared between these two infection conditions using the 
available CDM as a comparison to the results obtained in Chapter 4 using the 
commercially available Sf900™III medium (Chapter 5). 
Following the investigation of limitations related to the drop in specific yields for high 
cell density infections of Sf9 cells in Sf900™III/CDM media (Chapters 4 & 5), it was of 
interest to investigate limitations related to the decline in cell specific yield with increasing 
ICD for another cell line/virus system, such as the wild-type HearNPV infected HzAM1 
system (Chapter 6). It is interesting to explore whether there are any differences in terms 
of limitations related to the cell density effect between different cell lines infected with 
different viruses when using the same medium for both cell lines.  
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The following chapter (Chapter 2) provides details of general materials and methods 
used in this research project. The techniques for insect cell culture and maintenance, 
preparation of budded virus stocks, and bioassays are included. The specific techniques/ 
methods used for particular experiments of the results chapters are described in the 
relevant chapters. Finally, Chapter 7 contains a general discussion, conclusions and 
provides recommendations for future investigations.  
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Chapter 2 
Materials and Methods
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2.1 Insect cell culture and maintenance 
2.1.1 Insect cell lines 
The insect cell lines used in this study are a Helicoverpa zea cell line (BCIRL-
HzAM1) and a Spodoptera frugiperda clone 9 cell line (Sf9; ATCC CRL 1711). 
The HzAM1 cell line was derived from the pupal ovarian tissue of H. zea 
(Lepidoptera: Noctuidae) (McIntosh and Ignoffo, 1981). This cell line was originally 
obtained from CSIRO, Division of Entomology, Canberra, Australia. In our lab, the cells 
were adapted to a low cost, home-made, serum free medium, VPM3 medium, which was 
disclosed in the PCT patent, WO/2005/045014 (Reid and Lua, 2005). The cells were then 
adapted to the serum-free medium Sf900™II (Gibco, Life Technologies, New York, USA) 
in suspension cultures using Erlenmeyer flasks (Corning Incorporate, NJ, USA) prior to 
being used in this study.  
The Sf9 cell line was originally purchased from the American Type Culture Collection 
(ATCC CRL 1711). This cell line was cloned from the Sf21 cell line by Smith et al. (1983). 
The Sf21 cell line originated from the ovarian tissue of several fall armyworm pupae 
(Spodoptera frugiperda) (Vaughn et al., 1977). The cells were adapted to Sf900™II 
medium by previous students in our laboratory and have been passaged 75 to 100 times 
prior to generation of the frozen stock used in this study. 
2.1.2 Insect cell serum free media 
The media used in this study are Sf900™II and Sf900™III. Both are commercially 
available serum-free media designed for insect cells (Gibco, Life Technologies, New York, 
USA). In addition to Sf900™II and Sf900™III, a fully chemically defined medium (CDM) is 
also used for testing (Life Technologies). This prototype CDM contains no peptides, and 
was designed for insect cells. 
2.1.3 Maintaining of working stock cells 
For the HzAM1 cell line, working stock cells were grown in 25 mL suspension 
cultures in 125mL Erlenmeyer flasks (Corning Incorporation, USA), on a Bioline Orbital 
Shaker (Edwards Instrument Company, Australia), operated at 120 rpm, inside a 
refrigerated incubator (Thermoline, Australia), at 28oC. Stock cells were passaged every 3 
to 4 days with seeding cell densities of 0.4×106 and 0.25×106 cells/mL, respectively. The 
final cell densities at the time for the next passage were around 3 to 4×106 cells/mL. All 
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cell passaging was conducted in a Biological Safety Cabinet Class II (Email Westinghouse 
Pty Ltd, Australia), using aseptic techniques. The working stock cells were maintained for 
about 30 passages after thawing. 
 For the Sf9 cell line, working stock cells were maintained as for the HzAM1 cell line. 
However, the peak cell density of Sf9 cells is much higher than that of HzAM1 cells in 
culture (around 1.8×107 cells/mL compared to 8×106 cells/mL, respectively), thus they 
were seeded at 0.3×106 and 0.5×106 cells/mL for stock cells maintained for 4 and 3 days, 
respectively. The final cell density at the time for the next passage was around 4 to 5×106 
cells/mL. Stock cells were also used for up to 30 passages after thawing. 
 
2.1.4 Cell density and cell viability determination 
Manual cell count using a microscope 
Cell density and viability of working stock cells were determined by manual counts 
using a microscope (Olympus, Japan). The cells were serially diluted with Sf900™II 
medium and then 1:1 with 0.1% Trypan Blue (Sigma-Aldrich) to give around 100 cells on 
each side of a haemocytometer (Weber, England). The dilution factor D of the original 
culture is calculated using the following equation to achieve the above counting cell 
density: 
 
In cases where the cell density (CD) was unknown before counting, its value was 
estimated based on the initial seeding cell density and the culture period with the 
assumption that cells double every 24 hours.  
Samples were counted immediately upon diluting with Trypan Blue to avoid the 
uptake of Trypan Blue by viable cells. In Trypan Blue, viable cells remain with a pale 
yellow colour, while dead cells uptake Trypan Blue and become blue. Both sides of a 
haemocytometer (18 squares) were measured as a single count. The volume enclosed in 
the 18 counting squares is exactly 1.8 x 10-3 ml when the cover slip is placed on top of the 
haemocytometer prior to loading the sample. Triplicate counts (3 haemocytometers) of 
each sample were performed each time to estimate cell density with the random relative 
error of 15% (Nielsen et al., 1991). Cell viabilities were determined by dividing the number 
of viable cells by the number of total cells counted (including viable and dead cells). 
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Manual cell counts using a microscope were conducted for determination of the cell 
density and viability of working stock cells and the viability of experiments. The total cell 
densities of all of the experiments were measured using a Multisizer™4 Coulter Counter 
(Beckman Coulter Inc., Fullerton, CA, USA). 
Cell count using the Multisizer™4 Coulter Counter 
A Multisizer™ Coulter Counter was used to measure total cell densities and cell 
volumes for all experiments. Although the viability cannot be measured by the 
Multisizer™4 Coulter Counter, measurements of cell densities using such a machine is 
more objective and less time consuming than are manual counts. The particle size that the 
machine can count ranges from 0 to 60 µm. For insect cells (HzAM1 cells with an average 
cell size of 17-18 µm, and 14-15 µm for Sf9 cells), the range for cell counts was set from 9 
to 60 µm. Cell densities obtained using this range matched the result of manual cell counts 
using a microscope. 
Samples need to be serially diluted with fresh medium to get the total cell density to 
around 0.5×106 cells/mL. The sample was then diluted a further 101X with IsoFlowTM 
(Beckman Coulter Pty. Ltd., Gladesville, Australia), in a special clear plastic vial Accuvette 
(add 0.2 mL culture into 20 mL IsoFlow), before counting using the Multisizer™4 Coulter 
Counter. 
 
2.2 Baculoviruses 
The viruses used in this study were the wild type Helicoverpa armigera single 
nucleopolyhedrovirus (HearNPV) and the recombinant Autographa californica multiple 
nucleopolyhedrovirus (rAcMNPV).  
The wild type HearNPV (strain H25EA1) used in this study was obtained from CSIRO 
(Entomology Division, Canberra, Australia), and is an Australian field isolate. These OB 
working stocks were harvested from later stage HearNPV infected caterpillars. These 
stocks were harvested from Helicoverpa armigera caterpillar colonies maintained by the 
Queensland Department of Primary Industries (QDPI), Brisbane, Australia. 
A recombinant rAcMNPV which expresses the Escherichia coli LacZ gene for 
producing the β−Galactosidase (β-Gal) protein under the control of the polyhedrin 
promoter was used to infect Sf9 cells in this study. This virus was from old frozen virus 
stocks which then underwent a plaque purification process to pick up a good virus isolate 
for producing a fresh working virus stock. 
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2.2.1 Preparation of budded virus stocks 
Wild type HearNPV virus 
Passage 1 (P1) virus stock was generated by infection of HzAM1 cultures (in 
Sf900™II or Sf900™III media), with the ODVs derived from caterpillar OB’s. In order to get 
ODVs, the OB’s were digested  by adding a 40 µL alkaline solution (0.5M Na2CO3 and 1M 
NaCl) into an aliquot of 0.5 mL of caterpillar OB containing 1010 OB in an eppendorf tube, 
and vortexed to mix well. The tube was incubated at 28oC for 30 minutes to destroy the 
polyhedron matrix to release the ODVs, and then transferred into a Petri dish and mixed 
with 10.5 mL of medium by gentle pipetting. The mixture of the virus (ODVs) and the 
medium was filtered by using 0.22 µm syringe filters (Sartorious, Australia), into a sterile 
10 ml tube. This filtered virus solution (~10 ml) was used to infect 90 ml of cell culture to 
get the final volume to 100 ml with a cell density of 0.5×106 cells/mL. The passage 1 
infected culture (P1) was incubated at 28oC and 120 rpm. P1 budded virus stock (BV) was 
harvested at 4 days post-infection and used for P2 infections. 
Passage 2 (P2) virus stock was prepared from the P1 virus stock. P2 virus was 
prepared by infecting the early exponential phase of an HzAM1 culture at 1×106 cells/mL 
(cultures were set up at 0.5×106 cells/mL and infection was conducted 24 hours later), with 
30% (v/v) P1 virus stock (whole culture). The P2 virus infected culture was incubated at 
28oC, 120 rpm. After 3 days of infection, the infected P2 culture was collected and 
centrifuged at 1000×g for 10 minutes (room temperature centrifugation). The P2 budded 
virus (BV) supernatant was harvested in the biosafety cabinet into 10ml tubes (~10ml 
each) and kept in the fridge (4oC) for quick use or stored in a -80oC freezer (Sanyo, 
Japan), for longer term use. Prior to use for infection, P2 supernatant virus was assayed to 
determine the virus titer using a suspension culture method. All experiments were 
conducted using P2 virus to initiate P3 infections. 
Recombinant AcMNPV virus 
The recombinant AcMNPV virus stocks were prepared by infecting early exponential 
phase Sf9 cell cultures (in Sf900™II or Sf900™III media) at the infection cell density (ICD) 
of 1.5×106 cells/mL and an MOI of 0.1 PFU/cell using a plaque purified virus stock, which 
had undergone 1 passage after the plaque purification process to generate the P1 virus 
stock. The infected culture was incubated at 28oC, 120 rpm for 3-4 days. The P2 virus 
stock was harvested when the total cell density reached around 5×106 cells/mL with a 
viability of around 60-70%. The supernatant was harvested by spinning the infected culture 
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at 1000×g for 10 minutes. The P2 supernatant virus was then stored at 4oC in the dark, as 
it is UV sensitive. The virus titer was determined by an endpoint assay prior to being used 
for infection. The P2 virus stock was used for experiments only when the BV titer was at 
least 1×109 PFU/mL. 
2.2.2 Virus titration 
Wild type HearNPV virus 
Fresh and frozen supernatant P2 virus was assayed to determine the virus titer using 
a suspension culture method as described by Matindoost et al. (2012). The titration 
involved 2 infected flasks at an ICD of 0.5×106 cells/mL infected with 2.5% of P2 virus (v/v) 
and 1 uninfected control flask at a seeding cell density of 0.5×106 cells/mL. Viable and 
total cell densities of the three shaker flasks were determined at 0, 2, 3 and 4 days post 
infection by manual counts using a microscope. The multiplicity of infection (MOI) was 
estimated based on the viable cell density at the time of infection and the total peak cell 
density (either at 3 or 4 days post infection) by a model using Matlab software (MathWorks 
Inc., USA). The budded virus titer was then calculated based on the initial viable cell 
density, MOI and the volume of virus used for infection. The model used was based on a 
model developed by (Power et al., 1994) and adapted to wild-type HearNPV infections 
based on virus kinetic data generated by Marcia Pedrini (Pedrini, 2003). 
Recombinant AcMNPV virus 
The virus titer of the rAcMNPV P2 stocks were estimated using an endpoint titration 
assay (Nielsen et al., 1992). The procedure of the assay is as follows. A Sf9 cell culture in 
Sf900™II or Sf900™III media was freshly prepared with a seeding cell density of about 
0.5×106 cells/mL the day before the assay, and was grown up to a cell density of around 
1×106cells/ml. The virus sample was serially diluted (10-fold, nine times, from 10-1 to 10-9) 
with fresh medium. Each dilution of the serial virus dilutions from 10-5 to 10-9 were mixed 
with an equal volume of cell culture (at a cell density of 1×106 cells/mL) using a vortex 
mixer. Each virus cell mixture (at each virus dilution), was then placed into 20 wells of 60-
well plates (Nalge Nunc) with 10 μL/well. The plates were then incubated in a humidified 
plastic box (filled with moist paper towels) at 28°C for 7 days in an incubator. After 
incubation of the virus titer plates, 8 μL X-gal (Progen, Brisbane, Australia) dissolved at 0.8 
mg/mL in water with 4% v/v DMSO (Sigma-Aldrich) was added to each well. X-gal (5-
bromo-chloryl-4-indyl-β-D-galactopyraniside) is a chromogenic substrate which is cleaved 
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by β-Gal to form a blue coloured compound. The plates were then left in the dark for 2-4 
hours for colour development. The wells containing virus will become blue because they 
contain β-Gal which was produced during the cell infection. The number of blue (positive) 
and clear (negative) wells were recorded and converted into plaque-forming units per 
milliliter (PFU/mL) using software developed by Nielsen et al. (1992). 
2.3 Cryopreservation  
2.3.1 Preparation for freezing cell stocks 
Master stocks of Sf9 and HzAM1 cells were cryopreserved in liquid nitrogen for long 
term storage and to ensure the continuation of research as master stock cells are not 
passaged beyond 30 times after thawing. In order to achieve successful freezing, the cells 
being frozen should be in an exponential phase of growth and have at least 98% of 
viability.  
For the Sf9 cell line, the procedure for freezing stock cells is as follows.  
1. Prepare cells prior to freezing: 100 mL of cell culture was prepared in a 250 mL 
shaker flask and incubated to a cell density of 4-6×106 cells/mL. The culture prepared for 
freezing must be growing optimally, with a doubling time of 24 hours or lower and viability 
of at least 95%, and definitely without sign of contamination. Otherwise, the culture was 
not used for making frozen stock cells and another fresh culture had to be prepared. At the 
time the desired cell density of stock cells was reached, the culture was aliquoted into two 
50 mL sterile tubes and centrifuged at a low speed, 200×g, for 5 minutes to get the cell 
pellet. The cell pellet in each tube was then re-suspended with 2.75 mL of conditioned 
medium, which is collected from the centrifugation step to separate the cells and the 
supernatant (conditioned medium). The two re-suspended cell pellets (about 2.75 mL 
each) were pooled together and diluted with 5.5 mL of fresh medium containing 15% (v/v) 
DMSO (Sigma-Aldrich, St. Louis, USA) to give a final volume of 11 mL.  
2. Freezing: The 11 mL of cell suspension prepared in step 1 was aliquoted into 11 
cryogenic ampoules (1 mL each) and then sealed with screw caps. The ampoules were 
placed on ice, and encased in an air-tight protective sheath (Cryoflex, Nalge Nunc). Then, 
the ampoules were inserted onto a slow freezing container, “Mr. Frosty” (Nagle Nunc 
International, USA), containing isopropanol. “Mr. Frosty” containers were placed in a fridge 
at 4oC for 1 hour and then kept in a -80oC freezer (Sanyo, Japan) overnight. After this, the 
frozen ampoules were transferred from the “Mr. Frosty” containers into canes, and the 
canes were stored in a dewar filled with liquid nitrogen. 
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For the HzAM1 cell line, the procedure for freezing stock cells also includes the steps 
as described above. The only difference is that the cell density of the culture at the time of 
the freezing step is lower (2.5-3×106 cells/mL) and a frozen volume of 1.8 mL was used 
instead of 1mL. 
2.3.2 Thawing frozen cells 
The frozen stock cells were thawed using the following procedure: 
1. A frozen ampoule was retrieved from the liquid nitrogen dewar and then the cryoflex 
was removed 
2. The ampoule was rapidly thawed in a 27oC water bath 
3. After thawing, decontaminate the outside of the ampoule using ethanol 70%  
4. Then, the cell suspension from the ampoule was transferred into a sterile 250ml flask, 
which contains 48 mL of fresh medium, using a transfer pipette. 
5. The culture was incubated at 28oC, 120 rpm 
6. Count the cells and check viability every day and passage the cells when the cell 
density reaches 2-3×106 cells/mL with a viability of around 90%, then passage the 
cells as usual as for stock cells. The growth of the new thawed cells was monitored for 
a few passages to ensure they were growing well before use as a working stock.  
 
2.4 Bioassays 
2.4.1 -Galactosidase (β-Gal) assay 
The amount of β-Gal was measured using a spectrophotometric assay (Miller, 1972). 
In this method, the enzymatic activity was measured based on the ability of the enzyme to 
catalyze cleavage of o-nitrophenyl-β-D-galactopyranoside (ONPG) to produce galactose 
and the yellow coloured compound o-nitrophenol. The absorbance of the latter compound 
was measured at 420 nm using a Spectramax M5 microplate reader (Molecular Devices 
Inc., USA). The colour development is linearly related to the concentration of hydrolyzed 
ONPG, (hence the activity of -Gal), and the reaction time.  
The protocol for the β-Gal assay is described as follows. Samples were diluted with 
MiliQ water to the point that provides an absorbance at 420 nm in the range of 0.3 to 0.8. 
50 L of diluted sample was mixed with 950 L of Z buffer (0.06 M Na2HPO4, 0.04 M 
NaH2PO4, 0.001M MgSO4, 0.01 M KCl, 0.035% v/v -mercaptoethanol in water) and 200 
L of ONPG (4 mg/L) in a 10 mL tube (Sarstedt, Australia). A blank was prepared as 
above with 50 L water instead of diluted sample being added. The mixture was incubated 
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at 370C for 30 minutes in a water bath. After this time, 500 L of stop buffer (1M Na2CO3) 
was added to cease the reaction. The reaction solution (1700 L) was transferred into a 
cuvette (Sarstedt, Australia) and the absorbance measured at 420 nm. The absorbance of 
sample was corrected with the blank sample to exclude the background. 
The -Gal activity was calculated as follows: 
 
Where:  VY : Volumetric yield of β-Gal (Units/mL) 
 A : Absorbance at 420 nm 
 ε  : Absorbance coefficient of o-nitrophenol at 420nm (4500 L/mole/cm) 
 l : Cuvette path length (1 cm) 
 t : Incubation time (30 minutes) 
 D : Dilution factor 
 Vtotal : Final volume in cuvette (1700 μL) 
 Vsample: Sample volume (50 μL) 
 
2.4.2 Polyhedra extraction and enumeration 
Polyhedra were extracted from infected cells using 1% sodium dodecyl sulphate 
(SDS). An equal volume of SDS 1% was added to an infected culture. The mixture was 
mixed well and incubated at 280C for 30 minutes to dissolve the cell membrane and 
release the polyhedra. The mixture was then diluted serially with MiliQ water to an 
appropriate dilution to allow a count of 25-30 OBs per small square of a haemocytometer. 
A total of 5 small squares (out of 25 squares) were counted on each side of the 
haemocytometer. Each sample was counted in 3 haemocytometers (both sides) using an 
optical microscope (Olympus, Japan), at a 400X magnification. Diluted samples were 
counted 10 minutes after loading to allow the polyhedra to settle to the base of the 
haemocytometer. The polyhedra concentration was determined as follows: 
OB/mL = number counted in 5 small squares x 5 x dilution factor x 104 
where 10-4 ml is the volume of diluted sample in 25 small squares.  
OB/mL of each sample was the average of the OB/mL obtained from each side (6 
sides in total) of the haemocytometer counts. The cell specific yield (polyhedra per cell) 
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was obtained by dividing the volumetric yield (polyhedra per mL) by the total peak cell 
density (cell/mL). 
2.4.3 ATP assay 
Intracellular ATP concentrations were determined using an ATPlite assay kit (Thermo 
scientific, USA). Dried cell extract samples were first re-suspended in MiliQ water and then 
diluted 4 times with ultrapure water. The ATP concentration of the samples was 
determined based on the ATP standard by measuring the luminescence at 500 ms 
integration using the Spectramax M5 microplate reader (Molecular Devices Inc., USA). 
ATP standard dilution series, (0-0.01 mM) were prepared by serial dilution of an ATP 
standard, 10 mM stock solution. The concentrations of standard include 0.01 mM, 0.005 
mM, 0.0025 mM, 0.00125 mM, 0.000625 mM, 0.0003125 mM and 0 mM (blank).  
First, 50 µL of cell lysis solution was loaded into each well of 96 well microplates 
(Costar black, Corning incorporated, NY, USA). Then samples or ATP standards were 
added into the wells, at 100µL/well. Three replicates were performed for each sample or 
ATP standard concentration. The plate was then mixed on a plate shaker for 5 minutes at 
700 rpm. Finally, 50 µL of enzyme/substrate (Luciferase/Luciferin) solution (which was 
reconstituted with substrate buffer solution), was added into each well. The plate was 
mixed again on a plate shaker for 5 minutes at 700 rpm. The plate was placed in the dark 
for 10 minutes before being measured for luminescence using the Spectramax M5. 
2.4.4 Total protein assay 
Total protein from the cells was analyzed using a BCA protein assay kit (Thermo 
Fisher Scientific, Rockford, IL, USA). About 1×106 cells were used for this analysis, so the 
volume of cell culture samples was taken depending on the cell density of the culture. In 
order to get the sample volume accurately, samples were measured by weighing (subtract 
the weight of tubes after adding the culture to empty tubes). The samples were spun down 
at 1000×g for 5 minutes (Eppendorf AG, Hamburg, Germany), to separate the cell pellets 
from the medium. The cell pellets were then washed twice with PBS solution (osmolarity of 
PBS was adjusted to 360 mOsmol/Kg). The cell pellets were frozen (-20oC) for the total 
protein assay to be performed later. Prior to analysis, the cell pellet was lysed using 
sodium hydroxide 0.1M at 40oC in a water bath for 20 minutes. Cell lysis samples were 
diluted further with ultrapure water. The total protein concentration of samples was 
determined based on a BSA (bovine serum albumin) standard as follows. Standards and 
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unknown samples were added into clear bottom 96-well plates at 25 µL/well in duplicate. A 
working reagent, containing 50 parts of reagent A (sodium carbonate, sodium bicarbonate, 
bicinchoninic acid and sodium tartrate in 0.1M sodium hydroxide) and 1 part of reagent B 
(cupric sulfate 4%), was added into each well at 200 µL each. The filled plate was covered, 
mixed thoroughly on a plate shaker for 30 seconds and then incubated at 37oC for 30 
minutes in a water bath. After that, the plate was cooled down to room temperature and 
then the absorbance at 562 nm was measured using a Spectramax M5 (Molecular 
Devices Inc., USA). The BSA standard curve was generated under a sigmoidal logistics 
plot using SigmaPlot 12.3 (Systat Software Inc., Chicago, IL, USA).  
2.4.5 Measurement of viral DNA copies 
 Recombinant AcMNPV  
Quantitative real time polymerase chain reaction (qRT-PCR) was developed to 
quantify targeted DNA by Heid et al. (1996). The method has been developed by Rosinski 
et al., (2002) and optimized further by Haas (2004) for quantifying viral DNA (vDNA) 
copies of recombinant β-Gal-AcMNPV (rAcMNPV) infected Sf9 cells. The primers were 
designed to amplify the vDNA polymerase gene. The required primers and probe were 
designed based on the published sequence (Accession number L22858) of the vDNA 
polymerase gene (Rosinski et al., 2002). The length of the amplicon was 67 bp. The 
annealing temperature for the primers is 60°C and for the probe 72°C, which ensure all 
target DNA sequences have probe bound prior to the extension commencing. The 
sequences of primers and probe are as follows: 
Forward primer: 5'-ATTAGCGTGGCGTGCTTTTAC-3' 
Reverse primer: 5'-GGGTCAGGCTCCTCTTTGC-3' 
DNA-probe: 5'-FAM-CAAACACGCGCATTAACGAGAGCACC-TAMRA-3' 
Prior to measuring the vDNA copies of infected samples, the vDNA standard was 
prepared from budded virus stock. For vDNA standard preparation, 10 mL of P2 budded 
virus stock with a virus titer of more than 1×109 PFU/mL was centrifuged at 100,000× g for 
45 minutes at 4°C to pellet BV using an ultracentrifuge (Beckman Coulter Inc., Brea, CA, 
USA). Subsequently, the Qiagen genomic tip mini kit (Qiagen, Venlo, Netherlands) was 
used for the vDNA isolation from the pellet. The protocol for purifying vDNA is as follows. 
The above pelleted budded virus was re-suspended with 1 mL buffer G2. The pellet should 
be re-suspended as thoroughly as possible as this is the critical step for a good flow rate 
on the Qiagen genomic tip. Then 25 µL proteinase K stock solution (20 mg/mL) was added 
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into the re-suspended budded virus as the mixture was incubated at 500C for 30 minutes. 
The sample was now ready to load into the Qiagen genomic tip. 
Before loading the sample, the Qiagen genomic tip 20/G was equilibrated with 1 mL 
buffer QBT and allowed to empty by gravity flow. Sample was applied to the equilibrated 
Qiagen genomic tip after vortexing at full speed for 10 seconds and allowed to enter the 
resin by gravity flow. The Qiagen genomic tip was washed 3 times with 1 mL buffer QC 
each time and left for the buffer QC to move out of the Qiagen genomic tip by gravity flow. 
Then the Qiagen genomic tip was placed over a clean 10 mL collection tube and the 
genomic DNA was eluted twice with 1 mL of buffer QF each time. The purified DNA was 
precipitated by adding 1.4 mL isopropanol into the eluted DNA solution. The mixture was 
mixed and centrifuged immediately at 5000×g for 15 minutes at 4oC. The supernatant was 
removed carefully and the pellet was washed with 1 mL cold ethanol 70%. The mixture 
DNA in ethanol 70% was vortexed briefly and centrifuged at 5000×g for 10 minutes at 4oC. 
The supernatant was removed carefully and the pellet was allowed to air-dry for 10 
minutes. The purified DNA was then re-suspended in 0.2 mL TE buffer.   
The purified vDNA was qualified by running in a 6% agarose gel with a 10 kb ladder. 
A clear band was observed above the 10kb band from the ladder indicating the integrity of 
the viral DNA fragment. The isolated DNA was then quantified using both a NanoDrop 
(Themoscientific) and a Picogreen DNA assay kit (Life Technologies). The protocol for 
quantifying purified viral DNA using the Picogreen DNA assay kit was as follows. The 
working solution of Lambda DNA standard (2 μg/mL) was prepared from the 100 μg/mL 
stock solution by diluting 50X with TE buffer. The purified vDNA sample prepared above 
was diluted by 100 and 200 fold with TE buffer. Sample (100 and 200 fold dilutions) and 
standard levels were loaded into each well of a Costar black clear bottom 96-well plate 
(Corning Inc., USA) at 100 µL/well in triplicate. The same volume of a working Quan-iT 
PicoGreen reagent, prepared from stock solution by 1/200 dilution with TE buffer, was 
added into each well of the plate. The plate was measured for fluorescence at 480/520 nm 
using a Spectramax M5 (Molecular Devices Inc., USA). A standard curve was generated 
from 6 levels of standard concentration from 0 to 2000 ng/mL under a sigmoidal logistics 
plot using SigmaPlot 12.3 (Systat Software Inc., USA). 
The standard curve was generated from 6 points with the DNA concentration ranging 
from 3×10-1 to 3×10-6 ng vDNA/μL which corresponds to 2×106 to 20 vDNA copies/μL, 
assuming a molecular weight of 1.359×10-7 ng/genome (Rosinski, et al. 2002). A 
regression equation was generated between the vDNA copy number and the Ct value. 
vDNA copy number of each sample was then calculated based on its Ct value. 
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Samples were taken from infected cultures at 12 hour intervals post infection from 0 
to 60 hours post infection (hpi) and preserved for subsequent analysis. Infected samples 
containing 1×106 cells/mL were pelleted by spinning down at 300x g for 5 minutes. The cell 
pellets were then stored at -200C until analysis. Accurate volumes of culture were obtained 
by weighing the empty tubes and tubes plus cell culture. Prior to measuring total vDNA 
using qRT-PCR, the cell pellet was digested for 15 hours in 1 mL digestion buffer at 50oC 
to expose the naked DNA. Digestion buffer contains 100 mM NaCl; 10 mM Tris.HCl, pH 
8.0; 25 mM EDTA, pH 8.0; 0.5 % sodium dodecyl sulphate (SDS); and 0.1 mg/mL 
Proteinase K. Proteinase K was prepared from a stock solution of 20 mg/mL (Amresco, 
Solon, OH, USA). The weight of tubes after adding digestion buffer was obtained to get 
accurate final volumes of samples. Digested samples were then subsequently diluted by a 
10 times dilution series with injection water. Two dilution levels of 10-3 and 10-4 were used 
for measuring vDNA copies. Dilutions less than 100-fold were found to inhibit the PCR 
reaction which may be caused by the SDS (Haas, 2004). 
The master mix for the PCR reaction was prepared in a laminar flow hood which is 
free from foreign DNA contamination. The master mix for each reaction contains 5μL Taq 
Man® Universal PCR Master Mix (2-fold concentrated; Life Technologies), 2 μL primers 
(forward and reverse) at the concentration of 1 μM and 1 μL probe of 1.25 μM. Template 
DNA was added at 2 μL to the above reaction mix to get a total volume of 10 μL for each 
reaction. The master mix and DNA template were added into each well of a 384 well plate 
automatically using an Eppendorf epMotion 5075 Robotics System (Eppendorf, Hamburg, 
Germany). Each sample or standard was added into triplicate wells in the same PCR 
plate. Prior to placing the loaded reaction plate into the ABI PRISM® 7900HT Sequence 
Detection System (Life Technologies) for amplification, detection and analysis, the plate 
was sealed and spun briefly to ensure that all liquid was collected at the bottom of the 
reaction wells. The cycling protocol was 2 minutes at 50°C, 10 minutes at 95°C and 45 
cycles of 30 seconds at 95°C and 60 seconds at 60°C (data collection period ) and then 
cooled to 25°C. 
The signal from the qRT-PCR is the number of cycles used until the fluorescent 
intensity of FAMTM crossed an arbitrary cycle threshold (Ct) as determined from the 
amplification plot. Samples from the same experiment or those that need to be compared 
to each other were run in the same plate to avoid any discrepancies among plates. The 
vDNA copy number was back calculated from the average of the triplicate wells of each 
sample, the calibration curve of the used reaction plate, the sample dilution, the final 
digestion volume, and the initial sample volume. The cell specific vDNA copies were 
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determined from the copy number of the initial volume and the cell density of the culture 
post infection. 
Wild-type HearNPV 
The qRT-PCR reaction for measuring vDNA copies of the wild-type HearNPV 
generally follows the principle described for recombinant AcMNPV. vDNA polymerase 
gene of the wild-type HearNPV was also used as the target for the qRT-PCR reaction. The 
sequence of primers and probe were as described by Pedrini et al. (2011) as follows.  
Forward primer: 5'-CATTGCCAACAGTATTTACGGATATT-3' 
Reverse primer: 5'-TTCTCTACCGATCTTGGTGATGTAAT-3' 
DNA-probe: 5'-FAM-TGGAATTTTTTTCAAACCGCTCGCC-TAMRA-3' 
The viral DNA standard was prepared from 80 mL of budded virus stock with a virus 
titer of 4×107 PFU/mL and followed the procedure as described above.   
2.4.6 HPLC analysis 
Intracellular nucleotides and both intra-and extra-cellular amino acids were analyzed 
by High Performance Liquid Chromatography (HPLC) using an Agilent 1200 series system 
(Agilent, Forest Hill, VIC, Australia). This system includes a binary pump (G1312A), a 
Micro-Vacuum Degasser (G1379B), a high-performance autosampler (HiP-ALS, G1367B) 
with an FC/ALS thermostat (G1330B) for cooling samples, a thermostatted column 
compartment (G1316A) to control the temperature of the column, and a detector. A diode 
array detector (DAD, G1315C) was used to detect nucleotides; and a fluorescence 
detector (FLD, G1321A) was used for amino acid detection. The HPLC analyses for 
nucleotides and amino acids were carried out by Metabolomics Australia, Queensland 
node (AIBN).  
Nucleotide analysis 
The detail of the method for determination of nucleotides by HPLC was as described 
in Dietmair et al. (2010). The following is a brief description of the methods. The 
concentration of nucleotides was determined by ion-pairing reverse phase HPLC using a 
Gemini C18 column (3 µm, 150 x 4.6 mm, Phenomenex, Lane Cove, NSW, Australia). The 
column temperature was set at 300C, and the flow rate at 0.8 ml/minute. The gradient 
program used is presented in Table 2.1. Nucleotide concentrations were determined by 
measuring the absorbance over the whole ultraviolet (UV) spectrum with a diode array 
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detector (DAD, G1315C, Agilent). Compounds were detected and identified at the 
wavelengths of 254 and 280 nm by comparing their retention times and their 254/280 
absorbance ratios or UV spectra with those of known standards. 
Table 2.1 HPLC gradient for nucleotide quantification 
Buffer A: 100mM KH2PO4/K2HPO4, 8mM Tetrabutylammoniumsulfate (TBAS), (pH 5.5) 
 Buffer B: 75% buffer A: 25% MeOH (v/v) 
 
Amino acid analysis 
Amino acids were quantified using a high-throughput method modified from previous 
work in the group (Dietmair et al., 2010). In brief, derivatised amino acids were analysed 
by RP-HPLC. Derivatisation was performed in a high-performance autosampler (Agilent 
HiP-ALS SL, G1367C). First, 0.5 uL of sample containing 250 uM of internal standards, 
sarcosine and 2-aminobutanoic acid, was added into 2.5 uL of borate buffer (0.4 N, pH 
10.2, Agilent PN: 5061-3339), mixed and incubated for 20 s at 4oC. Then 1 uL of OPA 
reagent (10 mg o-pthalaldehyde/mL in 3-mercaptopropionic acid, Agilent PN: 5061-3335) 
was added to initially derivatise primary amino acids. The reaction was mixed and 
incubated for 20 s at 4oC. Next, 0.4 uL of FMOC reagent (2.5 mg 9-fluorenylmethyl 
chloroformate/mL in acetonitrile, Agilent PN: 5061-3337) was added, mixed and incubated 
for 20 s at 4oC, to derivatise other amino acids. After that, 45.6 uL of Buffer A (40 mM 
Na2HPO4, 0.02% NaN3, pH 7.8) was added to lower the pH of the reaction prior to injecting 
the 50 uL reaction onto an Agilent Zorbax Extend C-18 column (3.5 um, 4.6 x 150 mm, 
Agilent PN: 763953-902) with a guard column (SecurityGuard Gemini C18, Phenomenex 
PN: AJO-7597). Column temperature was kept at 37oC in a thermostatted column 
compartment (Agilent TCC, G1316B). Chromatography was performed using an Agilent 
Time (min) %A %B Flow rate (mL/min) 
0.0 100 0 0.8 
8.0 100 0 0.8 
27.0 65 35 0.8 
42.0 62 38 0.8 
44.0 0 100 0.8 
54.0 0 100 0.8 
56.0 100 0 0.8 
54.0 100 0 0.8 
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1200-SL HPLC system, equipped with an active seal wash and a degasser (Agilent 
Degasser, G1379B). The HPLC gradient was 2-45% B from 0-18 min, 50-60% B from 
18.1-20 min, 100% B from 20.1-24 min, and 2% B from 24.1-27 min – using a binary pump 
(Agilent Bin Pump SL, G1312B).  Buffer B was 45% acetonitrile, 45% methanol and 10% 
water. Flow rate was 2 mL/min. Derivatised amino acids were monitored using a 
fluorescence detector (Agilent FLD, G1321A). OPA-derivatised amino acids were detected 
at 340ex and 450em nm from 1-18 min, and FMOC-derivatised amino acids at 266ex and 
305em nm from 18-27 min. 2-aminobutanoic acid and sarcosine were used as internal 
standards for primary (0-18 min) and secondary (18-27 min) amino acids, respectively. 
Chromatograms were integrated using ChemStation (Rev B.03.02[341]).  
Organic acid and sugar analysis 
In addition to nucleotides and amino acids, extracellular organic acids (α-
ketoglutarate, pyruvate, succinate, lactate, fumarate, acetate and propionate) and sugars 
(sucrose, glucose and maltose) were analyzed by HPLC (Agilent 1200 series, Agilent, 
Mulgrave, Victoria, Australia) using both MWD and RID detectors. Maltose and sucrose 
tend to co-elute on the column as both have similar molecular weight. Thus, prior to 
analyzing using a HPLC, samples were hydrolyzed with 6M HCl at 65oC for 15 minutes in 
order to convert sucrose into glucose and fructose (Radford, 1995), while maltose is not 
hydrolyzed by this method (Lua and Reid, 2003). The samples were then separated on 
Phenomenex Rezex RHM Monosaccharide H+ 300×7.8mm 8microns + Guard column at 
70oC with the mobile phase of 100% 0.008N sulfuric acid and flow rate of 0.6 mL/min. 
Running time was 25 minutes. Injection volume was 30 μL with the injector program being 
set up as follows:  
1 Draw 40 μL from sample, max. speed (100 μL/min), -1.5 mm offset 
2 Wait 0.1 min 
3 Draw 5 μL from air, max. speed (100 μL/min) 
4 Needle wash in flush port, 10 sec 
5 Eject 15μL into waste, max. speed (100 μL/min) 
6 Inject 
Four levels of calibration standard were used for the calibration curve: level 1 (1:10 
dilution), level 2 (1:5 dilution), level 3 (1:2 dilution), and level 4 (undiluted). The amount of 
organic acids or sugars in samples was calculated from the regression equation derived 
from the known standard concentrations. The fructose level then equated to the sucrose 
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level, while the glucose level was the total glucose from the sample and from hydrolyzed 
sucrose (same amount as fructose). Glucose concentration in the sample was indirectly 
calculated by subtracting the fructose concentration from the total glucose.  
 
Calculation of specific substrate consumption, and production rates 
 
The overall cell and biomass specific rates of substrate consumption and production, 
qs (mmol/10
3 cells/hour), and qs (mmol/10
3 mm3 cell biomass/hour), can be calculated 
using following equation: 
Xq
dt
dS
S  
where S  is the substrate concentration (mM), 
 X is the average total cell density (cells/ mL) or cell volume (mm3/mL). 
As the substrate concentrations in the culture medium were measured at various 
times post-infection/inoculation, a plot of the substrate concentrations over the time post-
infection/inoculation was generated. The slope of the line was used to calculate the 
substrate consumption rate as per the following equation:  
Sq
X
Slope
  
where X is the average total cell density (cells/mL) or cell volume (mm3/mL) over the 
above period post-infection/inoculation.  
In the case of measuring the substrate concentrations at only 2 points at the 
beginning and end of the period, the substrate consumption rate was calculated as follows: 
S
tt
q
ttX
SS



)( 0
0  
where t is the time at the end of the period (hour), t0 is the time at the beginning of the 
period, St and St0 are substrate concentrations (mM) at t and t0, respectively and X is the 
average total cell density (cells/mL) or cell volume (mm3/mL) over the above period post-
infection/inoculation.
 
2.4.7 LC-MS analysis 
Intracellular nucleotides and TCA cycle intermediates were also measured by LC-
MS/MS as described previously (Dietmair et al., 2012). Briefly, the Dionex UltiMate 3000 
liquid chromatography system (Dionex, California, USA) coupled with the ABSciex 4000 
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QTRAP mass spectrometer (ABSciex, Concord, Canada) were used to measure 
concentrations of intracellular metabolites. A Gemini-NX C18 150×2.0mm, 3μm 100 Å 
particle column (Phenomenex, Aschaffenburg, Germany) was used to separate 
metabolites by chromatography. The column was maintained at 55oC in the column oven. 
The mobile phase was 7.5 mM aqueous tributylamine solution adjusted with ice-cold acetic 
acid (eluent A) and acetonitrile (eluent B) to pH 4.95. The gradient profile is shown in 
Table 2.2. The injection volume was 10 μL. The flow rate of the mobile phase was 0.3 
mL/min that was introduced directly into the mass spectrometer with no split. 
 
Table 2.2 Gradient profile for LCMS/MS 
Time (hours) Eluent A (%) 
0 100 
8 100 
20 80 
30 73 
31 0 
33 0 
34 100 
50 100 
 
The mass spectrometer, equipped with a Turbo V electro-spray ion source, was 
operated in negative ionization mode. The turbo ion spray voltage was set to -4500 V. The 
nebulizer (GS1), auxiliary (GS2), curtain (CUR) and collision (CAD) gases were 60, 20 and 
medium (arbitrary units), respectively that were generated from pressurized air in a 
N300DR nitrogen generator (Peak Scientific, Massachusetts, USA). Temperature of the 
auxiliary gas remained at 350oC. All transitions were fixed at an entrance potential of -10V. 
Declustering potential, collision energy and collision cell exit potential were set up based 
on previously optimized settings for the individual analytes. The mass spectrometer was 
set to unit resolution and scheduled Multiple Reaction Monitoring mode after determining 
the updated retention time of each analyte under the chromatographic conditions 
described above to obtain adequate selectivity and sensitivity. Randomization has been 
applied for sample acquisition and 2 quality control (QC) samples were included randomly 
for every 10 samples injected. QC1 was the repeat injection of calibration level 3 (12.5 μM) 
and QC2 was a pooled sample for the entire sample set (Sangster et al., 2006). By this 
way, acquisition stability and reproducibility were monitored. 
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To achieve higher performance and accuracy of the LCMS/MS data the following 
modifications have been made to the above protocol. The analytical column was equipped 
with a pre-column Security Guard Gemini-NX C18 4 mm × 2 mm I.D. cartridge 
(Phenomenex, Aschaffenburg, Germany). The samples were run with sample- and 
analyte-relevant calibration standards and pooled QC samples (Hodson et al., 2009; 
Sangster et al., 2006) to control for reproducibility of data acquisition and to ensure data 
integrity. Analyte stock solutions were prepared in purified water (Veolia Water Solution & 
Technologies, Pyrmont, Australia) and aliquots of each solution were mixed to achieve a 
final calibrant solution at 200 μM.  This calibrant solution was serially diluted and the 
dilutions used as calibration standards from 200 to 0.006 μM, constituting 9≤x≤20 
calibration points for all analytes to account for differential responses in the mass 
spectrometer. Data were processed and analysed in Analyst 1.5.2 and MultiQuant 2.1.1 
(ABSciex, Canada). 
2.5 Evaluation of insect cells grown in 50 mL tube bioreactors 
Prior to developing a method for quenching and extraction of intracellular metabolites 
of cultured insect cells, the growth of insect cells in tube cultures was investigated. The 
advantage of tube cultures is that it allows conducting the quenching process quickly by 
pouring immediately the culture in each tube into a cold quenching solution. Since the 
working volume of the tube culture can be set up at 10 ml, this volume is sufficient for one 
intracellular extraction sample. As the whole culture can be sacrificed for analysis, 
sampling and quenching is achieved very rapidly (within seconds). The growth of cells in 
50 ml tubes was tested for both HzAM1 and Sf9 cell lines compared with shaker flasks as 
controls. 
Tube testing was conducted for both non-infected and infected cultures of HzAM1 
and Sf9 cells with different shaking speeds 200, 220, 240, and 260 rpm, and different 
working volumes of 10ml and 20ml. The control was a culture in shaker flasks (25 ml 
working volume) at 120 rpm. 
The testing showed that tube cultures worked well compared to the shaker controls 
for the HzAM1 cells but not for the Sf9 cells. Hence shaker cultures rather than tube 
cultures were used for Sf9 experiments. 
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Development of intracellular 
metabolite extraction protocol for 
insect cells 
Development of quenching and washing protocols for quantitative
intracellular metabolite analysis of uninfected and baculovirus-infected insect cells
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a b s t r a c t
Metabolomics refer to the global analysis of small moleculemetabolites in a biological system, and can be a
powerful tool to elucidate andoptimize cellular processes, particularlywhen integrated into a systemsbiol-
ogy framework. Determining the endometabolome in cultured animal cells is especially challenging, due to
the conﬂicting demands for rapid quenching of metabolism and retention of membrane integrity, while
cells are separated from the complex medium. The challenge is magniﬁed in virus infected cells due to
increased membrane fragility. This paper describes an effective methodology for quantitative intracellular
metabolite analysis of the baculovirus–insect cell expression system, an important platform for the produc-
tion of heterologous proteins and baculovirus-based biopesticides. These two applications were repre-
sented by Spodoptera frugiperda (Sf9) and Helicoverpa zea (HzAM1) cells infected with recombinant
Autographa californica andwild-typeHelicoverpa armigeranucleopolyhedroviruses (AcMNPVandHaSNPV),
respectively. Speciﬁcally, an ice-cold quenching solution comprising 1.1%w/v NaCl and 0.2%w/v Pluronic
F-68 (NaCl + P) was found to be efﬁcacious in preserving cell viability and minimizing cell leakage during
quenching and centrifugation-based washing procedures (prior to extraction using cold 50% v/v acetoni-
trile). Good recoveries of intracellular adenosine triphosphate, total adenosine phosphates and amino acids
were obtained after just one wash step, for both uninfected and infected insect cells. The ability to imple-
ment wash steps is critical, as insect cell media are metabolites-rich, while infected insect cells are much
more fragile than their uninfected counterparts. Hence, a promising methodology has been developed to
facilitate endometabolomic analysis of insect cell–baculovirus systems for bioprocess optimization.
Crown Copyright  2011 Published by Elsevier Inc. All rights reserved.
1. Introduction
The baculovirus–insect cell expression system is widely used in
research for efﬁcient production of near-authentic recombinant
eukaryotic proteins [1–3], and has evolving applications in human
biologics such as humanized N-glycoproteins, baculovirus display
immunogens and gene delivery vectors for mammalian cells
[2,4]. Recently, baculovirus-expression has gained considerable
momentum as a regulatory-approved manufacturing platform for
human (Cervarix, Provenge) and veterinary (Ingelvac, Porcilis)
vaccines [3]. Furthermore, baculoviruses can be developed as effec-
tive biopesticides for many agriculturally-important insect pests,
especially as part of an integrated pest management program [5,6].
For commercial viability, baculovirus–insect cell bioprocesses
have to be optimized for high protein product yields, and this likely
involves a high cell density production process using fed-batch cul-
tures in stirred-tank bioreactors [7]. However, scaling-up such a
process is challenging, as insect cell–baculovirus interactions are
complex, and may have variable outcomes depending on changes
in the nutrient (medium and feed) and ﬂuid-mechanical (bioreac-
tor) environments. This is especially the case when nutrient levels
in feeds are progressively increased for high cell density infections,
leading to perturbations such as osmotic shock and toxin accumu-
lation [7]. A systems biology approach, involving the integration of
various omics platforms such as transcriptomics and metabolomics
into genome-scale computational models, could bring about better
elucidation of complex biological systems, and offer rational strat-
egies towards bioprocess optimization [8,9]. With this in mind, a
methodology was developed in this study for quantitative intracel-
lular metabolite analysis of insect cells, to enable the application of
metabolomics for the baculovirus–insect cell expression system.
Two particular baculovirus applications were tested in this study,
representing recombinant protein production (Autographa californi-
ca nucleopolyhedrovirus in Spodoptera frugiperda (Sf9) cells) and
biopesticide production (Helicoverpa armigera nucleopolyhedrovi-
rus in Helicoverpa zea (HzAM1) cells).
While the exometabolome of cell cultures has been well-
researched in the past [10], it is the endometabolome that offers
the most comprehensive information regarding cell metabolism
[8]. However, quantitative intracellular metabolite analysis is the
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doi:10.1016/j.ymeth.2011.11.009
⇑ Corresponding author. Address: Australian Institute for Bioengineering and
Nanotechnology, Building 75, Corner College/Cooper Road, The University of
Queensland, St. Lucia, QLD 4072, Australia. Fax: +61 7 3346 3973.
E-mail address: lars.nielsen@uq.edu.au (L.K. Nielsen).
Methods 56 (2012) 396–407
Contents lists available at SciVerse ScienceDirect
Methods
journal homepage: www.elsevier .com/locate /ymeth
most challenging aspect of a metabolomics study [11], as there is a
requirement for efﬁcient quenching and extraction procedures to
preserve the metabolic state of cells at the point of sampling. An
ideal quenching solution is one that rapidly terminates all enzy-
matic activities to avoid degradation of high-turnover metabolites
(e.g. adenosine triphosphate), while an ideal extraction solution
should be able to extract all intracellular metabolites – which have
a wide range of chemistries, physical attributes and concentrations
[12,13]. In reality, complete metabolome proﬁling remains an aspi-
ration, while methodologies for metabolite recovery and analysis
are still under active development [8].
Samplepreparationprotocols for endometabolomeanalysis have
been developed for yeast [14–16], bacteria [17–20] andmammalian
cells [11–13,21,22], but as yet not for insect cells. Dietmair et al.
developed an optimized methodology for quantitative metabolo-
mics of Chinese Hamster Ovary (CHO) cells, using ice-cold isotonic
NaCl (0.9%w/v) and very cold 50% v/v acetonitrile (40 C) for effec-
tive quenching and extraction of intracellular metabolites, respec-
tively [12]. This CHO cell methodology was anticipated to be
applicable for insect cells, since both cell types are similar physically
in terms of size and lack of cell walls. Hence in this study, quenching
andwashingprocedureswere optimized for uninfectedand infected
insect cells, using ice-cold saline and improved saline-based formu-
lations as quenching solutions (at 1.1% w/v NaCl, which is isotonic
for insect cells). After these procedures, the intracellularmetabolites
were extractedusing acetonitrile and analyzedusingHPLCusing the
same methodologies described by Dietmair et al. [12].
Therewas a particular focus onquenching and cell pelletwashing
procedures in this study for a number of reasons. Firstly, infected in-
sect cell plasma membranes are likely to be more fragile than those
of CHOcells, sincebaculovirus infection is a cell-lytic process [23,24].
Hence saline alone may not be able to prevent metabolite leakage,
especially when the infected cells are subjected to ﬂuid-mechanical
shear stress during samplepreparation. In this study, the cell-protec-
tant Pluronic F-68 [25] was tested as an additive in the default sal-
ine quenching solution, to determine its effectiveness inminimizing
metabolite leakage. Secondly, insect cells are grown in complex
media that contain high concentrations of certain metabolites (e.g.
amino acids), hence one or more wash steps are necessary post
quenching so that the measured intracellular metabolite content is
free from media-contamination. Thirdly, the washing method itself
has to be carefully evaluated for insect cells, since this step increased
cell damage/leakagewhen applied to CHO cells [12,13], and cell sep-
aration via fast ﬁltration resulted inmuch reducedmetabolite recov-
eries when compared to that using centrifugation [12]. Hence, a
centrifugation-based washing method was applied to insect cells,
and the Pluronic F-68-supplemented salinewas tested as a promis-
ing leakage-minimizing washing solution.
2. Materials and methods
2.1. Cell lines, media and virus stocks
2.1.1. Sf9–rAcMNPV system
The S. frugiperda clone 9 cell-line (Sf9; ATCC CRL 1711) and re-
combinant b-Galactosidase-expressing A. californica multi-capsid
nucleopolyhedrovirus (rb-Gal AcMNPV) have been described previ-
ously [26]. Cell stocks were propagated in the commercial serum-
free medium Sf-900 II (Invitrogen, Carlsbad, CA), and maintained
by regular passaging every 3–4 days in 25 mL shaker ﬂask cultures
(125 mL single-use Erlenmeyer ﬂasks; Corning, Lowell, MA) at
seeding densities of 3–5  105 cells/mL. The shaker cultures were
agitated at 120 rpm on an orbital shaker platform (Thermoline,
NSW, Australia) and incubated at 28 C in a refrigerated incubator
(Thermoline).
The passage 1 (P1) virus stockwas prepared by infecting Sf9 cells
in Sf-900 II medium, at a Time of Infection (TOI) of 1.5  106 cells/
mL and aMultiplicity of Infection (MOI) of 0.1 Plaque Forming Units
(PFU)/cell, using frozen virus stocks [26]. At 4 days post-infection
(d.p.i.), the infected culture was centrifuged (1000g, 10 min) to re-
trieve the supernatant as the virus stock (containing infectious bud-
ded virus, BV). The working virus stock (P2) was prepared from the
P1 virus in a similar fashion, at a TOI of 0.5  106 cells/mL and aMOI
of 0.001 PFU/cell. Virus stocks were stored at 4 C, and were titered
prior to use.
2.1.2. HzAM1–HaSNPV system
The H. zea cell-line (BCIRL-HZAM1) and wild-type H. armigera
single-capsid nucleopolyhedrovirus (wtHaSNPV, strain H25EA1)
have been described previously in the PCT patent by Lua and Reid,
WO/2005/045014 [27]. HzAM1 cell stocks were maintained as de-
scribed for the Sf9–rAcMNPV system, in Sf-900 II medium.
Passage 1 (P1) HaSNPV stock was prepared by extracting occlu-
sion-derived virus (ODV) from caterpillar-produced occlusion
bodies (OB) as described in the PCT patent WO/2005/045014
[27]. Brieﬂy, 500 lL of OB suspension (1010 OBs/mL) was lyzed
with 40 lL of alkaline saline (0.5 M Na2CO3, 1.0 M NaCl), at 28 C
for 30 min. The resulting ODV suspension was neutralized, steril-
ized with 0.2 lm syringe ﬁlters (Sartorius–Stedim Biotech, Auba-
gne, France), and then used to infect a 100 mL shaker culture
seeded at 5  105 cells/mL (250 mL Erlenmeyer ﬂask, Corning).
The P1 infected culture was incubated for 4 d.p.i., and was then
used to establish the P2 infection (5  105 cells/mL, 100 mL, 15%
v/v virus inoculum). The P2 infected culture was incubated for
3 d.p.i. and then centrifuged (1000g, 10 min) to retrieve the BV-
containing supernatant as the working virus stock, which was
stored at 4 C and was titered prior to use.
2.2. Analytical methods
2.2.1. Cell, virus and product quantiﬁcation
For general cell passaging, viable and total cell densities were
estimated from triplicated hemocytometer (Improved Neubauer;
Brand, Germany) counts under a phase-contrast microscope (Olym-
pus, Japan), which resulted in a relative error of 15% [28]. Cell viabil-
ities were estimated using the 0.05% w/v Trypan Blue exclusion
method [28]. For metabolomic experiments, total cell densities
were enumerated using a Multisizer-4™ coulter counter (Beckman
Coulter, Fullerton, CA), because it provided a much reduced count
variability (1–2%). In this case, cell viabilities were determined via
Propidium Iodide staining using the Cell Lab Quanta™ SC MPL ﬂow
cytometer (Beckman Coulter), or via Trypan Blue staining using a
hemocytometer.
An endpoint dilution assay was used to estimate the titer (PFU/
mL) of rAcMNPV virus stocks, which was based on a modiﬁed Reed
and Muench protocol [29,30], and was described previously [31].
The HaSNPV virus stocks were titered using an in-house suspension
culture (SC) titration assay [32], which was informed by the Power-
Nielsen baculovirus infection model [33] and HaSNPV–HzAM1
infection kinetics [34]. The product of rAcMNPV infections (rb-
Gal) was quantiﬁed using a well-established colorimetric assay
based on the enzymatic hydrolysis of o-nitrophenyl-galactopyran-
oside (ONPG), as described previously [26]. The product of
wtHaSNPV infections (OBs) was quantiﬁed via triplicated
hemocytometer counts under a phase-contrast microscope, after
liberation from infected cells using 0.5% w/v SDS, as described
previously [35].
2.2.2. Metabolite analysis
Intracellular nucleotide and amino acid concentrations were
measured via high performance liquid chromatography (HPLC),
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using an Agilent 1200 Series system (Agilent Technologies, Santa
Clara, CA). In particular, nucleotides were measured via ion-pairing
reverse phase HPLC, using a Gemini C18 column (3 lm, 150 
4.6 mm, Phenomenex, Torrance, CA) and a diode array detector
(DAD, G1315C, Agilent). Amino acids were measured via reverse
phase HPLC, using a Gemini C18 column (as described above) and
a ﬂuorescence detector (FLD, G1321A, Agilent). Primary and second-
ary amines were precolumn-derivatized using the HPLC autosam-
pler, with o-phthalaldehyde (OPA, PN5061-3335, Agilent) and 9-
ﬂuorenylmethyl chloroformate (FMOC, PN5061-3337, Agilent),
respectively. The full methodologies have been comprehensively
described by Dietmair et al. [12].
Intracellular ATP was also measured using the ATPlite lumines-
cence ATP detection assay system (PerkinElmer Life Sciences, Bos-
ton, MA), particularly in the case of the quenching solution efﬁcacy
study. This assay is based on the production of light when ATP re-
acts with D-Luciferin in the presence of Luciferase, and was con-
ducted according to the manufacturer’s instructions.
2.2.3. Statistical analysis
One-way analysis of variance (ANOVA), incorporating Tukey’s
Honestly Signiﬁcant Difference (HSD) test, was used to determine
whether the means from two or more groups of data were signiﬁ-
cantly different at the 95% conﬁdence level. Minitab 15 Statistical
Software (Minitab, State College, PA) was used for all data analysis.
2.3. Metabolomics studies
2.3.1. Evaluating the efﬁcacy of three NaCl-based quenching solutions
for intracellular metabolite analysis of uninfected Sf9 cells
Three quenching solutions (QS) were tested in this study, to
determine their efﬁcacy in preserving the intracellular ATP levels
of uninfected Sf9 cells. The ﬁrst QS was 1.1% w/v NaCl (NaCl),
which was based on the 0.9% w/v saline shown to be efﬁcacious
for quenching CHO cells in a previous study [12]. A higher concen-
tration of NaCl was used for insect cells, as they require a higher
optimum medium osmolality when compared to mammalian cells
(350–385 vs 290 mOsmol/kg, respectively) [36]. The other two QSs
were ﬁrst developed in this study, being 1.1% w/v NaCl supple-
mented with 0.2% w/v Pluronic F-68 (PF68) (NaCl + P), and 0.8%
w/v NaCl supplemented with 0.2% w/v PF68, 1.65 g/L sucrose,
0.5 g/L CaCl2, 0.918 g/L MgSO4, 1.2 g/L KCl, 0.35 g/L NaHCO3 and
1.16 g/L NaH2PO4.H2O (NaCl + P + S). All three QSs were adjusted
to a ﬁnal osmolality of around 365 mOsmol/kg, and NaCl + P + S
was adjusted to a ﬁnal pH of 6.0.
Uninfected Sf9 cell cultures were set up as follows, to ensure
that the cells were in very good condition for metabolomics anal-
ysis (early-exponential growth phase). Multiple 30 mL shaker ﬂask
cultures (125 mL Erlenmeyer ﬂasks, 120 rpm, 28 C) were seeded
at 5  105 cells/mL in Sf-900 II medium, and then allowed to dou-
ble in cell density over 24 h. Taking out one ﬂask at a time from the
incubator, the contents of each ﬂask (30 mL) were quickly poured
into either 30 mL of very cold 100% acetonitrile (pre-cooled in a dry
ice/ethanol bath to 40 C), 120 mL of room temperature QS, or
120 mL of ice-cold QS (pre-cooled in an ice bath to 0.5–1 C). These
treatments were referred to as direct extracted (DE), unquenched
(UQ) and quenched (Q).
The DE culture (in centrifuge tubes) was vortex-mixed and
incubated for 10 min in an ice bath. The extracted cell lysate was
then clariﬁed by centrifugation (5000g, 5 min, 0 C), frozen at
80 C, and placed on a sample holder in the freeze-dryer (Alpha
I-4 LSC, Martin Christ, Germany), with the tubes’ screw-caps
slightly loosened. The samples were freeze-dried according to the
manufacturer’s instructions, at settings of 0.021 mbar vacuum
and 20 C, and a duration of up to 24 h. The freeze-dried samples
were then stored at 80 C until analysis.
The UQ culture (in centrifuge tubes) was centrifuged (1000g,
1 min, 0 C) and the cell pellet was then extracted by resuspension
in very cold 50% v/v acetonitrile in deionized water (pre-cooled in a
dry ice/ethanol bath to 40 C, 0.5 mL/106 cells), vortex-mixing,
and incubation for 10 min in an ice bath. The cell lysate was clari-
ﬁed by centrifugation (5000g, 5 min, 0 C) and then freeze-dried as
described for the DE protocol. The Q treatments had three cases: no
wash (Q0W), one wash (Q1W) and two wash (Q2W) steps. The
quenched cells from the Q0W case were extracted and freeze-dried
as described for the UQ case. The Q1W and Q2W cases involved
extra centrifugation steps (1000g, 1 min, 0 C) to pellet and resus-
pend the quenched cells with an equal volume of ice-cold QS
(washing), which were then extracted and freeze-dried as de-
scribed for the UQ case. Cell pellet resuspension during wash steps
was performed gently by multiple tube inversions. The freeze-
dried cell extracts from all treatments were resuspended in deion-
ized water just prior to analysis. Each treatment (UQ, Q0W, Q1W,
Q2W) for the three quenching solutions being tested, and the DE
case, were performed in three biological replicates.
Cold 50%acetonitrilewas shownpreviously to be themost efﬁca-
cious among a wide range of extraction solvents for the recovery of
multiple types ofmetabolites in CHOcells [12]. In this study, a selec-
tion of extraction solvents (cold50% acetonitrile, cold 50%methanol,
hot 80%methanol, hot 75% ethanol and cold 75% ethanol)was tested
for Sf9 insect cells, and cold 50% acetonitrilewas found to be the best
in terms of ATP recovery and reproducibility (data not reported),
hence it was used as the default extraction solvent. Solvent/water
removal from the cell extracts was a critical step, since solvents
may interfere with the metabolite analysis procedure, and fully
dried extracts exhibit excellent stability and can be stored almost
indeﬁnitely [37]. Freeze drying is the ideal method to achieve this,
as the process of sublimation of frozen samples does not expose
the metabolites to thermal degradation and concentration effects.
Intracellular ATP levels were measured using the ATPlite assay
kit. This assay has been validated previously to demonstrate that it
was not affected by the sample matrix. Brieﬂy, reconstituted
freeze-dried cell extracts were either spiked or not spiked with an
ATP standard, then assayed to determine the measured spiked ATP
concentration. The same amount of ATP standard was also added
to deionized water, and the measured spiked ATP concentration in
water was compared to that from the cell extract, and both were
shown to be not signiﬁcantly different (P = 0.121, one-way ANOVA).
2.3.2. Optimizing the washing procedure for intracellular metabolite
analysis of uninfected and baculovirus-infected Sf9 and HzAM1 cells
Uninfected Sf9 cell cultures were set up in shaker ﬂasks and
processed for intracellular metabolite analysis, in exactly the same
way as that described for the ﬁrst study, except that quenching
was performed only with NaCl + P, and a 3rd wash step was also
implemented (DE, UQ, Q0W, Q1W, Q2W, Q3W). Uninfected HzAM1
cells were set up and processed in a similar fashion to Sf9 cells, ex-
cept that the cells were propagated as 10 mL shaker tube cultures
using 50 mL conical-bottom/vented tubes (single-use TubeSpin
bioreactors; TPP, Switzerland). The tube cultures were incubated
in an upright position on a tube-rack that was secured onto an
orbital shaker platform (220 rpm, 28 C). Quenching and extraction
solutions were added to HzAM1 cells in the same volumetric ratios
as those used for Sf9 cells. The motivation for using tube cultures is
the potential for enhanced efﬁciencies in the use of labor, time and
resources, especially for large replicated experiments. Preliminary
experiments showed that tube cultures were as good as shaker cul-
tures in supporting HzAM1 cell growth, but unfortunately this was
not the case for Sf9 cells (data not published). Hence tube cultures
were only employed for HzAM1 experiments.
Infected experiments were set up using the following protocols.
Sf9 and HzAM1 cultures were set up as 100 mL cultures in 250 mL
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shaker ﬂasks (at 1.5 and 0.75  106 cells/mL, respectively), allowed
to double in cell density over 24 h (to ensure good cell condition),
then diluted back to 1.5 and 0.75  106 cells/mL, respectively with
virus inoculum and fresh Sf-900 II medium to a ﬁnal volume of
200 mL in 1 L single-use bottles (Corning). High MOIs were then
applied, being 20 PFU/cell (rb-Gal-AcMNPV) and 17 PFU/cell
(wtHaSNPV) for the Sf9 and HzAM1 cultures respectively, to ensure
synchronous infections (minimal cell growth post-infection).
Once infected, the 200 mL cultures were immediately aliquoted
into multiple smaller cultures (with good mixing between each ali-
quot), i.e. 30 mL shaker ﬂask cultures (125 mL Erlenmeyer ﬂasks,
120 rpm, 28 C) for the AcMNPV-Sf9 infections, and 10 mL shaker
tube cultures (50 mL TubeSpin bioreactors, 240 rpm, 28 C) for
the HaSNPV–HzAM1 infections. These infected cultures were incu-
bated for 24 h post-infection (h.p.i.), then processed for intracellu-
lar metabolite analysis as described for the uninfected cultures
(DE, UQ, Q0W, Q1W, Q2W, Q3W).
High levels of free amino acids are present in Sf-900 II medium
(according to in-house analysis), which could contribute to the
intracellular amino acids content being measured if they were
inadequately removed from the cell pellet’s liquid residue during
the washing procedure. To resolve this issue, Norvaline (Nva)
was spiked into the QS (for the quenching step only), so that its
presence in the intracellular fraction can be monitored, and to
determine the required number of cell pellet wash steps (using
Nva-free QS). Nva was chosen as the spiking agent as it is a non-
standard/non-proteinogenic amino acid [38]. Nva was spiked into
the QS at a concentration of 2.5 mM, which was based on the levels
of three highly abundant amino acids in the medium (Asp, Asn and
Glu). In addition, the extent of reduction in the intracellular amino
acids content between wash steps was also used as an indicator of
cell pellet washing efﬁciency.
All experiments in this study were conducted in three biological
replicates. The cell extracts were analyzed for 11 nucleotides (up to
2 wash steps) and 20 amino acids (up to 3 wash steps) using HPLC.
For the infected experiments, separate infected cultures (and unin-
fected controls) were set up identical to those intended for meta-
bolomics analysis, so that the infection progress (cell density and
protein production) can be monitored on a daily basis.
For both metabolomics studies, the total cell number and aver-
age cell volume of each pellet had to be determined accurately
prior to the acetonitrile extraction step, so that the intracellular
metabolite levels can be calculated in terms of both mol/cell and
mol/cell volume. Hence the cell density/volume, cell viability and
total volume of each processed sample (prior to the ﬁnal centrifu-
gation step before extraction) were measured via the Multisizer-4
coulter counter, Cell Lab Quanta ﬂow cytometer and 5-decimal dig-
ital balance (Shimadzu, Japan), respectively. For volume measure-
ments, the sample container (centrifuge tube) was weighed
before and after sample addition to obtain the net sample weight,
which was converted to sample volume by assuming that the sam-
ple had the same density as water (1 g/mL), a reasonable assump-
tion for a dilute cell suspension/aqueous solution. For the DE case,
these measurements were made 1 h prior to acetonitrile extrac-
tion, to allow sufﬁcient time for re-equilibration of the designated
shaker culture (post sampling) in the incubator.
3. Results
3.1. Efﬁcacy of three NaCl-based quenching solutions for intracellular
metabolite analysis of uninfected Sf9 cells
Quenching of uninfected Sf9 cells with ice-cold QS without cell
pellet wash steps (Q0W) was most effective when the default QS
(NaCl) was supplemented with PF68 (NaCl + P), or with PF68, su-
crose and additional salts (NaCl + P + S), which supported intracel-
lular ATP recoveries of 88 or 89% respectively (Fig. 1A), and high
cell viabilities of 96% or 98% respectively (Fig. 1B). The ATP recov-
ery (%) for a particular quenching/washing treatment was calcu-
lated with respect to the ATP level in the direct extracted (DE)
case. Although the DE case exhibited a higher ATP concentration,
it was not signiﬁcantly different from the NaCl + P (Q0W) and
NaCl + P + S (Q0W) cases (P > 0.05, one-way ANOVA, Tukey’s
HSD). In contrast, the default QS supported a signiﬁcantly lower
ATP recovery (81%) and a substantially lower cell viability (89%)
when compared to the DE case (Fig. 1A and 1B).
When one or two cell pellet wash steps were implemented post
quenching (Q1W or Q2W), the use of either ice-cold NaCl + P or
NaCl + P + S as the washing solution resulted in insigniﬁcant de-
clines in ATP concentration (P > 0.05, Fig. 1A) and minimal declines
in cell viability (Fig. 1B), when compared to the corresponding
cases in Q0W. In contrast, these indicators were much reduced
when NaCl alone was used (62% ATP recovery and 67% viability
for Q2W). Unquenched Sf9 cells (UQ, i.e. using room temperature
QS) exhibited uniformly and signiﬁcantly lower ATP recoveries
(48–57%) for all three QSs tested (P < 0.05, Fig. 1A). However, the
viabilities of UQ cells were high, in particular for the NaCl + P
and NaCl + P + S cases (96–97%, Fig. 1B).
Hence NaCl + P and NaCl + P + S were the best performing of the
three QSs tested, in terms of intracellular ATP recovery and reten-
tion of high cell viabilities after quenching and washing proce-
dures. Since both QSs were very similar in performance, NaCl + P
(being a simpler formulation) was chosen as the new default QS
for subsequent studies.
3.2. Washing optimization for intracellular metabolite analysis of the
Sf9–rAcMNPV system
The cell growth and b-Gal production temporal proﬁles of rAc-
MNPV-infected Sf9 cells are presented in Fig. 2A. The intracellular
concentrations of selected metabolites in uninfected and rAc-
MNPV-infected Sf9 cells are shown in Fig. 3A and B respectively
(adenosine phosphates, AdoP), and in Fig. 4A and B respectively
(amino acids), to illustrate the differences between the ﬁve types
of sample treatment (DE, Q0W, Q1W, Q2W, UQ). ATP and total
AdoP recoveries (%) for a particular treatment were calculated with
respect to the corresponding ATP and total AdoP levels in the DE
case (Table 1).
Despite the application of a high MOI (20 PFU/cell), the infected
culture grew from a TOI of 1.5  106 cells/mL to a peak total cell
density (PTCD) of 2  106 cells/mL at 48 h.p.i. (Fig. 2A). However,
this growth was minor and the cells could be considered to be syn-
chronously infected. In contrast, the uninfected control demon-
strated a 24-hour doubling time over the exponential growth
phase and reached a PTCD of 17.6  106 cells/mL (data not shown),
which indicated that the stock cells were in good condition, and
that cell growth retardation was due only to virus infection. The
b-Gal production also peaked at 48 h.p.i., demonstrating that the
infection kinetics were rapid [33,34]. Hence, the Sf9–rAcMNPV
infections set up in this study were optimally-infected, and were
suitable for metabolomic studies.
Analysis of the intracellular AdoP content of uninfected and in-
fected Sf9 cells (Fig. 3A and B) showed that quenching with ice-cold
NaCl + P (Q0W) resulted in ATP recoveries of 85% and 81%, respec-
tively (Table 1). However, the difference in ATP levels between
the Q0W and DE cases was not signiﬁcant for uninfected cells
(P > 0.05, one-way ANOVA, Tukey’s HSD), while it was signiﬁcant
for infected cells (P < 0.05). Uninfected Sf9 cells that have been
washed once or twice with ice-cold NaCl + P post quenching
(Q1W or Q2W) did not exhibit a signiﬁcant reduction in ATP level,
when compared to the DE or Q0W cases (P > 0.05). The ATP level of
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infected Sf9 cells did not change signiﬁcantly between the Q0W and
Q1W cases (P > 0.05), but did decline signiﬁcantly between the
Q1W and Q2W cases (P < 0.05), leading to a low ATP recovery of
61%. The lowest ATP recovery recorded was for the UQ uninfected
case (37%). For both uninfected and infected Sf9 cells, ADP levels
did not differ signiﬁcantly between the DE, Q0W, Q1W and Q2W
cases (P > 0.05). AMP was not detected in Sf9 cells for the DE case,
but was present after quenching and washing steps. The total intra-
cellular AdoP (ATP, ADP and AMP) content of uninfected Sf9 cells
was not signiﬁcantly different between the DE, Q0W, Q1W and
Q2W cases (P > 0.05). The total AdoP of infected Sf9 cells was also
unchanged for the DE, Q0W and Q1W cases (P > 0.05) but decreased
signiﬁcantly by 16% between Q1W and Q2W (P < 0.05). The total
AdoP of unquenched Sf9 cells was better retained when infected
rather than when uninfected (83% and 41% of DE, respectively).
Intracellular amino acids analysis of uninfected and infected Sf9
cells (Fig. 4A and B) showed that QS-derived Norvaline (Nva) was
present at a high level (27.9 and 13.8 mM respectively) after
quenching without washing (Q0W), presumably originating from
the cell pellet’s residual liquid fraction. Intracellular Nva levels de-
clined dramatically (7 and 5-fold respectively for uninfected and
infected cases) when quenching was followed by 1 wash step
(Q1W), but further declines were minimal when additional wash
steps were implemented, with Nva levels between Q1W and
Q2W cases, and between Q2W and Q3W cases, being not signiﬁ-
cantly different (P > 0.05, one-way ANOVA, Tukey’s HSD). As with
Nva, there was a dramatic decline in the intracellular level of each
standard (proteinogenic) amino acid between the Q0W and Q1W
cases, for both uninfected and infected Sf9 cells (Fig. 4A and B).
When additional wash steps (Q2W or Q3W) were implemented,
further declines in intracellular amino acid levels were not signif-
icant for uninfected Sf9 cells (P > 0.05). However, two amino acids
(Asp and Glu) experienced signiﬁcant modest declines between the
Q1W and Q2W cases (P < 0.05), and seven amino acids (Asp, Glu,
Asn, Gln, Gly, Phe and Pro) experienced signiﬁcant modest declines
between the Q2W and Q3W cases (P < 0.05), for infected Sf9 cells.
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Fig. 1. Evaluation of three ice-cold (0.5–1 C) quenching solutions (QS) for the recovery of intracellular ATP in uninfected Sf9 cells. The QSs were 1.1% w/v NaCl (NaCl), 1.1%
w/v NaCl + 0.2% w/v Pluronic F-68 (NaCl + P), and 0.8% w/v NaCl + 0.2% w/v Pluronic F-68 + 1.65 g/L sucrose + 0.5 g/L CaCl2 + 0.918 g/L MgSO4 + 1.2 g/L KCl + 0.35 g/L
NaHCO3 + 1.16 g/L NaH2PO4H2O (NaCl + P + S). Early-exponential phase Sf9 cell cultures (1  106 cells/mL) were either direct extracted (DE) with 1:1 cold 100% acetonitrile
(40 C), quenched with 1:5 QS (Q0W), quenched and washed once with 1:5 QS (Q1W), quenched and washed twice with 1:5 QS (Q2W), or unquenched by adding 1:5 room
temperature QS (UQ). The quenched/washed and unquenched cell pellets were extracted with cold 50% v/v acetonitrile in deionized water (40 C). Cell extracts were freeze-
dried and resuspended in deionized water prior to analysis using the ATPlite luminescence assay. (A) Intracellular ATP concentration. (B) Cell viability prior to the extraction
step. Error bars show the standard deviation of biological triplicates. Tukey’s HSD test (a = 0.05) was used to compare the means (ATP concentration) from different
treatments, means with the same letter indicate that they are not signiﬁcantly different.
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3.3. Washing optimization for intracellular metabolite analysis of the
HzAM1–HaSNPV system
The cell growth and OB production temporal proﬁles of HaS-
NPV-infected HzAM1 cells are presented in Fig. 2B. The intracellu-
lar concentrations of selected metabolites in uninfected and
HaSNPV-infected HzAM1 cells are shown in Fig. 3C and D respec-
tively (AdoP), and in Fig. 4C and D respectively (amino acids), to
illustrate the differences between the DE, Q0W, Q1W, Q2W and
UQ cases. ATP and total AdoP recoveries (%) for a particular treat-
ment were calculated with respect to the corresponding ATP and
total AdoP levels in the DE case (Table 1).
The infected culture grew minimally from a TOI of 0.75 
106 cells/mL to a PTCD of 1.0  106 cells/mL at 2 d.p.i., which could
be considered to be synchronously-infected, and was consistent
with the high MOI that was applied (17 PFU/cell) (Fig. 2B). The
uninfected control doubled in cell density on a daily basis during
the exponential growth phase, and reached a PTCD of
8.3  106 cells/mL (data not shown), indicating that the HzAM1
stock cells were in good condition. The OB production peaked at
72 h.p.i., which was consistent with the slower kinetics of HaSNPV
infections when compared to AcMNPV infections [34]. A high max-
imum cell-speciﬁc yield of around 400 OB/cell was obtained [32].
Hence, the HzAM1–HaSNPV infections set up in this study were
optimally-infected, and were suitable for metabolomic studies.
Analysis of the intracellular AdoP content of uninfected and in-
fected HzAM1 cells (Fig. 3C and D) showed that quenching with
ice-cold NaCl + P (Q0W) resulted in ATP recoveries of 95% and
85% respectively (Table 1). However, the difference in ATP levels
between the Q0W and DE cases was not signiﬁcant for both unin-
fected and infected HzAM1 cells (P > 0.05, one-way ANOVA, Tu-
key’s HSD). Uninfected HzAM1 cells that have been washed once
or twice with ice-cold NaCl + P post quenching (Q1W or Q2W)
did not exhibit a signiﬁcantly reduced ATP level compared to
Q0W (P > 0.05), but only the Q1W case was not signiﬁcantly re-
duced from the DE case (P > 0.05). For infected HzAM1 cells, both
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Fig. 2. Total cell density (TCD) and volumetric protein yield proﬁles over time for two baculovirus-infected insect cell systems used for intracellular metabolite analysis. (A)
Sf9 cells infected with recombinant b-galactosidase-expressing AcMNPV at a TOI of 1.5  106 cells/mL and an MOI of 20 PFU/cell. (B) HzAM1 cells infected with occlusion
body (OB) producing wild-type HaSNPV at a TOI of 0.75  106 cells/mL and an MOI of 17 PFU/cell. Error bars show the standard deviation of biological triplicates.
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the Q1W and Q2W cases did not exhibit signiﬁcantly reduced ATP
levels when compared to that of the Q0W or DE cases (P > 0.05).
Uninfected and infected HzAM1 cells exhibited the lowest ATP
recoveries (31% and 21%, respectively) when unquenched (UQ).
For both uninfected and infected HzAM1 cells, neither ADP nor
AMP levels were signiﬁcantly different between the DE, Q0W,
Q1W and Q2W cases (P > 0.05). The total intracellular AdoP (ATP,
ADP and AMP) content of uninfected HzAM1 cells was not signiﬁ-
cantly different between the DE, Q0W and Q1W cases (P > 0.05),
but declined signiﬁcantly by 10% between Q1W and Q2W
(P < 0.05). The total AdoP of infected HzAM1 cells was not signiﬁ-
cantly different between the DE, Q0W, Q1W and Q2W cases
(P > 0.05). The total AdoP of unquenched HzAM1 cells was better
retained when infected rather than when uninfected (103% and
65% of DE, respectively).
Intracellular amino acids analysis of uninfected and infected
HzAM1 cells (Fig. 4C and D) illustrated that QS-derived Nva was
present at a high level (13.1 and 14.3 mM respectively) for the
quenched/unwashed case (Q0W). The intracellular Nva level de-
clined dramatically (6- and 5-fold, respectively for uninfected
and infected cases) when quenching was followed by 1 wash step
(Q1W), but it did not decline further when a second wash step
(Q2W) was conducted (P > 0.05, one-way ANOVA, Tukey’s HSD).
When a third wash step was implemented (Q3W), the Nva level
declined signiﬁcantly for uninfected HzAM1 cells (P < 0.05), but
did not decline signiﬁcantly for infected HzAM1 cells (P > 0.05).
The intracellular levels of the standard amino acids also declined
dramatically between the Q0W and Q1W cases, for both uninfected
and infected HzAM1 cells (Fig. 4C and D). When additional wash
steps (Q2W or Q3W) were implemented, further declines in intra-
cellular amino acid levels were not signiﬁcant for infected HzAM1
cells (P > 0.05). For uninfected HzAM1 cells, the majority of amino
acids did not decline signiﬁcantly between the Q1W and Q2W
cases (P > 0.05) except for Lys (P < 0.05), while none of the amino
acids declined signiﬁcantly between the Q2W and Q3W cases
(P > 0.05).
4. Discussion
4.1. Pluronic F-68 supplementation improved the quenching and
washing efﬁcacy of ice-cold saline for uninfected Sf9 cells
As many metabolites such as nucleotides have rapid turnover
rates [39], it is necessary to quench the cells upon sampling to ter-
minate cellular metabolism and hence preserve the intracellular
metabolite proﬁles at the instant of sampling. The ideal quenching
protocol should meet this objective, as well as prevent the leakage
of metabolites from the cells [40,41]. However, the development of
quenching protocols can be challenging, especially for mammalian
and insect cells which are more vulnerable to mechanical damage
due to the absence of cell walls.
Buffered and non-buffered cold methanol solutions (60% v/v in
water,40 C) have been used widely for quenching yeast and bac-
teria [15,39,42–46], but they have been reported to cause metabo-
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lite leakage from these cells [16,19,47]. The extent of intracellular
metabolite leakage was worse when these QSs were used for mam-
malian cells [12,13]. Recently, Dietmair et al. demonstrated that
ice-cold isotonic NaCl (0.9% w/v, 0.5 C) was the most efﬁcacious
QS for Chinese Hamster Ovary (CHO) cells, which effectively min-
imized the conversion of intracellular ATP to ADP and AMP [12].
Since insect cells are similar physically to mammalian cells, a
NaCl-based QS was anticipated to be just as effective for the former
(using 1.1% w/v NaCl, which is isotonic for insect cells). However,
this study showed that ice-cold NaCl (0.5–1 C) was not outstand-
ing for quenching uninfected Sf9 insect cells, since only about 80%
of intracellular ATP was recovered after the quenching step with
respect to direct extraction (DE), with a corresponding 10% decline
in cell viability (Fig. 1A and B). In addition, ATP recovery and cell
viability declined substantially when quenching was followed by
cell pellet wash steps using the same QS, indicating that signiﬁcant
ﬂuid-mechanical damage had occured (Fig. 1A and B). Cell damage
was also observed in CHO cells that have been quenched and
washed once in ice-cold NaCl [12]. In other studies, cell damage
and metabolite leakage were reported for quenched/washed bacte-
ria [48] and mammalian cells [13].
This outcome was disappointing, as cell pellet washing is essen-
tial for intracellular metabolite analysis of insect cells, which are
grown in a complex medium containing an abundance of metabo-
lites such as amino acids. Furthermore, if washing causes damage
to uninfected insect cells, it would be even more damaging to bac-
ulovirus-infected insect cells, which have compromised cell mem-
branes due to the lytic infection process. Hence, an alternative QS
was required to minimize ﬂuid-mechanical damage during the
quenching and washing procedures. An obvious strategy involves
the addition of a cell-protective agent such as Pluronic F-68
(PF68) to the default NaCl-based QS. PF68 is a non-ionic surfactant
that has been used for decades to enable animal cell cultures to be
scaled-up in gas-sparged stirred-tank bioreactors [25,49–53], and
is typically applied at a concentration of 0.1% v/v in insect cell cul-
tures [54]. In this study, the alternative QS (NaCl + P) was supple-
mented with twice this level of PF68, which was found to be
efﬁcacious in the development of a high cell density fed-batch sus-
pension culture process for HaSNPV biopesticides (personal com-
munication, Leslie Chan). A second alternative QS (NaCl + P + S)
was also tested, which contained 0.2% v/v PF68 as well as sucrose
and the major basal salts of IPL-41 medium [54]. Preliminary stud-
ies showed that quenching with ice-cold Sf-900 II medium resulted
in excellent ATP recoveries (99%) and preservation of high cell
viabilities (data not reported). Hence, NaCl + P + S was formulated
as a streamlined version of the commercial medium, with the
rationale being that a balanced salts composition (optimal Na/K
and Mg/Ca ratios) and the buffering of pH and osmolality (sucrose)
could result in a better QS than one comprising only NaCl and PF68
(but this was found to be not the case).
At ice-cold temperatures, NaCl + P and NaCl + P + S were better
than NaCl alone for quenching uninfected Sf9 cells, since the for-
mer two QSs supported statistically insigniﬁcant differences in
ATP levels, and very similar cell viabilities, to those of the DE case
(Fig. 1A and B). Most importantly, PF68 supplementation in the QS
allowed high ATP recoveries and cell viabilities to be maintained
when one or two cell pellet wash steps were implemented after
quenching, while the unsupplemented default QS was clearly
unsuccessful in this respect (Fig. 1A and B). The quenching and
washing procedures involved multiple centrifugation and cell pel-
let resuspension steps, but since the latter was performed by gen-
tle tube inversion the shear stresses encountered by cells were
mainly from the centrifugal forces [55]. The ability of PF68 to pro-
tect animal cells from ﬂuid-mechanical damage may derive from a
fast-acting biological mechanism involving direct interaction be-
tween the surfactant molecules and the cell plasma membrane,
resulting in a more rigid and shear-resistant membrane [52,56].
The cell-protective effect of PF68 was not cold temperature-depen-
dent, as Sf9 cells processed with NaCl + P or NaCl + P + S solutions
at room temperature (UQ case) also exhibited high cell viabilities
(Fig. 1B). However, the efﬁcacy of a QS is assessed by both the abil-
ity to terminate cellular metabolism and to prevent cell damage/
metabolite leakage (i.e. maintain high cell viabilities), and ice-cold
temperatures were clearly required to achieve both outcomes.
4.2. Optimizing the number of wash steps for intracellular metabolite
analysis of uninfected and baculovirus-infected Sf9 and HzAM1 cells
Having established that ice-cold NaCl + P was an effective
quenching/washing solution for uninfected Sf9 cells, in terms of
preserving the intracellular content of a highly-labile metabolite
(ATP), it was necessary to determine whether it was equally efﬁca-
cious in this capacity for AcMNPV-infected Sf9 cells and for another
insect cell–baculovirus system (HzAM1–HaSNPV). As discussed
previously, cell pellet washing post quenching is not an optional
step for insect cells grown in a metabolites-rich medium, yet
excessive washing is likely to damage fragile plasma membranes
and result in metabolite leakage. Hence this phase of the study
was designed to determine an optimal number of wash steps that
will remove most of the medium-derived metabolites from the
intracellular fraction without compromising cell integrity (for
medium-prominent metabolites represented by amino acids),
while maintaining good preservation of the more labile intracellu-
lar metabolites (represented by nucleotides), for the two insect
cell–baculovirus systems. Nucleotides were represented by adeno-
sine phosphates (AdoPs) due to their rapid turnover rates, in par-
ticular ATP (1.5 mM/s) and ADP (2 mM/s) [12,39].
4.2.1. Nucleotides
For uninfected cultures, the recovery of ATP with respect to di-
rect extraction from Sf9 (85%) or HzAM1 (95%) cells after quench-
ing (Q0W) was similar to that obtained by Dietmair et al. for CHO
cells (89%) [12], albeit such declines were not statistically signiﬁ-
cant (Fig. 3A and C, Table 1). Most importantly, ATP levels did
not decline signiﬁcantly when quenching was followed by one or
two wash steps with ice-cold NaCl + P (Q1W or Q2W), for both
types of uninfected insect cells. This outcome was not achieved
in the previous CHO cell study [12], which used an unsupple-
mented ice-cold NaCl solution for quenching and washing steps.
Furthermore, ADP or total AdoP levels were largely not signiﬁ-
cantly different between the DE, Q0W, Q1W and Q2W cases, which
suggested that nucleotide degradation and cell leakage had been
minimal.
Table 1
Intracellular ATP and total adenosine phosphate (AdoP) levels in quenched but not
washed (Q0W), quenched and washed one or two times (Q1W, Q2W) and
unquenched (UQ) samples, expressed as a percentage of the levels in the corre-
sponding direct extracted (DE) sample, from uninfected Sf9 and HzAM1 cells, and
from rb-Gal-AcMNPV-infected Sf9 and wtHaSNPV-infected HzAM1 cells. Ice-cold
NaCl + P (0.5–1 C) was used for both quenching and washing, while room temper-
ature NaCl + P was used for the UQ case. One hundred percent acetonitrile (40 C)
was used for direct extraction of cell cultures, while 50% v/v acetonitrile in deionized
water (40 C) was used to extract quenched and unquenched cell pellets.
AdoP recovery (% of direct extract, DE)
Q0W Q1W Q2W UQ Q0W Q1W Q2W UQ
Uninfected Sf9 cells Uninfected HzAM1 cells
ATP 85 84 83 37 95 93 88 31
Total AdoP 100 105 83 41 101 97 87 65
Infected Sf9 cells Infected HzAM1 cells
ATP 81 79 61 64 85 85 69 21
Total AdoP 101 93 78 83 98 98 88 103
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Among the two types of infected insect cells, infected HzAM1
cells were best able to tolerate quenching and washing procedures,
exhibiting insigniﬁcant differences in AdoP (ATP, ADP and total
AdoP) levels between the DE, Q0W, Q1W and Q2W cases
(Fig. 3D). In contrast, infected Sf9 cells were more vulnerable to
such procedures, exhibiting signiﬁcant (but moderate) declines in
ATP content between the DE and Q0W cases, and between the
Q1W and Q2W cases (Fig. 3B), although total AdoP and ADP levels
were not changed signiﬁcantly (up to 1 and 2 wash steps
respectively).
AMP levels after quenching/washing steps were quite different
between the two cell lines, being insigniﬁcantly changed for unin-
fected and infected HzAM1 cells, and signiﬁcantly changed for
uninfected and infected Sf9 cells (Fig. 3). For uninfected Sf9 cells,
ATP, ADP or total AdoP levels were unchanged statistically up to
2 wash steps, hence it follows that the corresponding AMP levels
should also be unchanged for the mass balance to close. However,
AMP levels were the lowest measured among the AdoPs, hence
they would be most affected by experimental error and the possi-
bility of a ‘false positive’ signiﬁcance difference test. For infected
Sf9 cells, ATP levels declined signiﬁcantly while ADP and total AdoP
levels did not (up to 1 wash step), hence there appeared to be a sig-
niﬁcant net conversion of some ATP to AMP for the Q0W or Q1W
cases, demonstrating that it was more challenging to preserve
metabolite levels in infected Sf9 cells.
Baculovirus infection being a cell-lytic process, it would not be
surprising if infected insect cells are shown to be more sensitive to
quenching/washing procedures and the ensuing mechanical dam-
age, than uninfected cells. In this study, AcMNPV-infected Sf9 cells
were more sensitive than uninfected Sf9 cells, but they were also
more vulnerable than HaSNPV-infected HzAM1 cells. This could
be related to the much faster infection kinetics of AcMNPV (e.g.
18-fold higher binding rate and 50-fold higher budding rate), in
comparison to those of HaSNPV [34], which would lead to a more
advanced infection at 24 h.p.i and potentially more compromised
plasma membranes. It remains to be seen whether an earlier sam-
pling time post-infection would result in better ATP recoveries for
infected Sf9 cells.
It was interesting to observe that total AdoP levels were vari-
able for unquenched samples (treated with room temperature
QS), ranging from low in uninfected Sf9 cells to high in infected
HzAM1 cells, when compared to DE samples (Fig. 3). When the
uninfected Sf9 cell experiment was repeated on a separate occa-
sion, the total AdoP level of the unquenched sample was this time
very close to the DE case, while those of quenched/washed samples
were found to be similar to previous levels (data not reported), fur-
ther demonstrating that total AdoP recoveries were variable for
unquenched insect cells. The expectation was that total AdoP levels
would be conserved, since high viabilities were maintained in un-
quenched cells, but reduced levels could be the result of ATP efﬂux
from cells [57,58] or the degradation of AdoP into IMP, nucleosides
and bases [59,60], due to continuing metabolic activity at room
temperature under conditions of stress like oxygen limitation (hy-
poxia) and ﬂuid-mechanical shear [57,61]. Such conditions were
likely to be present during the centrifugation step prior to cell pel-
let extraction, and could be the source of the variability observed in
unquenched samples.
This study has conﬁrmed that ice-cold NaCl + P was largely
effective in minimizing the degradation of highly-labile metabo-
lites such as ATP and ADP, as well as minimizing cell leakage due
to mechanical damage (from PF68 supplementation), during
quenching and washing of uninfected and infected insect cells.
However, substantial leakage (or further degradation) may occur
after the second wash step (particularly for infected Sf9 cells),
hence quenching followed by one wash step is the most prudent
protocol going forward.
4.2.2. Amino Acids
This study has shown that the measured intracellular amino
acids content would be largely free from medium-derived amino
acids contamination after just one wash step post quenching with
ice-cold NaCl + P, for both uninfected and infected (at 24 h.p.i.) in-
sect cells (Sf9 and HzAM1). This ﬁnding was indicated by the steep
declines in the intracellular concentration of 19 standard amino
acids (and the spiked non-standard Nva) between the Q0W and
Q1W cases, followed by largely insigniﬁcant declines upon one
(Q2W) or two (Q3W) additional wash steps (Fig. 4). The exception
was infected Sf9 cells, which experienced signiﬁcant declines for
many amino acids after the second wash step, but these were min-
or when compared to those between Q0W and Q1W. The increased
sensitivity of infected Sf9 cells to quenching/washing procedures
may be attributed to the faster kinetics of AcMNPV infections, as
discussed previously in Section 4.2.1. In general, the minor decline
(if any) in amino acids content after the second and third succes-
sive wash steps also indicated that cell integrity was largely intact,
which again conﬁrmed that PF68 was efﬁcacious in protecting both
uninfected and infected insect cells from serious mechanical dam-
age during multiple centrifugation and pellet resuspension steps.
4.2.3. Effect of PF68 on HPLC analysis
Although PF68 supplementation of the QS was largely success-
ful in protecting insect cells during quenching and washing proce-
dures, resulting in the preservation of high cell viabilities and
reduction in metabolite leakage, it may be argued that PF68 resi-
dues in the intracellular extract could interfere with HPLC analysis.
To address this concern, 11 nucleotides and 20 amino acids (stan-
dards) were analyzed separately using HPLC, with and without the
presence of 0.1% PF68 (data not shown). This level of PF68 is the
estimated residual concentration in the freeze-dried cell extracts
of Q0W, Q1W, Q2W and Q3W samples after resuspension with
water. One-way ANOVA demonstrated that there were insigniﬁ-
cant differences between the negative and positive PF68 cases,
for the analysis of nucleotides (P = 0.051) and amino acids
(P = 0.503). Hence, it appeared that the presence of a small amount
of PF68 in the cell extracts would not be detrimental to metabolites
analysis.
4.2.4. Intracellular ATP levels of uninfected and infected insect cells,
and comparison with other cell types
Uninfected HzAM1 cells were around 70% larger than unin-
fected Sf9 cells (approximately 3200 and 1900 lm3 respectively),
while infected HzAM1 and Sf9 cells were around 30% larger than
their uninfected counterparts (approximately 4300 and 2500 lm3
respectively). The sizes of uninfected and infected insect cells ap-
peared to be positively-correlated with their speciﬁc intracellular
ATP yields (fmol/cell), as illustrated in Table 2. In particular, unin-
fected HzAM1 cells exhibited around 80% more ATP/cell than unin-
fected Sf9 cells, while infected HzAM1 and Sf9 cells exhibited
around 30–50% more ATP/cell than their uninfected counterparts.
The increased speciﬁc ATP yield of insect cells upon infection
was also observed previously [62], and corresponded with a previ-
ous positive correlation between insect cell size and recombinant
protein production capacity [63].
When the intracellular ATP content was expressed as a volu-
metric yield in terms of the cell volume (mM), the differences be-
tween HzAM1 and Sf9 cells, and between uninfected and infected
cells, became much less pronounced. In fact, the volumetric ATP
yield of all insect cell treatments were around 4–5 mM (DE case,
Table 2). Interestingly, the volumetric ATP levels of insect cells
were similar to those reported for mammalian cells (CHO, rat
hepatocyte) and bacteria (Lactobacillus, Eschericia coli) (Table 2),
which suggested a universality in energy metabolism on a per bio-
mass basis.
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This notion is supported by a previous study by Beis et al., who
reported ATP/biomass levels in the snap-frozen muscle tissues of a
variety of invertebrates and vertebrates, including insects (5–
9 lmol/g, equivalent to mM), mammals (4–6 lmol/g) and birds
(6–8 lmol/g) [64].
4.3. Conclusions
Insect cells are similar to mammalian cells in terms of fragility
during processing for intracellular metabolite analysis, but would
be even more challenging to process when subjected to baculovi-
rus infection (a cell-lytic process). Although ice-cold saline is an
ideal quenching solution for CHO cells [12], it was found to be
inadequate for insect cells in this study. However, addition of the
cell-protectant PF68 to ice-cold saline resulted in a successful
quenching solution for both uninfected and infected Sf9 and
HzAM1 insect cells, and furthermore permitted wash steps to be
carried out post quenching with minimal impact on cell integrity
and metabolites retention. Wash steps are important when pro-
cessing insect cells, since they are usually grown in media contain-
ing high concentrations of metabolites, which have to be removed
from the intracellular fraction. This study has shown that quench-
ing following by one wash step was the ideal procedure for remov-
ing medium-derived metabolites (represented by amino acids) and
for preserving the levels of labile metabolites (represented by
adenosine phosphates), for both uninfected and 24 h-infected Sf9
and HzAM1 cells (using AcMNPV and HaSNPV, respectively). Hav-
ing developed a suitable protocol for intracellular metabolite anal-
ysis of insect cells, future studies will be focused on more
comprehensive metabolome proﬁling of baculovirus-infected Sf9
and HzAM1 cells, particularly via time-course studies and meta-
bolic ﬂux analysis, to provide insights into the mechanisms that
cause lower yields of recombinant protein and occlusion body
when infections are carried out at high cell densities.
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Chapter 4 
Metabolic study of the cell 
density effect - Sf9/rAcMNPV in 
Sf900™III medium 
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4.1 Introduction 
There is an ongoing interest in using the baculovirus insect cell expression system as 
a research tool for producing recombinant proteins (Kost et al., 2005; Mena and Kamen, 
2011), human and veterinary vaccines (Mena and Kamen, 2011; van Oers, 2006), and as 
vectors for gene delivery (Hitchman et al., 2010; Hu, 2008). Moreover, the system is also 
of interest for the production of baculoviruses as biological control agents for agricultural 
insect pests, for use as part of integrated pest management programs (Moscardi et al., 
2011; Szewczyk et al., 2006; Szewczyk et al., 2009).  
To be commercially successful, baculovirus insect cell bioprocesses need to be 
optimized to deliver higher protein yields, and this normally involves a high cell density 
production process using fed-batch cultures in stirred-tank bioreactors (Elias et al., 2000). 
However, it has been well documented that there is a drop in cell specific yield when cells 
are infected at high cell densities, a phenomenon known as “the cell density effect” 
(Carinhas et al., 2009; Caron et al., 1990; Chakraborty et al., 1996; Chan et al., 2002; 
Doverskog et al., 2000; Huynh et al., 2013; Radford et al., 1997; Taticek and Shuler, 1997; 
Wong et al., 1996). There has been much speculation as to the cause of the cell density 
effect, including nutrient limitation, toxic compound accumulation as well as cell-to-cell 
contact inhibition but the reasons for this effect remain unidentified (Doverskog et al., 
1997; Taticek and Shuler, 1997). 
It has been suggested that the cause of the drop in productivity at high cell densities 
for baculovirus infection processes is related to nutrient limitations rather than 
accumulation of toxins (Drews et al., 1995; Radford et al., 1997; Wong et al., 1996). This is 
supported by the fact that there is an increase in the cell specific yield with an 
improvement of the nutrient supply through fed-batch strategies (Chan et al., 1998; Elias et 
al., 2000; Jardin et al., 2007). However, the process limitation for the cell density effect 
may not be entirely related to nutrient supply, but could be complex involving interactions 
between the virus infection process, cellular physiology and physico-chemical 
environmental effects. The reduction in recombinant protein production has been shown to 
be strongly correlated with limitations in the upstream processes of virus replication and 
transcription (Huynh et al., 2013). Other possible factors causing low productivity in high 
density cultures have been suggested, including oxygen limitations (Lecina et al., 2006; 
Palomares et al., 2004; Taticek and Shuler, 1997), the cell cycle phase at the time of 
infection (Calles et al., 2006; Doverskog et al., 2000) and the history of the culture 
(Doverskog et al., 2000). 
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Many attempts have been made to identify the cause of the cell density effect and to 
overcome this bottleneck. These include the measurement of extracellular metabolites to 
identify the limiting nutrients in the medium (Caron et al., 1990; Drews et al., 1995; 
Reuveny et al., 1993); the measurement of consumption rates and fluxomics analysis 
(Bernal et al., 2009); and supplementing culture media with glucose, glutamine, complex 
nutrient mixtures, and key intermediate metabolites (Carinhas et al., 2010; Reuveny et al., 
1993).  However, a possible limitation of these approaches is that the metabolite levels in 
the media do not necessarily reflect intracellular metabolite levels. The metabolite 
environment inside the cells at low and high cell densities at the time of infection may 
reveal the cause of the cell density effect. In particular intracellular metabolite 
measurements in combination with consumption rates of key metabolites may identify 
limitations during high cell density infections. It is possible, for example, that poor transport 
of key metabolites into cells at high cell densities or post-infection contribute to the cell 
density effect, rather than a limitation of metabolites in the medium. 
It is important to note that a number of metabolism-based studies of infected insect 
cells have been conducted under optimal infection conditions, (i.e. infections performed at 
relatively low cell densities of 1-2×106 cells/mL). In this study, the drop in cell specific yield 
at a high cell density at the time of infection has been investigated using a metabolomics 
approach. Substrate consumption rates as well as intracellular metabolite levels of infected 
cells at both low and high cell densities at the time of infection have been measured and 
compared between these two infection conditions.  
 
4.2 Materials and methods 
4.2.1 Cell line, virus stock and medium 
The Spodoptera frugiperda clone 9 cell line (Sf9; ATCC CRL 1711) and a 
recombinant Autographa californica multiple nucleopolyhedrovirus (rAcMNPV) expressing 
E. coli LacZ gene under the control of the polyhedrin promoter used in this study have 
been described previously (Chan et al., 1998; Wong et al., 1996). Working stock cells were 
maintained by regular passaging every 3-4 days in single-use shaker flasks (Corning, 
Lowell, MA) at seeding densities of 0.3-0.5×106 cells/mL. The shaker cultures were 
agitated at 120 rpm on an orbital shaker platform (Thermoline, NSW, Australia) and 
incubated at 28oC in a refrigerated incubator (Thermoline). The preparation of virus stock 
has been previously described (Huynh et al., 2013; Tran et al., 2012). Virus stocks were 
stored at 4oC, and were titered prior to use. The titers of virus stocks were 1-1.5×109 
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PFU/mL as determined by using a modified endpoint dilution method (Nielsen et al., 1992). 
The Sf900™III serum free medium (Gibco, Life Technologies, USA) was used in all 
experiments. 
4.2.2. Experimental procedures 
Two experiments were conducted to evaluate the extraction protocol post-infection 
and to investigate the difference between low and high infection cell densities (ICDs) in 
terms of intracellular metabolite concentrations, substrate consumption and protein 
production rates.  
The first experiment involved evaluation of the extraction protocol for intracellular 
metabolites (Tran et al., 2012) for infected Sf9 cells via a time-course infection experiment. 
This experiment aimed to identify the latest time point post-infection at which the infected 
cells still maintain their membrane integrity during quenching and washing procedures. Sf9 
cells were setup at the initial cell density of 0.5×106 cells/mL and allowed to grow for 2 
doubling times (2 days) and then infected at an ICD of approximately 2.5×106 cells/mL and 
a multiplicity of infection (MOI) of 10 PFU/cell. Infection was conducted in a 1 L bottle and 
then aliquoted into various shaker flasks at 20 mL each for intracellular metabolite 
extractions at 12 hour intervals from 0-72 hours post-infection (hpi). Three shaker flasks 
were set up at 35 mL each as the infected control for measuring total cell density (TCD) 
and viability, -Gal yield, viral DNA (vDNA) copies and extracellular metabolite 
measurements at the various time points mentioned above. The uninfected control (in 
triplicate) was set up and allowed to grow to a peak cell density of 1.8-2×107 cells/mL 
demonstrating the cells were in optimal condition during the experimental period. 
The second experiment investigated the changes in the intra- and extra-cellular 
metabolome as well as the -Gal production and metabolite consumption rates of the cells 
infected at low and high cell densities. The initial seeding cell density was at 0.5×106 
cells/mL. For the low cell density infection, cells were infected at the ICD of 2×106 cells/mL 
(48 hours post-inoculation). For the high cell density infection, cells were allowed to grow 
to 6×106 cells/mL (84 hours post-inoculation) at the time of infection. All of the infections 
were conducted at an MOI of 10 PFU/cell (0.02 and 0.06 mL of virus stock was added into 
1 mL of culture for low and high ICDs, respectively). The experiment was conducted in 
shaker flasks with biological triplicates at each cell density. Samples for intracellular 
metabolite analysis were taken at 12 hour intervals from 0-48 hpi in triplicate. Samples for 
extracellular metabolite analysis and for measuring TCD, viability, intracellular vDNA 
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copies and -Gal yield were collected from 3 infected control shakers at 12 hour intervals 
from 0-72 hpi. An uninfected control was also set up and left to grow to a peak cell density 
in batch culture (1.8-2×107 cells/mL). 
4.2.3 Intracellular metabolite extraction 
Intracellular metabolites were extracted using the optimized protocol as described 
previously (Tran et al., 2012). Briefly, infected cultures were set up in 125 mL shaker flasks 
at a working volume of 20 mL, involving three flasks for each treatment at each time point 
as biological triplicates. Quenching solution (QS)  (1.1% NaCl, 0.2% Pluronic F68) was 
prepared in 250 ml shaker flasks at 80 mL each and placed in an ice bath to ensure the 
temperature of the quenching solution was 0.5 to 1ºC. Taking out each flask at a time from 
the incubator, the culture of each flask (20 mL) was quickly poured into 80 mL of ice-cold 
QS. The quenched culture was then centrifuged (1000× g, 1 min) at 0ºC. The supernatant 
was removed and the cell pellet was washed with the sample volume of ice-cold QS. 
Another centrifugation step was applied (1000× g, 1 min, 0ºC) to collect the cell pellet 
which was then extracted with a cold 50% acetonitrile (ACN) solution at the ratio of 1 mL 
for 2×106 cells. The cell extracts were clarified by centrifugation (5000×g, 5 min, 0ºC), with 
the supernatants collected, frozen at -80ºC and then lyophilised in a freeze-dryer (Alpha 1-
4 LSC, Martin Christ, Germany). The freeze-dried samples were then stored at -80ºC until 
analysed. For the direct extract, infected cultures were poured directly into the same 
volume of 100% ACN and then the supernatants were collected for subsequent steps as 
described above with the cell extract samples. 
4.2.4 Assays 
Total cell density (cell/mL) and cell diameter was estimated using a MultisizerTM4 
Coulter Counter (Beckman Coulter, Fullerton, CA, USA). Samples of various cell densities 
were initially diluted with medium to a TCD of around 0.5×106 cells/mL before proceeding 
with the cell enumeration process. Cell viabilities were estimated from triplicated 
hemocytometer counts using the 0.05 %w/v Trypan Blue exclusion method (Nielsen et al., 
1991). 
The β-Gal protein yield of infected whole-culture samples was quantified using a well-
established colorimetric assay based on the enzymatic hydrolysis of ONPG, as described 
previously (Power et al., 1994; Radford et al., 1997; Wong et al., 1996). Briefly, fresh 
samples were initially diluted appropriately with MiliQ water, and then 50 µL of the diluted 
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sample was added into 950 µL Z buffer (0.06M Na2HPO4, 0.04 M NaH2PO4, 0.001 M 
MgSO4, 0.01 M KCl and 0.035%v/v β-mercaptoethanol).  The mixture was then incubated 
for 30 minutes at 37ºC after adding 200 µL of substrate (4 mg/mL ONPG). A stop buffer 
(1M Na2CO3) was added at 500 µL to terminate the reaction. The absorbance was 
measured at 420 nm using a spectrophotometer, and was accepted if it fell within the 
linear range (0.3-0.8) and converted to β-Gal activity units (U/mL) using Beer's Law (Chan 
et al., 1998). The β-Gal assay of each sample was conducted three times as technical 
triplicates. 
Total cell protein was estimated using a BCA protein assay kit (Thermo Fisher 
Scientific, Rockford, IL, USA) as described previously (Huynh et al., 2012). Briefly, a 
volume of each culture containing 1×106 cells was pelleted (1000× g, 5 min) and the cell 
pellets were washed twice with PBS (adjusted with NaCl to a final osmolarity of 350 
mOsmol/kg as in Sf900™III medium) and kept in a -20ºC freezer for subsequent analysis. 
The cell pellets were lysed with 1 mL of NaOH, 0.1 M, at 40ºC for 20 minutes and then 
diluted four fold prior to conducting total protein analysis, following the manufacturer’s 
protocol using BSA as a standard. The BSA standard curve was fitted with a sigmoidal 
logistic model using SigmaPlot 11 (Systat Software Chicago, IL).  
The intracellular vDNA copies were measured using a quantitative real time 
polymerase chain reaction assay (qRT-PCR) as described by Rosinski et al. (2002). The 
detail of the procedure for the preparation of the vDNA standard and for qRT-PCR has 
been previously described (Huynh et al. 2013). Briefly, cultures containing 1×106 cells/mL 
were pelleted (300×g, 5 min) and kept at -20 ºC until analysed. Pellets were treated with 1 
mL of a digestion buffer (100 mM NaCl, 10 mM Tris.HCl, 25 mM EDTA, 0.5% SDS, 0.1 
mg/mL Proteinase K) at 50 ºC for 15 hours prior to measuring the vDNA. The Eppendorf 
epMotion 5075 Robotics System (Eppendorf, Germany) and the ABI PRISM® 7900HT 
Sequence Detection System (Life Technology, USA) were used for qRT-PCR analysis. 
Each sample was measured using technical triplicates in the same PCR plate. The 
estimated genome size of 1.359×10-7 ng/genome (Rosinski et al., 2002) was used to 
convert the mass production to a genome copy number. 
Intracellular nucleotides and TCA cycle intermediates were measured by LC-MS/MS 
as described in Dietmair et al. (2012) with the following modifications: the analytical 
column was equipped with a pre-column Security Guard Gemini-NX C18 4mm x 2 mm I.D. 
cartridge (Phenomenex, Aschaffenburg, Germany). Azidothymidine was added as an 
internal standard to all samples and the 12.5 µM calibrant at a final concentration of 10 
µM. The samples were run with sample- and analyte-relevant calibration standards and 
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pooled QC samples (Hodson et al., 2009; Sangster et al., 2006) to control for 
reproducibility of data acquisition and to ensure data integrity. Analyte stock solutions were 
prepared in purified water (Veolia) and aliquots of each solution were mixed to achieve a 
final calibrant solution at 200 μM.  This calibrant solution was serially diluted and the 
dilutions used as calibration standards from 200 to 0.006μM, constituting 9≤x≤20 
calibration points for all analytes to account for differential responses in the mass 
spectrometer. Data were processed and analysed in Analyst 1.5.2 and MultiQuant 2.1.1 
(ABSciex, Canada). 
A HPLC system was used to analyse extra- and intra-cellular amino acids (AAs) as 
described previously (Dietmair et al., 2010) with some modifications including the increase 
of flow rate from 1 mL/min to 2 mL/min and the decrease of the running time. The detail of 
the method was presented in Chapter 2 of this thesis. 
Extracellular organic acids (α-ketoglutarate, pyruvate, succinate, lactate, fumarate, 
acetate and propionate) and sugars (sucrose, glucose and maltose) were also analyzed by 
HPLC (Agilent 1200 series, Agilent, Mulgrave, Victoria, Australia) using both MWD and 
RID detectors. The detail of the method was presented in Chapter 2 of this thesis. 
The intracellular ATP in the first experiment was measured using the ATPlite 
luminescence ATP detection assay system (PerkinElmer Life Sciences, Boston, MA), 
which was  described in Tran et al. (2012). This assay is based on the production of light 
when ATP reacts with D-Luciferin in the presence of Luciferase, and was conducted 
according to the manufacturer's instructions. 
4.2.5 Statistical analysis 
One-way analysis of variance (ANOVA), followed by Tukey's Honestly Significant 
Difference (HSD) test, was used to determine whether the means from two or more groups 
of data were significantly different at the 95% confidence level. Minitab 15 Statistical 
Software (Minitab, State College, PA) was used for all data analysis.  
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4.3 Results  
4.3.1 Assessment of the extraction protocol for infected Sf9 cells post-infection 
Results for the evaluation of the extraction protocol at different times post-infection 
are presented in Fig. 4.1. At a high MOI infection (10 PFU/cell), the cell density increase 
post-infection (cells/mL) of 40% was almost negligible compared with the uninfected 
culture that reached a peak cell density of 1.8-2×107 cells/mL (Fig.4.1a). Also as shown in 
Figure 4.1a, the increase in cell diameter post-infection was rapid for the first 24 hpi, and 
then gradually increased until 48 hpi, with a peak increase in cell diameter of 18% and 
then declined after that point. Cell viability of the infected culture remains as high as that of 
the uninfected one (above 90%) until 48 hpi and then dropped sharply after that (Fig. 
4.1a). These results indicate that the cell integrity was affected greatly after 48 hpi when 
infected cells began to die and lyse. The kinetics of vDNA and β-Gal production for 
infected Sf9 cells were as expected for rAcMNPV infected Sf9 cells (Fig. 4.1b). As shown, 
vDNA production started after 6 hpi and increased rapidly from 12 until 24 hpi to a value 
close to the peak yield seen at 36 hpi, while β-Gal production commenced by 24 hpi and 
rapidly increased until 60 hpi then slightly increased to the peak yield at 72 hpi. The results 
of vDNA and β-Gal yield shows that the rAcMNPV infected Sf9 cells set up in this study 
were optimally-infected, and were suitable for endometabolome studies.  
The intracellular ATP content of infected Sf9 cells and the recovery of cell extract 
samples compared to the direct extract over the time course post-infection (from 0 to 72 
hpi) are shown in Figure. 4.1c. There was good recovery of ATP in cell extract samples 
until 48 hpi (recovery of at least 90% of the direct extract). In other words, the extraction 
protocol still works for infected Sf9 cells until 48 hpi. Intracellular ATP concentrations 
remained at a peak level of around 3.8 mM (Fig. 4.1c), from 0-48 hpi and started to 
decrease after 48 hpi, presumably due to cell lysis after that point. In addition, intracellular 
AA concentrations of Sf9 infected cells at various times post-infection (Fig. 4.1d) remained 
unchanged during the first 48 hpi for most AA and dropped significantly after that. The 
drop (after 48 hpi) also occurred with alanine which gradually increased during the first 48 
hpi. These results indicate that 48 hpi is the latest time that the infected cells can be 
quenched and extracted without a significant loss of intracellular metabolites. 
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Fig. 4.1 The kinetics of cell growth, cell size expansion and viability (a), specific vDNA and -Gal 
production (b), intracellular ATP levels and ATP recovery at different times post-infection (c) and 
intracellular amino acid levels (AAs) (d) of Sf9 cells infected with a recombinant baculovirus 
(rAcMNPV) at an MOI of 10 PFU/cell. Infections were conducted in Sf900™III serum free medium 
at an infection cell density (ICD) of 2.5×106 cells/mL. The experiment was conducted in shaker-
flask suspension cultures. Each data point is the average from three biological replicates, and the 
error bars represent the standard deviation. Abbreviations, TCD: total cell density, Via: viability, 
Dia: cell diameter, INF: infected, UINF: uninfected. 
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4.3.2 Low versus high cell densities at the time of infection 
Figure 4.2 represents data obtained from infected Sf9 cells with a rAcMNPV at low 
and high ICDs. The results confirmed the cell density effect when Sf9 cells were infected 
with a rAcMNPV at low (2×106) and high (6×106 cells/mL) ICDs. There was no significant 
difference in the cell density increase post-infection (cells/mL) when infections were 
conducted at low or high ICDs, with an increase of 49% and 46% for low and high ICDs, 
respectively (Fig. 4.2a). However, the cell diameter increase post-infection of the low ICD 
(21%) was significantly higher than that of the high ICD (14%) (Fig. 4.2a). Cell viabilities of 
the infected cultures of both ICDs were comparable with the uninfected culture until 48 hpi, 
and then significantly reduced after that point (Fig. 4.2a) as was also shown for the case of 
the previous experiment for evaluating the extraction protocol (Fig. 4.1a).  
 
Table 4.1. Total cell protein (TCP) per cell increase post-infection (pi) and the proportion of 
β-Gal protein over TCP increase pi for Sf9 cells infected with a recombinant baculovirus 
(rAcMNPV) at either low (2×106) or high (6×106 cells/mL) ICDs 
 0-24 hpi 24-60 hpi 0-60 hpi 
 Low ICD High ICD Low ICD High ICD Low ICD High ICD 
TCP increase pi (pg/cell) 65±29 72±10 151±16 66±4 217±27 139±13 
β-Gal yield (pg) - - 88±6 31±2 - - 
β-Gal/TCP increase (%) - - 57±7 46±5 40±2 22±3 
TCP produced 24-60 
hpi/0-24 hpi 
- - 2.78±1.66 0.93±0.11 - - 
 
Although the early events of the virus infection and cessation of cell growth was 
similar between low and high ICDs (Fig. 4.2a), there was a contrast between these two 
ICDs in terms of cell specific yields (Fig. 4.2b). The peak specific β-Gal yield for the low 
and high ICDs was 0.14 and 0.05 U/cell, respectively, and the specific vDNA yield for 
these two ICDs was 4.4 and 3×104 copies/cell. However, the time frame from the starting 
point of vDNA and β-Gal production to the point where peak yields were achieved was 
similar for both ICDs (Fig. 4.2b). This indicates that the infection process follows a similar 
time sequence for low and high ICDs, but the vDNA and -Gal productivities during the 
post-infection period are lower for the high density infection.  
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Fig. 4.2 Total cell density and cell hypertrophy (a), specific vDNA and -Gal production (b), and total 
cell protein vs -Gal (c) of Sf9 cells infected with a rAcMNPV. Infections were conducted in Sf900™III 
serum free medium at low (2×10
6
) and high (6×10
6
 cells/mL) ICDs and at an MOI of 10 PFU/cell. The 
experiment was conducted in shaker-flask suspension cultures. Each data point is the average from 
three biological replicates, and the error bars represent the standard deviation. Abbreviations, TCD: 
total cell density, Via: viability, Dia: cell diameter, LICD: low infection cell density, HICD: high infection 
cell density. 
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The total cell protein (TCP) content of the low and high ICDs, (Fig. 4.2c) shows that 
both cultures started at a similar level of TCP content at ~155 pg/cell. For the first 24 hpi, 
the TCP increase was similar for the low and high ICDs. The TCP increase for these two 
ICDs was, however, divergent after 24 hpi which coincided with the starting time of β-Gal 
production, with a faster rate of increase shown for the lower ICD. The TCP peaked at 60 
hpi for both cultures and quickly declined after that point due to cell death and lysis, while 
the β-Gal protein continued to increase at a lower rate up to 96 hpi. The TCP was 
measured from cell pellets, while β-Gal protein was measured from whole cultures, hence, 
β-Gal protein increased despite the decrease in TCP after 60 hpi. The gap between the 
peak specific TCP of low and high ICDs (81 pg/cell) was larger than the difference in the 
specific β-gal protein content of cells from low and high ICDs, which at most is 57 pg/cell 
(calculated based on the conversion factor of 0.8 mg/106 U of β-gal protein (Chan et al., 
1998)) (Table 4.1). These data clearly indicate that significant protein production occurs 
post-infection other than that accounted for by β-Gal protein. For the low ICD, the β-Gal 
produced accounted for 40% of the TCP produced post-infection and 57% of the TCP 
produced after 24 hpi. For the high ICD, the β-Gal produced accounted for only 22% of the 
total protein produced post infection and 46% of the total protein produced after 24 hpi 
(Table 4.1). The TCP increase during the late infection stage (24-60 hpi) was 2.78 and 
0.93 times of the TCP increase at the early infection stage (0-24 hpi) for low and high 
ICDs, respectively (Table 4.1). 
4.3.3 Intracellular metabolite measurements of low versus high ICDs 
In the multivariate classification of numerous metabolites at different times post-
infection, principle component analysis (PCA) models have been applied using the soft 
independent modelling of class analogy (SIMCA). The orthogonal projection to latent 
structure (OPLS) is a linear multivariate regression method that is used for classification 
and prediction of multiple parameters in biological application. OPLS is a modification of 
the usual partial least squares (PLS) regression method which filters out variations that not 
directly related to the response (Eriksson et al., 2006). The OPLS couple with the 
discriminant analysis (OPLS-DA) is a powerful tool for the regression prediction and 
classification of various components in a metabolomics study. The main benefit of using 
OPLS-DA lies in the ability to separate predictive from non-predictive (orthogonal) variation 
(Bylesjo et al., 2006). Therefore, it improves the detection limit for outliers in the scores 
and decreases the total number of components used. 
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Fig. 4.3 Multivariate analysis of intracellular metabolite concentrations of Sf9 infected cells at low 
(2x106 cells/mL) and high (6x106 cells/mL) ICDs. Orthogonal projection to latent structures–
discriminant analysis (OPLS-DA) scores (a) and loadings (b) plots of the 5 time points post-
infection at low and high ICDs, classified by cell density. OPLS-DA model metrics: Predictive 
component R2X = 0.197; R2 = 0.913; Q2 = 0.869; R2Y = 1: Orthogonal component R2X = 0.278.  
Figure 4.3 presents the intracellular concentrations of 37 metabolites (including 
nucleotides, nucleotide sugars and organic acids) of 5 time points  post-infection (0, 12, 
24, 36, 48 hpi) at low (2×106 cells/mL) and high (6×106 cells/mL) ICDs. The orthogonal 
projection to latent structures – discriminant analysis (OPLS-DA) of all the samples over 
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the time course of infection (Fig. 4.3a) showed a clear separation of low and high ICDs.  
Figure 4.3a also indicates that the biological replication is reliable as the scores for the 
three replicates indicate similar positions in biochemical space. Based on the OPLS-DA 
loadings (Fig. 4.3b), the metabolites most influential in the projected separation between 
low and high ICDs are the nucleoside tri-phosphates, nucleoside di-phosphates, 
nucleoside mono-phosphates, α-ketoglutarate,  pyruvate, fumarate, lactate, succinate and 
UDP sugars (UDP-glucose, UDP-glucuronic acid, and UDPN-acetylglucosamine). These 
metabolites have a variable importance on projection (VIP) score of >1 and have been 
selected for further statistical analysis as detailed in Table 4.2 and Fig. 4.4. Generally, 
intracellular metabolite levels at the low ICD were higher than those at the high ICD with 
the exception of succinate (Table 4.2, Fig. 4.4). 
 
Fig. 4.4 Intracellular concentrations of organic acids and UDP sugars for infected Sf9 cells at low 
(2×106) and high (6×106 cells/mL) ICDs. Infections were conducted in Sf900™III serum free 
medium at an MOI of 10 PFU/cell in shaker-flask suspension cultures. Each data point is the 
average from three biological replicates, and the error bars represent the standard deviation. 
The concentrations of nucleoside tri-, di-, and mono-phosphates of infected Sf9 cells 
at low (2×106) and high (6×106 cells/mL) ICDs over the time course of infections are 
presented in Fig.4.5. Intracellular ATP levels appeared to increase over time post-infection 
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for the low ICD, while the levels slightly decrease post-infection for the high ICD (Fig. 
4.5a). There were significant differences in ATP levels between the low ICD at 24 and 36 
hpi and the high ICD at 48 hpi. In contrast, ADP concentrations tended to be higher for the 
high ICD at all time points and for the low ICD at the late infection stage (Table 4.2, Fig. 
4.5a).  In general, the ADP concentration of the high ICD infection was significantly higher 
than that of the low ICD cases. Unlike the low ICD, there was a significant amount of AMP 
in the high ICD cases (Table 4.2, Fig. 4.5a). As a result, the total adenosine (ATP+ADP+ 
AMP) was similar between low and high ICDs except for the low ICD at 0 and 12 hpi, 
which were lower than the other time points. The trends for intracellular concentrations of 
other nucleotides (uridine, guanine and cytosine) were similar to that of adenosine with the 
nucleotide tri-phosphate levels during the low ICD being generally higher than those during 
the high ICD (Fig. 4.5 b, c, d). The trend for total uridine, guanine and cytosine 
concentrations over various time points post-infection for low and high ICDs were similar to 
that for total adenosine. 
It is interesting to note that at 24 hpi towards the end of the rapid rise in vDNA for 
both low and high ICDs (Fig 4.2b), the UTP, CTP, GTP and ATP levels in the low ICD 
case are all significantly higher than the levels of these metabolites in the high ICD case 
(Table 4.2). Indeed the UTP level at 24 hpi is 8 times higher in the low ICD case compared 
to that in the high ICD case at the same time post-infection. Similarly the CTP level is 5 
times higher, GTP 3 times higher and ATP 1.6 times higher at 24 hpi in the low versus 
high ICD case. It is possible that the supply of UTP, CTP, GTP and ATP is rate limiting for 
the production of vDNA during the 6-24 hpi period for high cell density infections. 
The intracellular amino acid (AA) concentrations of infected Sf9 cells at low and high 
ICDs over the 0-48 hpi period and a comparison of this data between low and high ICDs at 
0 and 36 hpi are shown in Fig. 4.6.  In the case of the low ICD, the levels of most AAs 
inside the cells were stable over time, except for alanine, which gradually increased (Fig. 
4.6a). In contrast, there is a slight decrease in intracellular levels of some AAs 
(asparagine, serine, methionine, isoleucine, leucine, and proline) for the high ICD case 
during the time post-infection, in particular the glutamine concentration dropped quickly 
over the period of 0-24 hpi (Fig. 4.6b).  The intracellular alanine concentration continuously 
increased over the time post-infection for the high ICD case as found in the case of the low 
ICD. Comparing between the low and high ICDs in terms of intracellular AA levels, Fig. 4.6 
c, d shows that the concentrations of most AA of the low ICD were significantly higher than 
those of the high ICD either at 0 hpi (Fig. 4.6c) or 36 hpi (Fig.4.6d). The significant 
74 
 
differences between intracellular AA levels of low and high ICDs were more pronounced 
during the latter stages of the infection (36 hpi, Fig. 4.6d). 
Table 4.2 Intracellular metabolite concentrations (mM) over various times post-infection for 
Sf9 cells infected with a recombinant baculovirus (rAcMNPV) at either low (2×106) or high 
(6×106 cells/mL) infection cell densities (ICDs). Data represented as an average of 
biological triplicates. The metabolites listed were selected on the basis of showing 
significant variations in levels between different ICDs or times post infection following the 
analysis shown in Fig. 4.3. 
Metabolites 
Low ICD (2×106 cells/mL) High ICD (6×106 cells/mL) 
P< 0 hpi 12 hpi 24 hpi 36 hpi 48 hpi 0 hpi 12 hpi 24 hpi 36 hpi 48 hpi 
KGA 0.15ab 0.18a 0.18a 0.12b 0.02cd 0.02cd 0.05cd 0.02cd 0.06c 0.00d 0.001 
UTP 1.79ab 1.86ab 2.11a 1.53abc 1.47abc 0.80cd 0.99bcd 0.26d 1.04bcd 0.71cd 0.001 
CTP 0.93a 0.93a 0.95a 0.65b 0.74ab 0.56bc 0.50bc 0.19d 0.52bc 0.34cd 0.001 
UDPGA 0.08de 0.09cd 0.12bc 0.15ab 0.17a 0.05e 0.05de 0.05de 0.06de 0.09cd 0.001 
FUM 0.11ab 0.14a 0.15a 0.11ab 0.10ab 0.11ab 0.07bc 0.00c 0.06bc 0.06bc 0.001 
SUC 0.07de 0.10cd 0.07de 0.08de 0.03e 0.08de 0.15abc 0.11bcd 0.16ab 0.20a 0.001 
LAC 8.47b 10.69a 5.90c 3.71d 3.89d 8.39b 4.23cd 2.79de 1.35ef 0.88f 0.001 
GMP 0.02b 0.01b 0.03b 0.07ab 0.08ab 0.07ab 0.04b 0.21a 0.04b 0.13ab 0.01 
UDPG 0.89abc 0.90abc 1.03ab 1.18a 1.12a 0.66c 0.66bc 0.67bc 0.58c 0.66bc 0.001 
GTP 1.47a 1.46a 1.34ab 1.23ab 1.25ab 0.95abc 1.03abc 0.40c 0.94abc 0.70bc 0.001 
PEP 0.03ab 0.05a 0.02ab 0.00b 0.00b 0.02ab 0.01b 0.01b 0.00b 0.00b 0.01 
CMP 0.02b 0.01b 0.01b 0.04b 0.05ab 0.04ab 0.04ab 0.05ab 0.03b 0.09a 0.001 
PYR 0.41ab 0.24b 0.53ab 0.80a 0.48ab 0.20b 0.12b 0.44ab 0.22b 0.46ab 0.001 
UDPNAG 0.72cd 0.76cd 0.90bc 1.10ab 1.34a 0.56d 0.61cd 0.64cd 0.64cd 0.85bcd 0.001 
AMP 0.07ab 0.04b 0.16ab 0.30ab 0.35ab 0.33ab 0.20ab 0.68a 0.15ab 0.66ab 0.05 
ADP 1.20c 1.00c 1.40bc 1.43abc 1.76bc 1.44bc 2.09abc 2.34ab 1.87bc 2.95a 0.001 
ATP 4.58abc 4.63abc 5.73a 5.92a 5.32ab 4.38abc 4.33abc 3.63bc 4.01abc 2.90c 0.001 
Adenosine 5.84b 5.66c 7.30abc 7.65a 7.43ab 6.14abc 6.62abc 6.65abc 6.03abc 6.51abc 0.01 
 Data in the same row with different superscripts were significantly different at P <0.05. 
Abbreviation: KGA: α-ketoglutarate, UTP: uridine tri-phosphate, CTP: cytidine tri-phosphate, 
UDPGA: uridine di-phosphate gluconic acid, FUM: fumarate, SUC: succinate, LAC: lactate, GMP: 
guanosine mono-phosphate; UDPG: uridine di-phosphate glucose, GTP: guanosine tri-phosphate; 
PEP: phosphoenol pyruvate, CMP: cytidine mono-phosphate, PYR: pyruvate, UDPNAG: uridine di- 
phosphate N-acetylglucosamine, AMP, ADP and ATP: adenosine mono-, di- and tri-phosphate. 
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Fig. 4.5 Stacked bar charts of (a) adenosine, (b) uridine, (c) guanosine and (d) cytidine nucleotide concentrations of Sf9 infected cells over 5 time 
points post-infection at low (2x106 cells/mL) and high (6x106 cells/mL) ICDs. Infections were conducted in Sf900™III serum free medium at an MOI of 
10 PFU/cell. The experiment was conducted in shaker-flask suspension cultures. Each data point is the average from three biological replicates, and 
the error bars represent the standard deviation. 
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Fig. 4.6 Intracellular AA concentration of infected Sf9 cells at various times post-infection at low (a) and high (b) ICDs, and the comparison between 
low and high ICD for intracellular AA levels at 0hpi (c) and 36 hpi (d). Infections were conducted in Sf900™III at low (2×106) and high (6×106 cells/mL) 
ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-flask suspension cultures. Each data point is the average from three 
biological replicates, and the error bars represent the standard deviation. 
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4.3.4 Glucose and AA consumption rates between low versus high ICDs 
Glucose and AA consumption rates of uninfected and baculovirus infected Sf9 cells 
at low and high ICDs are shown in Table 4.3.  The cell specific glucose consumption rate 
of infected cells at the low ICD was significantly higher than that of the uninfected cells. 
However, the glucose consumption rate of infected cells at the high ICD was not 
significantly different to either infected cells at the low ICD or to uninfected cells. However, 
the glucose consumption rate per unit of cell biomass was similar among uninfected and 
infected cultures (Table 4.4) due to the enlargement of infected cells post-infection. In this 
Table cell volume is assumed to reflect cell biomass. 
AA consumption rates of infected cells at the low ICD were significantly higher than 
those at the high ICD for most of the AAs except for aspartate, glutamate, tyrosine and 
tryptophan (Table 4.3). Differences in AA consumption rates between low and high ICDs 
were less pronounced for the consumption per unit of cell volume, Table 4.4, as the lower 
ICD generated a larger cell volume post-infection. However, the AA consumption rates per 
unit of cell biomass at the low ICD were still significantly higher than those at the high ICD, 
except for the four AAs mentioned above plus serine, glutamine and alanine (Table 4.4). 
The consumption rates of AAs for uninfected Sf9 cells were somewhere in between of the 
values for the two infection cases (Table 4.3). Interestingly, the consumption rate of 
glutamine for uninfected cells was much higher than that for infected cells (both low and 
high ICDs). In addition, the asparagine consumption rate of uninfected cells was almost 
double that of the low ICD infected cells. Based on consumption per unit cell volume the 
AA consumption rates of uninfected cells were significantly higher than those of infected 
cells in many cases at both low, (9 out of 19 AAs measured), and high, (14 out of 19 AAs 
measured) ICDs (Table 4.4). The change of extracellular glucose, maltose and AA 
concentrations over the time post-infection/post-inoculation can be seen in Appendix A2.1 
& A2.2. 
Comparison of the AA consumption rates between early (0-24 hpi) and late stages 
(24-60 hpi) of the virus infection process at the same ICD or between infected Sf9 cells at 
low and high ICDs are shown in Fig. 4.7. For the low ICD, there was almost no difference 
in AA consumption rates between the early and late stages of the virus infection. In this 
case, significant differences in AA consumption rates were only seen for serine, glutamine 
and tyrosine (Fig. 4.7a). In contrast, a larger number of significant differences were found 
in the AA consumption rates between the early and late infection stages in the case of 
infected cells at the high ICD, with significant differences found for 12 out of the 19 AAs 
quantified (Fig. 4.7b). 
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Table 4.3. Glucose and AA consumption rates (×10
-12
mmol/cell/hour) of uninfected and 
rAcMNPV infected Sf9 cells at low and high ICDs. Uninfected and infected cultures were set 
up at 0.5×10
6
 cells/mL. For uninfected cultures no infection was made and sampling was 
conducted at every 24 hours until the total cell density reached 6×10
6
 cells/mL. For infected 
cells, cultures were infected with a baculovirus at an MOI of 10 PFU/cell when the cell density 
reached 2×10
6
 cells/mL (48 hours) or 6×10
6
 cells/mL (84 hours) and sampling was conducted 
every 12 hours until 60 hours post-infection. Data is the average of biological triplicates. 
 Uninfected  2×106 cells/mL† 6×106 cells/mL† P< 
Glucose -25.58b -40.90a -27.86ab 0.05 
Glucose, 0-24 hpi - -34.34 -46.67 NS 
Glucose, 24-60 hpi - -48.42a -15.15b 0.05 
Maltose -5.62 -5.68 -8.22 NS 
Amino acids     
Aspartate -4.50 -5.02 -2.98 NS 
Glutamate -5.96 -4.72 -4.54 NS 
Asparagine -8.66a -4.97b -0.62c 0.001 
Serine -5.81a -5.48ab -4.89b 0.05 
Glutamine -43.65a -14.91b -6.64c 0.001 
Histidine -0.82b -1.36a -0.59b 0.001 
Glycine -2.37a -2.50a -1.07b 0.01 
Threonine -2.41ab -3.49a -1.70b 0.05 
Arginine -2.39b -4.71a -1.65b 0.01 
Alanine 23.05a 26.25a 18.37b 0.01 
Tyrosine -1.62 -0.72 -1.12 NS 
Valine -1.87b -4.06a -1.63b 0.001 
Methionine -0.43b -4.02a -0.64b 0.001 
Tryptophan -1.92 -1.29 -0.40 NS 
Phenylalanine -0.40b -3.43a -0.71b 0.001 
Isoleucine -2.33ab -3.68a -1.35b 0.01 
Leucine -3.55ab -5.21a -2.75b 0.05 
Lysine -1.92b -3.74a -1.32b 0.01 
Proline -6.04a -4.53a -0.98b 0001 
† Infected cultures at low (2×106 cells/mL) and high (6×106 cells/mL) ICDs 
Consumption rates in the same row with different superscripts were significantly different at P<0.05 
NS: Not significant 
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Table 4.4. Comparison of sugar and AA consumption rates (×10-6mmol/mm3 cell volume/ 
hour) between uninfected and infected cells at low (2×106) and high (6×106 cells/mL) ICDs. 
Detailed description is presented in Table 4.3. 
 Uninfected  2×106 cells/mL† 6×106 cells/mL† P< 
Glucose -19.73 -19.47 -14.85 NS 
Maltose -2.80a -2.62b -4.51a 0.05 
Amino acids     
Aspartate -3.31 -2.32 -1.64 NS 
Glutamate -4.33a -2.18b -2.49b 0.05 
Asparagine -6.33a -2.29b -0.34c 0.001 
Serine -4.24a -2.53b -2.69b 0.001 
Glutamine -71.53a -6.88b -3.65b 0.001 
Histidine -0.60a -0.63a -0.32b 0.01 
Glycine -1.73a -1.15b -0.59c 0.01 
Threonine -1.76a -1.61a -0.93b 0.05 
Arginine -1.75a -2.17a -0.91b 0.01 
Alanine 16.86a 12.11b 10.09b 0.001 
Tyrosine -1.19a -0.33b -0.61ab 0.05 
Valine -1.36b -1.87a -0.89c 0.001 
Methionine -0.31b -1.86a -0.35b 0.01 
Tryptophan -1.40 -0.60 -0.22 NS 
Phenylalanine -0.29b -1.58a -0.39b 0.01 
Isoleucine -1.70a -1.70a -0.74b 0.05 
Leucine -2.60a -2.40a -1.51b 0.05 
Lysine -1.40ab -1.73a -0.73b 0.05 
Proline -4.41a -2.09b -0.54c 0001 
† Infected cultures at low (2×106 cells/mL) and high (6×106 cells/mL) ICDs 
Consumption rates in the same row with different superscripts were significantly different at P<0.05 
NS: Not significant 
Comparing between the low and high ICDs, AA consumption rates at the early 
infection stage (0-24 hpi) of infected cells at low ICDs was higher than those at the high 
ICD in most of the AAs with significant differences observed in 10 out of 19 AAs measured 
(Fig. 4.7c). At the late infection stage the significant differences were expanded in terms of 
the level of difference as well as the number of AAs involved, with significant differences 
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found in 11 out of 19 AAs measured (Fig. 4.7d). The difference in AA consumption rates 
calculated based on a cell biomass basis between early and late infection stages as well 
as between low and high ICDs (Fig. 4.8) followed the same pattern as found when 
calculated based on a per cell basis. This result indicates that infected cells at the low ICD 
consume AAs at higher rates than those at the high ICD and the consumption of AAs by 
infected cells at high ICDs were poorer at the late stage of the baculovirus infection 
process. 
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Fig. 4.7 AA consumption rates (mmol/cell/hour) between early (0-24 hpi) and late (24-60 hpi) infection stages for low (a) and high ICD (b) and 
between low and high ICDs for early (c) and late infection (d) of Sf9 cells infected with a rAcMNPV. Infections were conducted in Sf900™III at low 
(2×106) and high (6×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-flask suspension cultures. Each data 
point is the average from three biological replicates, and the error bars represent the standard deviation. 
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Fig. 4.8 AA consumption rates (mmol/mm3 cell biomass/hour) between early (0-24 hpi) and late (24-60 hpi) infection stages for low (a) and high ICD 
(b) and between low and high ICDs for early (c) and late infection (d) of Sf9 cells infected with a rAcMNPV. Infections were conducted in Sf900™III at 
low (2×106) and high (6×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-flask suspension cultures. Each 
data point is the average from three biological replicates, and the error bars represent the standard deviation. 
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4.3.5 Ratios between high and low ICDs and between intra- and extracellular AAs  
When comparing AA concentrations between high and low ICDs, Fig. 4.9 a, b shows 
that extra- and intra-cellular AA levels of infected cells at the high ICD were generally 
lower than those for the low ICD, as indicated by the ratios of high/low ICD AA values 
being less than 1 for the majority of the AAs. At 0 hpi, the ratios of high/low ICDs for 
extracellular AA levels were mostly similar to those for intracellular AA levels (Fig. 4.9a). At 
the late infection stage (36 hpi), ratios were almost maintained for extracellular AA levels, 
while those for intra-cellular AA levels were reduced significantly. Therefore, ratios of 
high/low ICDs for extracellular AA levels, at 36 hpi were significantly higher than those for 
intracellular AA levels for the majority of AAs (14 out of 19 AAs) (Fig. 4.9b). This result 
indicates a possibly poorer AA uptake into the cells at the late stage of virus infection for 
infected cells at the high ICD compared with those at the low ICD. Serine, glutamine, 
threonine, tyrosine, leucine and lysine are among the AAs that have low intracellular levels 
at the high ICD compared with the low ICD, (ratio of AAs between high/low ICDs less than 
0.5).  
When comparing the ratios of intra-/extra-cellular AA levels for low and high ICDs, 
these two ratios were also similar among the majority of AAs at 0 hpi (Fig. 4.9c). It is of 
interest that the intra-/extra-cellular ratios for most AAs for both low and high ICDs are 
close to one (16 out of 19 AAs). This suggests that the AA uptake by cells in culture before 
and after infection reaches an equilibrium of the AAs in the cell with the level in the 
external medium or alternatively that the external AA level dictates the extent of AA 
uptake. This in turn suggests the only way to keep intracellular AA levels high is to have 
high AA levels in the external media. At 36 hpi, these ratios increased in the case of the 
low ICD (more AAs had a ratio above 1), but they decreased significantly in the case of the 
high ICD (Fig. 4.9d). As a result, ratios of intra-/extra-cellular AA levels for the low ICD 
were significantly higher than those for the high ICD in many of the AAs (12 out of 19 AAs 
investigated). Again this result indicates low intracellular AA levels of infected cells for the 
high ICD in comparison with the low ICD. 
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Fig. 4.9 Ratios of AA levels between high versus low ICDs for extra- and intra-cellular AAs at 0 hpi (a) and 36 hpi (b) and ratios between intra- versus 
extra-cellular AA levels for low and high ICDs at 0 hpi (c) and 36 hpi (d) of Sf9 cells infected with a recombinant baculovirus (rAcMNPV). Infections 
were conducted in Sf900™III at low (2×106) and high (6×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-
flask suspension cultures. Each data point is the average from three biological replicates, and the error bars represent the standard deviation. 
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4.4 Discussion 
A quantitative and reproducible intracellular metabolite extraction protocol for infected 
Sf9 cells has been developed previously (Tran et al., 2012). However, this previous report 
only evaluated the one time point post-infection of 24 hpi. Since baculovirus infections 
ultimately kill the cells, accurate profiling of intracellular metabolite levels is likely to be 
restricted to a relatively short timeframe post-infection, prior to significant cell lysis. 
Therefore, it was necessary to investigate the extent of this timeframe, which is important 
for determining the dynamics of the endometabolome post-infection before designing 
subsequent studies to explore whether limitations in the endometabolome are implicated in 
the decline in productivity when insect cells are infected at high cell densities. 
At a high MOI infection (e.g ≥ 5 PFU/cell), rAcMNPV infected Sf9 cells exhibit a 
synchronous infection pattern leading to a minimal increase in cell density post-infection 
(O'Reilly et al., 1994; Wong et al., 1996). With an MOI of 10 PFU/cell, the cell density 
increase post-infection of the two experiments in this report was less than half of a cell 
doubling (Fig. 4.1 a, 4.2 a). The cell growth post-infection together with the cell diameter 
enlargement post-infection (Fig. 4.1 a, 4.2 a) as well as the timing of virus replication, -
Gal production and the peak virus yields (Fig. 4.1 b, 4.2 b) were typical for rAcMNPV 
infected Sf9 cells and were similar to those reported previously for these ICDs (Huynh et 
al., 2013). In addition to a reduction in cell diameter after 48 hpi, the cell viability also 
significantly declined after that point (Fig. 4.1 a, 4.2 a). The decrease in cell diameter and 
viability after 48 hpi means that the membrane integrity was affected and hence, the 
accuracy of intracellular metabolite measurements would be impacted when infected cells 
are processed through the quenching and washing steps prior to extracting intracellular 
metabolites. These results indicate that these infected cultures were suitable for further 
investigation of extra- and intra-cellular metabolite patterns, as they display typical 
behaviour for infected cultures for this cell line/virus system. 
As reported previously (Tran et al., 2012), the recovery of ATP in the cell extract 
compared to direct extract controls is one of the key indicators for evaluating the efficiency 
of the extraction protocol for intracellular metabolite studies. This is because ATP has a 
rapid turnover rate of 1.5 mM/s (de Koning and van Dam, 1992; Theobald et al., 1997; 
Weibel et al., 1974) and it is present in the cell at high levels given its role of energy supply 
for the cell. The ATP recovery reduced after 48 hpi and the intracellular ATP level of the 
cell extract samples also significantly decreased after that point (Fig 4.1c). The drop in 
intracellular ATP after 48 hpi has previously been reported (Olejnik et al., 2004). In 
addition, the intracellular AA levels of the cell extract also showed a significant reduction at 
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60 and 72 hpi (Fig. 4.1 d). All together, these results indicate that the extraction protocol 
was effective for infected Sf9 cells up to 48 hpi. 
It is known that the cell specific yield of foreign proteins expressed by recombinant 
baculoviruses drops when the cell density at the time of infection increases. The 
phenomenon has been widely reported in the literature (Carinhas et al., 2009; Caron et al., 
1990; Chakraborty et al., 1996; Chan et al., 2002; Doverskog et al., 2000; Huynh et al., 
2013; Radford et al., 1997; Taticek and Shuler, 1997; Wong et al., 1996).  A recent study 
for Sf9 cells infected with a rAcMNPV (Huynh et al., 2013) indicated that the reduction in 
cell specific protein yield for infections at high cell densities was related to a reduction in 
the upstream processes of vDNA replication and lacZ mRNA transcription. However, there 
is still limited information on the differences in intracellular metabolite levels as well as the 
uptake rates of metabolites from culture medium between cells at low and high ICDs. Thus 
there is a need to investigate whether there are any differences in uptake rates of key 
nutrients and the intracellular metabolite levels between low and high ICDs during the 
time-course of such infections. 
As reported previously (Huynh et al., 2013), the specific -Gal yield (expressed under 
control of the polyhedral promoter by a rAcMNPV as used in this study), reduced linearly 
with the increasing ICD, commencing at 1×106 cells/mL. In the current study, the ICD of 
2×106 cells/mL was chosen instead of 1×106 cells/mL to represent a low cell density 
infection since the cell specific -Gal yield of the former was comparable to the latter 
(~80%) (Huynh et al., 2013) and it is more accurate to calculate the consumption rates 
(glucose and AAs) for a culture infected at 2×106 cells/mL instead of 1×106 cells/mL.  For 
the high cell density case, the ICD of 6×106 cells/mL was selected as it still provided a 
reasonable specific -Gal yield (~0.05U/cell) and there was a good contrast in specific -
Gal yield between the low (2×106 cells/mL) and high (6×106 cells/mL) ICDs of 
approximately 3-fold based on the data of Huynh et al. (2013). Therefore, these two ICDs 
represented the low and high ICDs for the process of investigating the difference in intra- 
and extracellular metabolite due to variations in the ICD for this report.  
At 0 hpi, the TCP (total cell protein) level was in the range of 130-180 pg/cell (Fig. 4.2 
c), which was similar to the TCP of uninfected cultures for the cell density range of 0.5-
8×106 cells/mL (data not shown) and was also comparable with that reported by (Wickham 
et al., 1992) for Sf9 cells of 204 pg/cell. The TCP was similar between the low and high 
ICDs until 24 hpi, the time -Gal production commenced. After that the TCP of infected 
cells at the low ICD increased faster than that of the high ICD case. At 60 hpi the gap in 
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TCP between these two ICDs was 81 pg/cell, while the gap in -Gal protein yield between 
these ICDs was 57 pg/cell. A difference of 24 pg/cell indicates that apart from higher -Gal 
production, low ICD cells also produced more non--Gal protein compared to the high ICD 
cells. It would be expected that the cells need to produce other proteins to support -Gal 
protein production and the more -Gal produced, the more supporting protein that would 
be required. Another possible explanation is that the conversion factor of 800 pg of 
protein/U β-Gal may be an under estimation. Due to cell lysis after 60 hpi, it is difficult to 
measure total cell protein accurately at the time of the peak -Gal yield (72-96 hpi).  
Generally, the intracellular metabolite levels at the low ICD were higher than those at 
the high ICD (Fig 4.3 a). The multivariate analysis (Fig. 4.3 b) highlighted the metabolites 
that showed the most significant differences between low and high ICDs and among the 
various time points post-infection (Table 4.2).  
The concentrations of nucleotide tri-phosphates (ATP, UTP, GTP and CTP) at the 
low ICD tended to be higher than those at the high ICD (Fig 4.5 a-d).This suggests a 
possible limitation in building blocks for vDNA and mRNA production at the high ICD. Low 
levels of intracellular nucleotide tri-phosphates with increasing ICD may lead to the 
limitation of deoxyribose nucleotide tri-phosphates that are required for DNA synthesis. As 
a result, vDNA and mRNA levels decrease with increasing ICD (Huynh et al., 2013). The 
nucleotide di- and mono-phosphates are higher in concentration at the high ICD and at 
later stages of infection, especially adenosine and guanosine (Fig. 4.5 a-d), most likely 
indicating that more energy was used in the case of the high ICD or late infection stage, or 
the cell struggled to maintain energy levels in these cases. This may be the result of 
deterioration of the glycolytic and TCA energy production pathways at the late infection 
stages. 
Among the intracellular organic acids, the TCA cycle intermediates including α-
ketoglutarate (KGA), fumarate (FUM), citrate (CIT), succinate (SUC) and pyruvate (PYR) 
were found to be significantly different between the low and high ICDs (Fig 4.4 a-e). In 
particular, the KGA levels at 0, 12, 24 and 36 hpi for the low ICD were significantly higher 
than those for the high ICD.  The intracellular concentrations of PYR and FUM at the low 
ICD also tended to be higher than those at the high ICD, whereas intracellular SUC 
concentrations were higher post-infection for the high ICD case compared to those for the 
low ICD case and they tended to increase during the later stages of the infection for the 
high ICD case (Fig. 4.4). KGA and PYR were found to be limiting at high cell density 
infections and the supplement of either PYR or KGA at the time of infection has been 
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previously shown to result in an improvement of budded virus yields by 6-7 fold (Carinhas 
et al., 2010). It is possible that the lower level of KGA in the high ICD case may contribute 
to the lower yield at the high ICD as it is a key metabolite that can be supplied into the 
TCA cycle through glutamine and glutamate. However, low intracellular concentrations of 
KGA and PYR at the high ICD case may not link directly to the extracellular levels of these 
metabolites as no differences were found in the extracellular levels of KGA and PYR 
between low and high ICDs (Fig. 4.10). The low intracellular KGA concentration at the high 
ICD may derive from the low intracellular glutamine concentration (Fig. 4.6 c, d) and low 
glutamine consumption rate (Fig. 4.7) for the high ICD in comparison with that for the low 
ICD cases. 
 
Fig. 4.10 Extracellular concentrations of sugars and organic acids for infected Sf9 cells at low 
(2×106) and high (6×106 cells/mL) ICDs over various times post-infection. Infections were 
conducted in Sf900™III serum free medium at an MOI of 10 PFU/cell in shaker-flask suspension 
cultures. Each data point is the average from three biological replicates, and the error bars 
represent the standard deviation 
Glucose consumption rates for uninfected and baculovirus infected Sf9 cells have 
been extensively reported in the literature (Benslimane et al., 2005; Bernal et al., 2009; 
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Kamen et al., 1996; Radford et al., 1997; Raghunand and Dale, 1999; Rhiel et al., 1997; 
Wong et al., 1994), but the values vary considerably, possibly due to cell size differences 
reported for the Sf9 cell line used. The consumption rate varied in the range of 4.52-
12×10-11 and 2.07-24.2×10-11 mmol/cell/hour for uninfected and infected Sf9 cells 
propagated in Sf900™II medium, respectively. Raghunand and Dale (1999) reported that 
there is an increase in glucose consumption rate after infection, while others showed a 
reduction in the consumption rate post-infection (Bernal et al., 2009; Rhiel et al., 1997; 
Wong et al., 1994). In the current study, the glucose consumption rate/cell was the highest 
for infected cells at the low ICD followed by infected cells at the high ICD and then the 
uninfected cells (Table 4.3). For infected cultures, the glucose consumption rate was 
similar between the low and high ICDs during the first 24 hpi. However, the consumption 
rate of infected cells at the low ICD was significantly higher than that at the high ICD at the 
later stage of infection, 24-60hpi (Table 4.3). The consumption rate of infected Sf9 cells in 
the current study was similar to that reported by Bernal et al. (2009), and Wong et al. 
(1994), whereas, the glucose consumption rate for uninfected Sf9 cells (25.6×10-12mmol/ 
cell/hour) was lower than most values reported in the literature. The discrepancy in the 
glucose consumption rate on a per cell basis among the literature may result from the 
differences in cell size. Calculations based on the unit of cell biomass show that the 
glucose consumption rate was not significantly different among uninfected and infected 
cells at low and high ICDs (Table 4.4). In addition, the glucose consumption rate of cells in 
culture may be influenced by the presence of other carbohydrate sources (maltose) and 
AAs used as an energy source (glutamine, asparagine) as well as other elements 
available in the medium. The interdependence of glucose and glutamine uptake for Sf9 
insect cells has been reported elsewhere (Bedard et al., 1993; Drews et al., 2000; 
Neermann and Wagner, 1996; Raghunand and Dale, 1999). 
Although the AA consumption rates varied  from the literature (Bernal et al., 2009; 
Radford et al., 1997) probably due to the differences in cell size, the reduction in 
consumption rates with increasing ICDs has been found for most of the AAs (Bernal et al., 
2009). Generally, AA consumption rates of infected cells at the low ICD were higher than 
those at the high ICD, whereas consumption rates of the uninfected Sf9 cells were 
intermediate but in general closer to the high ICD consumption rates for most of the AAs 
(Table 4.3). However, AA consumption rates of uninfected cells were the highest for most 
of the AAs and AA consumption rates for the low ICD were significantly higher than those 
for the high ICD when calculated on a unit of cell biomass basis (Table 4.4). This means 
that the AA consumption rate per cell biomass was reduced for infected cells in 
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comparison with uninfected cells and the reduction was more severe for the high cell 
density infection. Over the post-infection period, consumption rates of most AAs at the 
early stage were generally higher than those of the late infection stage (Fig. 4.7 a, b), 
indicating a possible limitation for protein production post-infection as compared to 
uninfected cells. The limitation post-infection was more severe for high cell density 
infections (Fig. 4.7 b, c, d). These results indicate that the efficiency of AA uptake reduced 
post-infection as well as with an increase of the ICDs. This may contribute to the reduction 
in β-Gal yield with increasing ICD regardless of the fact that the uninfected culture is still 
doubling as normal after that high cell density (6×106 cells/mL) to the peak cell density of 
1.8-2×107 cells/mL. 
Although intracellular AA levels do not necessarily reflect the flux of AA into the cell 
and subsequent utilisation for protein synthesis, the measurement of intracellular AA levels 
at various times post-infection reveals whether there is a change in intracellular AA 
concentrations post-infection. As the result of possible poorer AA uptake rates at the late 
infection stage as well as at high cell densities at the time of infection, intracellular AA 
levels in mM were found to be stable or to reduce post-infection, especially for the case of 
the high ICD (Fig. 4.6 a, b). The intracellular AA levels that were found to be reduced post-
infection were glutamine and to a lesser extent asparagine, valine, isoleucine and proline 
for the high ICD case since these AA are not only used as building blocks for protein 
synthesis but also as a possible energy source (Drews et al., 1995), and so these AAs 
may be utilized at a much higher rate than would be the case if they were consumed for 
protein synthesis alone (Ferrance et al., 1993). The only case of an increase in 
intracellular concentration post-infection was for alanine. Alanine is the main by-product of 
nitrogen metabolism by Sf9 cells (Bedard et al., 1993; Benslimane et al., 2005; Drews et 
al., 2000; Ohman et al., 1995). As a result of possible poor AA uptake rates post-infection, 
as well as with the increasing ICD, the intracellular AA levels of the low ICD were 
significantly higher than those of the high ICD for the majority of AAs at both 0 and 36 hpi 
(Fig. 4.6 c, d). The differences in intracellular AAs levels between low and high ICDs were 
more significant at the later stage in the virus infection process (36 hpi), with a significant 
difference being found for 15 out of 19 AAs investigated (Fig. 4.6 d). Poorer uptake rates 
for AA, resulting in lower intracellular AA levels, particularly during the late stage of 
baculovirus infections at high cell densities could be partially responsible for the reduction 
in cell specific yields with increasing ICDs. 
The poorer uptake efficiency for the high ICD compared with the low ICD found 
above was clearly indicated through the ratios between high and low ICDs for extra- and 
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intra-cellular AA levels at 0 and 36 hpi (Fig. 4.9 a, b). Extra- and intra-cellular AA level 
ratios of high over low ICDs were <1 in most cases. The ratios of high over low ICDs for 
intra-cellular AA levels were significantly lower than those for extra-cellular AA ratios at 36 
hpi but less significant at 0 hpi, indicating that the AA uptake efficiency reduced 
significantly in combination with the increase in ICD and the time post-infection. In 
addition, the active uptake of AAs seemed to increase over the time post-infection for the 
low ICD (compare intra/extra cellular ratios for 2×106 cells/mL at 36 hpi in Fig 4.9 d, versus 
the corresponding ratios at 0 hpi in Fig 4.9 c), but significantly decreased for the high ICD 
(compare intra/extra cellular ratios for 6×106 cells/mL at 36 hpi in Fig 4.9 d versus the 
corresponding ratios at 0 hpi in Fig 4.9 c). These Figures also indicate that the uptake 
efficiencies for aspartate, arginine and lysine were very poor compared to the other AAs. 
These AAs may be the first ones to become limiting for recombinant protein production, 
especially arginine and lysine as they are both essential AAs. 
4.5 Conclusion 
The cell density effect in baculovirus infected insect cells is a complex phenomenon 
that relates to many factors and the interaction among them. Of these factors, nutrient 
limitation is an important consideration as the cell specific yield is often recovered when 
fresh medium or fed-batch approaches are used for high density infections (Chan et al., 
1998; Huynh et al., 2013). However, nutrient limitation may not only be related to the 
depletion of particular nutrients in the medium but may be also related to the uptake 
efficiency of nutrients into the cells at the late infection stage in the case of high infection 
cell densities. Results from the current study shows that there was a reduction in 
intracellular nucleotide tri phosphate concentrations when the infection cell densities 
increased. As a result, there may be a limitation in the availability of substrates for nucleic 
acid synthesis that may account for the low vDNA and mRNA production levels previously 
reported for high density infections (Huynh et al., 2013). In addition, infected Sf9 cells at a 
high ICD had lower intracellular AA levels as well as possible lower AA uptake efficiencies 
at the late infection stage in comparison with those at the low ICD. The lower AA uptake 
rates with increasing ICD may be the result of cell regulation due to lower AA requirements 
for protein synthesis, which was affected from the reduction in vDNA and mRNA levels at 
the high ICD. Lower AA consumption rates with increasing ICD may be also the result of 
the poor active transport of AAs by infected cells at the high ICD during the late stage of 
protein production. Serine, glutamine and leucine are among possible limiting AAs at high 
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ICDs, while aspartate, lysine and, to a lesser extent, arginine are among AAs showing a 
poor uptake efficiency. Furthermore, intracellular organic acid concentrations and in 
particular, TCA cycle intermediates, were also found to be reduced for high ICDs. Overall 
the data shows a reduction in the cell metabolism capacity with increasing cell density 
which may lead to a reduction in the cell specific yield at high cell densities. 
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Chapter 5 
Metabolic study of the cell 
density effect -Sf9/rAcMNPV in 
chemically defined medium 
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5.1 Introduction 
The media used for culturing insect cells currently in this thesis is serum free, 
whereby the growth factors, lipids and shear protectants normally provided by serum are 
supplied alternatively by protein hydrolysates and a manufactured lipid emulsion which 
contains the shear protectant Pluronic F-68. The use of hydrolysates in insect cell culture 
medium is considered as a revolution in serum free medium (SFM) development. 
However, the reliance on hydrolysates for supplying amino acids and growth factors has 
disadvantages in terms of the lot to lot variability of these undefined components (Reid et 
al., 2013). The variations of materials and processes for hydrolysate production lead to the 
variations of the medium and ultimately the cell culture process (Pasupuleti and Braun, 
2010). Although ultrafiltration processes may help to improve the consistency, the 
underlining variability in chemical composition is still present (Reid et al., 2013). In 
addition, hydrolysates also provide an amount of undesirable components together with 
desirable ones. Desirable components include amino acids, peptides and low molecular 
weight growth factors while undesirable components include high levels of inorganic salts, 
leading to high osmolarities (Pasupuleti and Braun, 2010), and possibly some undefined 
components imparting cellular toxicity (Lu et al., 2007). Other problems associated with 
protein hydrolysates include a wide divergence in aqueous solubility that limits their 
inclusion at high levels, especially in concentrated feeds. 
 The problems associated with hydrolysates may be addressed by the development 
of a chemically defined medium (CDM). CDM are also useful for metabolomics and 
fluxomics studies as all the ingredients are chemically defined. Although it is feasible to 
gain some metabolic insights using insect cells propagated in hydrolysate containing 
media, the replacement of hydrolysates by chemically defined substitutions would enhance 
the range and scope of metabolic studies (Bhatia et al., 1997). Currently, CDM 
formulations are well established for mammalian cell culture, but are not yet available for 
insect cell culture (Reid et al., 2013). However, it should be feasible to have a CDM for 
insect cell culture as insects have generally similar nutritional requirements to that of 
vertebrates, and there are high levels of similarities in the chemical composition between 
insect and mammalian basal media (Schlaeger, 1996). Fortunately, a CDM was made 
available for testing by Life Technologies for inclusion in the studies of this thesis. 
This chapter aims to investigate the adaptation of Sf9 insect cells to the CDM 
provided and to study such adapted cells during cell growth and baculovirus infections in 
relation to the cell density effect. The intracellular metabolite concentrations and the 
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consumption rates of substrates of infected Sf9 cells in CDM at low (1×106 cells/mL) 
versus high (5×106 cells/mL) infection cell densities (ICDs) are investigated. The chapter 
also examines differences in the intracellular metabolite levels of the Sf9 cells in a fully 
chemically defined medium compared to that for cells in Sf900™III, especially for high cell 
density infections. The CDM contains no peptides, and the free amino acid levels of most 
amino acids (except for glutamine and alanine) are higher than that in Sf900™III (Fig. 5.1). 
The difference in amino acid (AA) concentrations between these two media vary from 4% 
for glycine to 108% for leucine, but generally they are within the range of 30-60% higher 
for most of the AAs in the CDM compared to Sf900™III. In addition, substrate consumption 
rates and intracellular metabolite levels of infected cells at low and high ICDs were 
measured and compared between these two infection conditions using the available CDM 
as a comparison to the results obtained in Chapter 4 using the commercially available 
Sf900™III medium. 
 
Fig. 5.1 Free AA concentrations of Sf900™III and CDM media. Sf900™III would be expected to 
contain other AAs in the form of small peptides from the yeast hydrolysate present in the medium. 
However the AA levels shown for the CDM are expected to represent the total AA concentration 
present in the medium. 
5.2 Materials and methods 
5.2.1 Cell line, virus stock and medium 
The Spodoptera frugiperda clone 9 cell-line (Sf9; ATCC CRL 1711) and a 
recombinant Autographa californica multiple nucleopolyhedrovirus (rAcMNPV) expressing 
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an E. coli LacZ gene under the control of the polyhedrin promoter used in this study have 
been described previously (Chan et al., 1998; Wong et al., 1996). Working stock cells were 
maintained by regular passaging every 3-4 days in single-use shaker flasks (Corning, 
Lowell, MA) at seeding densities of 4-5×105 cells/mL. The shaker cultures were agitated at 
120 rpm on an orbital shaker platform (Thermoline, NSW, Australia) and incubated at 28oC 
in a refrigerated incubator (Thermoline). The preparation of virus stock was described in 
previous publications (Huynh et al., 2013; Tran et al., 2012). Virus stocks were stored at 
4oC, and were titered prior to use. The titers of virus stocks were around 1-1.5×109PFU/mL 
as determined by using a modified endpoint dilution method (Nielsen et al., 1992). The 
prototype chemically defined medium (CDM) (Life Technologies, USA) was used in all of 
the experiments. Sf9 cells propagated in Sf900™III medium were used as a control. 
5.2.2 Experimental procedures 
Sf9 cells in Sf900™III medium were first adapted into the CDM. Cells were then 
passaged in CDM for 5 passages prior to cryo-preserving in liquid nitrogen. Sf9 cells used 
in the current study were from frozen stocks stored in liquid nitrogen which had previously 
been adapted to the CDM. The stability of cell growth in the CDM was recorded over 14 
passages of 3-4 days each at the seeding cell density of 0.4-0.5×106 cells/mL. Sf9 cells in 
Sf900™III were routinely passaged in parallel with Sf9 cells in CDM as a control. A growth 
curve was conducted of uninfected Sf9 cells propagated in either Sf900™III or CDM using 
biological triplicates. Cultures in shaker flasks were seeded at 0.5×106 cells/mL and left to 
grow over 7 days. Total cell density (TCD) and viability were recorded everyday over the 
above period. The ability to support a baculovirus infection of the Sf9 cells in the CDM was 
also investigated at both a low (1×106) and a high (5×106 cells/mL) ICD in triplicate. 
Infections were conducted with a rAcMNPV virus stock prepared in Sf900™III at a 
multiplicity of infection (MOI) of 10 PFU/cell. 
The experiment investigating the changes in the intra- and extra-cellular environment 
as well as the -Gal production and metabolite consumption rates of infected Sf9 cells in 
CDM at a low and a high infection cell density (ICD) was as follows. The initial seeding cell 
density was at 0.5×106 cells/mL after which they were left to grow to 1×106 cells/mL (about 
24 hours post-inoculation), and then the cells were infected with the virus. This case 
represented the low cell density infection. For the case of a high cell density infection, cells 
were allowed to grow to around 5×106 cells/mL (72 hours post-inoculation) prior to 
infection with the virus inoculum. All of the infections were conducted at an MOI of 10 
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PFU/cell. The experiment was conducted in shaker flasks with biological triplicates at each 
cell density. Samples for intracellular metabolite analysis were taken at 12 hour intervals 
from 0-48 hpi in duplicate. Samples for extracellular metabolite analysis and for measuring 
TCD, viability and -Gal yield were collected from 3 infected control shakers at 12 hour 
intervals from 0-96 hpi. An uninfected control was also set up and left to grow to a peak 
cell density in batch culture (1-1.2×107 cells/mL). 
5.2.3 Intracellular metabolite extraction 
Intracellular metabolites were extracted using the optimized protocol as described 
previously (Tran et al., 2012). Briefly, infected cultures were set up in 125 mL shaker flasks 
at a working volume of 20 mL, involving three flasks for each treatment at each time point 
as biological triplicates. Quenching solution (QS)  (1.1% NaCl, 0.2% Pluronic F68) was 
prepared in 250 ml shaker flasks at 80 mL each and placed in an ice bath to make sure 
the temperature of the quenching solution was  around 0.5 to 1oC. The culture of each 
flask (20 mL) was quickly poured into 80 mL of ice-cold QS straightaway after taking out 
from the incubator. The quenched culture was then centrifuged (1000× g, 1 min) at 0oC. 
The supernatant was removed and the cell pellet was washed with the sample volume of 
ice-cold QS. Another centrifugation step was applied (1000× g, 1 min, 0oC) to collect the 
cell pellet which was then extracted with a cold 50% acetonitrile (ACN) solution at the ratio 
of 1 mL for 2×106 cells. The cell extracts were clarified by centrifugation (5000×g, 5 min, 
0oC), with the supernatants collected, frozen at -800C and then dried in a freeze-dryer 
(Alpha 1-4 LSC, Martin Christ, Germany). The freeze-dried samples were then stored at -
800C until analysed. For the direct extract, infected cultures were poured directly into the 
same volume of 100% ACN and then the supernatants were collected for subsequent 
steps as described above with the cell extract samples. 
5.2.4 Assays 
Total cell density (cell/mL) and cell diameter was estimated using a MultisizerTM4 
Coulter Counter (Beckman Coulter, Fullerton, CA, USA). Samples of various cell densities 
were initially diluted with medium to a TCD of around 0.5×106 cells/mL before proceeding 
with the cell enumeration process. Cell viabilities were estimated from triplicated 
hemocytometer counts using the 0.05 %w/v Trypan Blue exclusion method (Nielsen et al., 
1991). 
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The β-Gal protein yield of infected whole-culture samples was quantified using a well-
established colorimetric assay based on the enzymatic hydrolysis of ONPG, as described 
previously (Power et al., 1994; Radford et al., 1997; Wong et al., 1996). Briefly, fresh 
samples were initially diluted appropriately with MiliQ water, and then 50 µL of the diluted 
sample was added into 950 µL Z buffer (0.06M Na2HPO4, 0.04 M NaH2PO4, 0.001 M 
MgSO4, 0.01 M KCl and 0.035%v/v β-mercaptoethanol).  The mixture was then incubated 
for 30 minutes at 37oC after adding 200 µL of substrate (4 mg/mL ONPG). A stop buffer 
(1M Na2CO3) was added at 500 µL to terminate the reaction. The absorbance was 
measured at 420 nm using a spectrophotometer, and was accepted if it fell within the 
linear range (0.3-0.8) and converted to β-Gal activity units (U/mL) using Beer's Law (Chan 
et al., 1998).The β-gal assay of each sample was conducted three times as technical 
triplicates. 
Intracellular nucleotides and TCA cycle intermediates were measured by LC-MS/MS 
as described in Dietmair et al. (2012) with the following modifications: the analytical 
column was equipped with a pre-column Security Guard Gemini-NX C18 4mm x 2 mm I.D. 
cartridge (Phenomenex, Aschaffenburg, Germany). The samples were run with sample- 
and analyte-relevant calibration standards and pooled QC samples (Hodson et al., 2009; 
Sangster et al., 2006) to control for reproducibility of data acquisition and to ensure data 
integrity. Analyte stock solutions were prepared in purified water (Veolia) and aliquots of 
each solution were mixed to achieve a final calibrant solution at 200 μM.  This calibrant 
solution was serially diluted and the dilutions used as calibration standards from 200 to 
0.006μM, constituting 9≤x≤20 calibration points for all analytes to account for differential 
responses in the mass spectrometer. Data were processed and analysed in Analyst 1.5.2 
and MultiQuant 2.1.1 (ABSciex, Canada). 
A HPLC system was used to analyze extra- and intra-cellular amino acids (AAs) as 
described previously (Dietmair et al., 2010). Extracellular sugars (sucrose, glucose, 
maltose) were also analyzed by HPLC after samples had been hydrolyzed using 6M HCl 
(Radford, 1995). The HPLC analysis for AAs and sugars is described in detail in Chapter 2 
of this thesis. 
5.2.5 Statistical analysis 
One-way analysis of variance (ANOVA), followed by Tukey's Honestly Significant 
Difference (HSD) test, was used to determine whether the means from two or more groups 
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of data were significantly different at the 95% confidence level. Minitab 15 Statistical 
Software (Minitab, State College, PA) was used for all data analysis.  
5.3 Results  
5.3.1 Adaptation of Sf9 cells into chemically defined medium (CDM) 
Sf9 cells in Sf900™III serum free medium were adapted into a chemically defined 
medium for insect cell culture. The results show that Sf9 cells adapted well into the CDM 
within 7 days. Passaging of stock cells in CDM and Sf900™III as a control over 50 days 
(14 passages) is shown in Fig. 5.2 a. Over 14 passages, Sf9 cells propagated in CDM 
showed a reasonable growth rate with close to a 24 hour doubling time that was 
comparable to Sf9 cells propagated in Sf900™III medium. The viability of Sf9 cells in CDM 
was high within the range of 95-98% and was similar to that found in Sf900™III (Fig. 5.2a). 
Figure 5.2 b shows the growth curve and viability of Sf9 cells propagated in either 
Sf900™III or CDM over 7 days post-inoculation. In CDM, uninfected Sf9 cells doubled 
almost every 24 hours during the first 3 days from 0.5 to 4×106 cells/mL and then slowed 
down and reached a peak cell density of around 1.2×107 cells/mL at 6 days and declined 
after that point. Whereas in Sf900™III medium, Sf9 cells grew faster to the peak 
uninfected cell density of 1.9-2×107 cells/mL at 5 days and slightly reduced in cell density 
after that time (Fig. 5.2 b). The cell viability remained at a high level (around 90% or 
higher) over 7 days post-inoculation for Sf9 cells propagated in both Sf900™III and CDM 
medium. This result indicates that Sf9 cells can adapt and grow well in CDM although the 
peak cell density achieved in CDM was much lower than that in Sf900™III medium. 
For infected cultures, Fig. 5.2 c shows that CDM also supported good infected 
cultures in comparison with Sf900™III medium. At a high MOI of 10 PFU/cell, good 
infections were found (inhibition of cell growth post-infection in a similar time frame) for 
infected Sf9 cells in CDM and Sf900™III media at both low (1×106 cells/mL) and high ICDs 
(5×106 cells/mLfor CDM, and 6×106 cells/mL for Sf900III) (data not shown). β-Gal yields of 
infected cultures in CDM at a low ICD (1×106 cells/mL) was even higher than that in 
Sf900™III medium (0.23 vs 0.19 U/cell) (Fig. 5.2 c). The cell specific yield reduced with 
increasing ICD as was observed for Sf9 cells propagated in both media. At a high ICD, the 
peak specific β-Gal yield was about 0.08 and 0.06 U/cell for infected Sf9 cells in CDM and 
Sf900™III, respectively. Generally, the timing of β-Gal production was similar between 
infected Sf9 cells in Sf900™III and CDM media.  
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Fig. 5.2 Stock cell maintenance of Sf9 cells propagated either in Sf900™III (blue) or CDM (red) 
over 50 days (a). Cells were passaged every 3-4 days at a seeding cell density of 4-5×105 
cells/mL. The growth curve of Sf9 cells propagated either in Sf900™III (blue) or CDM (red) over 
168 hours post-inoculation (b). Cell specific β-Gal yield of Sf9 cells infected at an MOI of 10 
PFU/cell either in Sf900™III or CDM at low (1×106 cells/mL) and high (6×106 or 5×106 cells/mL for 
Sf900™III or CDM, respectively) ICDs, (c). Cell cultures were maintained in shaker flasks with 
three biological replicates and the error bars are the standard deviation of the triplicates. 
5.3.2 Investigation of intra- and extra-cellular metabolites for infected Sf9 cells in 
CDM at low and high ICDs 
Total cell density, cell diameter increase post-infection and β-Gal yield of low vs high ICDs 
The total cell density and viability, cell diameter and β-Gal yield post-infection for Sf9 
cells propagated in CDM at  low (1×106) and  high (5×106 cells/mL) ICDs are presented in 
Fig. 5.3.  
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Fig. 5.3 The kinetics of cell growth and cell viability (a), cell size expansion (b) and specific β-Gal 
yield (c) of infected Sf9 cells propagated in CDM at low (1×106 cells/mL) and high (5×106 cells/mL) 
ICDs. Infections were conducted at a multiplicity of infection (MOI) of 10 PFU/cell in shaker-flask 
suspension cultures. Each data point is the average from three biological replicates, and the error 
bars represent the standard deviation. 
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There was no significant difference in cell density increase post-infection when 
infections were conducted at low or high ICDs, with an increase of 20% and 16% for low 
and high ICDs, respectively (Fig. 5.3 a). Whereas, the total cell density of the uninfected 
control increased as normal from the initial cell density of 1×106cells/mL up to the peak cell 
density of 1.2×107 cells/mL. The cell viability of infected cultures of both low and high ICDs 
remained at a high level (>80%) until 48 hpi and then declined significantly after that (Fig. 
5.3 a). For the uninfected control, the viability remained as high as 90% beyond the point 
where the peak cell density was achieved. Although the cell density increase post-infection 
was similar between low and high ICDs, the cell diameter increase post-infection of the low 
ICD (23%) was significantly higher than that of the high ICD (10%) (Fig. 5.3 b).The cell 
diameter of the uninfected control was almost unchanged or slightly declined over the time 
post-inoculation. It is interesting to note that the size of the Sf9 cells in CDM and Sf900™III 
are similar (compare Fig. 5.3 b to Fig. 4.1 a and 4.2 a as presented in Chapter4). 
Although the early events of the virus infection and cessation of cell growth were 
similar between low and high ICDs (Fig. 5.3 a), there was a contrast between these two 
ICDs in terms of cell specific yields (Fig. 5.3 c). The peak specific β-Gal yield for the low 
and high ICDs was 0.23 and 0.08 U/cell, respectively. However, the time frame from the 
starting point of β-Gal production to the point where peak yields were achieved was similar 
for both ICDs (Fig. 5.3 c). This indicates that the infection process follows a similar time 
sequence for low and high ICDs, but the -Gal productivity during the post-infection period 
is lower for the high density infection.  
Intracellular metabolite concentration of low versus high ICDs 
Figure 5.4 presents the intracellular concentration of 34 metabolites (including 
nucleotides, nucleotide sugars and organic acids) of 4 time points  post-infection (0, 24, 36 
and 48 hpi) at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs. The orthogonal 
projection to latent structures – discriminant analysis (OPLS-DA) of all the samples over 
the time course of infection (Fig. 5.4 a) showed a clear separation of low and high ICDs.  
Fig. 5.4a also indicates that the biological replication is reliable as the scores for the two 
replicates indicate similar positions in biochemical space. Based on the OPLS-DA loadings 
(Fig. 5.4 b), the metabolites most influential in the projected separation between low and 
high ICDs are the nucleoside triphosphates, nucleoside diphosphates, nucleoside 
monophosphates, UDP sugars (UDP-glucose, UDP-glucuronic acid, and UDP N-
acetylglucosamine), α-ketoglutarate, fumarate, nicotinamide adenine dinucleotide 
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andnicotinamide adenine dinucleotide phosphate. These metabolites have a variable 
importance on projection (VIP) score of >1 and have been selected for further statistical 
analysis as detailed in Table 5.1. Generally, intracellular metabolite levels at the low ICD 
were higher than that at the high ICD (Table 5.1). 
 
Fig. 5.4 Multivariate analysis of intracellular metabolite concentrations of infected Sf9 cells 
propagated in CDM at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs. Orthogonal projection 
to latent structures–discriminant analysis (OPLS-DA) scores (a) and loadings (b) plots of the 4 time 
points post-infection at low and high ICDs, classified by cell density. OPLS-DA model metrics: 
Predictive component R2X = 0.279; R2 = 0.987; Q2 = 0.907; R2Y = 1: Orthogonal component R2X 
= 0.203. Infections were conducted at a multiplicity of infection (MOI) of 10 PFU/cell in shaker-flask 
suspension cultures.  
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Table 5.1. Intracellular metabolite concentrations (mM) over various times post-infection 
for Sf9 cells infected with a recombinant baculovirus (rAcMNPV) in a chemically defined 
medium at either low (1×106) or high (5×106 cells/mL) infection cell densities (ICDs). Data 
represented as an average of biological duplicates. The metabolites listed were selected 
on the basis of showing significant variations in levels between different ICDs or times post 
infection following the analysis shown in Fig. 5.4 
Metabolites 
Low ICD (1×106 cells/mL) High ICD (5×106 cells/mL) 
P< 
0 hpi 24 hpi 36 hpi 48 hpi 0 hpi 24 hpi 36 hpi 48 hpi 
Adenosine 8.882 9.64 9.78 9.53 9.39 9.59 9.69 9.66 NS 
ATP 5.54abc 6.83ab 6.88a 6.48abc 5.25bc 4.98c 4.91c 5.08c 0.01 
ADP 2.66 2.58 2.56 2.82 2.46 2.56 2.78 2.94 NS 
AMP 0.61b 0.23b 0.34b 0.23b 1.68a 2.04a 2.00a 1.63a 0.001 
UTP 1.79ab 1.90a 1.37bc 1.26c 0.64d 0.66d 0.38d 0.76d 0.001 
UDP 0.43a 0.38ab 0.35ab 0.27b 0.07c 0.11c 0.03c 0.27b 0.001 
UMP 0.27a 0.11b 0.09b 0.06b 0.02b 0.15ab 0.07b 0.10b 0.01 
CTP 1.07c 2.03a 1.91ab 1.23bc 0.65c 0.67c 0.66c 0.73c 0.001 
CMP 0.13 0.05 0.06 0.04 0.09 0.13 0.15 0.05 NS 
GDP 0.48a 0.31ab 0.38ab 0.28ab 0.12b 0.23ab 0.42ab 0.32ab 0.05 
GMP 0.14 0.05 0.07 0.04 0.19 0.13 0.29 0.08 NS 
UDPG 2.38a 2.56a 2.28ab 1.98bc 1.56d 1.89c 1.88c 1.54d 0.001 
UDPGA 0.54a 0.46a 0.51a 0.45a 0.14b 0.22b 0.23b 0.26b 0.001 
UDPNAG 1.38ef 2.12ab 2.18a 1.94abc 1.24f 1.74cd 1.86bcd 1.56de 0.001 
FUM 0.16a 0.16a 0.12ab 0.12ab 0.03c 0.07bc 0.05c 0.05c 0.001 
KGA 0.13b 0.22a 0.05c 0.05c 0.02c 0.02c 0.01c 0.02c 0.001 
NAD 1.48a 1.27bc 1.18bcd 1.11cd 1.02d 1.27bc 1.32ab 1.05d 0.001 
NADP 0.11a 0.06ab 0.05ab 0.05ab 0.08ab 0.06ab 0.04b 0.04b 0.05 
 Data in the same row with different superscripts were significantly different at P <0.05 
Abbreviation: AMP, ADP and ATP: adenosine mono-, di- and tri-phosphate; UMP, UDP and UTP: 
uridine mono-, di- and tri-phosphate; CMP and CTP: cytidine mono- and tri-phosphate; GMP and 
GDP: guanosine mono- and di-phosphate; UDPG: uridine di-phosphate glucose; UDPGA: uridine 
di-phosphate gluconic acid; UDPNAG: uridine di- phosphate N-acetylglucosamine, FUM: fumarate; 
KGA: α-ketoglutarate; NAD: nucotinamideadenine dinucleotide; NADP: NAD phosphate 
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The concentrations of adenosine, uridine and cytosine tri-, di-, and mono-phosphates 
of infected Sf9 cells at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs over the time 
course of infections are presented in Fig. 5.5 and Table 5.1. Intracellular ATP levels were 
not significantly different over the time course post-infection for both low and high ICDs 
(Fig. 5.5 a). However, ATP concentrations for the low ICD at 24 and 36 hpi were 
statistically higher than those for the high ICD at 24, 36 and 48 hpi (Table 5.1). In contrast, 
AMP concentrations at various times post-infection for the low ICD were significantly lower 
than those for the high ICD. Intracellular ADP concentrations were not different among 
treatments (Table 5.1, Fig. 5.5 a). As a result, the total adenosine (ATP+ADP+AMP) was 
similar among treatments (Table 5.1).  
The trends for intracellular concentrations of uridine and cytidine tri phosphates were 
similar in that they reduced over the 24-36 h post-infection period, (Fig. 5.5 b, c). In 
addition, the nucleoside triphosphate (UTP and CTP) levels at the low ICD were 
statistically higher than those at the high ICD throughout the infection period, (Table 5.1). 
Uridine di- and mono-phosphate levels for the low ICD tended to be higher than those for 
the high ICD (Fig. 5.5 b, Table 5.1), while no difference among treatments was found in 
terms of intracellular CMP concentrations (Table 5.1). 
It is interesting to note that at 24 hpi, presumably the time of the rapid rise in vDNA 
towards the peak yield for both low and high ICDs for infected Sf9 cells the UTP, CTP and 
ATP levels in the low ICD case are all significantly higher than the levels of these 
metabolites in the high ICD case (Table 5.1). In fact, at 24 hpi the UTP, CTP and ATP 
level in the low ICD case were 2.9, 3.0 and 1.4 times higher than those in the high ICD 
case, respectively. It is possible that the supply of UTP, CTP and ATP is rate limiting for 
the production of vDNA during the 6-24 hpi period for high cell density infections. 
It is presumed that the rise in vDNA for CDM infections shows similar timing to that 
seen for infections in Sf900™III given the similarities in the timing of the B-Gal yields seen 
in both media (compare B-Gal increase of Fig. 5.3 c to Fig.4.1 b, 4.2 b). UTP in particular 
may be limiting the rate of vDNA synthesis when it is considered that UTP is ultimately the 
source of dTTP (deoxythymidine tri-phosphate) required for DNA synthesis (Table 5.1, Fig. 
5.5 b).  
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Fig. 5.5 Stacked bar charts of (a) adenosine, (b) uridine, and (c) cytidine nucleotide concentrations 
for four time points post-infection of infected Sf9 cells propagated in CDM at low (1×106 cells/mL) 
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and high (5×106 cells/mL) ICDs. Infections were conducted at an MOI of 10 PFU/cell in shaker-
flask suspension cultures. Each data point is the average from two biological replicates, and the 
error bars represent the standard deviation. 
Apart from nucleotides, other metabolites were found to be significantly different 
between low and high ICDs including TCA cycle intermediates (α-ketoglutarate (KGA), 
fumarate (FUM)), UDP sugars (UDP-glucose (UDPG), UDP-glucuronic acid (UDPGA), and 
UDP N-acetylglucosamine (UDPNAG)), nicotinamide adenine dinucleotide (NAD) and 
NAD phosphate (NADP) as presented in Table 5.1. Generally, intracellular concentrations 
of these metabolites at the low ICD were significantly higher than those at the high ICD. 
These differences may contribute to the higher yields for the low ICD in comparison with 
those for the high ICD. KGA is of particular interest in that it is at a low level throughout the 
high density infection (0.02 mM or lower) and drops to 0.05 mM at 36-48 hpi from a peak 
value of 0.22 mM at 24 hpi for the low density infection. 
Intracellular AA concentrations of infected Sf9 cells at low and high ICDs over the 
time course of 0-48 hpi and a comparison of this data between low and high ICDs at 0 and 
36 hpi are shown in Fig. 5.6. Generally, the levels of most AAs inside the cells were stable 
over the time course post-infection, except for glutamate, asparagine and glutamine that 
decreased at 48 hpi, while alanine and arginine gradually increased for both low and high 
ICD cases (Fig. 5.6 a, b).  The relatively large drop in levels of some of the AAs from 36-48 
hpi may be partially explained by cell lysis of some of the cells during the quenching and 
washing procedures during this late infection period.  
Comparison between the low and high ICDs in terms of intracellular amino acid 
levels, Fig. 5.6 c, d, shows that the concentrations of most amino acids for the low ICD 
were higher than those for the high ICD either at 0 hpi (Fig. 5.6c) and 36 hpi (Fig. 5.6d), 
(except for glutamate, arginine and alanine), with a significant difference being found for 
11 out of 19 AAs at 0 hpi and for 10 out of 19 AAs at 36 hpi. The significant differences 
between intracellular AA levels of low and high ICDs were similar for the early (0 hpi) and 
late (36 hpi) stages of the infection process (Fig. 5.6 c, d). 
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Fig. 5.6 Intracellular AA concentrations of infected Sf9 cells at four times post-infection for low (a) and high (b) ICDs, and the comparison between 
low and high ICDs for intracellular AA levels at 0hpi (c) and 36 hpi (d). Infections were conducted in CDM at low (1×106 cells/mL) and high (5×106 
cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-flask suspension cultures. Each data point is the average 
from two biological replicates, and the error bars represent the standard deviation. *indicates significant differences in the levels observed. 
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Fig. 5.7 Comparison of AA consumption rates (mmol/cell/hour) between early (0-24 hpi) and late (24-60 hpi) infection stages for low (a) and high 
ICDs (b) and between low and high ICDs for early (c) and late infection stages (d) of Sf9 cells infected with a rAcMNPV. Infections were conducted in 
CDM at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-flask 
suspension cultures. Each data point is the average from two biological replicates, and the error bars represent the standard deviation. *indicates 
significant differences in the levels observed 
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Fig. 5.8 Comparison of AA consumption rates (mmol/mm3 of cell volume/hour) between early (0-24 hpi) and late (24-60 hpi) infection stages for low 
(a) and high ICDs (b) and between low and high ICDs for early (c) and late infection stages (d) of Sf9 cells infected with a rAcMNPV. Infections were 
conducted in CDM at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs and at an MOI of 10 PFU/cell. The experiment was conducted in shaker-
flask suspension cultures. Each data point is the average from two biological replicates, and the error bars represent the standard deviation. 
*indicates significant differences in the levels observed. 
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Glucose and AA consumption rates 
Table 5.2. Glucose and amino acid consumption rates (×10-12 mmol/cell/hour) of 
uninfected and infected Sf9 cells infected with a rAcMNPVat low (1×106) and high (5×106 
cells/mL) ICDs in a chemically defined medium (CDM). Uninfected and infected cultures 
were set up at 0.5×106 cells/mL. For the case of uninfected cultures no infection was made 
and sampling was conducted at every 24 hours during the 24-hour doubling time period. 
For infected cases, cultures were infected with a baculovirus at an MOI of 10 PFU/cell at 
1×106 and 5×106 cells/mL and sampling was conducted every 12 hours until 60 hours 
post-infection. Data is the average of biological duplicates. 
 Uninfected  Low ICD infection High ICD infection P< 
Glucose -45.12a -33.29b -22.01c 0.01 
Maltose -6.20ab -8.57a -5.12b 0.05 
Amino acids     
Aspatate -3.03b -27.38a -2.83b 0.05 
Glutamate -1.49b -22.82a -2.29b 0.05 
Asparagine -2.03b -27.35a -2.34b 0.05 
Serine -5.75b -18.12a -2.80b 0.01 
Glutamine -21.80b -39.87a -3.99c 0.01 
Histidine -1.00b -5.40a -0.58b 0.01 
Glycine -1.73b -8.61a -0.71b 0.001 
Threonine -2.25b -10.18a -1.43b 0.001 
Arginine -2.27b -14.13a -1.73b 0.01 
Alanine 27.78ab 34.24a 16.92b 0.05 
Tyrosine -0.77b -6.40a -0.35b 0.01 
Valine -2.89b -17.64a -2.18b 0.05 
Methionine -1.89b -17.69a -1.32b 0.01 
Tryptophan -0.52b -3.76a -0.35b 0.05 
Phenylalanine -1.55b -17.21a -1.39b 0.05 
Isoleucine -2.27b -17.55a -1.68b 0.01 
Leucine -3.24b -14.06a -1.52b 0.01 
Lysine -3.05b -13.32a -1.01b 0.05 
Proline -3.15b -20.01a -1.89b 0.001 
Consumption rates in the same row with different superscripts were significantly different (P<0.05) 
NS: Not significant 
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Table 5.3. Comparison of AA consumption rates (×10-6 mmol/mm3 cell volume/hour) 
between uninfected and infected Sf9 cells infected with a rAcMNPV at low (1×106cells/mL) 
and high (5×106 cells/mL) ICDs in a chemically defined medium (CDM). Further 
description details are as shown in Table 2. 
 Uninfected  Low ICD infection High ICD infection P< 
Glucose -27.57a -13.00b -11.44b 0001 
Maltose -3.79 -3.35 -2.66 NS 
Amino acids     
Aspatate -1.99b -10.54a -1.44b 0.05 
Glutamate -0.99b -8.78a -1.17b 0.05 
Asparagine -1.34b -10.52a -1.19b 0.05 
Serine -3.78b -6.98a -1.43b 0.01 
Glutamine -14.25b -15.32a -2.04c 0.01 
Histidine -0.65b -2.08a -0.30b 0.01 
Glycine -1.14b -3.32a -0.36c 0.001 
Threonine -1.48b -3.92a -0.73b 0.001 
Arginine -1.49b -5.44a -0.88b 0.01 
Alanine 18.15a 13.19ab 8.64b 0.05 
Tyrosine -0.49b -2.46a -0.18b 0.01 
Valine -1.88b -6.79a -1.11b 0.05 
Methionine -1.24b -6.81a -0.68b 0.01 
Tryptophan -0.35b -1.45a -0.18b 0.01 
Phenylalanine -1.05b -6.62a -0.71b 0.05 
Isoleucine -1.49b -6.76a -0.86b 0.01 
Leucine -2.12b -5.41a -0.78b 0.01 
Lysine -2.00b -5.13a -0.52b 0.01 
Proline -2.07b -7.71a -0.97b 0.001 
Consumption rates in the same row with different superscripts were significantly different (P<0.05) 
NS: Not significant 
Tables 5.2 and 5.3 represent consumption rates of glucose and AAs between 
uninfected and baculovirus infected Sf9 cells at low and high ICDs in CDM based on a per 
cell or per unit of cell volume basis, respectively. The cell specific glucose consumption 
rate of uninfected Sf9 cells propagated in CDM was the highest followed by that of the 
infected cells at the low ICD and the consumption rate of infected cells at the high ICD was 
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the lowest, and there was a significant difference in glucose consumption rate among them 
(Table 5.2). Based on a per cell basis, the maltose consumption rate of infected cells at 
the low ICD was significantly higher than that of the high ICD case, while the maltose 
consumption rate of uninfected cells was not significantly different in comparison to both 
the infected cases. However, the maltose consumption rate per unit of cell volume was 
similar among uninfected and infected cultures (Table 5.3). In addition, no significant 
difference between infected cultures at low and high ICDs was found in terms of the 
glucose consumption rate per unit of cell volume (Table 5.3). However the glucose 
consumption/unit volume of non-infected cells was higher than that seen for the infected 
cultures. 
Table 5.2 shows that infected cells at the low ICD consumed AAs at significantly 
higher rates than those at the high ICD for all of the common AAs investigated, except for 
alanine which showed an increase at both ICDs. Significantly higher AA consumption rates 
for infected cells at the low ICD in comparison with those at the high ICD were also found 
for the consumption on a per unit of cell volume basis (Table 5.3), although the peak cell 
volume post-infection for the low ICD was much larger than that for the high ICD case (Fig. 
5.3 b). The AA consumption rates for uninfected Sf9 cells were close to the high ICD for 
the majority of the AAs (16 out of 19 AAs) for both consumption rates on a per cell and a 
per volume basis (Table 5.2, 5.3). 
Comparison of the AA consumption rates between early (0-24 hpi) and late stages 
(24-60 hpi) of the virus infection process at the same ICD or between infected Sf9 cells at 
low and high ICDs are shown in Fig. 5.7. Although consumption rates at the late infection 
stage appeared to be higher than those at the early infection stage for all of the AAs, there 
was no significant difference in AA consumption rates between the early and late stages of 
the virus infection for the low ICD case for all of the AAs, except for threonine (Fig. 5.7 a). 
In contrast, the AA consumption rates at the early infection stage appeared higher than 
those at the late infection stage for most of the AAs in the case of the high ICD (Fig. 5.7 b). 
However, significant differences in AA consumption rates between the early and late 
infection stages for the high ICD case were only found for asparagine, serine, glutamine 
and threonine. Comparison between early and late infection stages within the same ICD in 
the case of the consumption rate per unit of cell volume (Fig. 5.8 a, b) also showed similar 
trends as above.  
Comparing low and high ICDs, the AA consumption rates on a per cell basis at the 
low ICD were significantly higher than those at the high ICD for all of the AAs measured for 
both the early and late infection stages, except for alanine (Fig. 5.7 c, d). Similar trends 
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were found for the consumption rates calculated based on a cell volume basis (Fig. 5.8). 
This result indicates that infected cells at the low ICD consume AAs at much higher rates 
than those at the high ICD and the consumption of AAs by infected cells at the high ICD 
were poorer at the late stage of the baculovirus infection process.  
Ratios between intra- and extracellular AAs and between AA levels for low and high ICDs 
Figure 5.9 shows the ratios of extra- and intra-cellular AA concentrations between 
high and low ICDs and the ratios between intra- and extracellular AA concentrations for 
low and high ICDs. When comparing AA concentrations between high and low ICDs, Fig. 
5.9a, b shows that extra- and intra-cellular AA levels of infected cells at the high ICD were 
generally lower than those for the low ICD, as indicated by the ratios of high/low ICD AA 
values being less than 1 for the majority of the AAs. At 0 hpi, the ratios between low and 
high ICDs of extracellular AA levels were mostly similar to those for intracellular AA levels 
(Fig. 5.9a), except for arginine and lysine. However, at 36 hpi, ratios between high and low 
ICDs for extracellular AA levels seemed to increase, while those for intra-cellular AA levels 
reduced significantly. As a result, ratios between high and low ICDs for extracellular AA 
levels, at 36 hpi were significantly higher than those for intracellular AA levels for the 
majority of the AAs (12 out of 19 AAs) (Fig. 5.9b). This result indicates a possibly poorer 
AA uptake into the cells at the late stage of virus infection for infected cells at the high ICD 
compared with those at the low ICD. Serine, glutamine, leucine and lysine are among the 
AAs that have low intracellular levels at the high ICD compared with the low ICD, (ratio of 
AAs between high/low ICDs around 0.5 or lower).  
When comparing the ratios between intra- and extra-cellular AA levels for low and 
high ICDs, these two ratios were also similar among the majority of AAs at 0 hpi (Fig. 5.9 
c). Intracellular AA levels of the majority of AAs were in the range of 70-90% of the 
extracellular ones for both low and high ICDs, except for glutamine and alanine, low ICD 
case, where the intracellular AA levels were higher than the extracellular levels. This 
suggests that the AA uptake by cells in culture before and after infection reaches an 
equilibrium of the AAs in the cell with the level in the external medium or alternatively that 
the external AA level dictates the extent of AA uptake. This in turn suggests the only way 
to keep intracellular AA levels high is to have high AA levels in the external media. At 36 
hpi, these ratios increased in the case of the low ICD (more AAs had a ratio above 1), but 
remained at similar levels in the case of the high ICD (Fig. 5.9 d). 
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Fig. 5.9 Ratios of AA levels between high versus low ICDs for extra- and intra-cellular AAs at 0 hpi (a) and 36 hpi (b), and ratios between intra- versus 
extra-cellular AA levels for low and high ICDs at 0 hpi (c) and 36 hpi (d) of Sf9 cells infected with a recombinant baculovirus (rAcMNPV). Infections 
were conducted in CDM at low (1×106 cells/mL) and high (5×106 cells/mL) ICDs, at an MOI of 10 PFU/cell. The experiment was conducted in shaker-
flask suspension cultures. Each data point is the average from two biological replicates, and the error bars represent the standard deviation. 
*indicates significant differences in the levels observed. The ratios of alanine are off scale in some cases in the above figure and so are listed here: 
3.7, 2.6 and 3.2 for extra and intracellular at 0hpi and extracellular at 36 hpi, respectively 
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It is of interest that the intra-/extra-cellular ratios for aspartate and lysine were very 
low (0.07 to 0.32) for both low and high ICDs (Fig. 5.9 c, d). This result indicates that it 
might be difficult for these AAs to get into the cell regardless of the extracellular 
concentrations, or that they are consumed at a high rate and unable to form an equilibrium 
with the external level present. 
5.3.3 Comparison between the two media of Sf900™III and CDM 
In this section, the data for infected Sf9 cells propagated in Sf900™III medium are 
calculated from the dataset described in Chapter 4. As the ICDs represented for low and 
high ICDs in the case of infected cells in Sf900™III (2×106 vs 6×106 cells/mL) differ from 
the case ofthe CDM (1×106 vs 5×106 cells/mL), the comparison between these two media 
in terms of the cell density effect was made through comparing the ratios of recorded 
parameters between high and low ICDs for these two media.  
When comparing the β-
Gal yield between low and 
high ICDs at various times 
post infection for Sf9 cells 
propagated in either 
Sf900™III or CDM media, Fig. 
5.10, shows that the ratios in 
β-Gal yield between low and 
high ICDs were comparable 
between the two media (within 
the range of 0.29 to 0.39 for 
Sf900™III and 0.15 to 0.36 for 
CDM). It is of interest to note 
that the largest difference 
between the media was at 24 
hpi where the ratio of the β-
Gal yield for the high ICD 
compared to the low ICD was 
much lower for the CDM case. 
This suggests that in the CDM, infections at high cell densities are delayed compared to 
those in Sf900™III but the β-Gal production level catches up by 36-48 hpi. 
 
Fig. 5.10 Ratios of specific β-Gal yield between high and low 
ICDs for infected Sf9 cells in Sf900™III and CDM media. The 
ratio was calculated from the average values (from biological 
triplicates) for high and low ICDs and the error bar is the 
standard deviation calculated from standard deviations of the 
dividend and divisor. Data for infected Sf9 cells in Sf900™III 
medium was from the dataset in Chapter 4. 
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The question of interest here is whether the ratios between high and low ICDs for 
other parameters (intracellular metabolite concentrations, AA consumption rates) for these 
two media were also similar to each other as was found for the β-Gal yield at various times 
post infection. 
 
Fig. 5.11 Ratios of intracellular ATP (a), total adenosine (b), UTP (c) and CTP (d) between high 
and low ICDs for infected Sf9 cells in Sf900™III and CDM media. The ratio was calculated from the 
average values (from biological triplicates) for high and low ICDs and the error bar is the standard 
deviation calculated from standard deviations of the dividend and divisor. Data for infected Sf9 
cells in Sf900™III medium was from the dataset in Chapter 4. 
As found for the β-Gal yield, there was no significant difference in the ratios of 
high/low ICDs between two media for ATP, total Adenosine, UTP and CTP (Fig. 5.11).The 
ratios between high/low ICDs for Sf900™III and CDM media respectively were in the 
range of 0.55 to 0.96 and 0.78 to 0.95 for ATP (Fig. 5.11a), 0.88 to 1.17 and 0.99 to 1.07 
for total adenosine (Fig. 5.11b), 0.12 to 0.68 and 0.28 to 0.61 for UTP (Fig. 5.11 c) and 0.2 
to 0.81 and 0.51 to 0.80 for CTP (Fig. 5.11 d). Limitations of these nucleotides at high 
ICDs in comparison with low ICDs were not as much as those seen for the β-Gal yield. 
Generally, there were large variations among different times post-infection and among 
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replicates within one time point resulting in large error bars in many cases. As shown in 
Fig. 5.11, the ratios displayed less variation at different times post infection for CDM in 
comparison with Sf900™III. 
 
Fig. 5.12 Ratios of intracellular KGA (a), FUM (b), UDPG (c) and UDPGA (d) between high and 
low ICDs for infected Sf9 cells in Sf900™III and CDM media. The ratio was calculated from the 
average values (from biological triplicates) for high and low ICDs and the error bar is the standard 
deviation calculated from standard deviations of the dividend and divisor. Data for infected Sf9 
cells in Sf900™III medium was from the dataset in Chapter 4. 
Other metabolites plotted in this regard include α-ketoglutarate (KGA), fumarate 
(FUM), UDP glucose (UDPG) and UDP gluconic acid (UDPGA) and they followed similar 
patterns to those found for the nucleotides above (Fig. 5.12). The ratios between high/low 
ICDs respectively for Sf900™III and CDM media were in the range of 0.12 to 0.49 and 
0.09 to 0.35 for KGA (Fig. 5.12 a), 0.22 to 0.99 and 0.19 to 0.44 for FUM (Fig. 5.12 b), 
0.49 to 0.74 and 0.66 to 0.82 for UDPG (Fig. 5.12 c) and 0.40 to 0.59 and 0.26 to 0.51 for 
UDPGA (Fig. 5.12 d). Ratios of the TCA cycle intermediate (KGA) at the high ICD in 
comparison with the low ICD were similar to those found for the β-Gal yield. Therefore, 
there might be a direct link between the limitation in intracellular KGA and the reduction in 
recombinant protein yield with increasing ICD for infected Sf9 cells propagated in different 
media, but this is speculative. 
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Fig. 5.13 Ratios between high/low ICDs for intracellular AAs at various time post-infection of infected Sf9 cells in Sf900™III (a) and CDM (b), and the 
comparison of these ratios for infected Sf9 cells in Sf900™III and CDM at 0 hpi (c) and 36 hpi (d). The ratio was calculated from the average values 
(from biological triplicates) for high and low ICDs and the error bar is the standard deviation calculated from standard deviations of the dividend and 
divisor. Data for infected Sf9 cells in Sf900™III medium was from the dataset in Chapter 4. 
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A comparison of the ratios of high/low ICDs between Sf900™III and CDM media for 
intracellular AAs, Fig. 5.13, shows that intracellular AA levels at the low ICD were higher 
than those at high ICD for the majority of AAs, except for the cases of aspartate, 
glutamate, arginine and alanine for both media. Serine, leucine and lysine are among the 
AAs that have the lowest ratios between the high/low ICDs (Fig. 5.13 a, b), especially at 
the late infection stage (36 hpi), and may become limiting for protein production at the high 
ICD. The ratios between high/low ICDs for intracellular AAs of infected Sf9 cells 
propagated in Sf900™III declined post-infection for many AAs, while these ratios of 
infected Sf9 cells propagated in CDM seemed to be maintained over the time course post-
infection (Fig. 5.13 a, b). 
Comparing between the two media, the ratios of intracellular AAs between high/low 
ICDs were similar at 0 hpi for most of the AAs, except for lysine (Fig. 5.13 c). At the late 
infection stage (36 hpi), the ratios of intracellular AAs between high/low ICDs declined for 
both media for many of the AAs. However, these declines were higher for the case of 
infected cells in Sf900™III medium. As a result, the ratios of intracellular AAs between 
high/low ICDs for the case of the CDM were higher than those for the case of the 
Sf900™III medium for all of the AAs except for lysine (Fig. 5.13 d). However, given the 
size of the error bars, most differences were not significant. 
 
Fig. 5.14 Comparison of AA consumption rates of uninfected cultures between Sf9 cells 
propagated in Sf900™III and CDM over the exponential period of 0-72 hours post-inoculation. The 
values were the average of biological triplicates and the error bar is the standard deviation of the 
triplicates. Data for infected Sf9 cells in Sf900™III medium was from the dataset in Chapter 4. 
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Fig. 5.15 Ratios of AA consumption rates between high/low ICDs over early stage (0-24 hpi) (a), 
late stage (24-60 hpi) (b) and the whole infection stage (0-60 hpi) (c) for infected Sf9 cells in 
Sf900™III and CDM. The ratio was calculated from the average values (from biological triplicates) 
for high and low ICDs and the error bar is the standard deviation calculated from standard 
deviations of the dividend and divisor. Data for infected Sf9 cells in Sf900™III medium was from 
the dataset in Chapter 4. 
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The AA consumption rates of uninfected Sf9 cells propagated in Sf900™III and CDM 
were similar for most of the AAs, except for glutamate, asparagine and glutamine, in 
which, the AA consumption rates of uninfected cells in Sf900™III were significantly higher 
than those in CDM (Fig. 5.14). Interestingly, the ratios of AA consumption rates between 
high/low ICDs for infected cells in CDM were much lower than those for Sf900™III medium 
(Fig. 5.15). The ratios of AA consumption rates between high/low ICDs for infected cells in 
Sf900™III medium were in the range of 0.13 to 0.96 with an average of 0.44, while for 
infected cells in CDM they were in the range of 0.06 to 0.49 with an average of 0.12 (Fig. 
5.15 c). It is not clear what leads to this difference in AA consumption given the similar 
levels of β-Gal/cell produced at the high ICD in both media. 
5.4 Discussion 
Insect cell culture media was first developed based on the analysed chemical 
composition of hemolymph, or insect blood, from chemically defined components. Heat 
treated hemolymph was included into the culture medium for supplying unknown but 
essential substrates to improve the performance of insect cell culture. Insect hemolymph 
was then successfully replaced by animal serum, most commonly fetal calf (bovine) serum 
(FCS) (Gardiner and Stockdale, 1975; Hink, 1970) as serum was cheaper and was 
available in large quantities compared with insect hemolymph (Schlaeger, 1996). Due to 
several limitations associated with serum (Reid et al., 2013; Schlaeger, 1996), serum free 
and protein free media were subsequently developed with the use of lipid emulsions and 
protein hydrolysates (Goodwin, 1991).  
Serum free medium has successfully supported insect cell culture to high cell 
densities in batch culture and allows good baculovirus infections (e.g. Sf900™III medium). 
However, the undefined nature of the hydrolysate containing medium may interfere with 
some down-stream processes as well as interfere with systems biology studies such as 
transcriptomics, metabolomics and fluxomics. Therefore, limitations due to the undefined 
nature of hydrolysates have been addressed through the development of a chemically 
defined medium (CDM). Although it is possible to gain some metabolic insights using 
insect cells propagated in hydrolysate containing media, its substitution with chemically 
defined components will greatly enhance the range and scope of such studies (Bhatia et 
al., 1997).  In addition, CDM also ensures reproducibility of optimized process conditions 
(Bhatia et al., 1997) because of the minimal effect from lot-to-lot variation caused by the 
presence of hydrolysates. 
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It should be feasible to develop a CDM for insect cell culture as originally, insect 
culture medium was developed from defined components to form a basal medium, and 
then undefined components (serum, hydrolysates) were added into the basal medium to 
get higher cell growth rates. Currently, CDM formulations are well established for 
mammalian cell culture, but are not yet commercially available for insect cell culture (Reid 
et al., 2013). A prototype CDM for insect cell culture has been developed by Life 
Technologies and has been trialed for insect cell culture in our laboratory. As it is a 
hydrolysate free medium, the concentrations of free AAs in the CDM are slightly higher 
than those in Sf900™III medium except for glutamine (Fig. 5.1). 
Sf9 insect cells propagated in Sf900™III adapted well into the CDM within 7 days. 
They grew well in CDM under the routine stock cell maintenance process used for cells 
propagated in Sf900™III (Fig. 5.2 a), although the peak uninfected cell density of Sf9 cells 
in CDM was much lower than that of Sf9 cells in Sf900™III medium (1.2×107 vs 2×107 
cells/mL, respectively) (Fig. 5.2 b). The presence of undefined growth promoters in the 
protein hydrolysate (yeast extract) together with other essential substrates including 
peptides, carbohydrates, vitamins and minerals in the Sf900™III medium (Ikonomou et al., 
2001; Siemensma et al., 2010; Sommer, 1996; Zhang et al., 2003) possibly explain the 
extra cell growth of the Sf900™III medium. The viability of Sf9 cells propagated in CDM 
was similar to that in Sf900™III (Fig. 5.2 a, b) indicating that the CDM can support Sf9 
insect cell growth as well as one of the best commercial medium for insect cell culture. In 
addition, the CDM supports good baculovirus infections with the peak specific β-Gal yield 
being slightly higher than that for Sf900™III (Fig. 5.2 c). The timing of β-Gal production 
post-infection was similar to that found for Sf900™III, which is typical for recombinant 
AcMNPV infected Sf9 cells. As the peak uninfected cell density of Sf9 cells in CDM was 
lower than that in Sf900™III, the reduction in specific β-Gal yield with increasing ICD for 
Sf9 cells in CDM would be expected to appear at a lower cell density than that for Sf9 cells 
in Sf-900™III. However this may not be the case as the specific β-Gal yield of infected Sf9 
cells in CDM at 5×106 cells/mL was slightly higher than that in Sf900™III at 6×106 cells/mL 
(Fig. 5.2 c). 
Typically for Sf9 cells infected with a recombinant baculovirus (rAcMNPV) at a high 
MOI (e.g. ≥5 PFU/cell) cell division is inhibited rapidly as a result of a synchronous 
infection (O’Reilly et al., 1994). In CDM, a minimal increase in cell density post-infection of 
Sf9 cells infected with a rAcMNPV at an MOI of 10 PFU/cell was also found for both low 
and high ICDs (Fig. 5.3a). In addition, the cell viability and cell diameter increase post-
infection for both low and high ICDs (Fig. 5.3 a, b) were also similar to those found for 
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infected Sf9 cells in Sf900™III at low and high ICDs. This result indicates that the infection 
process of Sf9 cells in CDM follows a similar pattern to that of Sf9 cells in Sf900™III. The 
peak specific β-Gal yield of infected Sf9 cells in CDM was slightly higher than that in 
Sf900™III and infected Sf9 cells in CDM were also influenced by the cell density effect (as 
discussed in Chapter 4) with the reduction in specific yield with increasing ICD appearing 
at a similar density for the case of infected cells in Sf900™III, based on the limited studies 
in this regard in this thesis. 
As found previously for infected Sf9 cells in Sf900™III (Chapter 4), the intracellular 
nucleotide concentrations for a low ICD were significantly higher than those for a high ICD, 
especially for the nucleotide tri-phosphates (Fig. 5.5, Table 5.1). These forms of 
nucleotides are used for nucleic acid synthesis. Therefore, the reduction in vDNA and 
mRNA production with increasing ICD as found previously (Huynh et al., 2013) may be 
explained by the limitation in intracellular nucleotide tri-phosphates when the ICD 
increases. In addition, intracellular levels of TCA cycle intermediates such as KGA and 
FUM for infected cells at a low ICD were significantly higher than those at a high ICD 
(Table 5.1) as found for infected cells in Sf900™III (Chapter 4). A reduction in intracellular 
KGA levels with increasing ICD is a possible contributor to the cell density effect. Carinhas 
et al. (2010) reported an improvement in cell specific yields at a high ICD with the 
supplement of KGA to the medium used for infections. Other metabolites were found to 
reduce significantly with the increasing ICD including UDP sugars (UDPG, UDPGA and 
UDPNAG) (Table 5.1) as was found for infected Sf9 cells in Sf900™III (Chapter 4).  
The low intracellular KGA concentration at the high ICD may be the result of the 
lower intracellular glutamine level at the high ICD in comparison with that of the low ICD 
(Fig. 5.6). However, the intracellular glutamate level at the high ICD was higher than that 
at the low ICD. Bernal et al. (2009) provides an extensive discussion of the role glutamate 
and glutamine play in the energy metabolism of Sf9 cells and shows how the levels of 
these AAs may influence KGA levels. 
Generally, intracellular AA concentrations for infected Sf9 cells in CDM followed a 
similar pattern to that found for infected Sf9 cells in Sf900™III, although the intracellular 
concentrations of many AAs in CDM (Fig. 5.6) were slightly higher than the levels 
observed  in Sf900™III (Fig. 4.6). For the AAs that showed a lower intracellular AA 
concentration for infected Sf9 cells in CDM in comparison with those in Sf900™III, 
especially at the late stage of the infection (36 hpi) (Fig. 5.6 c, d) suggests that they may 
limit protein production at the high ICD (lysine, tryptophan) but the fact that these AAs 
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remain at reasonable levels in the outside medium (Fig A3.2) suggest they are unlikely to 
be limiting. 
Low intracellular AA concentrations at high ICDs in comparison with those at low 
ICDs may be the result of poorer uptake rates of AAs at high ICD, especially at the late 
infection stage (Fig. 5.9). However the intra/extracellular ratio for the AAs at the high ICD 
at 36 hpi are not much lower than for the low ICD at this stage of the infection, except 
perhaps for lysine (Fig 5.9 d). It is noted that there were huge differences in AA 
consumption rates between low and high ICDs for infected cells in CDM with significant 
differences being found for all of the AAs during the early and late infection stages (Fig. 
5.7c, d). All of the AA supply in the CDM comes from free AAs, while peptides in Sf900™III 
may contribute to part of the AAs required by the cells grown in that medium. Therefore, 
AA consumption rates measured in infected cells propagated in CDM may be closer to the 
real values in comparison with those in Sf900™III. The less significant differences in AA 
consumption rates between the low and high ICDs for infected Sf9 cells in Sf900™III 
(Chapter 4) may be the result of the role peptide consumption plays as a source of AAs by 
the infected cells at low ICDs in the Sf900™III medium. 
AA consumption rates obtained in this work with the CDM medium varied greatly 
from the literature (Bernal et al., 2009; Radford et al., 1997) which may be the result of the 
discrepancy in the size of infected cells as well as the presence of peptides in the culture 
media used by others and the proportions of the peptides used by the cells as a source of 
AAs. 
Use of a CDM is the most suitable medium for measuring AA consumption rates as 
the AA supply comes from free AAs only. Although the CDM does not contain peptides as 
for Sf900™III, the AA consumption rate of uninfected Sf9 cells in CDM were similar to 
those in Sf900™III for most of the AAs, except for glutamate, asparagine and glutamine 
with the AA consumption rates for these AAs in CDM being significantly lower than those 
in Sf900™III (Fig. 5.14). AA consumption rates on a per cell basis (Table 5.2) or on a per 
unit of biomass (cell volume) basis (Table 5.3) for infected Sf9 cells at a low ICD were 
significantly higher than those at a high ICD for most of the AAs. This result most likely 
reflects the decline in cell specific yield with increasing ICD due to a drop in vDNA and 
LacZ mRNA levels as discussed in Chapter 4 rather than reflecting an AA substrate 
limitation for protein production. 
As discussed in Chapter 4 of this thesis, the glucose consumption rate for uninfected 
and baculovirus infected Sf9 cells have been reported with a vast difference among 
investigators (Benslimane et al., 2005; Bernal et al., 2009; Kamen et al., 1996; Radford et 
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al., 1997; Raghunand and Dale, 1999; Rhiel et al., 1997; Wong et al., 1994). The values 
reported fall within a range of 4.5-12×10-11 and 2.1-24.2×10-11 mmol/cell/hour for 
uninfected and infected Sf9 cells propagated in Sf900™II medium, respectively. 
Raghunand et al., (1999) reported that there is an increase in glucose consumption rate 
after infection, while others showed a reduction in the glucose consumption rate for 
infected cells in comparison with uninfected cells (Bernal et al., 2009; Rhiel et al., 1997; 
Wong et al., 1994).  
The current study for Sf9 cells in CDM found that the glucose consumption rate of 
uninfected cells was the highest, followed by infected cells at a low ICD and the lowest 
glucose consumption rate was found for infected cells at a high ICD (Table 5.2). The 
glucose consumption rate for uninfected cultures of the current study (4.5×10-11 mmol/ 
cell/hour) was similar to that reported by Kamen et al. (1996) and Wong et al. (1994), but 
was lower than others (Benslimane et al., 2005; Bernal et al., 2009; Radford et al., 1997; 
Raghunand and Dale, 1999; Rhiel et al., 1997). The glucose consumption rate of infected 
Sf9 cells in the current study was lower than that reported by Bernal et al. (2009) and 
Wong et al. (1994). The discrepancy in glucose consumption rate on a per cell basis 
among the literature may result from the differences in cell size and medium used by the 
various groups. In addition, the glucose consumption rate of cells in culture was influenced 
by the presence of other carbohydrate sources (maltose) and AAs used as an energy 
source (glutamine, asparagine) as well as other elements available in the medium. Many 
investigators (Bedard et al., 1993; Drews et al., 2000; Neermann and Wagner, 1996; 
Raghunand and Dale, 1999) pointed out that there is an interrelationship in the glucose 
and glutamine uptake rates for Sf9 insect cells. 
The prototype CDM used in these studies is a promising medium for metabolomics 
and fluxomics studies, especially in terms of AA uptake and protein production rates as it 
does not contain undefined peptides from hydrolysates that the cells can be used in 
parallel with free AAs. Therefore, the measurement of AA consumption rates for cells in 
CDM has the advantage of eliminating the effect of AAs originating from peptides. As a 
result, AA consumption rates for cells in CDM are expected to be higher than those in 
hydrolysate containing medium (Sf900™III) if cells require the same amount of AAs. 
Unfortunately, the total cell density for low and high ICD of cells in CDM and Sf900™III 
were not the same (2×106 and 6×106 cells/mL for Sf900™III and 1×106 and 5×106 cells/mL 
for CDM). Therefore, it is difficult to compare AA consumption rates (as well as other 
parameters) directly between these two media in this study. Fortunately, the ratios 
between high/low ICDs for the β-Gal yield of infected Sf9 cells in these two media were 
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comparable. A question of interest is whether the ratios between high/low ICDs for other 
parameters (intracellular metabolites, AA consumption rates) were also similar between 
these two media. 
It is interesting to note that the ratios between high/low ICDs for AA consumption 
rates of infected Sf9 cells in CDM were much lower than those in Sf900™III (Fig. 5.15) 
despite the ratios for β-Gal yield of infected Sf9 cells in these two media being similar (Fig. 
5.10). This result may be explained by a high level of peptides consumed by infected Sf9 
cells in Sf900™III at the low ICD. There is evidence that very small peptides contribute to 
the nutritional value of a medium as a source of AAs (Heidemann et al., 2000; Nyberg et 
al., 1999) and so it is possible that the use of small oligo-peptides as an AA source is 
preferable than the use of free AAs in some situations. Di-peptides and tri-peptides are 
taken up more readily in the intestine than corresponding free amino acids (Grimble et al., 
1987; Silk et al., 1985). In addition, the uptake of peptides seems to be independent of free 
amino acid uptake and their transport can be affected by other peptides but not by free 
amino acids (Brandsch et al., 1995a; Brandsch et al., 1995b). As a result, Sf9 cells in 
Sf900™III at the low ICD likely consumed small peptides as a source of AAs which is not 
accounted for in the AA consumption calculation, while less peptides would be available 
for consumption at the high ICD and hence, more free AAs are required in this case. 
Consequently, the ratio of AA consumption rates between high/low ICD for the case of 
infected Sf9 cells in Sf900™III were much higher than those for CDM, which does not 
contain peptides from hydrolysates. The ratios between high and low ICDs for other 
parameters including intracellular nucleotides, nucleotide sugars, organic acids and AAs of 
infected cells in either Sf900™III or CDM were not significantly different (Fig. 5.11-5.12). 
5. 5 Conclusion 
A Chemically Defined Medium (CDM) is a useful medium for metabolic studies as 
well as for avoiding some downstream process problems of recombinant protein 
production. This initial study using a prototype CDM for Sf9 insect cells from Life 
Technologies showed cells can be easily adapted into this medium. Although the peak cell 
density of the uninfected culture in the CDM was much lower than that in Sf900™III, the 
peak β-Gal yield at a low ICD in CDM was slightly higher than that in Sf900™III. Infected 
Sf9 cells in CDM were also subject to the cell density effect with the cell specific 
recombinant protein yield being reduced significantly with an increasing ICD. As found for 
infected Sf9 cells in Sf900™III, nutrient limitations remain as a possible cause of the cell 
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density effect. Results from the current study show that infected Sf9 cells in the CDM at a 
high ICD had a lower intracellular concentration of nucleotides, TCA cycle intermediates 
and AAs than those at a low ICD. The poorer AA uptake rates at the high ICD in 
comparison with those at the low ICD may partially explain the lower recombinant protein 
yield at the high ICD versus the low ICD. Although the ratios of the β-Gal yield between the 
high/low ICDs of infected Sf9 cells in CDM were similar to that in Sf900™III, the ratios of 
AA consumption rates of infected cells in CDM for high versus low ICDs was much lower 
than those in Sf900™III. This is a major difference between the two medium that 
presumably comes from the presence or absence of peptides originating from 
hydrolysates, which are available in Sf900™III but not in the CDM. As found for infected 
Sf9 cells in Sf900™III, aspartate, lysine and, to a lesser extent, arginine are among the 
AAs that show a poor uptake efficiency, although they do not appear to be limiting in the 
culture medium. 
Based on data from Chapter 4 and Huynh et al. (2013), the most likely cause of the 
drop in yield at higher ICDs for CDM infections is an earlier drop in vDNA and recombinant 
protein mRNA levels possibly caused by a substrate limitation related to the supply of 
nucleotides. This chapter along with Chapter 4 supplies some data to support this 
possibility (low UTP levels at the high ICD versus the low ICD for example). However, this 
chapter does supply new data to suggest that peptides are an important source of amino 
acids post-infection and if vDNA/recombinant protein mRNA levels can be maintained for 
high cell density infections, the supply of sufficient amino acids to support correspondingly 
high protein production levels will become a challenge.  
129 
 
Chapter 6 
 
Metabolic study of the cell 
density effect of HzAM1/HearNPV 
system in Sf900™III medium 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
130 
 
6.1 Introduction 
The baculovirus-insect cell expression systems have been widely used as a research 
tool for producing recombinant proteins (Kost et al., 2005; Mena and Kamen, 2011), 
human and veterinary vaccines (Mena and Kamen, 2011; van Oers, 2006), and as vectors 
for gene delivery (Hitchman et al., 2010; Hu, 2008). Besides being a valuable commercial 
tool for recombinant protein production, the baculovirus insect cell systems have been 
studied for the production of baculoviruses which can be developed as effective 
biopesticides to control various types of insect pests (Chakraborty et al., 1996; 
Chakraborty et al., 1999; Pedrini et al., 2006), especially as part of an integrated pest 
management program (Moscardi et al., 2011; Szewczyk et al., 2009).  
Helicoverpa spp. are the major pests of field crops worldwide and it becomes  difficult 
to control them because of the development of  resistance to existing methods of chemical 
and biological control. In addition to the resistance to existing chemical pesticides, the 
increasing concern about the environment and food safety issues, and the desire of 
farmers to use safer pesticides are all reasons for the interest in biopesticides (Franzmann 
et al., 2008; Jacobson et al., 2009). Hence, the development of a viral biopesticide, as 
alternatives to the use of chemical pesticides, to control Helicoverpa pest species is 
potentially of great benefit for agriculture. 
Baculoviruses, among other insect viruses, are regarded as safe and selective 
bioinsecticides, restricted to invertebrates (Moscardi, 1999). Baculoviruses are one of the 
most promising biocontrol agents, with a low chance of resistance development and 
proven high safety levels (Szewczyk et al., 2006). More than 50 baculovirus based 
pesticides have been registered and used worldwide (Moscardi et al., 2011). In fact, 
baculoviruses have been used to control caterpillar pests that affect major crops such as 
soybean, sorghum, maize, tomato, cotton, pigeon pea, and pepper in many counties 
including Brazil, China, India, America, and Australia (Buerger et al., 2007; Szewczyk et 
al., 2009). It is considered as an ideal tool for Integrated Pest Management (IPM) 
programs (Buerger et al., 2007; Moscardi et al., 2011).The market share for baculovirus 
biopesticides was estimated at about 5-10% of the potential market for biopesticides with a 
14% annual increment (Glare et al., 2012).  
Traditionally, baculovirus biopesticides have been widely produced in vivo from 
infected larvae raised in insectaries. A number of successful production processes of 
baculovirus biopesticides using infected larvae have been documented (Buerger et al., 
2007; Harrison and Hoover, 2012; Moscardi et al., 2011). However, this production method 
is also associated with several limitations including high cost of production, requirement for 
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specific facilities for insect rearing, quality control problems in relation to the purity of 
products and contamination of insect rearing facilities by other viruses, bacteria or fungi. In 
vitro baculovirus biopesticide production in insect cell culture overcomes disadvantages 
associated with in vivo production (Harrison and Hoover, 2012; Moscardi et al., 2011). In 
vitro production is more promising in terms of process scalability and reliability (Moscardi, 
1999). The production of wild-type NPVs using insect cell culture for use as biopesticides 
is thought to be a promising strategy (Murhammer, 1996). 
In vitro production is a key focus of industry for producing baculovirus biopesticides. 
In fact, it has been indicated as a key element in making biopesticides more desirable in 
the market (Szewczyk et al., 2006). However, there are several technical limitations that 
need to be solved in order to successfully commercialize baculovirus biopesticide 
production in vitro. At the present, none of the in vitro production systems reported for 
baculoviruses have achieved economically viable yields for commercial use because of 
high production costs even with the use of fed-batch cultures. One of the bottlenecks is the 
reduction in cell specific yield at high cell density infections regardless of the ability to grow 
cells to a very high cell density as uninfected cultures. The so called ‘cell density effect’ 
has been reported thoroughly for the Spodoptera frugiperda (Sf9/Sf21) cell line (Carinhas 
et al., 2009; Caron et al., 1990; Doverskog et al., 2000; Huynh et al., 2013; Jesionowski 
and Ataai, 1997; Radford et al., 1997; Reuveny et al., 1993; Taticek and Shuler, 1997; 
Wong et al., 1996; Yamaji et al., 1999). There are also a few papers that have investigated 
the reduction in cell specific yield for wild-type baculovirus infected Heliothis zea (HzAM1) 
cells (Chakraborty et al., 1996) and Antacarsia gemmatilis cells (Micheloud et al., 2009). 
This issue is a key drawback for improving the yield of the baculovirus infected insect cell 
systems while there is a critical need to reduce production costs given the low margin 
nature of biopesticide products.  
It has been suggested that the cause of the drop in productivity at high cell densities 
for baculovirus infection processes is related to nutrient limitations rather than 
accumulation of toxins (Drews et al., 1995; Radford et al., 1997; Wong et al., 1996). Many 
attempts have been made to identify the cause of the cell density effect including the 
measurement of extracellular metabolites to identify the limiting nutrients in the medium 
(Caron et al., 1990; Drews et al., 1995; Reuveny et al., 1993); the measurement of 
consumption rates and fluxomics analysis (Bernal et al., 2009); and supplementing culture 
media with glucose, glutamine, complex nutrient mixtures, and key intermediate 
metabolites (Carinhas et al., 2010; Reuveny et al., 1993).  However, the limitation of these 
approaches is that the metabolite levels in the media might not reflect intracellular 
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metabolite levels. For many reasons, some metabolites may not get into the cells even if 
they are available in the culture medium at reasonable levels. Therefore, intracellular 
metabolite measurements can provide a better understanding of what happens inside the 
cells and consequently, appropriate actions may be taken to improve yields. 
The limitations related to the reduction in cell specific yield at high cell density 
infections have been investigated in the Sf9/rAcMNPV system, as a control system, using 
a metabolomics approach (Chapter 4). In particular, intracellular metabolite concentration 
and consumption rates of key metabolites were measured in order to possibly identify 
limitations during high cell density infections. For the HzAM1 cell line infected with a wild-
type baculovirus, the question addressed in this chapter is whether or not potential 
intracellular limitations identified in the Sf9/rAcMNPV system also apply to the 
HzAM1/HearNPV? Therefore, in this study, substrate consumption rates as well as 
intracellular metabolite levels of infected cells at both low and high cell densities at the 
time of infection have been measured and compared between these two infection 
conditions. 
6.2 Materials and methods 
6.2.1 Cell line, virus and medium 
The Helicoverpa zea cell line (BCIRL-HZAM1) and wild-type Helicoverpa 
armigerasingle nucleopolyhedrovirus (HearNPV, Strain H25EA1) have been described 
previously in the PCT patent WO/2005/045014 by Reid and Lua (2005). Working stock 
cells were maintained in 25 ml suspension cultures in 125ml Erlenmeyer flasks (Corning 
Incorporation, Corning, USA) and routinely passaged every 3-4 days in single-use shaker 
flasks (Corning, Lowell, MA) at seeding densities of 0.3-0.5×105 cells/mL. The shaker 
cultures were agitated at 120 rpm on an orbital shaker platform (Thermoline, NSW, 
Australia) and incubated at 28oC in a refrigerated incubator (Thermoline). Cells were 
propagated in Sf900TMIII serum-free medium (Life Technologies, Carlsbad, USA).  
The virus stock was prepared as described previously (Tran et al., 2012). Virus 
stocks were stored at -80oC, and were titered prior to use. The titers of the HearNPV virus 
stock used in the experiments were around 4-6×107 PFU/ml as determined by a 
suspension culture assay (Matindoost et al., 2012). Due to the low titer of the HearNPV 
virus stocks, this necessitated the use of high volumes of virus to achieve high MOI 
infections. This was not a problem for the Sf9/rAcMNPV system as very high titer stocks 
are readily prepared for AcMNPV.  
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6.2.2 Experimental procedures 
 There were two experiments conducted to assess the efficiency of the extraction 
protocol for infected HZAM1cells at different times post-infection, and to investigate the 
difference between low and high infection cell densities (ICDs) in terms of intracellular 
metabolite concentrations, substrate consumption rates and occlusion body (OB) yield. 
The first experiment involved evaluation of the extraction protocol for intracellular 
metabolites (Tran et al., 2012) for infected HzAM1cells via a time-course infection 
experiment. This experiment identified the latest time point post-infection at which the 
infected cells still maintain their membrane integrity during quenching and washing 
procedures. The cells were setup at the initial cell density of 1×106 cells/mL and allowed to 
grow to 2×106 cells/mL (after 1 day post inoculation) and then diluted back to 1×106 
cells/mL for infection at an ICD of approximately 1×106 cells/mL with a multiplicity of 
infection (MOI) of 5 PFU/cell. The infection was conducted in a 1 L bottle and then 
aliquoted into various shaker flasks at 20 mL each for intracellular metabolite extractions at 
12 hour intervals from 0-96 hours post-infection (hpi). Three shaker flasks were set up at 
35 mL each as infected controls for measuring the total cell density (TCD) and viability, OB 
yield, and viral DNA (vDNA) copies at the various time points mentioned above. The 
uninfected control (in triplicate) was set up and grown to a peak cell density of 1×107 
cells/mL demonstrating that the cells were in optimal condition during the experimental 
period. 
 The second experiment investigates the changes in the intra- and extra-cellular 
environment as well as the production and consumption rate of various metabolites by the 
cells infected at low (0.5×106 cells/mL) and moderately high (2×106 cells/mL) cell densities. 
In addition, this experiment also aims to investigate the difference in cell condition before 
infection among different cell densities at the time of infection (with a wide range from 0.5 
×106 up to 8×106 cells/mL).  For the case of a low cell density infection, the culture was set 
up at 0.55×106 cells/mL but the ICD after adding the virus was 0.5×106 cells/mL. For the 
case of a moderate high cell density infection, the initial seeding cell density was at 
0.5×106 cells/mL and the cells were allowed to grow to about 2.7×106 cells/mL and the ICD 
after adding the virus was 2×106 cells/mL. For the case of the other ICDs, the initial 
seeding cell density was at 0.5×106 cells/mL and the cells were allowed to grow to different 
cell densities at the time of infection in order to get the cell densities after adding virus, of 
around 1, 1.5, 3 and 4×106 cells/mL, corresponding to the cell density before infection of 
1.2, 2, 5 and 8×106 cells/mL, respectively. All of the infections were conducted at an MOI 
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of 5 PFU/cell. The experiment was conducted in shaker flasks with biological triplicates at 
each ICD. Samples for intracellular metabolite analysis were taken at 12 hour intervals 
from 0-60hpi in triplicate for both the low (0.5×106 cells/mL) and the moderately high 
(2×106 cells/mL) ICDs. For the other infection cell densities (1, 1.5, 3 and 4×106 cells/mL), 
samples for intracellular metabolite analysis were taken at 0 hpi only. The additional 0 hpi 
samples were taken in order to assess whether, as cells grow in culture prior to infection, 
there is a consistent change in intracellular levels of certain key metabolites. Such 
changes are likely to affect the yield post-infection. While ideally samples would have been 
taken post-infection for all cell densities investigated this would have greatly increased the 
cost of the experiment.   
Samples for extracellular metabolite analysis and for measuring the TCD, viability, 
intracellular vDNA copies and OB yield were collected from 3 infected control shakers at 
12 hour intervals from 0-72 hpi (each infection cell density had 3 infected control shakers). 
An uninfected control was also set up and left to grow to a peak cell density in batch 
culture (around 1×107 cells/mL). 
6.2.3 Intracellular metabolite extraction 
Intracellular metabolites were extracted using the optimized protocol as described 
previously (Tran et al., 2012). Briefly, infected cultures were set up in 125 mL shaker flasks 
at a working volume of 20 mL, involving three flasks for each treatment at each time point 
as biological triplicates. Quenching solution (QS)  (1.1% NaCl, 0.2% Pluronic F68) was 
prepared in 250 ml shaker flasks at 80 mL each and placed in an ice bath to make sure 
the temperature of the quenching solution was  around 0.5 to 1oC. Taking out each flask at 
a time from the incubator, the culture of each flask (20 mL) was quickly poured into 80 mL 
of ice-cold QS. The quenched culture was then centrifuged (1000×g, 1 min) at 0oC. The 
supernatant was removed and the cell pellet was washed with the sample volume of ice-
cold QS. Another centrifugation step was applied (1000×g, 1 min, 0oC) to collect the cell 
pellet which was then extracted with a cold 50% acetonitrile (ACN) solution at the ratio of 1 
mL for 2×106 cells. The cell extracts were clarified by centrifugation (5000×g, 5 min, 0oC), 
with the supernatants collected, frozen at -800C and then dried in a freeze-dryer (Alpha 1-4 
LSC, Martin Christ, Germany). The freeze-dried samples were then stored at -800C until 
analysed. For the direct extract, infected cultures were poured directly into the same 
volume of 100% ACN and then the supernatants were collected for subsequent steps as 
described above with the cell extract samples. 
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6.2.4 Assays 
Total cell density (cell/mL) and cell diameter data was obtained using a MultisizerTM4 
Coulter Counter (Beckman Coulter, Fullerton, CA, USA). Samples of various cell densities 
were initially diluted with medium to a TCD of around 0.5×106 cells/mL before proceeding 
with the cell enumeration process. Cell viabilities were estimated from triplicated 
hemocytometer counts using the 0.05 % (w/v) Trypan Blue exclusion method (Nielsen et 
al., 1991). 
Baculovirus occlusion bodies (OBs) were extracted from infected cells using SDS 
digestion, and were enumerated via microscopy using a hemocytometer, as described 
previously (Pedrini et al., 2005). The OB count for each sample was conducted in technical 
triplicates. 
The number of vDNA copies was quantified using the quantitative real time 
polymerase chain reaction (qRT-PCR) as described previously (Pedrini et al., 2011; 
Rosinski et al., 2002). Briefly, the vDNA standard was prepared from budded virus and 
purified using mini kit genomic tips (Qiagen, Venlo, Netherlands), and then quantified 
using a Quant-iT picoGreen dsDNA assay kit (Life Technologies). The vDNA standard 
curve was generated from 6 dilutions ranging from 3×10-1 to 3×10-6 ng/µL. Samples (1×106 
cells/mL) were pelleted (300×g, 5 min) and kept in -200C for later analysis. Supernatants 
from the same samples were also kept for measuring extra-cellular vDNA. Prior to 
measuring intra-cellular vDNA, pellets were treated with 1 mL of digestion buffer (100 mM 
NaCl, 10 mM Tris.HCl, 25 mM EDTA, 0.5% SDS, 0.1 mg/mL Proteinase K) at 50oC for 15 
hours. Supernatant samples were also treated in the same way with the same volume of a 
2X digestion buffer. Alkaline saline (25 mM Na2CO3, 50 mM NaCl) was used to release 
ODV from the cell lysate samples. The Eppendorf epMotion 5075 Robotics System 
(Eppendorf, Germany) and the ABI PRISM® 7900HT Sequence Detection System (Life 
Technology, USA) were used for qRT-PCR analysis. Each sample was measured using 
technical triplicates in the same PCR plate. The estimated genome size of 1.4×10-7 
ng/genome (Pedrini et al., 2011) was used to convert the mass production into the 
genome copy number basis. 
Intracellular nucleotides and TCA cycle intermediates were measured by LC-MS/MS 
as described in Dietmair et al. (2012) with the following modifications: the analytical 
column was equipped with a pre-column Security Guard Gemini-NX C18 4mm x 2 mm I.D. 
cartridge (Phenomenex, Aschaffenburg, Germany). The samples were run with sample- 
and analyte-relevant calibration standards and pooled QC samples (Hodson et al., 2009; 
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Sangster et al., 2006) to control for reproducibility of data acquisition and to ensure data 
integrity. Analyte stock solutions were prepared in purified water (Veolia) and aliquots of 
each solution were mixed to achieve a final calibrant solution at 200 μM.  This calibrant 
solution was serially diluted and the dilutions used as calibration standards from 200 to 
0.006 μM, constituting 9≤x≤20 calibration points for all analytes to account for differential 
responses in the mass spectrometer. Data were processed and analysed in Analyst 1.5.2 
and MultiQuant 2.1.1 (ABSciex, Canada). 
A HPLC system was used to analyse extra- and intra-cellular amino acids (AAs) as 
described previously (Dietmair et al., 2010) with some modifications including the increase 
of flow rate from 1 mL/min to 2 mL/min which resulted in a time reduction for each run. In 
brief, derivatised amino acids were analysed by RP-HPLC. Derivatisation was performed 
in a high-performance autosampler (Agilent HiP-ALS SL, G1367C). First, 0.5 uL of sample 
containing 250 uM of internal standards, sarcosine and 2-aminobutanoic acid, was added 
into 2.5 uL of borate buffer (0.4 N, pH 10.2, Agilent PN: 5061-3339), mixed and incubated 
for 20 s at 4oC. Then 1 uL of OPA reagent (10 mg o-pthalaldehyde/mL in 3-
mercaptopropionic acid, Agilent PN: 5061-3335) was added to initially derivatise primary 
amino acids. The reaction was mixed and incubated for 20 s at 4oC. After that 0.4 uL of 
FMOC reagent (2.5 mg 9-fluorenylmethyl chloroformate /mL in acetonitrile, Agilent PN: 
5061-3337) was added, mixed and incubated for 20 s at 4oC, to derivatise other amino 
acids. 45.6 uL of Buffer A (40 mM Na2HPO4, 0.02% NaN3, pH 7.8) was added to lower the 
pH of the reaction prior to injecting the 50 uL reaction onto an Agilent Zorbax Extend C-18 
column (3.5 um, 4.6×150 mm, Agilent PN: 763953-902) with a guard column (Security 
Guard Gemini C18, Phenomenex PN: AJO-7597). Column temperature was kept at 37oC 
in a thermostatted column compartment (Agilent TCC, G1316B). Chromatography was 
performed using an Agilent 1200-SL HPLC system, equipped with an active seal wash and 
a degasser (Agilent Degasser, G1379B). The HPLC gradient was 2-45% B from 0-18 min, 
50-60% B from 18.1-20 min, 100% B from 20.1-24 min, and 2% B from 24.1-27 min – 
using a binary pump (Agilent Bin Pump SL, G1312B).  Buffer B was 45% acetonitrile, 45% 
methanol and 10% water. Flow rate was 2 mL/min. Derivatised amino acids were 
monitored using a fluorescence detector (Agilent FLD, G1321A). OPA-derivatised amino 
acids were detected at 340ex and 450em nm from 1-18 min, and FMOC-derivatised amino 
acids at 266ex and 305em nm from 18-27 min. Chromatograms were integrated using 
ChemStation (Rev B.03.02[341]).  
Extracellular organic acids (α-ketoglutarate, pyruvate, succinate, lactate, fumarate, 
acetate and propionate) and sugars (sucrose, glucose and maltose) were also analyzed by 
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HPLC (Agilent 1200 series, Agilent, Mulgrave, Victoria, Australia) using both MWD and 
RID detectors. The detail of the method is presented in chapter 2 of this thesis. 
The intracellular ATP in the first experiment was measured using the ATPlite 
luminescence ATP detection assay system (PerkinElmer Life Sciences, Boston, MA, 
USA), which was  described in Tran et al. (2012). This assay is based on the production of 
light when ATP reacts with D-Luciferin in the presence of Luciferase, and was conducted 
according to the manufacturer's instructions. 
6.2.5 Statistical analysis 
One-way analysis of variance (ANOVA) was used to determine whether the means 
from two or more groups of data were significantly different at the 95% confidence level. 
Minitab 15 Statistical Software (Minitab, State College, PA, USA) was used for all data 
analysis. Treatment mean differences were tested using the Tukey’s HSD test. 
6.3 Results 
6.3.1 Assessment of the extraction protocol for infected HzAM1 cells post-infection 
Figure 6.1 presents results for the evaluation of the extraction protocol at different 
times post-infection. For an infection at a high MOI (5 PFU/cell), the cell density (cells/mL) 
increase post-infection was minimal (about 41%) that was almost negligible compared with 
the uninfected culture that reached a peak cell density of around 1×107 cells/mL (data not 
shown). In addition, the cell diameter post-infection quickly increased for the first 24 hpi, 
and then increased slowly until 60 hpi, with a peak increase in cell diameter of about 9% 
and then declined quickly after 60 hpi (Fig. 6.1 a). Also as shown in Fig. 6.1a, the cell 
viability of infected cultures is very high (more than 90%) for the first 48 hpi; after which it 
started to decrease to around 80% at 60 hpi and then dropped sharply after that (Fig. 6.1 
a). These results indicate that the cell integrity was slightly affected after 48 hpi, and more 
badly after 60 hpi when infected cells began to die and lyse.  
Figure 6.1 b shows the kinetics of vDNA and OB production for infected HzAM1 cells 
being as expected for wild-type HearNPV infected HzAM1 cells in Sf900™III serum free 
medium. The vDNA production started at 6 hpi and showed a rapid increase from 12 until 
24 hpi to a value of about 83% of the peak yield (2.5×105 copies/cell) seen at 36 hpi. The 
OB production commenced later (around 24 hpi) and sharply increased until 60 hpi, and 
then slowly increased to the peak yield between 72-168 hpi. The peak OB yield may be 
achieved as early as 72 hpi. However, an OB count using a microscope is subject to a 
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high level of error, especially for immature OB at early stages. Therefore, OB yields 
estimated at the later stage of 168 hpi (7 days post infection) is more accurate and is 
normally used for estimating the OB yield of an infected culture. The peak specific OB 
yield achieved was 354 OB/cell for the current experiment. The results of the vDNA and 
OB yields indicated that the HearNPV infected HzAM1 cells set up in this study were 
optimally-infected, and were suitable for evaluation of the extraction protocol for 
endometabolite studies. 
The intracellular ATP concentration of infected HzAM1 cells and the ATP recovery of 
cell extract samples compared to the direct extract over the time course post-infection 
(from 0 to 96 hpi) are shown in Fig. 6.1 c. The recovery of ATP in the cell extract samples 
was very high (recovery of over 93% of the direct extract) for the first 48 hpi. The ATP 
recovery was reasonable until 60 hpi (about 85% of the direct extract) but reduced quickly 
after that point. This indicates that the extraction protocol works well for infected HzAM1 
cells propagated in Sf900™III medium until 48 hpi and possibility until 60 hpi. The peak 
intracellular ATP level of the cell extract was around 4 mM obtained during the first 48 hpi. 
There was no significant difference among intracellular ATP levels up to 60 hpi (Fig. 6.1 c) 
although the ATP level at 60 hpi was about 85% of the peak value. This result indicates 
that 48 hpi and possibly 60 hpi is the latest time that the infected cells can be extracted 
without a significant loss of intracellular metabolites. 
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Fig. 6.1 The kinetics of cell growth, cell size expansion and viability (a), specific vDNA and OB 
yields (b) and intracellular ATP levels and ATP recovery over various times post-infection (c) of 
HzAM1 cells infected with a wide-type baculovirus (HearNPV) at a multiplicity of infection (MOI) of 
5 PFU/cell. Infections were conducted in Sf900™III medium at infection cell densities (ICD) of 
1×106 cells/mL. The experiment was conducted in shaker-flask suspension cultures. Each data 
point is the average from three biological replicates, and the error bars represent the standard 
deviation. 
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6.3.2 Kinetics of cell growth post-infection and yields of various ICDs 
Figure 6.2 shows the results of cell growth (cells/mL) and cell size increase post-
infection and the virus yields for various ICDs of 0.5-4×106 cells/mL for wild-type 
baculovirus infected HzAM1 insect cells. The cell density increase post-infection was in the 
range of 25-48% when infections were conducted at the different ICDs indicated above, 
and there was no significant difference among different ICDs (Fig. 6.2a). The total cell 
density peaked around 48-60 hpi for most of the ICDs. The early infection events of virus 
getting into the cell and inhibiting cell growth were similar for the different ICDs and 
showed a typical pattern for a baculovirus infection process. The total cell density of the 
control uninfected cultures continued to double almost every 24 hours to the peak cell 
density expected for HzAM1 insect cells propagated in Sf900™III of around 1×107 cells/mL 
(Fig. 6.2 a).  
In all infected cultures, the average cell diameter increased rapidly within the first 24 
hpi followed by a further slow increase to a peak value by 48 hpi and reduced after that 
point for most of the cases, except for the high ICDs (3 and 4×106 cells/mL), in which 
cases the cell diameter started to reduce after 24 hpi (Fig. 6.2 b). Unlike the increase in 
cell density post-infection, the enlargement of the cell diameter post-infection reduced with 
the increase of the ICD. The highest increase of cell volume post-infection of 50% was 
obtained at the ICD of 0.5×106 cells/mL. The cell size increase post-infection reduced to 
33% at the ICD of 2×106 cells/mL and 20% for the highest ICD investigated of 4×106 
cells/mL. The difference in cell volume increase post-infection is a good indicator of the 
difference in cell specific yields among the various ICDs. 
As shown in Fig. 6.2 c, the timing for vDNA production was in general similar among 
the various ICDs. The vDNA production commenced at 6 hpi, rapidly increased in the 
period of 12-24 hpi, and achieved a peak value at 36 hpi. Higher ICDs seemed to reach 
the peak vDNA yield earlier than that of the lower ICDs. In general, the time frame from the 
starting point of vDNA production to the point where peak yields were achieved was similar 
for different ICDs (Fig. 6.2 c). This indicates that the infection process follows a similar 
time sequence for low and high ICDs, at least in terms of the time at which vDNA 
synthesis commences, but the vDNA productivity during the post-infection period and the 
period of vDNA production is lower for the high density infections. For OB production, the 
timing of OB production post-infection was not available due to the inaccuracy and time 
required for counting of immature OBs at the early infection periods. Therefore, only the 
peak yield at 168 hpi is presented and this shows a rapid reduction in specific OB yields as 
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the ICD increased (Fig. 6.2 d). Although there was no difference among ICDs in terms of 
cell density increase post-infection (Fig. 6.2 a), the cell specific yields (vDNA, OB) 
significantly reduced with increasing ICD (Fig. 6.2 c, d). 
 
 
Fig. 6.2 Total cell density (a), cell hypertrophy (b), specific vDNA (c) and OB production (d) of 
HzAM1 cells infected with a wild-type HearNPV. Infections were conducted in Sf900™III serum 
free medium at various ICDs from 0.5-4×106 cells/mL at an MOI of 5 PFU/cell. The experiment was 
conducted in shaker-flask suspension cultures. Each data point is the average from three biological 
replicates, and the error bars represent the standard deviation. For OB yield, measurement was 
conducted only once at 168 hpi due to the low accuracy of OB counts at earlier stages. 
The data presented previously can be summarized by plotting the peak yields of each 
infection against its associated peak cell density (PCD) for both volumetric and specific 
yields (Fig. 6.3). The volumetric production of vDNA (Fig. 6.3 a) or OB (Fig. 6.3 c) initially 
increased linearly with increasing PCD until the peak values were obtained at the PCD of 
2.4×106 cells/mL for both cases with peak volumetric yields of 4.5×1011 copies/mL and 
9.2×108 OB/mL for vDNA and OB yields, respectively. Volumetric yields of vDNA and OB 
significantly reduced when the PCD increased above the optimal PCD for the media used. 
The cell-specific production of vDNA (Fig. 6.3 b) and OB (Fig. 6.3 d) declined quickly with 
increasing PCD from 0.6×106 cells/mL until 4.9×106 cells/mL. Specific yields declined from 
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2.88×105 copies/cell to 0.19×105 copies/cell for vDNA and from 640 OB/cell to 27 OB/cell 
for OB production. There were significant differences in specific vDNA and OB yields 
among various PCDs investigated, except for those at PCDs in the range of 1.1-2.4×106 
cells/mL, which were statistically similar for both specific vDNA and OB yields (Fig. 6.3 b, 
d). 
 
Fig. 6.3 Correlations between the peak yields (volumetric or specific) of vDNA (a, b) or OB(c, d) 
and the peak cell density (PCD) from HzAM1 cell cultures infected with a wild-type baculovirus 
(HearNPV) at various ICDs of 0.5 to 4×106 cells/mL, and a MOI of 5 PFU/cell. The experiment was 
conducted in shaker-flask suspension cultures. Each data point is the average from three biological 
replicates, and the error bars represent the standard deviation. Significance testing was performed 
separately for each experimental set of data points with different letters indicating values that are 
significantly different according to Tukey's HSD (α=0.05). 
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6.3.3 Intracellular nucleotide and amino acid concentrations of uninfected cultures 
 
Fig. 6.4 Intracellular concentrations of adenosine (a), uridine (b) and cytidine (c) nucleotides and 
amino acids of uninfected HzAM1 cell cultures at various cell densities from 0.5 to 8×106 cells/mL. 
Cultures were propagated in Sf900™III serum free medium. The experiment was conducted in 
shaker-flask suspension cultures. Each data point is the average from three biological replicates, 
and the error bars represent the standard deviation. Significance testing was performed separately 
for each experimental set of data points with different letters indicating cases that are significantly 
different according to Tukey's HSD (α=0.05). 
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 Figure 6.4 represents the intracellular nucleotide and amino acid (AA) 
concentrations of uninfected HzAM1 insect cells at various cell densities (0.5-8×106 
cells/mL). Intracellular nucleotide tri phosphates (ATP, UTP and CTP) reduced significantly 
with the increase of total cell density of the uninfected cultures (Fig. 6.4 a, b, c). In all 
cases, there was no significant difference in the levels of nucleotide tri-phosphates 
between the two lowest cell densities of 0.5 and 1×106 cells/mL, but then the levels 
reduced when the cell density increased further (2-8×106 cells/mL). In particular, at the cell 
density of 8×106 cells/mL, the concentrations of UTP and CTP dropped to very low levels 
in comparison with those at the cell density of 1×106 cells/mL, about 2% and 19%, 
respectively. The ATP level at the cell density of 8×106 cells/mL also decreases compared 
to that for the cells at 1×106 cells/mL (50%), but the levels of total adenosine generally 
remain at a similar level for all cell densities. In addition, the intracellular concentrations of 
most amino acids (AA) decreased with the increase of the total cell density, especially for 
the case of the very high cell density of 8×106 cells/mL, where the intracellular AA 
concentrations were significantly reduced in most cases (Fig. 6.4 d). These results indicate 
that substrate limitations for nucleic acid and protein production are already potentially 
appearing inside the cells at high cell densities in cultures even before infections are 
initiated. 
6.3.4 Intracellular metabolites of infected cultures at low and moderately high ICDs 
Intracellular concentrations of 33 metabolites (including nucleotides, nucleotide 
sugars and organic acids) at 6 time points post-infection (0, 18, 24, 36, 48 and 60 hpi) of 
low (0.5×106 cells/mL) and high (2×106 cells/mL) ICDs have been analysed and results are 
presented in Fig. 6.5. The orthogonal projection to latent structures – discriminant analysis 
(OPLS-DA) of all the samples over the time course of the infections (Fig. 6.5 a) showed a 
clear separation of low and high ICD data. The biological replication is reliable as the 
scores for the three replicates indicate similar positions in the biochemical space (Fig. 6.5 
a). Based on the OPLS-DA loadings (Fig. 6.5 b), the metabolites that are most influential in 
the projected separation between low and high ICDs are the nucleoside tri-phosphates 
(ATP, CTP, UTP), nucleoside di-phosphates (ADP, GDP, UDP), nucleoside mono-
phosphates (AMP, GMP, CMP, UMP), fumarate (FUM), malate (MAL), ribose-5-phosphate 
(R5P), nicotinamide adenine dinucleotide (NAD), nicotinamide adenine dinucleotide 
phosphate (NADP) and UDP glucose (UDPG). These metabolites have a variable 
importance on projection (VIP) score of more than 1 and have been selected for further 
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statistical analysis as detailed in Table 6.1. Generally, intracellular metabolite 
concentrations at the low ICD were higher than those at the high ICD (Table 6.1). 
 
Fig. 6.5 Multivariate analysis of intracellular metabolite concentrations of infected HzAM1 at low 
(0.5x106 cells/mL) and moderately high (2x106 cells/mL) ICDs. Orthogonal projection to latent 
structures–discriminant analysis (OPLS-DA) scores (a) and loadings (b) plots of the 6 time points 
post-infection at low and high ICDs, classified by cell density. OPLS-DA model metrics: Predictive 
component R2X = 0.124; R2 = 0.857; Q2 = 0.685; R2Y = 1: Orthogonal component R2X = 0.26. 
Infections were conducted in Sf900™III serum free medium at an MOI of 5 PFU/cell. The 
experiment was conducted in shaker-flask suspension cultures. 
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Fig. 6.6 Stacked bar charts of (a) adenosine, (b) uridine, and (c) cytidine nucleotide concentrations 
of 6 time points post-infection of infected HzAM1 cells at low(0.5x106 cells/mL) and moderately 
high (2x106 cells/mL) ICDs. Infections were conducted in Sf900™III medium at an MOI of 5 
PFU/cell (HearNPV). The experiment was conducted in shaker-flask suspension cultures. Each 
data point is the average from three biological replicates, and the error bars represent the standard 
deviation. 
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The concentrations of nucleotide tri-, di-, and mono-phosphates of infected HzAM1 
cells at low (0.5×106) and moderately high (2×106 cells/mL) ICDs over the time course of 
infections are presented in Figure 6.6. Intracellular nucleotide tri-phosphate levels seemed 
to reduce over time post-infection and when the ICD increased (Fig. 6.6 a, b, c). However, 
statistical analysis only showed significant differences between early and late infection 
stages of the same ICD, but no significant difference was found between low and high 
ICDs at the same time points post-infection for the case of ATP (Table 6.1). For the total 
Adenosine (ATP+ADP+AMP), there was no statistical difference between low and high 
ICDs. Also, no significant difference among treatments was found for ADP, UDP, UMP and 
GMP.  In contrast, the intracellular concentrations of UTP and CTP at the early infection 
stages of the low ICD were significantly higher than those at the late infection stages and 
at the high ICD of the same infection stage (Fig. 6.6 b, c and Table 6.1). 
Figure 6.7 represents the intracellular AA concentrations of infected HzAM1 cells with 
a wild-type HearNPV at low and moderately high ICDs over the period of 0-60 hpi and a 
comparison of the data between low and moderately high ICDs at 0 and 36 hpi. 
Intracellular AA concentrations (in mM) tended to reduce over the time course post-
infection, especially at 60 hpi where values were significantly lower than other time points 
for most of the AAs (Fig. 6.7 a, b). The significant reduction in intracellular AA 
concentrations at 60 hpi might indicate a leakage of intracellular metabolites at this late 
infection stage when infected cells underwent quenching and washing procedures. 
Comparing between low and high ICDs, intracellular AA concentrations were not 
significantly different for most of the AAs, except for aspartate, asparagine and serine at 0 
hpi and asparagine, serine and leucine at 36 hpi, in which cases the AA concentrations for 
the low ICD were significantly higher than those for the high ICD (Fig. 6.7 c, d). 
Interestingly, intracellular alanine concentrations of the moderately high ICD were 
significantly higher than that of the low ICD either at 0 and 36 hpi. 
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Table 6.1. Intracellular metabolite concentrations (mM) for HzAM1cells infected with a wild-type baculovirus (HearNPV) at either low 
(0.5×106) or moderately high (2×106 cells/mL) infection cell densities (ICDs) over various times post-infection. Data represented as an 
average of biological triplicates. The metabolites listed were selected on the basis of showing significant variations in levels between 
different ICDs or times post infection following the analysis shown in Fig. 6.5. 
Metabolites 
Low ICD (0.5×106 cells/mL) High ICD (2×106 cells/mL) 
P< 
0 hpi 18 hpi 24 hpi 36 hpi 48 hpi 60 hpi 0 hpi 18 hpi 24 hpi 36 hpi 48 hpi 60 hpi 
Adenosine 7.34ab 7.04ab 7.07ab 7.54a 6.34ab 5.70bc 7.25ab 7.35ab 7.40a 6.93ab 6.04ab 4.34c 0.001 
ATP 5.39a 5.17a 4.36ab 4.01ab 3.16bc 3.21bc 4.36ab 3.95ab 4.28ab 3.34bc 3.49b 1.86c 0.001 
ADP 1.41 1.57 1.85 2.11 2.12 1.59 1.57 1.99 1.91 2.10 1.34 1.98 NS 
AMP 0.54bcd 0.30d 0.86abcd 1.41ab 1.06abcd 0.90abcd 1.32abc 1.41abc 1.21abcd 1.49a 1.21abcd 0.49cd 0001 
UTP 1.15a 1.08ab 1.03abc 0.84abcd 0.56de 0.89de 0.77bcd 0.78bcd 0.71cde 0.52de 0.59de 039e 0.001 
UDP 0.09 0.12 0.10 0.03 0.05 0.06 0.04 0.04 0.09 0.03 0.05 0.01 NS 
UMP 0.03 0.01 0.04 0.01 0.03 0.03 0.00 0.01 0.02 0.01 0.01 0.01 NS 
CTP 0.61ab 0.60ab 0.67a 0.42bc 0.35c 0.30cd 0.37c 0.30cd 0.37c 0.24cd 0.30cd 0.15d 0.001 
CMP 004ab 0.01b 0.03ab 0.10a 0.02b 0.05ab 0.04ab 0.07ab 0.05ab 0.04ab 0.01b 0.05ab 0.05 
GDP 0.30ab 0.08b 0.21ab 0.38ab 0.10b 0.09b 0.33ab 0.55a 0.24ab 0.30ab 0.20b 0.19b 001 
GMP 0.13 0.06 0.14 0.22 0.05 0.01 0.31 0.29 0.07 0.09 0.12 0.05 NS 
R5P 0.05ab 0.04a 0.04a 0.02bc 0.01bc 0.02b 0.01bc 0.02bc 0.02bc 0.01c 0.01bc 0.01bc 0.001 
MAL 1.28a 1.20ab 1.23a 0.65ab 0.80ab 0.77ab 0.75ab 0.67ab 0.63ab 0.46ab 0.58ab 0.29b 0.05 
FUM 0.37a 0.18bc 0.22b 0.13bc 0.12bc 0.12bc 0.15bc 0.11bc 0.13bc 0.08c 0.09c 0.07c 0.001 
NAD 1.62a 1.25abc 1.17abcd 1.04bcde 0.73de 0.79de 1.33ab 1.13bcd 1.01bcde 0.84cde 0.94bcde 0.63e 0.001 
NADP 0.10ab 0.07bc 0.08abc 0.06bc 0.02c 0.06bc 0.10ab 0.14a 0.08bc 0.07bc 0.08abc 0.05bc 0.001 
UDPG 2.10a 1.64ab 1.49bc 1.19bcde 0.76de 0.81de 1.71ab 1.69ab 1.26bcd 0.95cde 1.09cde 0.70e 0.001 
Data in the same row with different superscripts were significantly different at P <0.05 
149 
 
 
Fig. 6.7 Intracellular AA concentrations at 6 times post-infection at low (a) and high (b) ICDs , and the comparison between low and high ICDs for 
intracellular AA levels at 0 (c) and 36 hpi (d) of infected HzAM1 cells. Infections were conducted in Sf900™III at low (0.5x106 cells/mL) and high 
(2x106 cells/mL) ICDs and at an MOI of 5 PFU/cell (HearNPV). The experiment was conducted in shaker-flask suspension cultures. Each data point is 
the average from three biological replicates, and the error bars represent the standard deviation. Data for the same AA with an (*) was significantly 
different according to Tukey’s HSD test (α=0.05), for high versus low ICDs at the indicated times post infection. 
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6.3.5 Consumption rates of glucose, maltose, and AAs 
Glucose and AA consumption rates of uninfected and infected HzAM1 cells at three 
ICDs of 0.5, 2 and 4×106 cells/mL are shown in Table 6.2. The cell specific glucose 
consumption rates were within the range of 43.4-71.6×10-12 mmol/cell/hour for uninfected 
and infected HzAM1 cells at the various ICDs indicated above. Although glucose 
consumption rates of uninfected cells appeared lower than those of infected cells, 
especially at the low ICD of 0.5×106 cells/mL (43.4×10-12 compared to 71.6×10-12 mmol/ 
cell/hour), there was no statistical difference in glucose consumption rates among 
uninfected and infected HzAM1 cells at the various ICDs (Table 6.2). Also as shown in 
Table 6.2, no significant difference was found in the glucose consumption rates among 
treatments at early (0-18 hpi) and late (18-72 hpi) stages of infections. The maltose 
consumption rates, however, significantly reduced with the increasing ICD and there were 
significant differences in maltose consumption rates among the ICDs (Table 6.2). The 
maltose consumption rate of uninfected cultures was statistically similar to that of the 
infected cultures at an ICD of 2×106 cells/mL. The low maltose consumption rate at the 
high ICD (4×106 cells/mL) did not mean poor maltose consumption but was due to the 
exhaustion of maltose at this high cell density in culture. In terms of consumption rate per 
unit of cell biomass, Table 6.3 shows that there was no significant difference in the glucose 
consumption rate among the treatments as shown for the consumption rates on a per cell 
basis. The differences among treatments in terms of maltose consumption rate per mm3 of 
cell biomass were also similar to those based on a per cell basis (Table 6.3). 
Table 6.2 also shows AA consumption rates on a per cell basis for uninfected and 
infected HzAM1 cells at various ICDs of 0.5, 2 and 4×106 cells/mL. AA consumption rates 
for the low ICD (0.5×106 cells/mL) were significantly higher than those of the moderately 
high (2×106) and the high (4×106 cells/mL) ICDs for most of the AAs, except for glutamate, 
histidine and phenylalanine. Generally, AA consumption rates of the ICD of 2×106 cells/mL 
were higher than those of the high ICD (4×106 cells/mL), in which, significant differences 
were found for 7 out of 19 AAs. AA consumption rates of uninfected cultures were 
statistically similar to those of infected cultures at an ICD of 2×106 cells/mL for most of the 
AAs (15 out of 19 AAs) (Table 6.2). 
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Table 6.2. Glucose and amino acid consumption rates (×10-12mmol/cell/hour) of uninfected 
and infected HzAM1 cells infected with a wild-type HearNPV at various ICDs. Uninfected 
and infected cultures were set up at 0.5×106 cells/mL. For the case of uninfected cultures 
no infection was made and sampling was conducted every 24 hours during the period that 
the culture maintained a 24-hour doubling time. For infected cultures, cultures were 
infected with an MOI of 5 PFU/cell at 0.5, 2 and 4×106 cells/mL and sampling was 
conducted every 12 hours until 60 hours post-infection. Data is the average of biological 
triplicates. 
 Uninfected  0.5×106† 2×106† 4×106† P< 
Glucose -43.38 -71.60 -51.05 -59.39 NS 
Glucose, 0-18 hpi  -59.43 -44.95 -60.57 NS 
Glucose, 18-60 hpi  -48.01 -48.27 -54.70 NS 
Maltose -9.61b -66.21a -14.21b -2.09c 0.001 
Amino acids      
Aspatate 0.15b 17.95a -2.87c -5.78c 0.001 
Glutamate -3.47 -3.97 -2.75 -2.87 NS 
Asparagine -30.58b -79.91a -23.96c -3.27d 0.001 
Serine -9.91b -11.95a -7.78c -1.21d 0.001 
Glutamine -29.57a -9.67b -7.16b -7.47b 0.001 
Histidine -1.52 -1.95 -1.20 -0.42 NS 
Glycine -2.63b -4.99a -1.13b -1.12b 0.001 
Threonine -3.91b -5.93a -3.73b -1.68c 0.001 
Arginine -4.43b -6.88a -3.73b -0.55c 0.001 
Alanine 18.05b 45.03a 14.99bc -11.42c 0.001 
Tyrosine -1.88bc -4.64a -3.22ab -0.70c 0.001 
Valine -5.29b -9.30a -4.77b -1.73c 0.001 
Methionine -4.47b -7.99a -3.36b -6.14ab 0.001 
Tryptophan -0.89b -2.02a -0.69b -0.87b 0.001 
Phenylalanine -2.09 -6.49 -3.94 -3.44 NS 
Isoleucine -3.49b -7.96a -3.87b -1.90b 0.01 
Leucine -5.54b -10.83a -6.05b -2.27c 0.001 
Lysine -4.55b -10.54a -3.68b -1.83b 0.001 
Proline -3.85a -3.86a -3.16ab -1.05b 0.05 
† Infected cultures at ICDs of 0.5, 2 and 4×106 cells/mL 
Consumption rates in the same row with different superscripts were significantly different (P<0.05) 
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NS: Not significantly different 
Table 6.3. Comparison of AA consumption rates (x10-6 mmol/mm3 cell volume/hour) of 
uninfected and infected HzAM1 cells infected with a wild-type HearNPV at various ICDs. 
Further details are as described in Table 6.2. 
 Uninfected  0.5×106† 2×106† 4×106† P< 
Glucose -18.85 -19.80 -16.91 -22.40 NS 
Glucose, 0-18 hpi - -19.46 -16.47 -21.77 NS 
Glucose, 18-60 hpi - -12.76 -15.67 -20.55 NS 
Maltose -4.19b -18.22a -4.67b -0.79c 0.001 
Amino acids      
Aspartate 0.32b 5.14a -0.98bc -2.08c 0.001 
Glutamate -1.31 -1.13 -0.95 -1.05 NS 
Asparagine -12.86b -22.80a -8.30c -1.21d 0.001 
Serine -4.15a -3.41b -2.69c -0.45d 0.001 
Glutamine -11.81a -2.77b -2.52b -2.74b 0.001 
Histidine -0.63 -0.55 -0.42 -0.16 NS 
Glycine -1.06ab -1.42a -0.39c -0.40bc 0.01 
Threonine -1.63ab -1.69a -1.28b -0.62c 0.001 
Arginine -1.84ab -1.96a -1.29b -0.20c 0.001 
Alanine 7.72b 12.86a 5.15c 4.14c 0.001 
Tyrosine -0.78a -1.33a -1.10a -0.26b 0.01 
Valine -2.19ab -2.65a -1.64b -0.64c 0.001 
Methionine -1.77ab -2.28a -1.17b -2.24a 0.05 
Tryptophan -0.36b -0.58a -0.24b -0.32b 0.01 
Phenylalanine -0.68 -1.87 -1.36 -1.26 NS 
Isoleucine -1.39ab -2.25a -1.33ab -0.69b 0.05 
Leucine -2.36b -3.09a -2.08b -0.83c 0.001 
Lysine -1.96ab -3.02a -1.27b -0.68b 0.01 
Proline -1.52a -1.10ab -1.08ab -0.39b 0.01 
† Infected cultures at ICDs of 0.5, 2 and 4×106 cells/mL 
Consumption rates in the same row with different superscripts were significantly different (P<0.05) 
NS: Not significantly different 
As the cell volume of uninfected cultures was almost unchanged throughout the 
culture (Fig. 6.2b), AA consumption rates on a per cell basis for uninfected cultures were 
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relatively low in comparison with those for cultures infected at a low ICD, where the cell 
volume increases significantly post infection. Consequently, AA consumption rates per 
mm3 of cell volume for uninfected cultures were statistically similar to those of infected 
cultures at the low ICD (0.5×106 cells/mL) in 12 out of 19 AAs in comparison with only 4 
out of 19 AAs in the case of AA consumption rates on a per cell basis (Table 6.2, 6.3). In 
this work cell volume is assumed to equate to cell biomass. The significant differences in 
AA consumption rates per unit of cell volume among infected cultures at various ICDs 
followed a similar trend as found for the consumption rates on a per cell basis. It is 
important to note that infected cells at a low ICD consumed a significant amount of 
asparagine compared with the consumption of glutamine, while uninfected cultures 
consumed similar levels of these two AAs. Consumption of these two AAs significantly 
reduced with an increase of the ICD (Table 6.2). The change of extracellular glucose, 
maltose and AA concentrations over the time post-infection/post-inoculation can be seen 
in Appendix A4.1 & A4.2. 
AA consumption rates of different infection stages of the virus infection process at 
early (0-18 hpi) and late (18-72 hpi) periods for the same ICD or between infected HzAM1 
cells at various ICDs are shown in Fig. 6.8 and 6.9. Within the same ICD, AA consumption 
rates at the early infection stage (0-18 hpi) were generally higher than those at the late 
infection stage (18-72 hpi) at least for the higher ICDs, (Fig. 6.8). For the low ICD (0.5×106 
cells/mL), there was almost no difference in AA consumption rates between the early and 
late stages of the virus infection (significant differences in AA consumption rates were only 
seen for aspartate, alanine and tyrosine, Fig. 6.8 a). Whereas, more significant differences 
were found in the AA consumption rates between the early and late infection stages with 
increasing ICDs. In the case of infected cells at the moderately high ICD (2×106 cells/mL), 
significant differences between early and late infection stages were found for 8 out of the 
19 AAs quantified (Fig. 6.8 b). Significant differences in AA consumption rates between 
early and late infection stages in the case of the high ICD (4×106 cells/mL) were found for 
14 out of the 19 AAs quantified (Fig. 6.8 c). 
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Fig. 6.8 Comparison of AA consumption rates (mmol/cell/hour) between early (0-18 hpi) and late 
(18-72hpi) infection stages for 3 different infection cell densities of 0.5×106 (a) 2×106 (b), and 4×106 
cells/mL (c) of infected HzAM1 cells. Infections were conducted in Sf900™III at an MOI of 5 
PFU/cell (HearNPV). The experiment was conducted in shaker-flask suspension cultures. Each 
data point is the average from three biological replicates, and the error bars represent the standard 
deviation. Data from the same AA with an (*) was significant difference according to Tukey’s HSD 
test (α=0.05). 
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Fig. 6.9 Comparison of AA consumption rates (mmol/cell/hour) among 3 infection cell densities of 
0.5×106, 2×106, and 4×106 cells/mL at either early (0-18 hpi) (a) or late (18-72hpi) (b) infection 
stages of infected HzAM1. Infections were conducted in Sf900™III at an MOI of 5 PFU/cell 
(HearNPV). The experiment was conducted in shaker-flask suspension cultures. Each data point is 
the average from three biological replicates, and the error bars represent the standard deviation. 
Comparing among various ICDs, the AA consumption rates of infected cells at a low 
ICD were generally higher than those at moderately high or high ICDs and the differences 
in AA consumption rates among ICDs were more pronounced at the late infection stage 
(18-72hpi) (Fig. 6.9). Significant differences among various ICDs were found in 8 out of 19 
AAs at the early infection stage (Fig. 6.9a), while 12 out of 19 AAs were found to have 
significant differences in consumption rates among ICDs at the late infection stage (Fig 
6.9b). Generally, AA consumption rates reduced with an increase of the ICD, especially for 
the case of the late stage of the infection. Based on a cell volume basis, the differences in 
AA consumption rates among various ICDs at early and late infection stages (Fig. 6.10) 
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generally followed the same pattern as found when calculated based on a per cell basis. 
This result indicates that infected cells at the low ICD consumed AAs at higher rates than 
those at the high ICD and the consumption of AAs by infected cells at high ICDs were 
poorer at the late stage of the baculoivirus infection process. These observations are 
consistent with the reduced OB yields observed for infections at higher cell densities 
particularly bearing in mind that the polyhedral protein is expressed in the latter infection 
period. 
 
 
Fig. 6.10 Comparison of AA consumption rates (mmol/mm3 of cell biomass/hour) among 3 
infection cell densities of 0.5×106 cells/mL, 2×106 cells/mL, and 4×106 cells/mL at either early (0-18 
hpi) (a) or late (18-72hpi) (b) infection stages of infected HzAM1 cells. Infections were conducted in 
Sf900™III at an MOI of 5 PFU/cell (HearNPV). The experiment was conducted in shaker-flask 
suspension cultures. Each data point is the average from three biological replicates, and the error 
bars represent the standard deviation. 
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6.3.6 Ratios of AA levels between moderately high and low ICDs, and between intra- 
and extracellular AAs  
Figure 6.11 represents the ratios of AA levels between moderately high and low ICDs 
for both extra- and intracellular AA concentrations, and the ratios between intra-and extra-
cellular AA concentrations of low and moderately high ICD samples at 0 and 36 hpi. When 
comparing AA concentrations between moderately high and low ICDs, Figure 11a and 11b 
show that extra- and intra-cellular AA levels of infected cells at the moderately high ICD 
were lower than those for the low ICD as indicated by the ratios of moderately high/low 
ICD AA values being less than 1 for the majority of the AAs. Generally, the ratios between 
moderately high and low ICDs of extracellular AAs were similar with the ratios for 
intracellular AAs either at early (0 hpi) or late (36 hpi) infection times. These results 
indicate that the intracellular AA concentrations were determined by the extracellular AA 
levels and that there was no difference in the capability of AA transport into the cell 
between low and moderately high ICDs at early or late infection stages. Low AA 
concentrations for the moderately high ICD in comparison with the low ICD (based on the 
ratio of AAs between high/low ICDs) were found for asparagine, serine and leucine; 
especially at the late infection stage (36 hpi), with the ratio of AAs between moderately 
high/low ICDs being less than 0.5 for these three AAs at 36 hpi (Fig. 6.11b).  
When comparing the ratios between intra- and extra-cellular AA levels for low and 
high ICDs, these two ratios were similar between low and high ICDs for the majority of the 
AAs at 0 and 36 hpi (Fig. 6.11c, d), except for glutamine (at 0 and 36 hpi), and asparagine 
and serine (at 36 hpi) where the ratios between intra- and extra-cellular AAs for the high 
ICD were higher than those for the low ICD. It is of interest that the intra-/extra-cellular 
ratios for most AAs for both low and high ICDs at 0 and 36 hpi were much lower than one. 
On average, intracellular AA levels were about two thirds of the extracellular levels. These 
results suggest that the AA uptake by cells in culture before and after infection reaches an 
equilibrium of the AAs in the cell with the level in the external medium or alternatively that 
the external AA level dictates the extent of AA uptake. This in turn suggests the only way 
to keep intracellular AA levels high is to have high AA levels in the external media. It is 
also noted that intracellular levels of arginine and lysine were very low compared with 
extracellular levels, especially for lysine, where the intracellular level is only about 10% of 
the extracellular level. This may indicate poor transport rates for these AAs into the cells, 
or a high consumption rate of these AAs in relation to their transport rate.  
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Fig. 6.11 Ratios of AA levels between high versus low ICDs for extra- and intra-cellular AAs at 0 hpi (a) and 36 hpi (b) and ratios between intra- 
versus extra-cellular AA levels for low and high ICDs at 0 hpi (c) and 36 hpi (d) of infected HzAM1 cells. Infections were conducted in Sf900™III at 
low (0.5×106 cells/mL) and high (2×106 cells/mL) ICDs and at an MOI of 5 PFU/cell (HearNPV). The experiment was conducted in shaker-flask 
suspension cultures. Each data point is the average from three biological replicates, and the error bars represent the standard deviation. 
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6.4 Discussion 
The intracellular metabolite extraction protocol has been optimized for infected 
HzAM1 cells with a wild-type HearNPV (Tran et al., 2012). However, the previous study 
only evaluated the protocol at the one time point post-infection of 24 hpi, while the cell 
integrity changes greatly post-infection due to cell death and lysis after being infected with 
a baculovirus at a high MOI (e.g ≥ 5 PFU/cell). It is possible after 24 hpi that the cell 
integrity deteriorates such that the extraction protocol is no longer adequate. Therefore, it 
was necessary to investigate the extent of the time frame post-infection for which the 
extraction protocol works. This will be important for designing experiments to determine 
the dynamics of the endometabolome post-infection to explore whether limitations in the 
endometabolome are implicated in the decline in productivity when insect cells are infected 
at high cell densities. 
Once a baculovirus infects insect cells at a high MOI (e.g. ≥ 5 PFU/cell), the virus 
rapidly takes over the cell metabolism and inhibits cell division at least for group I 
baculoviruses (O'Reilly et al., 1994). The virus quickly replicates inside the cells and shuts 
down many of the cells metabolic pathways and ultimately, the virus kills the cell as early 
as about 48 hpi (Slack and Arif, 2007). For group II baculovirus infections (HearNPV 
infected HzAM1 cells as used in the current study) using Sf900™II medium, it was 
reported that the virus infection process was delayed by about 24 hours or even longer in 
comparison with Sf9 cells infected with an AcMNPV (Lua and Reid, 2000; Pedrini et al., 
2011). Therefore, for a synchronous infection with a high MOI as in the current study, it is 
expected that the cell integrity would be maintained for up to 72 hpi or later compared with 
48 hpi for the Sf9/AcMNPV system (Chapter 4). However, the timing of the HearNPV 
infection in the current study using Sf900™III medium was comparable to that of the group 
I AcMNPV baculovirus with a rapid production between 12-24 hpi for vDNA and 24-72 hpi 
for OB (Fig. 6.1b). This means that the cell integrity may be maintained only until 48-60 hpi 
at the latest. Indeed this is what was observed in the current study, with the intracellular 
ATP level and the ATP recovery over the direct extract dropping quickly after 60 hpi (Fig. 
6.1c) while the intracellular AA levels were reduced significantly at 60 hpi (Fig., 6.7a, b) 
compared to that observed at 48 hpi (most noticeable for aspartate, glutamate and 
glutamine, particularly for the high cell density infection). The drop of intracellular ATP after 
48 hpi was also found for the Sf9/AcMNPV system (Chapter 4) and has been reported 
previously in the literature (Olejnik et al., 2004). 
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It is well known from the literature that for baculovirus insect cell systems, the cell 
specific protein yield drops when the cell density at the time of infection increases. The 
phenomenon, often called the cell density effect has been widely reported in the literature; 
mainly for recombinant baculovirus AcMNPV infected Sf9 or Hi5 cells (Carinhas et al., 
2009; Caron et al., 1990; Chan et al., 2002; Doverskog et al., 2000; Huynh et al., 2013; 
Radford et al., 1997; Taticek and Shuler, 1997; Wong et al., 1996; Yamaji et al., 1999; 
Yang et al., 1996).  There were also limited reports about the cell density effect for HzAM1 
cells infected with a wild-type HearNPV (Chakraborty et al., 1996; Huynh et al., 
unpublished data). This bottleneck is common to different biological systems, especially for 
animal cells (Ferreira et al., 2005; Henry et al., 2005). In a recent study for HzAM1 cells 
infected with a wild-type HearNPV (Huynh et al., unpublished data) it was shown that the 
reduction in cell specific OB yield with increasing ICD was related to a reduction in the 
upstream processes of vDNA replication and polyhedron mRNA transcription. In this 
chapter, the differences in intracellular metabolites as well as the uptake rates of key 
nutrients between low and moderately high ICDs for infected HzAM1 cells has been 
investigated to search for evidence of intracellular metabolic changes that might help 
explain the cell density effect for this cell line/virus system. 
As reported previously (Huynh et al., unpublished data), the specific OB yield 
reduced significantly with the increasing ICD, commencing for infections conducted at cell 
densities above 0.5×106 cells/mL. Therefore, 0.5×106 cells/mL was used as the low ICD in 
the current study. In this study, the specific OB yield also reduced significantly with 
increasing peak cell density (Fig. 6.3). In this case, the ICD of 2×106 cells/mL was chosen 
as the moderately high ICD as the specific OB yield was about 60% of the peak yield at 
0.5×106 cells/mL. Higher ICDs (3 or 4×106 cells/mL) were not chosen as a contrast 
comparison with the low ICD because of the need to add significant amounts of budded 
virus stock at the time of infection (e.g. 50% v/v is required to infect a culture at 8×106 
cells/mL to give a final ICD of 4×106 cells/mL) due to the low titer of HearNPV budded 
virus stocks (typically 2-4×107 PFU/mL at most).  
Prior to investigating changes in intracellular metabolites of infected cultures at low 
and high ICDs, the intracellular nucleotide and AA levels of uninfected cultures at various 
cell densities were investigated. Generally, intracellular nucleotide tri-phosphates (ATP, 
UTP and CTP) decreased significantly with increasing cell density after 1×106 cells/mL 
(Fig 6.4a, b, c). Lower UTP and CTP levels at the high cell density, especially at 8×106 
cells/mL compared to that of 1×106 cells/mL, possibly leads to limitation in supplying 
substrates for nucleic acid synthesis and then protein production, which are already 
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appearing inside the cells at high cell densities in cultures, even before infections are 
initiated. Intracellular AA concentrations also reduced with increasing cell density. These 
results indicate that the cell condition prior to infection differs for cells infected at low and 
high cell densities and this may affect their ability to support high virus yields, especially as 
nucleotide tri-phosphates are the substrates for vDNA and mRNA production. As a result, 
the reduction in the cell specific yield with increasing ICD not only occurs in relation to the 
late stage of protein production but also during virus replication and mRNA transcription as 
described previously for Sf9 cells (Huynh et al., 2013) and HzAM1 cells (Huynh et al., 
unpublished data and this work). 
For infected cultures, the levels of nucleoside tri-phosphates (ATP, UTP and CTP) 
significantly reduced during the post-infection period as well as with the increasing cell 
density (Fig 6.6 a-c), especially for the case of UTP and CTP (Table 6.1). For example, at 
the time of infection, the levels of intracellular ATP, UTP and CTP for the high ICD were 
80, 67 and 61% of those for the low ICD, respectively. The UTP and CTP levels for the 
high ICD dropped to 60-70% of the corresponding levels at the low cell density at 0 hpi 
and the specific vDNA/OB yields also declined by a similar amount for the infection at the 
high cell density compared to that at the low cell density (Fig. 6.3). CTP and UTP are 
precursors for dCTP and dTTP, so the drop in nucleotide concentrations could lead to the 
vDNA and OB drops. This suggests a possible limitation in building blocks for vDNA and 
mRNA production during the time post-infection and when the ICD increases. This result 
was also in agreement with that for infected Sf9 cells where the intracellular nucleoside tri-
phosphates trended to reduce during the time post-infection and with increasing ICD 
(Chapter 4). The nucleoside di- and mono-phosphates were not significantly different or 
tended to increase for high ICDs and at later stages of infection, especially for the case of 
Adenosine (Fig. 6.3a-c) indicating that more energy was used in the case of the high ICD 
or late infection stage, or the cell struggled to maintain energy levels in these cases. This 
may be the result of deterioration of the glycolytic and TCA energy production pathways at 
the late infection stages. It should be noted that the nucleoside di- and mono-phosphates 
were much lower than that for the corresponding tri-phospates (10% or lower in many 
cases), so the accuracy of the quantification of these metabolites will likely be lower (Table 
6.1). 
A similar trend of reduction in concentrations during the time post-infection and with 
increasing ICD was found for other metabolites, especially the TCA cycle intermediates 
including malate (MAL) and fumarate (FUM) (Table 6.1). At the time of infection (0 hpi) the 
intracellular levels of MAL and FUM for the high ICD were only 59 and 40% of those for 
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the low ICD, respectively. α-ketoglutarate (KGA) was found to be significantly higher at the 
low ICD compared with the high ICD investigated for infected Sf9 cells (Chapter 4). In 
addition, Carinhas et al. (2010) claimed that KGA was found to be limiting at high cell 
density infections and the supplement of KGA at the time of infection resulted in an 
improvement of budded virus yields by 6-7 fold. In this study, however, comparison 
between low and high ICDs for the intracellular KGA concentration was not possible due to 
a failure to get accurate data for this metabolite at some time points. The intracellular 
concentrations of pyruvate (PYR) were not different between low and moderately high 
ICDs. It is possible that the lower level of TCA cycle intermediates may contribute to the 
lower yield at the high ICD.  
Generally, the intracellular AA patterns over various times post-infection for low and 
moderately high ICDs of infected HzAM1 cells (Fig. 6.7a, b) were similar to that for 
infected Sf9 cells (Chapter 4). This result was in agreement with previous findings for 
intracellular AA concentrations of infected Sf9 and HzAM1 cells at 24 hpi (Tran et al., 
2012). Comparing intracellular AA concentrations between infected Sf9 and HzAM1 cells, 
the aspatate level of infected Sf9 cells was much lower (about 1/3) than that of infected 
HzAM1 cells. Lysine, an AA required at a relatively high proportion for protein production  
in general (King and Jukes, 1969) and for polyhedrin protein in particular (Cheng et al., 
1998), was found at a very low concentration inside of both infected Sf9 and HzAM1 cells 
although extracellular lysine concentrations remained at relatively high levels (see 
Appendix A4.2). This suggests that there is a difficulty for lysine to get into the cells, or this 
AA is being consumed at a high rate compared to its uptake rate. This may be the first 
limiting AA inside the cells for protein production at both low and high ICDs.  
Although intracellular AA concentrations at the low ICD were higher than those at the 
moderately high ICD, the gaps were narrow and significant differences were only found in 
a few AAs (Fig. 6.7c, d). As a result, there was not a big contrast in OB yield (about 60%) 
between moderately high and low ICDs in this experiment. In contrast, there were 
significant differences in intracellular AA concentrations for most of the AAs between 
moderately high and low ICDs and a large contrast in protein yield between moderately 
high and low ICDs for the case of infected Sf9 cells (Chapter 4). This data overall indicates 
that there may be a link between intracellular AA concentrations and the protein yield of 
infected insect cells. As discussed previously, limitation of intracellular nucleotides with 
increasing ICD might lead to the reduction of vDNA and mRNA levels that were found in a 
previous study for this cell line/virus system (Huynh et al., unpublished data). The 
reduction in intracellular AAs and AA consumption rates with increasing ICD could be the 
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result of poorer AA transport associated with the increasing ICD or it could be the result of 
cell regulation as it is not necessary to have such a high level of AAs inside the cell while 
the capacity for protein synthesis (mRNA level) is limiting. Therefore, the key limiting 
element here is possibly the nucleotides as they are not available in the external medium 
for the cells to take up, and they have to be synthesized inside the cells. 
Unlike intracellular metabolite information that is limited from the literature, the 
measurement of extracellular substrates of uninfected and infected insect cell cultures, 
especially glucose and AAs has been investigated by many research groups. The glucose 
consumption rate for uninfected and baculovirus infected insect cells has been reported 
widely with the majority of the reports relating to Sf9 cell cultures (Bernal et al., 2009; 
Kamen et al., 1996; Radford et al., 1997; Raghunand and Dale, 1999; Rhiel et al., 1997; 
Wong et al., 1994). For HzAM1 insect cells, there have been limited publications 
investigating cell metabolism and substrate consumption rates apart from Lua and Reid 
(2003). The glucose consumption rate for uninfected cultures from the above study in 
Sf900™II medium (12×10-11 mmol/cell/hour) was almost 3 times higher than the current 
study for uninfected cultures propagated in Sf900™III medium (4.34×10-11 mmol/cell/hour) 
(Table 6.2). Discrepancies in cell size, medium (Sf900™II vs Sf900™III) and peak cell 
density obtained (5×106 cells/mL vs 1×107 cells/mL in the current study) are possible 
explanations for the variation in the glucose consumption rates observed. The maltose 
consumption rate of the current study (0.96×10-11mmol/cell/hour) (Table 6.2) was 
comparable with that reported by Lua and Reid (2003) of 1.08×10-11 mmol/cell/hour. 
Calculations based on the cell biomass; glucose consumption rates of uninfected and 
infected HzAM1 cells (Table 6.3) were comparable with those of uninfected and infected 
Sf9 cells (Chapter 4). HzAM1 consumed maltose faster than Sf9 cells (4.19×10-6 mmol/ 
mm3/hour vs 2.80×10-6 mmol/mm3/hour) for uninfected cultures. Therefore, the maltose 
consumption rate at the high ICD (4×106 cells/mL) was minimal (0.79×10-6 mmol/ 
mm3/hour) due to the very low level of maltose available in the medium during the high cell 
density infection (see appendix A4.1 & 4.2). In media containing both glucose and 
maltose, maltose consumption may occur during the early growth phase as evidenced 
from an initial rise in the glucose level and a decline in the maltose concentration by 
Bedard et al. (1993) and Ferrance et al. (1993). 
In comparison with the recombinant AcMNPV infected Sf9 cell system, the HearNPV 
infected HzAM1 cell system has only a limited application as a biopesticide product and 
hence, research on the metabolism for this system is limited in the literature. An initial 
investigation on the metabolism for uninfected HzAM1 cells was conducted previously 
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(Lua and Reid, 2003). Consumption rates of asparagine, glutamate, and glutamine for 
uninfected HzAM1 cells of the current study were comparable with the results reported by 
the above authors. However, the production rate of alanine in the current study was about 
double of that previously reported. Interestingly, HzAM1 cells consumed asparagine at a 
comparable rate to that seen for glutamine for uninfected cultures but at a much higher 
rate for infected cultures at the low ICD but consumption of this AA dramatically reduced 
with increasing ICD (Table 6.2) due to the significant reduction of asparagine 
concentration in the culture medium (see Appendix A4). In contrast, Sf9 cells consumed 
glutamine at a much higher rate than asparagine for both uninfected and infected cultures 
(Chapter 4). Lua and Reid (2003) concluded that HzAM1 cell metabolism is closer to that 
of Hi5 cells than to Sf9 cells. In Hi5 cell cultures, asparagine is rapidly consumed in 
comparison with glutamine (Rhiel et al., 1997; Yang et al., 1996).  
As found for infected Sf9 cells (Chapter 4), within the same ICD, AA consumption 
rates reduced at the late infection stage (18-72 hpi). The reduction in AA consumption 
rates at the late infection stage compared with the early infection stage (0-18 hpi) was 
more severe at higher ICDs (Fig. 6.8). In fact, the gap in AA consumption rates between 
early and late infection stages became larger when the ICD increased from 0.5 to 2 and 
then 4×106 cells/mL. This result possibly indicates that the ability for absorbing substrates 
into the cell reduces with increasing time post-infection and this effect becomes worse in 
combination with an increased ICD. Another explanation is that the reduction in the protein 
production rate at the late infection stage simply requires a lower AA uptake. As a result, 
the reduction in AA consumption rates with increasing ICD were more significant at the 
late infection stage (18-72 hpi) compared with those at the early infection stage (0-18 hpi) 
on both a consumption per cell basis (Fig. 6.9) and on a per biomass basis (Fig. 6.10).  
Unlike infected Sf9 cells (Chapter 4), there was no evidence for a reduction in AA 
uptake efficiency with increasing ICD for infected HzAM1 cells, despite the result of the 
reduction in extracellular AA levels at the high ICD (Fig 6.11). The AA uptake efficiencies 
were comparable between low and moderately high ICDs for infected HzAM1 cells (Fig. 
6.11c, d). 
6.5 Conclusion 
There could be multiple factors involved in the cell density effect phenomenon and it 
seems to be a general behaviour of baculovirus infected insect cell cultures. Among these 
factors, nutrient limitation is believed to be the most important element affecting the cell 
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specific yield when the infection cell densities increase. However, nutrient limitations were 
not related to the exhaustion of macro nutrients in the medium as they are still present at 
high amounts in the used medium and the uninfected cells can grow to a cell density of 2-3 
times higher than at the cell density that displays a significant reduction in cell specific 
yield. Results from the current study show that intracellular nucleotides reduced with an 
increase in cell density for both uninfected and baculovirus infected HzAM1 cells. The key 
issue here might relate to the limitation in intracellular nucleotide levels for high cell density 
infections which may account for the low vDNA and mRNA production levels previously 
reported for high density infections (Huynh et al., 2013). Intracellular nucleoside tri-
phosphates significantly reduced with increasing cell density in uninfected cultures, 
especially for the case of UTP. The reduction of intracellular nucleoside tri-phosphates 
was also found for infected cultures over the time course post-infection. In addition to 
nucleotides intracellular, organic acid levels, TCA cycle intermediates in particular, were 
also found to be lower for high ICDs. 
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Chapter 7 
 
General discussion and 
conclusions  
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The improvement of the yield of the baculovirus-insect cell expression system is a 
major task for commercial viability of the products produced from this system. The 
challenge is that the specific protein yield (per cell basis) drops when cells are infected at a 
high cell density, which is known as “the cell density effect”. Many studies have been 
conducted to identify the limitations that result in the reduction in specific yield at high 
infection cell densities (ICDs), including the measurement of extracellular metabolites to 
identify the limiting nutrients in the medium (Caron et al., 1990; Drews et al., 1995; 
Reuveny et al., 1993), the measurement of consumption rates and fluxomics analysis 
(Bernal et al., 2009).  However, the limitation of these approaches is that the metabolite 
levels in the media might not necessarily reflect intracellular metabolite levels. For many 
reasons, some metabolites may not get into the cells at high cell densities post-infection, 
although they are available at reasonable level in the culture medium. Therefore, the 
metabolite environment inside the cells at low and high cell densities at the time of 
infection provides a better understanding of what happens inside the cells and may reveal 
the cause of the cell density effect. In particular, intracellular metabolite measurements in 
combination with consumption rates of key metabolites may identify limitations during high 
cell density infections. Especially, at the very late phase of infection which involves a high 
level of protein production, it is likely that a high demand for energy and amino acids is 
placed upon the cell, but the cell is entering a death phase at this time and so the uptake 
of nutrients may be compromised.  
In this thesis, we aimed to investigate the intracellular levels of some key metabolites 
at high ICDs in comparison with infections conducted at low ICDs. The analysis of 
intracellular metabolite levels is a potentially useful approach for understanding host cell 
and virus interactions, as well as the response of cells to their environment.  
In order to address the issue regarding possible intracellular limitations during high 
cell density infections, key metabolites involved in the supply of energy and substrates for 
DNA, RNA, and protein synthesis such as intracellular nucleotides and amino acids were 
measured. However, there was no sample preparation protocol for quantitative intracellular 
metabolite analysis available for insect cells at the start of this work. Thus, a methodology 
for quantitative intracellular metabolite analysis of insect cells (for both uninfected and 
infected cases) was developed and optimized (Chapter 3). With this extraction protocol, 
subsequent studies could be designed to investigate whether limitations in the 
endometabolome are implicated in the decline in productivity when insect cells are infected 
at high cell densities. The limitations related to the drop in specific yield for a high cell 
density infection of Sf9 cells in SF900III medium was investigated using a metabolomics 
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approach (Chapter 4). In this chapter, substrate consumption rates as well as intracellular 
metabolite levels of infected cells at low and high cell densities at the time of infection were 
measured and compared between these two infection conditions.  
Ideally, the cells should be cultured using a fully chemically defined medium (CDM) 
for the investigation of extra- and intra-cellular environments. However, a CDM for insect 
cells is not commercially available yet, and the development of such a CDM is beyond the 
scope of a research laboratory. Fortunately, a prototype CDM for insect cell culture was 
made available for testing by Life Technologies. This CDM contains no peptides, and the 
free amino acid levels are higher than those in Sf900™III for most of the amino acids. It is 
interesting to investigate any differences in intracellular metabolite levels of the Sf9 cells in 
the CDM compared to that for cells in Sf900™III, especially for high cell density infections. 
Substrate consumption rates and intracellular metabolite levels of infected cells at low and 
high ICDs were measured and compared between these two infection conditions using the 
available CDM, (Chapter 5), as a comparison to the results obtained in Chapter 4 using 
the commercially available Sf900™III medium. 
Following the investigation of limitations related to the drop in specific yields for high 
cell density infections of Sf9 cells in Sf900™III and CDM media (Chapters 4 & 5), it was of 
interest to investigate limitations related to the decline in cell specific yield with increasing 
ICD for another cell line/virus system, such as the wild-type HearNPV infected HzAM1 
system (Chapter 6). It is interesting to explore whether there are any differences in terms 
of limitations related to the cell density effect between different cell lines infected with 
different viruses when using the same medium for both cell lines.  
In this Chapter, a further discussion of the results, brief summary of the main findings 
of this thesis or conclusions, and recommendations for further studies will be mentioned. 
7.1 Intracellular metabolites extraction procedure for insect cells 
 Protocols for intracellular metabolite extraction and measurement have been 
reported widely for bacteria (Jaki et al., 2006; Winder et al., 2008; Wittmann et al., 2004; 
Wu et al., 2010), yeast (Castrillo et al., 2003; Loret et al., 2007; Villas-Boas et al., 2005a) 
and mammalian cells (Dietmair et al., 2010; Grob et al., 2003; Ritter et al., 2008; Sellick et 
al., 2009; Sellick et al., 2010). To our knowledge, however, no such protocol has been 
validated for insect cell cultures, especially baculovirus infected insect cells. This study 
aimed to develope and validates the extraction protocol for quantitative intracellular 
metabolite analysis of uninfected and baculovirus infected insect cells. Two particular 
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baculovirus applications were tested, representing recombinant protein production (β-Gal-
rAcMNPV in Sf9 cells) and biopesticide production (HearNPV in HzAM1 cells). 
Based on the protocol developed for mammalian cells (Dietmair et al., 2010), this 
extraction procedure has been optimized and validated for insect cells, particularly for 
infected insect cells. As insect cells are propagated in a very rich culture medium, 
especially amino acids (AAs) based on the high AA concentrations of hemolymph 
(Schlaeger, 1996), washing is a critical step in the intracellular metabolite extraction 
procedure for insect cell cultures. The washing step, however, increases the chance of 
intracellular metabolite leakage, especially for infected insect cells, which possess a more 
fragile cell plasma membrane than uninfected ones since the baculovirus infection is a cell 
lytic process (King and Possee, 1992). Therefore, an extra protection needs to be included 
during the quenching and washing procedure. In the current study, the cell protectant, 
Pluronic® F-68 was added into the default saline quenching solution to protect cell 
membranes from leakage of intracellular metabolites. The addition of 0.2% Pluronic® F-68 
into the cold saline quenching solution successfully protected uninfected and infected 
insect cells and minimized the intracellular metabolite leakage during quenching and 
washing steps. The ice-cold saline quenching solution (without Pluronic® F-68) brought 
about only 70% of ATP recovery after one wash step, while the addition of Pluronic® F-68 
into the ice-cold saline quenching solution improved ATP recovery significantly (86%). 
As mentioned above, washing is a critical step in the intracellular metabolite 
extraction protocol because of the rich medium used for insect cell culture, especially for 
AAs. However, the more washing steps, the more chance of intracellular metabolite 
leakage as the cell plasma membrane is exposed to damage through the washing, and 
this is expected to be more severe for the case of infected insect cells. Therefore, a 
compromise is considered between the gain in removal of extracellular metabolites 
attached to the cell membrane and the loss of intracellular metabolites through leakage. 
With a range of washing steps after quenching (0, 1, 2 and 3) investigated in the current 
study, the result shows that one wash post quenching is the most suitable for intracellular 
metabolite extraction of uninfected and baculovirus infected insect cells. 
The intracellular metabolite extraction protocol developed and validated in this study 
has been used successfully for intracellular metabolite analysis of infected Sf9 and HzAM1 
cells at low versus high ICDs. 
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7.2 The role of intracellular metabolite levels on the cell density effect of Sf9/ 
rAcMNPV in SF900™III 
In this study, Sf9 cells infected with a recombinant AcMNPV was first investigated as 
it is an important system for recombinant protein applications. Prior to studying intra- and 
extra-cellular metabolites of low versus high ICDs, a preliminary study was conducted at 
an ICD of 2.5×106 cells/mL to investigate how late post-infection the extraction protocol 
developed above remained efficient for. As a baculovirus infection is a cell lytic process, 
the cell membrane integrity only remains to a certain time post-infection. The result shows 
that for Sf9 cells infected with a rAcMNPV, the intracellular extraction protocol works until 
48 hpi. It means that 48 hpi is the latest time point one can get intracellular metabolite 
concentrations reliably. For Sf9 cells infected with AcMNPV, cell death and lysis 
commences around 48 hpi (O'Reilly et al., 1994; Slack and Arif, 2007). 
Extracellular and intracellular metabolite measurements were conducted in infected 
Sf9 cells at low (2×106) and high (6×106 cells/mL) ICDs. Although previous studies 
indicated that the reduction in protein yield with increasing ICD started as early as 1×106 
cells/mL (Huynh et al., 2013), the ICD of 2×106 cells/mL was selected as a low ICD since it 
is a reasonable cell density for measuring substrate consumption rates and it allows the 
cells to undergo two doubling times prior to infection (seeding cell density at 0.5×106 
cells/mL). Results from the current study confirmed the reduction in cell specific yields with 
increasing ICD not only for protein production but also for viral DNA replication. This 
finding agrees with the study reported previously (Huynh et al., 2013). The reduction in 
protein productivity, when the cell densities at the time of infection increase, might result 
from the upstream limitation of vDNA, which leads to poor mRNA expression (Huynh et al., 
2013). The lower vDNA copy number of the high ICDs compared to that of the low ICDs is 
possibly because of the reduction in intracellular nucleotide concentrations with increasing 
ICD, especially for nucleoside tri-phosphates. This reduction with increasing ICDs was not 
obvious for ATP, but they were clearer for the cases of GTP, CTP and especially for UTP. 
The lower UTP/dUTP levels of the high ICDs compared to the low ICDs might lead to a 
limitation of the dTTP level that would be required for DNA synthesis. As a result, a 
reduction in specific vDNA copies with increasing ICD will result.  Although the uninfected 
culture still doubles at such high cell densities, vDNA production reduces significantly at 
the high ICD in comparison with that at the low ICD. This is reasonable as vDNA 
production by infected cells can exceed that required to duplicate the DNA of the cell 
genome (Huynh et al., 2013; Nguyen et al., 2013). Furthermore, limitations associated with 
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high ICDs were found for the intracellular concentrations of TCA cycle intermediates, 
particularly for KGA and PYR. Through flux balance analysis, Carinhas et al. (2010) found 
that KGA and PYR were limited for high ICDs and a supplement of these substrates into 
the culture medium increased the budded virus yield significantly. However, extra-cellular 
levels of these metabolites were not different between low and high ICDs in the current 
study. In addition, the lower intra-cellular AA concentrations as well as the lower AA 
uptake rates with increasing ICD may reduce protein production rates. However, low 
protein production at high ICDs is most likely determined by low mRNA levels (in turn due 
to low vDNA levels), and not by poor AA uptake rates. AA consumption drops at high 
ICD’s due mainly to less demand for AAs by the cells, not due to a lack of external AAs or 
poor transport of AAs. 
7.3 The role of intracellular metabolite levels on the cell density effect of Sf9/ 
rAcMNPV in CDM 
One of the obvious advantages of using a CDM for metabolomic studies is for 
measuring AA consumption rates as a CDM does not contain peptides that can be used by 
the cells together with free AAs. Therefore, measurements of AA consumption rates for 
cells in a CDM will be more accurate than for cells in a hydrolysate containing medium. 
The prototype CDM used in the current study was developed by Life Technologies 
and was available for trials in the laboratory. Sf9 insect cells grew well in the CDM 
provided (displaying a 24-hour doubling time during the exponential phase) compared to 
their growth in Sf900™III, although the peak cell density of uninfected cultures in the CDM 
was much lower than that in Sf900™III. At a low ICD (1×106 cells/mL) the cell specific β-
Gal yield of infected Sf9 cells in the CDM was slightly better than that in Sf900™III. 
However, with an increasing ICD the cell specific yield reduced for the CDM as seen for 
the Sf900™III medium. 
It seems that the cell metabolism remains stable irrespective of the media used as 
long as they are rich media that support high cell and virus yields. Differences in yield and 
intra-cellular metabolites between low and high ICDs followed similar trends for both cells 
in CDM and Sf900™III media. The main difference between these two media is in the case 
of AA consumption rates. The presence/absence of peptides in the culture media is the 
likely cause for this difference. As the current free AA detection method is unable to 
quantify the consumption of peptides by the cells, it will likely underestimate AA 
consumption rates for cells propagated in peptide containing medium (Sf900™III). 
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7.4 The role of intracellular metabolite levels on the cell density effect of HzAM1/ 
HearNPV in SF900™III 
As found for Sf9 insect cells infected with a recombinant baculovirus (rAcMNPV), the 
HzAM1 insect cells infected with a wild-type baculovirus (HearNPV), which is used for 
biopesticide production, also displayed a reduction in cell specific yields with increasing 
ICD. It is important to investigate the intra and extracellular metabolite patterns between 
low and high ICDs for the HzAM1/HearNPV system to see whether similar metabolic 
patterns are found for different baculovirus/insect cell systems. Prior to conducting 
intracellular metabolite extractions and measurements for low and high ICDs, it was again 
necessary for this cell/virus system to investigate at which time point post-infection the 
extraction protocol developed above remained efficient for. Previous studies showed that 
the timing post-infection for HzAM1 cells infected with a wild-type HearNPV was delayed 
by about 24 hours or even longer in comparison with Sf9 cells infected with a rAcMNPV 
(Lua and Reid, 2000; Pedrini et al., 2011). Therefore, it was expected that the cell 
membrane integrity of infected HzAM1 cells post-infection would be maintained for at least 
24 hours later than that of infected Sf9 cells. However, results from current study as well 
as some recent studies showed that the timing post-infection for infected HzAM1 cells in 
Sf900™III medium was comparable with that for infected Sf9 cells. Consequently, the 
extraction protocol is efficient only until 60 hpi for the case of ATP, and only up to 48 hpi 
for the case of AA measurements for the HzAM1 cell/HearNPV system.  
The reduction in cell specific yield with increasing ICD for infected HzAM1 cells 
commenced as early as the ICD of 0.5×106 cells/mL and at a higher rate than that for 
infected Sf9 cells due to the peak cell density of uninfected HzAM1 in Sf900™III being only 
about half of that for uninfected Sf9 cells in the same medium. Therefore, for infected 
HzAM1 cells, intra- and extra-cellular metabolite studies were conducted at the ICDs of 
0.5×106 and 2×106 cells/mL to represent the low and moderately high ICDs, respectively. 
In addition, being a group II virus with a low virus titer in comparison with the group I 
AcMNPV virus, the ICD of 2×106 cells/mL required a large volume of virus stock to be 
added. Infections at higher cell densities for this system would not be ideal for 
metabolomics studies due to the excessive volume of used media that would be added 
along with the virus inoculum at the time of infection. 
As found for infected Sf9 cells, a reduction in the intracellular nucleoside tri-
phosphates with increasing ICD of the HzAM1cells coincided with the decline in vDNA 
production at the higher ICDs. This potentially then leads to lower mRNA expression levels 
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as the ICD increased, and consequently a reduction in polyhedrin protein yields. The 
substrate limitations for nucleic acid and protein production are already potentially 
appearing inside the cells at high cell densities in cultures, even before infections are 
initiated. Indeed, at the high cell density in culture (8×106 cells/mL), the concentrations of 
UTP and CTP dropped to very low levels in comparison with those at the low cell 
density(1×106 cells/mL), about 2% and 19%, respectively. After infection, the nucleoside 
tri-phosphates (ATP, UTP and CTP) levels of the high ICD significantly reduced compared 
to the low ICD, especially for the case of UTP and CTP. The UTP and CTP levels for the 
high ICD dropped to 60-70% of the corresponding levels at the low cell density at 0 hpi 
and the specific vDNA/OB yields also declined by a similar amount for the infection at the 
high cell density compared to that at the low cell density. CTP and UTP are precursors for 
dCTP and dTTP, so the drop in nucleotide concentrations probably leads to the vDNA and 
OB reduction. This suggests a possible limitation in building blocks for vDNA and mRNA 
production during the time post-infection and when the ICD increases. This result was also 
in agreement with that for infected Sf9 cells where the intracellular nucleoside tri-
phosphates trended to reduce during the time post-infection and with increasing ICD 
(Chapter 4). Moreover, there were signs of a reduction in some TCA cycle intermediates 
with increasing ICDs. These reductions with increasing ICD might contribute to the 
reduction in specific protein/OB yield at the high ICD. There was no significant difference 
in the intracellular AA or ATP/total adenosine levels between the low and moderately high 
ICDs for this system.  In addition, there was no evidence for a reduction in AA uptake 
efficiency with increasing ICD for infected HzAM1 cells. Generally then, it can be 
concluded that the AA and energy supply is not limiting at high ICDs for the HzAM1 
cell/HearNPV system. 
7.5 Summary of the main findings or conclusions 
The main findings of the thesis are summarized as follows. Firstly, an intracellular 
metabolite extraction protocol has been optimized and validated for insect cell cultures, 
especially for infected insect cells. In the method development process, an ice-cold saline 
quenching solution used for mammalian cells was shown to be inefficient for insect cell 
cultures, especially infected insect cells. The addition of Pluronic F-68 helped to protect 
cells during the quenching and washing procedure and improved the extraction efficiency. 
In addition, one washing step after quenching was found to be optimal for the intracellular 
metabolite extraction of insect cell cultures, which are propagated in a rich media 
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(containing high AA levels). Once the extraction protocol had been validated, the protocol 
was then used for the analysis of intracellular metabolite concentrations at low versus high 
ICDs in order to investigate discrepancies related to the cell density effect. 
The extraction protocol developed above was only initially investigated for infected 
insect cells (both Sf9 and HzAM1 cell lines) up until 24 hpi. Therefore, the extraction 
protocol was investigated over the time course post-infection prior to measuring 
intracellular metabolite concentrations of low vs. high ICDs as infected insect cells undergo 
a cell lytic process and start to die at a certain time period after infection. It was then 
confirmed that it is possible to extract intracellular metabolites of infected insect cells (both 
Sf9 and HzAM1) up to 48-60 hpi using the one washing protocol developed above. 
Reductions in intracellular metabolites and consumption rates were found with 
increasing ICDs. A limitation in intracellular nucleotides, especially the tri-phosphate forms 
may be a key factor in the reduction of vDNA and mRNA production with increasing ICDs 
which was found recently (Huynh et al., 2013). This might in turn lead to the reduction in 
protein yield with increasing ICDs. The reduction in intracellular AA concentrations and AA 
consumption rates with increasing ICDs likely result from the reduction in protein 
production at the high ICDs since there is no clear sign of AA limitations from the 
extracellular environment. In addition, the supply of energy seems to be not limiting at high 
ICDs as the level of ATP/total adenosine does not significantly decrease compared to that 
at low ICDs.  
Two insect cell lines, Sf9 cells infected with a recombinant AcMNPV and HzAM1 cells 
infected with a wild-type HearNPV, behave in the same way with the increase in ICD in 
terms of reduction in protein/OB yield, reduction in intracellular metabolites (nucleotide tri 
phosphates, AAs) and reduction in AA consumption rates. Reduction in these parameters 
with increasing ICDs is the result of a combination of the reduction at the time of infection 
and reduction during the infection process. In addition, the use of a CDM is valuable for 
measuring the AA consumption rates as the consumption of peptides is not taken into 
account when a peptide containing medium is used. 
7.6 Recommendations and remarks for future works 
7.6.1 Investigation of the limitation in intracellular nucleotides of uninfected Sf9 
cells at high cell densities 
It would be useful to investigate whether there is a drop in intracellular nucleotide tri-
phosphate levels of the Sf9 cells in culture with increasing cell densities as found for the 
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HzAM1 cells in this study. For example it would be useful to know if UTP drops to very low 
levels as the cells approach their peak cell density as seen for HzAM1 cells in Fig. 6.4b. 
7.6.2 Development/optimization of a method for measuring the dNTPs in insect cells 
It would be useful to develop/optimize a method to measure deoxyribonucleotides 
(dRNs), especially dNTP levels in infected insect cells at low and high cell densities and 
also in uninfected cells as they reach their peak cell density. These levels would be useful 
to understand the role of nucleotide supply in limiting baculovirus vDNA yields. 
It is known that the deoxyribonucleotides (dRNs) are generally essential metabolites 
that play an important role in a broad range of key cellular functions. There is a limitation of 
studies done to determine the intracellular dRN pools because of the relatively low levels 
of dRNs present in most cells. In addition, it is not easy to separate them from the more 
abundant ribonucleotides (Zhang et al., 2011). Many research groups have tried to 
develop a method for quantifying endogenous nucleotides generally or deoxy-
ribonucleotide triphosphates (dNTPs) in particular (Hennere et al., 2003; Shewach, 1992). 
However, there are some limitations related to these approaches including a complexity of 
sample preparations.  
7.6.3 Supply of nucleotides to the culture medium 
If it is confirmed by some additional work that nucleotide supply is the bottle neck 
leading to the cell density effect, it is worth supplying these substrates to the culture 
medium in order to investigate whether they are able to improve the yield during high 
density infections.   
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1. Introduction 
As metabolites turnover rapidly (de Koning and van Dam, 1992), the most critical 
step in the intracellular metabolite extraction procedure is stopping the cell metabolism to 
preserve the metabolic stage of cells at the point of sampling. Therefore, the cells need to 
be quenched before extracting intracellular metabolites, and it should be performed as 
quickly as possible. In order to achieve a quick quenching step, a sufficient amount of 
culture should be used and poured directly into the quenching solution as soon as it is 
taken out of the incubator. This step can be performed very quickly using 50-mL tube 
bioreactors. 
Increasing culture throughput for bioprocess development has become progressively 
important to rapidly screen and optimize process parameters (Chen et al., 2009; Micheletti 
et al., 2006; Puskeiler et al., 2005). Traditionally, shake flasks and spinner flasks have 
been used to screen large numbers of clones, cell lines and experimental conditions (Chen 
et al., 2009; Doig et al., 2006). In recent years, a number of high throughput systems have 
been developed and reported in the literature including shake flasks, tubes, bubble 
columns, stirred tank bioreactors and shaken microplates (Betts and Baganz, 2006; Kumar 
et al., 2004). 
The application of 50-mL tube bioreactors with a working volume from 5ml to 20ml, 
usually 20% of the total volume of the test tube, (Kumar et al., 2004), is a further scaling 
down step compared with the current widely used system of shaker flasks in dealing with 
the large number of cultures required for medium optimization processes. The tube culture 
system was developed by De Jesus et al. (2004), and this work confirmed the usefulness 
of this system for CHO cells. The main advantage of 50-mL tube bioreactors is the scaling 
down of the system, while still providing enough sample volume for further analysis and 
minimizing evaporation problems (Betts and Baganz, 2006; de Jesus et al., 2004; Jordan 
and Jenkins, 2007). Tube cultures are able to mimic large scale vessel behaviour, as the 
results discovered from 50ml tube bioreactors can be fitted into the “real” condition found 
in large scale bioreactors (de Jesus and Wurm, 2009). Recently, 50ml tube bioreactors 
have been applied widely for work with mammalian cell cultures. Xie et al. (2011) reported 
the successful application of TubeSpin reactors for Sf9 insect cells infected with a 
baculovirus. 
The aim of this work is to optimize culture conditions for insect cells using high 
throughput 50-mL tube bioreactors. This step was conducted prior to developing the 
method for quenching and extraction of intracellular metabolites of cultured insect cells to 
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investigate the growth of insect cells in tube cultures. The advantage of tube cultures is 
that it allows conducting the quenching process quickly by pouring immediately the culture 
in each tube into a cold quenching solution. Since the working volume of a tube culture 
can be set up at 10 mL, this volume is sufficient for one intracellular extraction sample. As 
the whole culture can be sacrificed for analysis, sampling and quenching is achieved very 
rapidly (within seconds). The growth of cells in 50-mL tubes was tested for both HzAM1 
and Sf9 cell lines compared with shaker flasks as controls. 
2. Materials and methods 
2.1 Cell lines, viruses and medium 
There were two continuous insect cell lines used in this study. The first cell line was 
Helicoverpa zea (BCIRL-HzAM1), which was derived from the pupal ovarian tissue of H. 
zea (Lepidoptera: Noctuidae) (McIntosh and Ignoffo, 1981). The second insect cell line 
was Spodoptera frugiperda clone 9 cell-line (Sf9; ATCC CRL 1711), which was derived 
from the ovarian tissue of several fall armyworm pupae (Spodoptera frugiperda) (Vaughn 
et al., 1977). Details of the cell line and stock cell maintenance are described in Chapter 2 
of this thesis. 
The wild type baculovirus of Helicoverpa armegia single nucleopolyhedra virus 
(HearNPV) was used to infect the HzAM1 cell line, while the recombinant Autographa 
californica multiple nucleopolyhedrovirus which expresses the Escherichia coli LacZ gene 
(rAcMNPV) was used to infect Sf9 cell line. Details of virus isolates and virus stock 
preparation are described in Chapter 2 of this thesis. 
 Sf900™II serum free medium (Life Technologies) was used for insect cell 
propagation. 
2.2 Tube culture 
Standard 50-mL centrifuge tubes (TPP, Trasadingen, Switzerland) were obtained 
from Lomb Scientific Australia and used for cell culture. Such a high-throughput culture 
system allows large multiple-run experiments being carried out with efficient use of 
resources and labor (de Jesus et al., 2004). This is a modified 50-mL centrifuge tube with 
a conical bottom and a ventilated cap with a filter. The ventilated cap contains 5 different 
filtered ventilation holes of different sizes from 0.5 mm in diameter (smallest) to 2 mm 
diameter (largest). Tubes were stacked into racks mounted on a rotational shaker platform 
(Thermo Fisher Scientific, USA) with an orbital throw of 25 mm. The set up was installed in 
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a refrigerated incubator for temperature control at 28oC. In all experiments, cultures in 125 
ml shaker flasks (Corning Incorporation, USA) with a working volume of 25 ml were used 
as the control. 
2.3 Experimental procedure 
2.3.1 Optimization of 50-mL tube culture for HzAM1 insect cell line 
A series of preliminary experiments were conducted to evaluate evaporation rate, 
and screening for the optimal agitation range for insect cell cultures. The evaporation test 
over 7 days was conducted with 50-mL tube cultures using a 10 mL working volume and 
shaking speed of 250 rpm, while the shaker flask culture control was set at 25 mL working 
volume and shaking speed of 120 rpm. In the preliminary experiment for screening of 
agitation speeds, insect cell growth in the 50-mL tube culture was first tested at 300 rpm 
with a seeding cell density of 0.5×106 cell/mL. Later on, the shaking speed of 250 rpm was 
tested with a range of working volumes of 5, 7.5, 10 and 20 mL and two different seeding 
cell densities of 0.5×106 and 1×106 cells/mL. Shaker flask cultures were used as a control 
and were set up at 25 mL, 120 rpm. Experiments were performed in triplicates. 
In order to evaluate concurrently the agitation speed and working volume of insect 
cell growth in 50 ml tube bioreactors, a 2×3 factorial experiment was conducted. In this 
experiment, insect cells grown in 50 ml tube bioreactors were tested at 2 agitation speeds: 
220 and 250 rpm and 3 working volumes: 7.5, 10 and 20 ml. All treatments were done in 
triplicate. Seeding cell density for this experiment was at 0.5×106 cells/ml. Cultures were 
prepared in a shaker flask and then aliquoted into tubes of different working volumes as 
per the trial design. Three 125 ml shaker flasks with a working volume of 25 mL were also 
set up as the control. The total cell density of cultures over 7 days was estimated daily 
using the Multisizer™4 Coulter Counter.  
To optimize the culture conditions for baculovirus infected HzAM1 cells in 50-mL 
tube bioreactors, an experiment was conducted at two infection cell densities (ICDs) of 
0.5×106 and 1×106 cells/mL and three working volumes of 7.5, 10 and 20 mL at an 
agitation of 250 rpm. Infections were conducted at a multiplicity of infection (MOI) of at 
least 6 PFU/cell. Experiments were conducted in triplicate. Shaker flask cultures (in 
triplicate) were also conducted at the two ICDs mentioned above at a working volume of 
25 ml. Volumetric and specific OB yields of infected cultures in 50-mL tube bioreactors 
were compared with that of the control of infected cultures in shaker flasks. 
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2.3.2 Optimization of 50-mL tube culture for Sf9 insect cell line 
The growth of Sf9 cells in 50-mL tube bioreactor was first investigated at the 
agitation of 220 rpm and 10 mL working volume as this was shown to be optimal for the 
HzAM1 cell line. Triplicate cultures were used for each treatment. Shaker flask cultures (in 
triplicate) at 120 rpm, 25 mL working volume were used as the control. As Sf9 cells in 50-
mL tube cultures did not grow as well as those in shaker flask cultures, another experiment 
was conducted at a range of shaking speeds of 200, 220, 240 and 260 rpm and working 
volume of 10 mL for Sf9 cells in 50-mL tube bioreactors. Again, shaker flask cultures at 
120 rpm, 25 mL working volume were also used as the control. All treatments were 
conducted in triplicates. 
 
2.4 Assays 
Total cell density and total cell volume of all experiments were measured using a 
Multisizer™4 Coulter Counter (Beckman Coulter Inc., Fullerton, CA, USA). The cell 
viability was estimated using Typan Blue exclusion method. Details for cell enumeration 
and cell viability estimation are described in Chapter 2.  
Baculovirus occlusion bodies (OBs) were extracted from infected cells using SDS 
digestion, and were enumerated via microscopy using a hemocytometer, as described in 
Chapter 2 of this thesis. The OB count for each sample was conducted in technical 
triplicates. 
3. Results and discussion 
3.1 Optimization of 50-mL tube culture for HzAM1 insect cell line 
The evaporation loss of cultures in 50-mL tubes and shaker flasks is presented in 
Fig. A1.1. The absolute amount of liquid loss during the culture time was similar in the 
tubes and shaker flasks. Since the working volume of the shaker flask was more than 
twice as much as that of the tube culture, the relative liquid loss over the initial volume of 
the tube culture (10 mL working volume) was nearly double of that of the shaker flask 
culture (25 mL working volume). Nevertheless, the relative liquid loss through evaporation 
in tube culture was in an acceptable range, 6.2% over 7 days of culture (Fig. A1.1). The 
low evaporation rate of 50-mL tube cultures makes them a useful tool for media 
optimization when dealing with slow-growing animal cells (Betts and Baganz, 2006). 
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Fig. A1.1 Evaporation loss of cultures of HzAM1 insect cells in 50-mL tube bioreactors at an 
agitation of 250 rpm and 10 mL working volume versus shaker flasks at 120 rpm and 25 mL 
working volume. The experiment was conducted in biological triplicates and the error bars are 
standard deviations of the triplicates. 
The 50-mL tube culture was first applied for mammalian cell culture by de Jesus et al. 
(2004) with a shaking speed of 200 rpm. Since then, 50-mL tube cultures have been used 
widely for mammalian cell culture with a common shaking speed set at 270 rpm for CHO 
cells. Initially, it was thought that insect cells required more oxygen than CHO cells (given 
their larger size) and thus, the shaking speed for insect cells in tube cultures should be 
higher. Consequently, a shaking speed of 300 rpm was first set up for testing insect cell 
growth in 50 ml tube cultures. The cell density and viability of HzAM1 cell cultures in 50-
mL tube bioreactors, grown at the agitation speed of 300 rpm is shown in Fig. A1.2. The 
total cell density (TCD) after 24 hours in the tube and shaker flask were similar. However, 
the TCD of the tube culture was far below that of the shaker flask culture at later times 
post-inoculation. At 120 hours, the TCD of the culture in the shaker flask was close to 
8×106 cells/mL, while the TCD of the culture in the 50-mL tube was only around 5×106 
cells/mL. There was no difference in the viability of the insect cell cultures grown in the 50-
mL tube and the shaker flask up to 72 hours post-inoculation. Then, the cell viability in the 
50-mL tube cultures significantly reduced after that point (Fig. A1.2). This result shows that 
the agitation speed of 300 rpm was not suitable for cultures of the HzAM1 cell line in 50-
mL tube bioreactors. 
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Fig. A1.2 Total cell density and viability of HzAM1 insect cell culture growth in 50-mL tube 
bioreactors at 10 mL working volume and 300 rpm agitation versus shaker flasks at 25 mL working 
volume and 120 rpm agitation. Experiment was conducted in biological triplicates and the error 
bars are standard deviations of the triplicates. 
The growth of HzAM1 insect cells in 50-mL tube bioreactors was investigated further 
at the lower agitation speed of 250 rpm and at various working volumes of 5, 7.5, 10 and 
20 mL at the seeding cell density of 0.5×106 cells/mL. Result in Fig. A1.3a shows that 
there was no significant difference among treatments in terms of the total cell density 
(TCD), except for the lowest working volume in 50-mL tube bioreactors (5 mL). The TCD 
of uninfected HzAM1 cells in tube cultures was similar to that in the shaker flask control; 
except for the case of the tube culture at a 5 mL working volume where the TCD was 
significantly lower than the other cases (Fig. A1.3a). The TCD of uninfected cells in tube 
cultures at a 20 mL working volume was slightly lower than those in tube culture volumes 
of 7.5 and 10 mL working volumes and the shaker control. Cell growth in the tube culture 
at a working volume of 7.5 ml was as good as the 10 mL case. If the working volume is too 
low (5 mL) or too high (20 mL) then the tube culture does not support cell growth as well 
as the shaker control. For the total cell volume (TCV), Fig. A1.3b shows that TCV of tube 
cultures at a working volume of 7.5, 10 and 20 mL were similar to that of the shaker flasks. 
However, the TCV of uninfected HzAM1 cells in 50-mL tube bioreactors at a low working 
volume (5 mL) was significantly lower than the other cases. From this preliminary 
experiment, it can be concluded that the HzAM1 insect cell line can grow well in 50-mL 
tube bioreactors at an agitation speed of 250 rpm and a working volume of 7.5 to 10 mL. 
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Fig. A1.3. Total cell density (a) and cell volume (b) of HzAM1 insect cell cultures seeded at 5×105 
cells/mL and grown in 50-mL tube bioreactors at 250 rpm and at the indicated working volumes 
versus shaker flasks at 120 rpm and 25 mL working volume. All values represent the average of 
the three biological replicates, and the error bars indicate the standard deviation of the biological 
triplicates. 
The cell growth results of a final tube optimization experiment, in which two different 
agitation speeds (220 and 250 rpm) was tested against three working volumes (7.5, 10 
and 20 mL) are shown in Fig. A1.4. In this case, there was no difference in the TCD 
(Fig.A1.4a) and TCV (Fig. A1.4b) between insect cell cultures in tubes and shaker flasks 
for all conditions investigated. In 50-mL tube bioreactors, the TCD and TCV of the cultures 
at the two different shaking speeds of 250 and 220 rpm were similar. 
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Fig. A1.4. Total cell density (a) and cell volume (b) of insect cell cultures seeded at 0.5×106 
cells/mL, grown in 50-mL tube bioreactors at 220 and 250 rpm (at the indicated working volumes) 
vs shaker flasks at 120 rpm and 25 mL working volume. All values represent the average of the 
three biological replicates, and the error bars indicate the standard deviation of the biological 
triplicates 
In summary, the result in Fig. A1.1 indicates that evaporation rates by tube cultures 
are within acceptable levels, (10 mL working volume, 250 rpm). Fig. A1.2 shows that 
excessive mixing (10 mL working volume, 300 rpm), results in poor cell growth. Fig. A1.3 
indicates that 7.5 to 10 mL is the best working volume for tube cultures (seeded at 0.5×106 
cells/mL, 250 rpm), while too low (5 mL) or too high (20 mL) a working volume of cultures 
produce a less optimal result. Fig. A1.4 indicates that 220 rpm is as good as 250 rpm for 
7.5 and 10 mL cultures in 50-mL tube bioreactors. This figure shows that a 20 mL working 
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volume is also good for tube cultures, but when considering all the data together, it is 
advisable to work with 7.5-10 mL culture volumes. 
Kumar et al. (2004) concluded that the best working volume for 50-mL tube 
bioreactors was from 5 mL to 20 mL and the most suitable working volume was usually 
20% of the total volume of the test tube. It could be concluded from this work (Fig. A1.1-4) 
that a shaking speed of 220 to 250 rpm and a working volume of 7.5 to 10 mL are the most 
suitable for HzAM1 insect cell growth in 50-mL tube bioreactors. 
The results above showed that uninfected HzAM1 insect cells grow well in 50-mL 
tube bioreactors at a shaking speed of 220 rpm and a working volume of 7.5 to 10 mL. At 
this agitation speed, however, baculovirus infected HzAM1 insect cells clumped and 
precipitated on the bottom of the tube. Therefore, 250 rpm was chosen for infected 
cultures in 50-mL tubes. 
Volumetric and specific OB yields of infected cultures in 50-mL tube bioreactors at 
250 rpm and various working volumes of 7.5, 10 and 20 ml are shown in Fig. A1.5. The 
cell density increase post-infection for the case of infected cells in 50-mL tube bioreactors 
at the 7.5 and 10 mL working volumes and the shaker flask control was in the range of 76-
93% and 64-82% for the infection cell density (ICD) of 0.5×106 and 1×106 cells/mL, 
respectively. There was no difference in cell density increase post-infection and the 
average cell volume between tube cultures at 7.5 and 10 mL working volumes and the 
shaker culture (Fig. A1.5a). For the case of infected cultures in 50-mL tube bioreactors at 
the working volume of 20 mL, the cell density decreased post-infection (Fig. A1.5a). At the 
high working volume (20 mL) in 50-mL tube cultures, infected cells were found to 
precipitate in the bottom of the tube. Hence, the cell population reduced, presumably as 
there was not enough oxygen for the precipitated cells. This result indicates that a 20 mL 
working volume in 50-mL tube cultures is too much to allow proper mixing of the infected 
HzAM1 cells. At this high working volume, infected cells clumped and settled on the 
bottom of the tube as the 250 rpm shaking speed was not enough to keep the virus 
induced clumped cells in suspension for such a high volume in the tube culture. The 
average cell volume of infected cultures at an ICD of 0.5×106 cells/mL was larger than that 
at an ICD of 1×106 cells/mL (Fig. A1.5a). The larger cell volume resulted in a higher cell 
specific yield (Fig A1.5a, b). Generally, however, there was no difference in the OB yield of 
infected cells grown in shaker flasks or in 50 ml tube bioreactors at 250 rpm with a working 
volume of 7.5 or 10 mL (Fig. A1.5b). The specific OB yield for cultures at an ICD of 
0.5×106 cells/mL were higher than that at an ICD of 1×106 cells/mL as found for the 
average cell volume. 
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Fig. A1.5. Total cell density and average cell diameter (a) and volumetric and specific OB yields 
(b) of infected HzAM1 insect cell cultures in 50-mL tube bioreactors at 250 rpm (at the indicated 
working volumes) vs shaker flasks at 120 rpm, 25 ml working volume. Two infection cell densities 
(ICDs) were used of 0.5×106 and 1×106 cells/mL. Infections were conducted at a multiplicity of 
infection (MOI) of at least 6 PFU/cell using the supernatant of P2 virus stock. All values represent 
the average of the three biological replicates, and the error bars indicate the standard deviation of 
the biological triplicates 
3.2 Optimization of 50-mL tube culture for Sf9 insect cell line 
As found above, HzAM1 insect cells can grow well at the shaking speed of 220 rpm 
and 10 mL working volume. Therefore, the cell growth of uninfected Sf9 cells in 50-mL 
tube bioreactors was tested at this agitation and working volume and the result is 
presented in Fig. A1.6. Unlike HzAM1 cells, Sf9 cells did not grow well in 50-mL tube 
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bioreactors. Cell growth in 50-mL tubes seemed to be similar to that of the shaker flasks 
over the first day. After that however the total cell density in 50-mL tube cultures increased 
only slightly, while cells nearly doubled every day, as normal, in shakers (Fig. A1.6). The 
viability of cells in 50 ml tube cultures also dropped quickly, while they remained at a high 
level in shaker flask cultures. Although Sf9 cells seemed to double over the first day in 50-
mL tube cultures, these cells already were likely to be in a suboptimal condition and this 
would not be suitable for intracellular metabolite studies.  
 
Fig. A1.6 Total cell density (TCD) and viability of uninfected Sf9 cells grown in 50-mL tubes at 220 
rpm, 10 ml working volume, and in shaker flasks at 120 rpm and 25 ml working volume. The 
seeding cell density was at 0.5×106 cells/mL using SF900II medium. All values represent the 
average of three biological replicates, and the error bars indicate the standard deviation of the 
biological triplicates. 
A further investigation was conducted under the wide range of shaking speeds of 
200, 220, 240, and 260 rpm for growing Sf9 cells in 50-mL tube bioreactors and the result 
is shown in Fig. A1.7. The result here indicates that 50-mL tube bioreactors seem to be not 
suitable for Sf9 insect cells as no response was found with different shaking speeds. 
However, Xie et al. (2011) reported that Sf9 insect cells grew well in 50-mL tube 
bioreactors at an agitation of 200 rpm and 10 mL working volume where the cell viability 
was maintained over 90% and the uninfected cell grew up to 1.6×107 cells/mL in Sf900™II 
medium. The reason why the Sf9 cells in the current study did not grow in 50-mL tube 
cultures is unclear.  
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Fig. A1.7 Total cell density (TCD) of uninfected Sf9 cells grown in 50 ml tubes (10 mL working 
volume) at different shaking speeds of 200, 220, 240 and 260 rpm and in shaker flasks (25 mL 
working volume, 120 rpm). The seeding cell density was at 0.5×106 cells/mL using SF900II 
medium. All values represent the average of three biological replicates, and the error bars indicate 
the standard deviation of the biological triplicates. 
4. Conclusions 
The high throughput means of 50-mL tube bioreactors are useful for the process of 
screening and optimization of cell culture conditions as they allow more replication of 
treatments using the same amount of lab resources (incubator space, medium), while 
providing sufficient culture volumes for sampling. Tube cultures also provide an 
opportunity for quick handling of intracellular metabolite quenching and extraction 
processes as the addition of quenching solution and centrifugation can be done using the 
same tube for cell culture. Therefore, if insect cells can grow well in 50-mL tube 
bioreactors as mammalian cells do, it provides a good opportunity for the intracellular 
metabolite extraction protocol to be performed in a quick and accurate manner. Results 
from the current study confirm that 50-mL tube bioreactors can support both uninfected 
and infected HzAM1 insect cells where the cell growth and baculovirus yield were as good 
as found in shaker flask controls. Therefore, 50-mL tube bioreactors can be used for 
intracellular metabolite studies for this insect cell line. In contrast, the Sf9 insect cell 
population used in these studies did not grow well in 50-mL tube bioreactors under the 
conditions employed, despite a previous report indicating Sf9 cells can grow well in tube 
cultures. For this case, therefore, shaker cultures should be used for intracellular 
metabolite extraction studies for Sf9 cells of both uninfected and infected cultures. 
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Appendix 2:  
Glucose and amino acid 
concentrations post-infection/ 
inoculation - Sf9/AcMNPV system 
in Sf900™III medium
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Fig. A2.1 Glucose, alanine, glutamate, glutamine, aspatate and asparagine concentrations at 
various times post-infection/inoculation for the infected and uninfected Sf9 cell/rAcMNPV system in 
Sf900™III medium. Infection cell densities (ICDs) investigated included a low (2×106 cells/mL) and 
a high (6×106 cells/mL) ICD by seeding a culture at an initial cell density of 0.5×106 cells/mL letting 
them grow and then infecting at different times post-inoculation to obtain the targeted ICDs. 
Infections were conducted at an MOI of 10 PFU/cell. The uninfected culture was set up at a 
seeding cell density of 0.5×106 cells/mL and left to grow until the peak cell density was obtained. 
The experiment was conducted in shaker-flask suspension cultures. Each data point is the average 
from three biological replicates, and the error bars represent the standard deviation. 
 
 
212 
 
 
Fig. A2.2 Maltose and various amino acid concentrations at various times post-infection/ 
inoculation for the infected and uninfected Sf9 cell/rAcMNPV system in Sf900™III medium. 
Conditions were as for Fig. A2.1. 
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Appendix 3:  
Glucose and amino acid 
concentrations post-infection/ 
inoculation - Sf9/AcMNPV system 
in chemically defined medium 
(CDM)
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Fig. A3.1 Glucose, alanine, glutamate, glutamine, aspatate and asparagine concentrations at 
various times post-infection/inoculation for the infected and uninfected Sf9 cell/rAcMNPV system in 
CDM. Two infection cell densities (ICDs) were investigated including a low (1×106 cells/mL) and a 
high (5×106 cells/mL) ICD by seeding a culture at an initial cell density of 0.5×106 cells/mL, letting 
them grow and then infecting them at various times post-inoculation to obtain the targeted ICDs. 
Infections were conducted at an MOI of 10 PFU/cell. The uninfected culture was set up at a 
seeding cell density of 0.5×106 cells/mL and left to grow until the peak cell density was obtained. 
The experiment was conducted in shaker-flask suspension cultures. Each data point is the average 
from three biological replicates, and the error bars represent the standard deviation. 
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Fig. A3.2 Maltose and various amino acid concentrations at various times post-infection/ 
inoculation for the infected and uninfected Sf9 cell/rAcMNPV system in CDM. Conditions were as 
for Fig. A3.1. 
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Appendix 4:  
Glucose and amino acid 
concentrations post-infection/ 
inoculation - HzAM1/HearNPV 
system in Sf900™III medium 
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Fig. A4.1 Glucose, alanine, glutamate, glutamine, aspatate and asparagine concentrations at 
various times post-infection/inoculation for the infected and uninfected HzAM1 cell/HearNPV 
system in Sf900™III medium. Various infection cell densities (ICDs) were investigated including 
0.5, 2 and 4×106 cells/mL by seeding a culture at an initial cell density of 0.5×106 cells/mL, letting 
them grow and then infecting them at various times post-inoculation to obtain the different ICDs. 
Infections were conducted at an MOI of 5 PFU/cell. The uninfected culture was set up at a seeding 
cell density of 0.5×106 cells/mL and left to grow until the peak cell density was obtained. The 
experiment was conducted in shaker-flask suspension cultures. Each data point is the average 
from three biological replicates, and the error bars represent the standard deviation. 
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Fig. A4.2 Maltose and various amino acid concentrations at various times post-infection/ 
inoculation for the infected and uninfected HzAM1 cell/HearNPV system in Sf900™III medium. 
Various infection cell densities (ICDs) have been investigated including 0.5 (), 2 () and 4 () 
×106 cells/mL. Conditions were as for Fig. A4.1.  
 
 
